fluconazole has been researched along with Candida Infection in 1963 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether Candida glabrata colonization and invasive candidiasis (IC) increased among critically ill surgical patients 3 years after the introduction of fluconazole prophylaxis to a surgical intensive care unit (SICU)." | 9.14 | The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. ( Colantuoni, EA; Fothergill, AW; Hendrix, CW; Lipsett, PA; Magill, SS; Merz, WG; Shields, CE; Swoboda, SM, 2009) |
| "This multicenter, randomized, evaluator-blinded study of subjects with HIV infection and oropharyngeal candidiasis compared efficacy of posaconazole with that of fluconazole." | 9.12 | A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. ( Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA, 2006) |
| "We evaluated the efficacy and safety of oral posaconazole for human immunodeficiency virus (HIV)-infected subjects with oropharyngeal candidiasis (OPC) and/or esophageal candidiasis (EC) who were clinically refractory to treatment with oral fluconazole or itraconazole." | 9.12 | Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. ( Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D, 2007) |
| " We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority trial of treatment for invasive candidiasis." | 9.12 | Anidulafungin versus fluconazole for invasive candidiasis. ( Betts, R; Chapman, SW; Goldstein, BP; Kett, DH; Krause, DS; Kumar, D; Pappas, PG; Reboli, AC; Rotstein, C; Schranz, J; Walsh, TJ; Wible, M, 2007) |
| " This randomized, double-blind, double-dummy study compared the efficacy and safety of intravenous anidulafungin to that of oral fluconazole in 601 patients with endoscopically and microbiologically documented esophageal candidiasis." | 9.11 | A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. ( Goldstein, BP; Henkel, T; Krause, DS; Simjee, AE; van Rensburg, C; Viljoen, J; Walsh, TJ; Wible, M, 2004) |
| "A total of 245 patients (age, > or =18 years) with a prior diagnosis of acquired immunodeficiency syndrome/human immunodeficiency virus (HIV) infection and esophageal candidiasis, confirmed by endoscopy and culture, were randomized to receive micafungin (50, 100, or 150 mg per day) or fluconazole (200 mg per day)." | 9.11 | A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. ( Baraldi, E; de Wet, N; Della Negra, M; Diekmann-Berndt, H; Krantz, EF; Llanos-Cuentas, A; Suleiman, J, 2004) |
| " intravenous fluconazole in the treatment of oesophageal candidiasis." | 9.11 | A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. ( Bester, AJ; Buell, D; de Wet, NT; Filho, F; Fisco, C; Lau, W; Llanos, EA; Suleiman, JM; Ticona, E; Viljoen, JJ, 2005) |
| "We tested the hypothesis that twice weekly prophylactic dosing of fluconazole prevents invasive candidiasis without promoting resistant Candida species in high-risk, preterm infants." | 9.11 | Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. ( Boyle, R; Grossman, LB; Hazen, KC; Kaufman, D; Patrie, JT; Robinson, M, 2005) |
| "Caspofungin is a new echinocandin drug with comparable in vitro activity against azole-susceptible and -resistant isolates of that could provide a less toxic alternative to amphotericin B for the management of esophageal candidiasis with clinical or laboratory evidence of decreased susceptibility to fluconazole." | 9.10 | Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole. ( Bartizal, K; DiNubile, MJ; Hicks, PS; Kartsonis, N; Ryan, D; Sable, CA, 2002) |
| "To evaluate the efficacy and safety of intravenous fluconazole for the prevention of intra-abdominal Candida infections in high-risk surgical patients." | 9.09 | Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. ( Bille, J; Calandra, T; Chapuis, G; Chiolero, R; Eggimann, P; Francioli, P; Geroulanos, S; Glauser, MP; Pannatier, A; Schilling, J; Schneider, R; Wu, MM, 1999) |
| "Two randomized, placebo-controlled trials previously showed that fluconazole (400 mg/d) administered prophylactically decreases the incidence of candidiasis in blood and marrow transplant (BMT) recipients." | 9.09 | Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. ( Boeckh, M; Bowden, RA; Corey, L; Flowers, ME; Marr, KA; Schoch, HG; Seidel, K; Slavin, MA, 2000) |
| "The efficacy, safety, and tolerability of voriconazole and fluconazole were compared in 391 immunocompromised patients with mycology- and biopsy-proven esophageal candidiasis." | 9.09 | A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. ( Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P, 2001) |
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 9.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "The aim of this study was to assess the role and therapeutic efficacy of two azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically-diagnosed Candida oesophagitis in patients with Acquired Immunodeficiency Syndrome (AIDS)." | 9.08 | Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbaro, G; Di Lorenzo, G, 1995) |
| "Symptoms resolved in 100% of patients with AIDS and oesophageal candidiasis receiving an oral suspension of fluconazole, and 90% of patients had symptom resolution within 2 weeks." | 9.08 | Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS. ( Laine, L; Rabeneck, L, 1995) |
| "The aim of this study was to assess the role and the therapeutic efficacy of 2 azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically diagnosed Candida esophagitis in patients with acquired immunodeficiency syndrome (AIDS)." | 9.08 | Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "One hundred fifty seven men with candidal balanitis were entered in a randomised, open-label parallel-group multicentre study comparing efficacy and safety of a single oral 150-mg fluconazole-dose with clotrimazole applied topically twice daily for 7 days." | 9.08 | Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis. ( Kinghorn, GR; Roy, RB; Soeltz-Szoets, J; Stary, A; Ziegler, C, 1996) |
| "To compare the efficacy and toxicity of fluconazole and amphotericin B in the treatment of hematogenous candidiasis in cancer patients." | 9.08 | Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. ( Abi-Said, D; Anaissie, EJ; Bodey, GP; Gardner, A; Gilbreath, J; Khoury, P; Kontoyiannis, DP; Papadakis, K; Pinczowski, H; Raad, II; Uzun, O; Vartivarian, SE, 1996) |
| "The aim of the study was to assess the effectiveness of a single-dose fluconazole treatment of fungal esophagitis in patients with alcoholic liver disease." | 9.08 | Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease. ( Horváth, Z; Makara, M; Péter, Z; Telegdy, L; Zágoni, T; Zala, J, 1996) |
| "A prospective clinical trial of topical fluconazole solution (2 mg/ml) was undertaken in six consecutive eyes of microbiologically proven Candida keratitis with abscess formation." | 9.08 | Topical fluconazole therapy of Candida keratitis. ( Angra, SK; Panda, A; Sharma, N, 1996) |
| "This study evaluated 2213 human immunodeficiency virus-positive patients at first episode of esophageal candidiasis diagnosed by endoscopy; 1105 received fluconazole and 1108 received itraconazole." | 9.08 | Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis. ( Alcini, P; Barbarini, G; Barbaro, G; Calderon, W; Di Lorenzo, G; Grisorio, B, 1996) |
| "To assess the role and the therapeutic efficacy of fluconazole and itraconazole-flucytosine association compared with placebo, in the treatment of endoscopically diagnosed esophageal candidiasis in a selected population of AIDS patients." | 9.08 | Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1996) |
| "This multicenter, randomized, double-blind study compared the efficacy and safety of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis." | 9.08 | A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. ( Darouiche, RO; Laine, L; Mallegol, I; Moskovitz, BL; Wilcox, CM; Wu, J, 1997) |
| "An open, prospective, randomized pilot study was performed to assess the efficacy and safety of oral fluconazole 3 mg/kg once daily compared with oral nystatin 50,000 units/kg/day in four divided doses in preventing candida infections in 50 children undergoing remission induction or consolidation therapy for cancer." | 9.08 | Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer. ( Groll, AH; Just-Nuebling, G; Kornhuber, B; Kurz, M; Mueller, C; Nowak-Goettl, U; Schwabe, D; Shah, PM, 1997) |
| "In patients without neutropenia and without major immunodeficiency, fluconazole and amphotericin B are not significantly different in their effectiveness in treating candidemia." | 9.07 | A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. ( Bennett, JE; Dine, AP; Edwards, JE; Karchmer, AW; Pappas, PG; Rex, JH; Scheld, WM; Sugar, AM; van der Horst, CM; Washburn, RG, 1994) |
| "A prospective, multicenter, open study of fluconazole prophylaxis was performed in AIDS patients to evaluate the efficacy and toxicity of the drug in preventing relapses of esophageal candidiasis." | 9.07 | Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study. ( Agresti, MG; Bellocco, R; Caputo, RM; Carosi, GP; Chiodo, F; de Bernardis, F; Giannini, V; Milazzo, F; Minoli, L; Mondello, F, 1994) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 9.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| "In order to evaluate the efficacy of 200 mg single weekly dose of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS, 18 patients who had an endoscopic confirmation of cure after an esophageal candidiasis, were studied." | 9.07 | [Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla Uriol, P; López Dupla, M; Ortiz Vázquez, J; Pintado, V; Valencia, E, 1992) |
| "To study the efficacy of fluconazole against chronic disseminated candidiasis (hepatosplenic candidiasis) in patients with leukemia in whom amphotericin B treatment had failed." | 9.07 | Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. ( Anaissie, E; Barnett, K; Bodey, GP; Bow, E; David, C; Defelice, R; Downs, N; File, T; Kantarjian, H; Karam, G, 1991) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 9.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 9.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| " Terms such as micafungin, aspergillosis, zygomycosis, invasive fungal infections, emerging fungal infections, antifungal treatment or therapy, antifungal prophylaxis, empiric or pre-emptive therapy were crossed." | 8.85 | [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. ( Salavert-Lletí, M; Zaragoza-Crespo, R, 2009) |
| " Available since 1990, fluconazole is well established as a leading drug in the setting of prevention and treatment of mucosal and invasive candidiasis." | 8.83 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? ( Charlier, C; Denning, DW; Dromer, F; Hart, E; Lefort, A; Lortholary, O; Ribaud, P, 2006) |
| " Fluconazole (Diflucan((R)), Pfizer) is a triazole that has established an exceptional therapeutic record for candida infections including oropharyngeal and esophageal candidiasis, vulvovaginal candidiasis, candidemia and disseminated candidiasis." | 8.82 | Fluconazole for the treatment of candidiasis: 15 years experience. ( Cha, R; Sobel, JD, 2004) |
| "Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery." | 8.82 | Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005) |
| "The administration of fluconazole in the ICU setting in dosages of > or = 800 mg/day or > or = 10 mg/kg/day has been reported in about 400 patients with candidiasis of different localisation including candidemia, with a rapidly increasing incidence of serious candidal infections." | 8.80 | [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine]. ( Duswald, KH; Penk, A; Pittrow, L, 1998) |
| " We present possibly the first reported case of Candida infection of the epiglottis in an adult with human immunodeficiency virus treated with oral fluconazole." | 8.79 | Candida epiglottitis in an adult with acquired immunodeficiency syndrome treated with oral fluconazole. ( Israel, L; Sadigh, M, 1995) |
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 8.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| "In preterm neonates, fluconazole clearance is best predicted by actual body weight and serum creatinine concentration." | 8.12 | Optimisation of fluconazole therapy for the treatment of invasive candidiasis in preterm infants. ( Alffenaar, JC; Brüggemann, RJ; Engbers, AGJ; Flint, RB; Knibbe, CAJ; Liem, KD; Reiss, I; Simons, S; Tibboel, D; Voeller, S, 2022) |
| "The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes." | 8.12 | Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. ( Dunaiski, CM; Jung, H; Kock, MM; Peters, RPH, 2022) |
| " NCL-EPO-NPs also significantly abrogated mucocutaneous candidiasis by fluconazole-resistant strains of C." | 8.12 | Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis. ( Alqarihi, A; Date, A; Filler, S; Ghebremariam, T; Ibrahim, AS; Nabeela, S; Singh, S; Solis, N; Sutar, Y; Uppuluri, P, 2022) |
| " Here, we report a case of a patient affected by extended cutaneous candidiasis diagnosed by culture examination; a JHR occurred after an accidental overdose of oral fluconazole." | 7.96 | A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole. ( Magri, F; Muscianese, M; Pranteda, G, 2020) |
| "We describe the microbiological characterization and clinical presentation of two fungemia cases caused by fluconazole-resistant Candida auris in neonatal intensive care unit of a hospital in Beijing, China." | 7.88 | Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. ( Chen, J; Chen, Y; Fan, W; Han, L; Liu, J; Qi, L; Wang, Z; Xia, X; Zhang, L; Zhao, J, 2018) |
| " We used the neutropenic mice model of disseminated candidiasis to challenge the therapeutic equivalence of three generic products of fluconazole compared with the innovator in terms of concentration of the active pharmaceutical ingredient, analytical chemistry (liquid chromatography/mass spectrometry), in vitro susceptibility testing, single-dose serum pharmacokinetics in infected mice, and in vivo pharmacodynamics." | 7.81 | Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis. ( Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF, 2015) |
| "We studied the prevalence of fluconazole resistance in esophageal candidiasis." | 7.80 | Is empiric therapy with fluconazole appropriate for esophageal candidiasis? ( Chacko, A; Dutta, AK; Esakimuthu, S; Sahni, RD; Sajith, KG, 2014) |
| "To report a case of a woman in whom alopecia appeared after several months of treatment with anidulafungin." | 7.80 | Anidulafungin-induced alopecia. ( Gil-Gómez, I; Lorente-Fernández, L; Monte-Boquet, E; Poveda-Andrés, JL; Ruiz-Ramos, J; Salavert-Lleti, M, 2014) |
| "The efficacy of allicin compared with fluconazole in alleviating systemic Candida albicans infections was evaluated both in vitro and in vivo through a systemic candidiasis mouse model." | 7.77 | Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model. ( Alizadeh, F; Chong, PP; Harmal, NS; Jahromi, MA; Khodavandi, A; Ng, KP; Othman, F; Sekawi, Z; Sidik, SM, 2011) |
| "To report a case of bilateral endogenous candida endophthalmitis treated with intravenous fluconazole." | 7.77 | Intravenous fluconazole for bilateral endogenous Candida endophthalmitis. ( Annamalai, T; Choo, MM; Fong, KC, 2011) |
| "Systemic Candida infections are a major cause of infectious morbidity and mortality during chemotherapy-induced neutropenia." | 7.77 | The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. ( Wingard, JR, 1992) |
| " We evaluated the trailing effect of Candida isolates tested with itraconazole in a guinea pig model of systemic candidiasis." | 7.76 | Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis. ( Chen, E; Leitz, GJ; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rex, JH; Rodriguez, JR, 2010) |
| "In this study, we investigated the in vivo efficacy of anidulafungin during the early phase of disseminated candidiasis in a neutropenic murine model and compared the results with those obtained for fluconazole." | 7.76 | Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model. ( Chandrasekar, PH; Cutright, JL; Krishnan-Natesan, S; Manavathu, EK, 2010) |
| " The aim of the present study was to investigate the effects of ascorbic acid (AA) on the antifungal activity of fluconazole (FCZ) in a systemic murine candidiasis model as well as in vitro." | 7.75 | Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis. ( Cao, YB; Cao, YY; Gao, PH; Jia, JH; Jia, XM; Jiang, YY; Li, MB; Liao, WQ; Wang, Y, 2009) |
| " Fluconazole is increasingly used to prevent and treat invasive candidiasis in infants." | 7.75 | Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants. ( Adamson, PC; Barrett, JS; Benjamin, DK; Gastonguay, MR; Jayaraman, B; Kaufman, DA; Smith, PB; Wade, KC; Ward, RM, 2009) |
| ", with that of amphotericin B, caspofungin and fluconazole, in an immunocompetent murine model of haematogenously disseminated candidiasis caused by a fluconazole-resistant Candida albicans." | 7.74 | Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis. ( Ghannoum, MA; Kim, HG; Long, L, 2007) |
| "To evaluate the efficacy of subconjunctival injection of micafungin in the treatment of experimental Candida albicans keratitis in rabbits compared with fluconazole." | 7.74 | Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. ( Hiraoka, T; Kaji, Y; Nanbu, PN; Okamoto, F; Oshika, T; Wakabayashi, T, 2007) |
| "To determine the cost-effectiveness of using empiric high-dose fluconazole in intensive care unit (ICU) with suspected invasive candidiasis." | 7.74 | High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. ( Bearden, DT; Chen, H; Garey, KW; Pai, MP; Suda, KJ; Turpin, RS, 2007) |
| "We report on the correlation of the outcomes for two cohorts of patients who had been treated for candidemia (126 episodes) or oropharyngeal candidiasis (110 episodes) with various doses of fluconazole and the MIC of fluconazole obtained by using the EUCAST standard for fermentative yeasts." | 7.74 | Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. ( Almirante, B; Cuenca-Estrella, M; Donnelly, JP; Laguna, F; Mouton, JW; Pahissa, A; Rodríguez-Pardo, D; Rodríguez-Tudela, JL, 2007) |
| " On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas." | 7.74 | Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008) |
| "The efficacy of fluconazole prophylaxis to prevent invasive candida infections in patients with acute leukaemia receiving chemotherapy is not clear." | 7.74 | Effect of fluconazole prophylaxis on the incidence of invasive candida infections and bacteraemias in patients with acute leukaemia. ( Anttila, VJ; Elonen, E; Juvonen, E; Nihtinen, A; Ruutu, T; Volin, L, 2008) |
| "We evaluated the impact of fluconazole prophylaxis for extremely low birth weight infants on invasive candidiasis incidence, invasive candidiasis-related mortality rates, and fluconazole susceptibility of Candida isolates." | 7.74 | Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. ( Baker, CJ; Campbell, JR; Healy, CM; Zaccaria, E, 2008) |
| "We investigated the effects of fluconazole and micafungin for the therapy of deep-seated candidiasis in a cyclophosphamide-induced immunosuppressed mouse model." | 7.73 | Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice. ( Mikamo, H; Ninomiya, M; Tamaya, T; Tanaka, K; Watanabe, K, 2005) |
| "An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 7.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
| "We assessed the impact of intravenous fluconazole prophylaxis (FP) in extremely low birth weight (ELBW [<1000 g]) infants on the incidence of and outcome from invasive candidiasis (IC) in all infants admitted to a neonatal intensive care unit (NICU)." | 7.73 | Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. ( Baker, CJ; Campbell, JR; Healy, CM; Zaccaria, E, 2005) |
| "We report a case of breakthrough invasive zygomycosis in a stem cell transplant recipient who was receiving caspofungin for treatment of a breakthrough Candida krusei fungemia that occurred during fluconazole prophylaxis." | 7.73 | Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. ( Barberi, W; Foà, R; Girmenia, C; Iori, AP; Martino, P; Micozzi, A; Moleti, ML, 2005) |
| "To investigate the relative pathogenicity of Candida albicans treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis." | 7.73 | Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. ( Duhamel, GE; Hoerrmann, N; Hornby, JM; Navarathna, DH; Nickerson, KW; Parkhurst, AM, 2005) |
| "A 7-year retrospective analysis of candidemia in patients with hematologic malignancies demonstrated that ten patients, who received itraconazole and fluconazole during neutropenia, developed breakthrough fungemia caused by fluconazole-resistant Candida albicans (C." | 7.73 | Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies. ( Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T, 2006) |
| "Although a fluconazole prophylaxis regimen for ELBW infants was effective in preventing invasive candidiasis, an increase in the incidence of conjugated hyperbilirubinemia was observed." | 7.73 | Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. ( Aghai, ZH; Amendolia, B; Kaki, S; Kemble, N; Longo, D; Mudduluru, M; Nakhla, TA; Saslow, JG; Stahl, GE; Sutsko, R, 2006) |
| " We performed 24-h pharmacodynamic studies to compare the efficacies of anidulafungin, fluconazole, and amphotericin B in neutropenic mice with disseminated candidiasis caused by one of three strains of Candida glabrata." | 7.73 | Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis. ( Deziel, MR; Drusano, GL; Drusano, MF; Gumbo, T; Liu, W; Louie, A; Ma, L, 2006) |
| "Several clinical trials have demonstrated the efficacy of fluconazole as empiric antifungal therapy in cancer patients with fever and neutropenia." | 7.73 | Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia. ( Bates, DW; Kumar, RN; Peterson, JF; Seger, DL; Yu, DT, 2006) |
| "The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole." | 7.72 | Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice. ( Fukuoka, T; Hosokawa, T; Kamai, Y; Kubota, M; Kuwahara, S; Maeda, N; Shibayama, T; Uchida, K; Yamaguchi, H, 2003) |
| "To determine if failure of recurrent Candida albicans vulvovaginitis to respond clinically to fluconazole is related to in vitro mycologic resistance." | 7.72 | Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. ( Carey, JC; MacNeill, C; Weisz, J, 2003) |
| " We studied the activity of PLD-118 in escalating dosages against experimental oropharyngeal and esophageal candidiasis (OPEC) caused by fluconazole (FLC)-resistant Candida albicans in immunocompromised rabbits." | 7.72 | Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. ( Bacher, J; Groll, AH; Kelaher, AM; Mickiene, D; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ, 2004) |
| "The aim of this study was to determine the retinal toxicity and intraocular pharmacokinetics of vitrectomy with fluconazole infusion in rabbit eyes and to study its efficacy in the treatment of experimental candidal endophthalmitis." | 7.72 | Vitrectomy with fluconazole infusion: retinal toxicity, pharmacokinetics, and efficacy in the treatment of experimental candidal endophthalmitis. ( Cheng, CK; Hsueh, PR; Liu, CM; Lu, HY; Yang, CH, 2004) |
| "This study aimed to test the MICs (minimal inhibitory concentrations) to fluconazole of Candida species isolated from mouthwash specimens of 54 HIV positive patients with oral candidiasis." | 7.71 | Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients. ( Bussaratid, V; Howe, P; Phonrat, B; Pitisuttithum, P; Simpson, A; Tansupasawasdikul, S; White, NJ, 2002) |
| " We studied the antifungal efficacy, the concentrations in saliva and tissue, and the safety of VER-002 at escalating dosages against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant Candida albicans in immunocompromised rabbits." | 7.71 | Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, J; Francesconi, A; Groll, AH; Lyman, CA; Petraitiene, R; Petraitis, V; Piscitelli, SC; Schaufele, RL; Sein, T; Walsh, TJ, 2001) |
| "To present a case of fluconazole-associated torsade de pointes (TDP) and discuss fluconazole's role in causing TDP." | 7.71 | Fluconazole-induced torsade de pointes. ( Hanley, JF; Merliss, AD; Potti, A; Tholakanahalli, VN, 2001) |
| "Although fluconazole is the therapy of choice for patients in the intensive care setting with Candida infections, two patients with multiple organ failure who received high-dose fluconazole appeared to develop adrenal insufficiency." | 7.71 | Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients. ( Albert, SG; DeLeon, MJ; Silverberg, AB, 2001) |
| " The fungal infection was successfully controlled using fluconazole, and the patient has been disease-free for more than 11 months after antileukemic chemotherapy without any recurrence of Candida infections." | 7.71 | Successful treatment of hepatosplenic candidiasis in an elderly patient with acute myeloid leukemia using liposomal daunorubicin and fluconazole. ( Barbera, V; Gambino, R; Mariani, G; Minardi, V; Quintini, G; Spadola, V, 2001) |
| "To assess efficacy and safety of fluconazole in neonates with Candida fungemia." | 7.70 | Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. ( Filka, J; Hartmanova, I; Huttova, M; Kralinsky, K; Krcmery, V; Krizan, S; Kurak, J; Uher, J, 1998) |
| "We determined the pharmacodynamic parameter and the magnitude of that parameter that was predictive of the efficacy of fluconazole in the treatment of disseminated candidiasis." | 7.70 | Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model. ( Andes, D; van Ogtrop, M, 1999) |
| "The purpose of this histological study was to present postmortem findings in both eyes of a 53-year-old male with liver dysfunction 2 weeks after short-time oral treatment with 200 mg/day fluconazole for metastatic Candida endophthalmitis due to intravenous hyperalimentation for 18 days." | 7.70 | Postmortem findings two weeks after oral treatment for metastatic Candida endophthalmitis with fluconazole. ( Arakawa, T; Ishibashi, T; Murata, T; Ohnishi, Y; Sakamoto, T; Tawara, A, 1999) |
| "We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 7.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
| "To study the efficacy of intravitreally injected plain and liposome encapsulated fluconazole in the doses of 100 and 200 microg in Candidal endophthalmitis in rabbit eyes." | 7.70 | Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes. ( Dhingra, N; Gupta, SK; Jaiswal, J; Velpandian, T, 2000) |
| "Candida peritonitis was treated with fluconazole in ten continuous ambulatory peritoneal dialysis (CAPD) patients without immediate removal of the peritoneal catheter." | 7.69 | Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter. ( Aguirre, R; González, O; Martinez, I; Montenegro, J; Saracho, R, 1995) |
| "We investigated the efficacy of oral fluconazole, alone or in combination with oral flucytosine (5FC), in treating Candida endophthalmitis using a rabbit model." | 7.69 | Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole. ( Baker, AS; D'Amico, DJ; Park, SS; Paton, B, 1995) |
| "Although fluconazole is increasingly utilized for the therapy of Candida oesophagitis in patients with AIDS, the time course of response has not been adequately defined." | 7.69 | Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. ( Wilcox, CM, 1994) |
| "A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole." | 7.69 | The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994) |
| "The present studies were performed to determine whether any beneficial interaction results from combination therapy with recombinant human granulocyte colony-stimulating factor (GCSF) and fluconazole in disseminated candidiasis in mice." | 7.69 | Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. ( Bocanegra, R; Graybill, JR; Luther, M, 1995) |
| "Since fluconazole achieves high urine concentrations, we assessed its usefulness in the treatment of urinary candidiasis." | 7.69 | [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]. ( Castrillón, MA; del Canto, E; Pino, M; Schenone, D; Thompson, L, 1995) |
| "Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis." | 7.69 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996) |
| "Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C." | 7.69 | Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996) |
| "To investigate the efficacy of pars plana vitrectomy and oral fluconazole without injection of intravitreal antimycotic agents in the treatment of vitritis resulting from Candida endophthalmitis." | 7.69 | Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. ( Christmas, NJ; Smiddy, WE, 1996) |
| "The clinical records of those patients with invasive candidiasis that cured with fluconazole were retrospectively reviewed." | 7.69 | [Curative treatment with fluconazole in 5 cases of invasive candidiasis]. ( Caballero-Granado, J; Jiménez-Mejías, ME; Martínez-Marcos, FJ; Moreno-Maqueda, I; Pachón-Díaz, J; Rodríguez-Hernández, MJ, 1996) |
| "To evaluate the role of Fluconazole in the management of neonatal systemic candidiasis." | 7.69 | Fluconazole in the management of neonatal systemic candidiasis. ( Agrawal, P; Chakraborti, A; Kumar, P; Narang, A, 1996) |
| "Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C." | 7.68 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 7.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "A 29-year-old former drug addict with candida albicans endophthalmitis determined by cultivation was treated with vitrectomy and systemic fluconazole." | 7.68 | Fluconazole in the treatment of candida albicans endophthalmitis. ( Degn, T; Urbak, SF, 1992) |
| "A patient with acute cholecystitis due to Candida albicans and Candida parapsilosis was treated with a percutaneous cholecystostomy and daily intravenous fluconazole." | 7.68 | Biliary concentrations of fluconazole in a patient with candidal cholecystitis: case report. ( Bozzette, SA; Fierer, J; Gordon, RL; Ito, MK; Rinaldi, M; Yen, A, 1992) |
| "An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B." | 7.68 | Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992) |
| "The effect of intravenous fluconazole on endogenous Candida endophthalmitis in rabbits was investigated." | 7.68 | Study of suppressive effect of intravenous fluconazole on endogenous Candida endophthalmitis in rabbits. ( Hatano, H; Isobe, Y, 1992) |
| " We report a case of hepatosplenic candidiasis in a patient with acute myelogenous leukemia who had clinical and radiographic improvement during fluconazole therapy." | 7.68 | Fluconazole in the treatment of hepatosplenic candidiasis. ( Adelman, HM; Altus, P; Flannery, MT; Saba, H; Simmons, DB; Wallach, PM, 1992) |
| "To determine if fluconazole is effective treatment for hepatosplenic candidiasis that has not resolved with amphotericin B and flucytosine treatment." | 7.68 | Hepatosplenic candidiasis: successful treatment with fluconazole. ( Bradley, SF; Kauffman, CA; Ross, SC; Weber, DR, 1991) |
| "We compared the efficacy of intravenous fluconazole (80 mg/kg of body weight per day) with that of amphotericin B (1 mg/kg/day) for the long-term treatment of endophthalmitis in rabbits with disseminated candidiasis." | 7.68 | Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. ( Crislip, MA; Edwards, JE; Filler, SG; Mayer, CL, 1991) |
| "Fluconazole, a new triazole derivative, was evaluated in a pilot study of 34 episodes of candidiasis in 24 children." | 7.68 | Fluconazole in the treatment of candidiasis in immunocompromised children. ( Barigione, G; Castagnola, E; Ciravegna, B; Fioredda, F; Terragna, A; Viscoli, C, 1991) |
| "The therapeutic effect of intravenous fluconazole against endogenous candida endophthalmitis was investigated in rabbits." | 7.68 | [The suppressive effect of intravenous fluconazole against endogenous candida endophthalmitis in rabbits]. ( Hatano, H; Isobe, Y, 1990) |
| "We have reviewed the efficacy of the use of fluconazole in patients with definitely proven Candida esophagitis (CE) associated with human immunodeficiency virus (HIV) infection, using a single 400 mg oral dose of fluconazole and evaluating the patient three days afterwards." | 7.68 | [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases]. ( Carrasco, R; Martínez, A; Medina, E; Navarro, V; Nieto, A; Roig, P; Salavert, M, 1990) |
| "To investigate the potential use of fluconazole for prevention and treatment of disseminated candidiasis in granulocytopenic patients, its in vivo antifungal activity was studied in three models of disseminated candidiasis in persistently granulocytopenic rabbits: acute, subacute, and chronic disseminated candidiasis." | 7.68 | Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. ( Aoki, S; Bacher, J; Lee, J; Mechinaud, F; Pizzo, PA; Rubin, M; Walsh, TJ, 1990) |
| "Using a reproducible model of Candida albicans keratitis in rabbits we studied the effect of topical fluconazole, a new triazole." | 7.68 | Topical fluconazole for experimental candida keratitis in rabbits. ( Behrens-Baumann, W; Klinge, B; Rüchel, R, 1990) |
| "The clinical efficacy of fluconazole at doses of 100-400 mg daily given intravenously in the treatment of 6 cases of deep mycosis complicated with leukemia was evaluated." | 7.67 | [Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia]. ( Fukawa, H; Kodama, F; Maruta, A; Matsuzaki, M, 1989) |
| "Efficacies of fluconazole, a new triazole antifungal agent, were evaluated in 11 cases of systemic mycoses (1 case each of candiduria, pulmonary cryptococcosis, pulmonary aspergillosis, pulmonary penicilliosis and suspected fungal pulmonary infection, and 3 cases each of candidemia and Candida endophthalmitis)." | 7.67 | [Fluconazole treatment of systemic mycoses]. ( Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K, 1989) |
| " Dosing instructions in product labels appear to be inconsistent with the emerging scientific evidence." | 6.87 | Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial. ( Aurich, B; Barin-Le Guellec, C; Biran, V; Coopman, S; Dusang, B; Elie, V; Garcia Sanchez, R; Goudjil, S; Jacqz-Aigrain, E; Legrand, F; Leroux, S; Manzoni, P; Zhao, W, 2018) |
| "Isavuconazole is a novel, broad-spectrum antifungal developed for the treatment of opportunistic fungal infections." | 6.80 | A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis. ( Azie, N; Ghannoum, M; Schmitt-Hoffmann, AH; Viljoen, J, 2015) |
| "Fluconazole prophylaxis was defined by a minimum of 5 prophylactic doses." | 6.69 | The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. ( Bowden, RA; Hackman, RC; Leisenring, W; McDonald, GB; Myerson, D; Sale, GE; Shulman, HM; van Burik, JH, 1998) |
| "Disseminated candidiasis is a serious infectious complication with a mortality as high as 50%." | 6.68 | An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. ( de Pauw, BE; Donnelly, JP; Kullberg, BJ; Meis, JF; Raemaekers, JM, 1995) |
| "Fungal urinary tract infections are increasingly prevalent in the elderly in acute and chronic care settings." | 6.68 | Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. ( Fox, N; Freeman, K; Jacobs, LG; Lipschultz, D; Skidmore, EA, 1996) |
| "Oral candidiasis is a frequent opportunistic infection in AIDS patients." | 6.67 | [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)]. ( Coll-Seck, AM; Diop, BM; Faye, MA; Ndiaye, I; Sow, PS, 1993) |
| "Fluconazole is a bis-triazole antifungal agent with a long serum half-life." | 6.67 | Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs. ( Hales, M; Kernoff, PB; Lee, CA; Lim, SG; O'Doherty, M; Winter, M, 1991) |
| " The mean duration of therapy was 6-8 weeks (maximum duration: lifelong) with an average dosage of 200-400 mg/d (maximum dosage: 800 mg/d and 14 mg/kg BW, resp." | 6.40 | [Status of fluconazole in the therapy of endogenous Candida endophthalmitis]. ( Penk, A; Pittrow, L, 1998) |
| "Fluconazole was effective and safe in acute therapy alone or in combination with surgery as well as in long term suppression therapy." | 6.40 | [Fungal arthritis--a rare complication of systemic candidiasis or orthopedic intervention. Review of therapeutic experience with fluconazole]. ( Penk, A; Pittrow, L, 1998) |
| "Fluconazole is a bis-triazole antifungal drug which has a pharmacokinetic profile characterised by its high water solubility, low affinity for plasma proteins, and metabolic stability." | 6.39 | Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis. ( McTavish, D; Perry, CM; Whittington, R, 1995) |
| "Fluconazole appears to be a safe and effective alternative or addition to conventional treatments for the management of candidal endophthalmitis." | 6.39 | Use of fluconazole in the treatment of candidal endophthalmitis. ( Akler, ME; Gold, WL; McNeely, DM; Vellend, H; Walmsley, SL, 1995) |
| "Fluconazole is a new triazole antifungal agent with good activity against Candida and cryptococcal meningitis." | 6.38 | Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis. ( Garber, GE, 1992) |
| "Candidiasis is the most common cause of fungal sepsis, and new agents are of interest to ameliorate current deficiencies in therapy." | 5.91 | Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates. ( Larwood, DJ; Martinez, M; Sass, G; Stevens, DA, 2023) |
| "Candida esophagitis was suspected." | 5.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
| " Previous in vitro data suggest that, in combination with certain antifungals, farnesol may have an adjuvant anti-biofilm agent." | 5.43 | The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model. ( Bozó, A; Domán, M; Kardos, G; Kovács, R; Majoros, L; Varga, I, 2016) |
| "The pharmacokinetic (PK) property of fluconazole might be significantly altered in major burn patients by medical interventions and physiologic changes." | 5.39 | Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection. ( Han, S; Hong, T; Hur, J; Jeon, S; Kim, J; Lee, J; Song, W; Woo, H; Yim, DS; Yim, H, 2013) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 5.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Fluconazole (100 mg/day) was administered from April 8, 2006." | 5.35 | [A case of nail candidiasis with severe deformities treated with oral fluconazole]. ( Ito, Y; Kobayashi, M; Sei, Y; Soude, E; Sukegawa, N; Takahashi, E, 2008) |
| "Fluconazole, 400 mg/day, was given as EPT." | 5.33 | Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. ( Lee, JC; Lin, PW; Shan, YS; Sy, ED; Wang, ST, 2006) |
| "In vivo studies have described the pharmacodynamic (PD) characteristics of several triazoles." | 5.32 | In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. ( Andes, D; Conklin, R; Marchillo, K; Stamstad, T, 2003) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 5.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| " The concentrations of fluconazole in plasma were maintained above the MICs for FS isolates throughout the dosing interval." | 5.31 | Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, JD; Gonzalez, CE; Katsov, V; Kligys, K; Lyman, CA; Peter, J; Piscitelli, S; Shetti, D; Torres, R; Walsh, TJ, 2000) |
| "Oral fluconazole was continued for 6 months." | 5.31 | Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole). ( Antoniadou, A; Dosios, T; Giamarellou, H; Petrikkos, G; Sabatakou, H; Skiada, A, 2001) |
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 5.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| "In this study we defined the pharmacodynamic parameter that optimizes outcome in deep-seated Candida albicans infections treated with fluconazole." | 5.30 | Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. ( Banerjee, P; Drusano, GL; Kaw, P; Liu, QF; Liu, W; Louie, A; Miller, MH; Shayegani, M; Taber, H, 1998) |
| "A case of Candida albicans spondylodiscitis in a 20-year-old female liver transplant recipient is reported." | 5.30 | Fluconazole therapy in Candida albicans spondylodiscitis. ( Nielsen, H; Rössel, P; Schønheyder, HC, 1998) |
| "Fungal peritonitis is a rare event in patients receiving peritoneal dialysis." | 5.30 | Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. ( Blowey, DL; Garg, UC; Kearns, GL; Warady, BA, 1998) |
| "Treatment by fluconazole for six months, in the first case in the beginning also by amphotericin B, lead to the healing of fungal spondylitis, accompanied by partial osseous consolidation." | 5.29 | [Candida albicans spondylitis: successful treatment with fluconazole. 2 case reports]. ( Brunner-La Rocca, HP; Rösler-Meier, D; Schlumpf, U; Senn, P, 1996) |
| "Treatment with fluconazole was ineffective, but amphotericin B was curative." | 5.29 | Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole. ( Arranz-Caso, JA; García-Altozano, J; Gomez-Herruz, P; Lopez-Pizarro, VM; Martinez-Martinez, J, 1996) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 5.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "Treatment with fluconazole alone also significantly lowered the number of C." | 5.28 | Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. ( Kullberg, BJ; Poell, RJ; van 't Wout, JW; van Furth, R, 1992) |
| "Fluconazole was well tolerated in all the patients." | 5.28 | [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla, P; López Dupla, M; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1992) |
| "No differences in efficacy or safety were found between fluconazole and other azoles for the treatment of candida oesophagitis." | 5.22 | Systemic antifungal therapy for oesophageal candidiasis - systematic review and meta-analysis of randomized controlled trials. ( Atamna, A; Ayada, G; Bishara, J; Margalit, I; Matsri, S; Mwassi, HA; Shargian, L; Yahav, D, 2022) |
| "Fluconazole prophylaxis is safe and efficacious in preventing invasive Candida infections." | 5.19 | Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety. ( Gurka, MJ; Hetherington, S; Kapik, B; Kaufman, DA; Morris, A, 2014) |
| "Fluconazole prophylaxis for the prevention of invasive Candida infections is safe in extremely low birth weight infants and does not appear to be associated with any long-term adverse effects on neurodevelopment and quality of life at 8 to 10 years of life." | 5.15 | Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. ( Boyle, R; Cuff, AL; Grossman, LB; Gurka, MJ; Kaufman, DA; Patrick, P; Wamstad, JB, 2011) |
| "To determine whether Candida glabrata colonization and invasive candidiasis (IC) increased among critically ill surgical patients 3 years after the introduction of fluconazole prophylaxis to a surgical intensive care unit (SICU)." | 5.14 | The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. ( Colantuoni, EA; Fothergill, AW; Hendrix, CW; Lipsett, PA; Magill, SS; Merz, WG; Shields, CE; Swoboda, SM, 2009) |
| "To see whether empirical fluconazole improves clinical outcomes more than placebo in adult ICU patients at high risk for invasive candidiasis." | 5.13 | Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. ( Biswas, P; Darouiche, RO; Edwards, JE; Hadley, S; Karchmer, AW; Panzer, H; Rex, JH; Schuster, MG; Slotman, G; Sobel, JD, 2008) |
| "This multicenter, randomized, evaluator-blinded study of subjects with HIV infection and oropharyngeal candidiasis compared efficacy of posaconazole with that of fluconazole." | 5.12 | A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. ( Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA, 2006) |
| "We evaluated the efficacy and safety of oral posaconazole for human immunodeficiency virus (HIV)-infected subjects with oropharyngeal candidiasis (OPC) and/or esophageal candidiasis (EC) who were clinically refractory to treatment with oral fluconazole or itraconazole." | 5.12 | Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. ( Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D, 2007) |
| " We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority trial of treatment for invasive candidiasis." | 5.12 | Anidulafungin versus fluconazole for invasive candidiasis. ( Betts, R; Chapman, SW; Goldstein, BP; Kett, DH; Krause, DS; Kumar, D; Pappas, PG; Reboli, AC; Rotstein, C; Schranz, J; Walsh, TJ; Wible, M, 2007) |
| "Prophylactic fluconazole reduces the incidence of colonization and invasive candida infection in neonates weighing less than 1500 g at birth." | 5.12 | A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. ( Arisio, R; Corona, G; Decembrino, L; Farina, D; Giovannozzi, C; Gomirato, G; Magnani, C; Manzoni, P; Maule, M; Merletti, F; Mosca, F; Mostert, M; Pedicino, R; Pugni, L; Stolfi, I; Stronati, M; Tridapalli, E; Vetrano, G, 2007) |
| " This randomized, double-blind, double-dummy study compared the efficacy and safety of intravenous anidulafungin to that of oral fluconazole in 601 patients with endoscopically and microbiologically documented esophageal candidiasis." | 5.11 | A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. ( Goldstein, BP; Henkel, T; Krause, DS; Simjee, AE; van Rensburg, C; Viljoen, J; Walsh, TJ; Wible, M, 2004) |
| "A total of 245 patients (age, > or =18 years) with a prior diagnosis of acquired immunodeficiency syndrome/human immunodeficiency virus (HIV) infection and esophageal candidiasis, confirmed by endoscopy and culture, were randomized to receive micafungin (50, 100, or 150 mg per day) or fluconazole (200 mg per day)." | 5.11 | A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. ( Baraldi, E; de Wet, N; Della Negra, M; Diekmann-Berndt, H; Krantz, EF; Llanos-Cuentas, A; Suleiman, J, 2004) |
| "Itraconazole was as effective as fluconazole in nosocomial candidiasis in children receiving intensive care and was devoid of serious side effects." | 5.11 | Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study. ( Chakrabarti, A; M, J; Mondal, RK; Singhi, SC, 2004) |
| " intravenous fluconazole in the treatment of oesophageal candidiasis." | 5.11 | A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. ( Bester, AJ; Buell, D; de Wet, NT; Filho, F; Fisco, C; Lau, W; Llanos, EA; Suleiman, JM; Ticona, E; Viljoen, JJ, 2005) |
| "We tested the hypothesis that twice weekly prophylactic dosing of fluconazole prevents invasive candidiasis without promoting resistant Candida species in high-risk, preterm infants." | 5.11 | Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. ( Boyle, R; Grossman, LB; Hazen, KC; Kaufman, D; Patrie, JT; Robinson, M, 2005) |
| "Caspofungin is a new echinocandin drug with comparable in vitro activity against azole-susceptible and -resistant isolates of that could provide a less toxic alternative to amphotericin B for the management of esophageal candidiasis with clinical or laboratory evidence of decreased susceptibility to fluconazole." | 5.10 | Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole. ( Bartizal, K; DiNubile, MJ; Hicks, PS; Kartsonis, N; Ryan, D; Sable, CA, 2002) |
| "Candida infections occurred less frequently in the fluconazole group (5." | 5.10 | Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. ( Auckenthaler, R; Garbino, J; Hugonnet, S; Lew, DP; Pittet, D; Romand, JA, 2002) |
| " By day 50, the incidence of Candida infections in the high-dose group was 4% (95% confidence interval [CI]: 1% to 7%; n = 5), compared with 1% in the low-dose fluconazole group (95% CI: 0% to 3%; n = 1; P = 0." | 5.10 | Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. ( DeFor, TE; Goodman, JL; MacMillan, ML; Weisdorf, DJ, 2002) |
| "To evaluate the efficacy and safety of intravenous fluconazole for the prevention of intra-abdominal Candida infections in high-risk surgical patients." | 5.09 | Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. ( Bille, J; Calandra, T; Chapuis, G; Chiolero, R; Eggimann, P; Francioli, P; Geroulanos, S; Glauser, MP; Pannatier, A; Schilling, J; Schneider, R; Wu, MM, 1999) |
| "Fluconazole seems to be an effective therapy for systemic and other forms of candidiasis in infants including very low birth weight infants (VLBWI; <1500 g)." | 5.09 | Treatment of candidal infections with fluconazole in neonates and infants. ( Penk, A; Pittrow, L; Schwarze, R, 2000) |
| "Two randomized, placebo-controlled trials previously showed that fluconazole (400 mg/d) administered prophylactically decreases the incidence of candidiasis in blood and marrow transplant (BMT) recipients." | 5.09 | Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. ( Boeckh, M; Bowden, RA; Corey, L; Flowers, ME; Marr, KA; Schoch, HG; Seidel, K; Slavin, MA, 2000) |
| "The efficacy, safety, and tolerability of voriconazole and fluconazole were compared in 391 immunocompromised patients with mycology- and biopsy-proven esophageal candidiasis." | 5.09 | A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. ( Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P, 2001) |
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 5.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "The aim of this study was to assess the role and therapeutic efficacy of two azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically-diagnosed Candida oesophagitis in patients with Acquired Immunodeficiency Syndrome (AIDS)." | 5.08 | Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbaro, G; Di Lorenzo, G, 1995) |
| "Symptoms resolved in 100% of patients with AIDS and oesophageal candidiasis receiving an oral suspension of fluconazole, and 90% of patients had symptom resolution within 2 weeks." | 5.08 | Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS. ( Laine, L; Rabeneck, L, 1995) |
| "The aim of this study was to assess the role and the therapeutic efficacy of 2 azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically diagnosed Candida esophagitis in patients with acquired immunodeficiency syndrome (AIDS)." | 5.08 | Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "One hundred fifty seven men with candidal balanitis were entered in a randomised, open-label parallel-group multicentre study comparing efficacy and safety of a single oral 150-mg fluconazole-dose with clotrimazole applied topically twice daily for 7 days." | 5.08 | Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis. ( Kinghorn, GR; Roy, RB; Soeltz-Szoets, J; Stary, A; Ziegler, C, 1996) |
| "To compare the efficacy and toxicity of fluconazole and amphotericin B in the treatment of hematogenous candidiasis in cancer patients." | 5.08 | Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. ( Abi-Said, D; Anaissie, EJ; Bodey, GP; Gardner, A; Gilbreath, J; Khoury, P; Kontoyiannis, DP; Papadakis, K; Pinczowski, H; Raad, II; Uzun, O; Vartivarian, SE, 1996) |
| "The aim of the study was to assess the effectiveness of a single-dose fluconazole treatment of fungal esophagitis in patients with alcoholic liver disease." | 5.08 | Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease. ( Horváth, Z; Makara, M; Péter, Z; Telegdy, L; Zágoni, T; Zala, J, 1996) |
| "A prospective clinical trial of topical fluconazole solution (2 mg/ml) was undertaken in six consecutive eyes of microbiologically proven Candida keratitis with abscess formation." | 5.08 | Topical fluconazole therapy of Candida keratitis. ( Angra, SK; Panda, A; Sharma, N, 1996) |
| "This study evaluated 2213 human immunodeficiency virus-positive patients at first episode of esophageal candidiasis diagnosed by endoscopy; 1105 received fluconazole and 1108 received itraconazole." | 5.08 | Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis. ( Alcini, P; Barbarini, G; Barbaro, G; Calderon, W; Di Lorenzo, G; Grisorio, B, 1996) |
| "To assess the role and the therapeutic efficacy of fluconazole and itraconazole-flucytosine association compared with placebo, in the treatment of endoscopically diagnosed esophageal candidiasis in a selected population of AIDS patients." | 5.08 | Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1996) |
| "The purpose of this prospective, open-label, noncomparative, multicentre study was to evaluate the efficacy and safety of fluconazole in the treatment of hospitalised patients with mycoses." | 5.08 | Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group. ( Troke, PF, 1997) |
| "This multicenter, randomized, double-blind study compared the efficacy and safety of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis." | 5.08 | A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. ( Darouiche, RO; Laine, L; Mallegol, I; Moskovitz, BL; Wilcox, CM; Wu, J, 1997) |
| "An open, prospective, randomized pilot study was performed to assess the efficacy and safety of oral fluconazole 3 mg/kg once daily compared with oral nystatin 50,000 units/kg/day in four divided doses in preventing candida infections in 50 children undergoing remission induction or consolidation therapy for cancer." | 5.08 | Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer. ( Groll, AH; Just-Nuebling, G; Kornhuber, B; Kurz, M; Mueller, C; Nowak-Goettl, U; Schwabe, D; Shah, PM, 1997) |
| " The association between Candida multicolonization and the occurrence of Candida infection seems to be confirmed by a double-blind placebo-controlled study performed in a small subgroup of the multicolonized patients treated with fluconazole." | 5.07 | Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. ( Boccanera, M; Cassone, A; De Bernardis, F; Girmenia, C; Martino, P; Micozzi, A, 1994) |
| "In patients without neutropenia and without major immunodeficiency, fluconazole and amphotericin B are not significantly different in their effectiveness in treating candidemia." | 5.07 | A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. ( Bennett, JE; Dine, AP; Edwards, JE; Karchmer, AW; Pappas, PG; Rex, JH; Scheld, WM; Sugar, AM; van der Horst, CM; Washburn, RG, 1994) |
| "A prospective, multicenter, open study of fluconazole prophylaxis was performed in AIDS patients to evaluate the efficacy and toxicity of the drug in preventing relapses of esophageal candidiasis." | 5.07 | Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study. ( Agresti, MG; Bellocco, R; Caputo, RM; Carosi, GP; Chiodo, F; de Bernardis, F; Giannini, V; Milazzo, F; Minoli, L; Mondello, F, 1994) |
| "After the first episode of esophageal candidiasis, 122 consecutive AIDS patients were randomly assigned to two different regimens of continuous long-term antifungal prophylaxis (ketoconazole 200 mg or fluconazole 50 mg/day p." | 5.07 | Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. ( Antinori, S; Ardizzone, S; Bianchi Porro, G; Cernuschi, M; Esposito, R; Lazzarin, A; Moroni, M; Parente, F, 1994) |
| "Efficacies of fluconazole (FLCZ) were evaluated in 8 cases of systemic mycosis (1 case each of candidemia, candiduria, 4 cases of pulmonary candidiasis, and 2 cases of suspected fungemia) complicated in immunocompromised children." | 5.07 | [A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children]. ( Hatae, Y; Ishikawa, A; Ishikawa, Y; Matsumoto, S; Sakiyama, Y; Shimizu, T; Takase, A; Takeda, T; Wagatsuma, Y, 1994) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 5.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| "The recently developed antifungal agents itraconazole and fluconazole have been evaluated for primary and maintenance therapy for mycoses in patients with acquired immune deficiency syndrome (AIDS) in comparative and non-comparative trials." | 5.07 | Opportunistic fungal infections in patients with acquired immune deficiency syndrome. ( Viviani, MA, 1992) |
| "In order to evaluate the efficacy of 200 mg single weekly dose of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS, 18 patients who had an endoscopic confirmation of cure after an esophageal candidiasis, were studied." | 5.07 | [Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla Uriol, P; López Dupla, M; Ortiz Vázquez, J; Pintado, V; Valencia, E, 1992) |
| "To study the efficacy of fluconazole against chronic disseminated candidiasis (hepatosplenic candidiasis) in patients with leukemia in whom amphotericin B treatment had failed." | 5.07 | Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. ( Anaissie, E; Barnett, K; Bodey, GP; Bow, E; David, C; Defelice, R; Downs, N; File, T; Kantarjian, H; Karam, G, 1991) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 5.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 5.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| " Our study was designed to assess the prevention of (1) staphylococcal and streptococcal infections using T when the central catheter is being placed, and (2) candida infection by the simultaneous use of a new anti-mycotic agent fluconazole (F) administered once-daily." | 5.06 | Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children. ( Arlet, G; Baruchel, A; Schaison, G, 1990) |
| " We report on a patient with sepsis and renal fungal ball who was treated with percutaneous nephrostomy and intravenous antifungal agent, but the patient did not respond so instillation of fluconazole through nephrostomy was given." | 4.98 | Treatment of Renal Fungal Ball with Fluconazole Instillation Through a Nephrostomy Tube: Case Report and Literature Review. ( Abdeljaleel, OA; Ali, O; Alnadhari, I; Khachatryan, G; Mahmoud, S; Salah, M; Shamsodini, A, 2018) |
| ", causing invasive candidiasis and an overall trend towards reduced fluconazole susceptibility." | 4.87 | Pharmacokinetic evaluation of fluconazole in critically ill patients. ( Lipman, J; Peake, SL; Playford, EG; Roberts, JA; Roberts, MS; Sinnollareddy, M, 2011) |
| " Terms such as micafungin, aspergillosis, zygomycosis, invasive fungal infections, emerging fungal infections, antifungal treatment or therapy, antifungal prophylaxis, empiric or pre-emptive therapy were crossed." | 4.85 | [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. ( Salavert-Lletí, M; Zaragoza-Crespo, R, 2009) |
| "Recent clinical trials have documented the clinical efficacy of the echinocandins and the newer triazoles for the management of invasive candidiasis." | 4.84 | Antifungals in the ICU. ( Calandra, T; Eggimann, P; Playford, EG, 2008) |
| " Although fluconazole use has been considered one of the main causes for the epidemiologic change in invasive candidiasis, especially in the increase of species less sensitive to this agent, this association remains unproven." | 4.84 | [Current treatment of candidemia. Role of anidulafungin]. ( Almirante, B; Pemán, J, 2008) |
| " Available since 1990, fluconazole is well established as a leading drug in the setting of prevention and treatment of mucosal and invasive candidiasis." | 4.83 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? ( Charlier, C; Denning, DW; Dromer, F; Hart, E; Lefort, A; Lortholary, O; Ribaud, P, 2006) |
| " Single-center studies have shown that prophylactic fluconazole reduces the rates of invasive candidiasis and/or colonization of extremely-low-birth-weight infants." | 4.83 | Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit. ( Saiman, L, 2006) |
| " Fluconazole (Diflucan((R)), Pfizer) is a triazole that has established an exceptional therapeutic record for candida infections including oropharyngeal and esophageal candidiasis, vulvovaginal candidiasis, candidemia and disseminated candidiasis." | 4.82 | Fluconazole for the treatment of candidiasis: 15 years experience. ( Cha, R; Sobel, JD, 2004) |
| "Prophylactic fluconazole administration for prevention of mycoses in SICU patients appears to successfully decrease the rate of these infections, but this strategy does not improve survival." | 4.82 | Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. ( Chung, K; Jackson, WL; Kollef, MH; Shorr, AF; Waterman, PE, 2005) |
| "Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery." | 4.82 | Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005) |
| " In general, it is possible to predict the therapeutic outcome, especially in HIV infected patients with oropharyngeal candidiasis treated with fluconazole." | 4.81 | [Correlation between in vitro susceptibility to antifungal drugs and the clinical evolution of patients with candidiasis and cryptococcosis]. ( Cantón, E; Gobernado, M; López-Ribot, JL; Pemán, J; Viudes, A, 2002) |
| " Oral candidiasis in immunocompromised patients also requires systemic treatment; oral fluconazole and itraconazole oral solution are highly effective in this setting." | 4.81 | Current management of fungal infections. ( Meis, JF; Verweij, PE, 2001) |
| "A systematic review of randomized clinical trials published between 1966 and April 2000 was undertaken to determine the strength of evidence for the effectiveness of antifungal drugs (nystatin, clotrimazole, amphotericin B, fluconazole, ketoconazole, and itraconazole) to prevent and treat oral candidiasis in human immunodeficiency virus-positive patients." | 4.81 | A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. ( Bonito, AJ; Patton, LL; Shugars, DA, 2001) |
| " Fluconazole (Diflucan) is currently the standard prophylactic agent for candidiasis, although mold-active agents and alternative strategies for polyene administration are being investigated." | 4.81 | Antifungal prophylaxis in hematopoietic stem cell transplant recipients. ( Marr, KA, 2001) |
| "The administration of fluconazole in the ICU setting in dosages of > or = 800 mg/day or > or = 10 mg/kg/day has been reported in about 400 patients with candidiasis of different localisation including candidemia, with a rapidly increasing incidence of serious candidal infections." | 4.80 | [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine]. ( Duswald, KH; Penk, A; Pittrow, L, 1998) |
| " We present possibly the first reported case of Candida infection of the epiglottis in an adult with human immunodeficiency virus treated with oral fluconazole." | 4.79 | Candida epiglottitis in an adult with acquired immunodeficiency syndrome treated with oral fluconazole. ( Israel, L; Sadigh, M, 1995) |
| "A patient with hepatitis experienced worsening of her liver function when treated with fluconazole for a Candida infection in her urine." | 4.79 | Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity. ( Gearhart, MO, 1994) |
| "The clinical use of fluconazole in dosages > or = 800 mg/day has been reported in about 900 patients against candidemia, oropharyngeal candidiasis and cryptococcal meningitis in HIV-infected patients as well as for initial therapy of endemic mycoses." | 4.79 | [High-dose therapy with fluconazole > or = 800 mg/day. Review]. ( Penk, A; Pittrow, L, 1997) |
| "Fluconazole dosages greater than 800 mg day-1 have been reported in about 900 patients treated for candidemia, oropharyngeal candidiasis and cryptococcal meningitis in HIV-infected patients, and for initial therapy of endemic mycoses." | 4.79 | High-dose therapy with fluconazole > or = 800 mg day-1. ( Duswald, KH; Penk, A; Pittrow, L, 1997) |
| " Therapeutic usage of amphotericin B, the agent of choice for serious Candida infection, is reviewed, along with usage of 5-flucytosine and fluconazole." | 4.78 | Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. ( Solomkin, JS, 1993) |
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 4.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| " lusitaniae osteomyelitis in whom treatment was successful with 5-fluorocytosine and fluconazole." | 4.78 | Candida lusitaniae osteomyelitis in a premature infant. ( Della-Latta, P; Oleinik, EM; Rinaldi, MG; Saiman, L, 1993) |
| " Amphotericin B remains the agent of choice for treatment of hematogenously disseminated candidiasis and for candidemia, although the optimal dosage and duration of this therapy are poorly defined." | 4.78 | Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. ( Edwards, JE; Filler, SG, 1992) |
| " II-6s also synergises with fluconazole by inhibiting the drug efflux pump, representing a promising antifungal agent for the control of candidiasis." | 4.31 | Small molecule II-6s synergises with fluconazole against Candida albicans. ( Luo, Y; Peng, X; Ren, B; Xu, X; Yang, S, 2023) |
| " Since all fluconazole resistance isolates were obtained from candidemia, we recommend amphotericin B as the first line therapy for this potentially fatal infection." | 4.31 | A 3-year study of ( Abastabar, M; Badiee, P; Haghani, I; Mohammadi, R; Morovati, H; Noorbakhsh, M; Sharifi, M, 2023) |
| "In a previous study, therapeutic activity of nikkomycin Z (NZ) in a model of invasive candidiasis did not appear to correlate with lesser activity in vitro (using classical MIC methods) with planktonic organisms." | 4.31 | Synergy In Vitro of Nikkomycin Z with Azole Against the Invasive Form of Candida albicans. ( Larwood, DJ; Sass, G; Stevens, DA, 2023) |
| " As expected, most compounds exhibited excellent in vitro antifungal activity against pathogenic fungi, especially fluconazole-resistant candidiasis." | 4.31 | Developing Novel Coumarin-Containing Azoles Antifungal Agents by the Scaffold Merging Strategy for Treating Azole-Resistant Candidiasis. ( Guo, C; Guo, M; Hou, Z; Huang, Y; Li, Z; Mou, Y; Wang, X; Wang, Y; Wei, Y; Yan, Z; Zhao, D, 2023) |
| "In preterm neonates, fluconazole clearance is best predicted by actual body weight and serum creatinine concentration." | 4.12 | Optimisation of fluconazole therapy for the treatment of invasive candidiasis in preterm infants. ( Alffenaar, JC; Brüggemann, RJ; Engbers, AGJ; Flint, RB; Knibbe, CAJ; Liem, KD; Reiss, I; Simons, S; Tibboel, D; Voeller, S, 2022) |
| "We performed a single-centre retrospective study to compare the incidence of invasive candidiasis during the first 6 post-transplant months in a cohort of 218 PTRs over two periods in which different agents for antifungal prophylaxis were used: fluconazole (Fluco-Px) from March 1995 to June 2012, and micafungin followed by fluconazole (Mica-Px) from July 2012 to December 2018." | 4.12 | Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods. ( Aguado, JM; Alonso-Carrillo, J; Andrés, A; Fernández-Ruiz, M; González, E; Herrero-Martínez, JM; Jiménez, C; Justo, I; Loinaz, C; López-Medrano, F; Lumbreras, C; Manrique, A; Marcacuzco, A; Muñoz de la Espada, M; Pérez-Jacoiste Asín, MA; Rodríguez-Goncer, I; San Juan, R, 2022) |
| " provided a novel perspective by identifying synergism between fluconazole and bacterial antagonism in the context of Candida albicans-Pseudomonas aeruginosa co-infection." | 4.12 | Competition for Iron during Polymicrobial Infections May Increase Antifungal Drug Susceptibility-How Will It Impact Treatment Options? ( Pohl, CH, 2022) |
| "The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes." | 4.12 | Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. ( Dunaiski, CM; Jung, H; Kock, MM; Peters, RPH, 2022) |
| " NCL-EPO-NPs also significantly abrogated mucocutaneous candidiasis by fluconazole-resistant strains of C." | 4.12 | Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis. ( Alqarihi, A; Date, A; Filler, S; Ghebremariam, T; Ibrahim, AS; Nabeela, S; Singh, S; Solis, N; Sutar, Y; Uppuluri, P, 2022) |
| "Fluconazole (FLZ) is the most widely used antifungal agent for treating cutaneous candidiasis." | 4.12 | Optimized D-α-tocopherol polyethylene glycol succinate/phospholipid self-assembled mixed micelles: A promising lipid-based nanoplatform for augmenting the antifungal activity of fluconazole. ( Ahmed, OAA; Aldawsari, HM; Alhakamy, NA; Alzahrani, AH; Badr-Eldin, SM; Elfaky, MA; Fahmy, UA; Hawsawi, SA; Kotta, S; Qassim, M; Sirwi, A; Yaseen, AY, 2022) |
| " Similarly, the methanolic extract of Rosmarinus officinalis could be effective for treating candidiasis by Candida glabrata and Candida tropicalis." | 4.02 | [Anti-microbial activity of Rosmarinus officinalis and Zingiber officinale extracts on the species of the genus Candida and on Streptococcus pneumonia]. ( Akroum, S, 2021) |
| " The abscess resolved after seven incision and drainage cycles and 4 weeks of intravenous fluconazole treatment with an appropriate control of diabetes mellitus." | 4.02 | Multiple facial candidal abscesses after self-administered acupuncture in a patient with undiagnosed diabetes mellitus: a case report. ( Kim, JM; Lee, JU; Lee, SB; Lee, YH; Sung, JY, 2021) |
| " Here, we report a case of a patient affected by extended cutaneous candidiasis diagnosed by culture examination; a JHR occurred after an accidental overdose of oral fluconazole." | 3.96 | A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole. ( Magri, F; Muscianese, M; Pranteda, G, 2020) |
| " When FE is complicated with prosthetic heart valve and/or atrial fibrillation, the coadministration of antifungal agents and warfarin is inevitable." | 3.96 | Fungal endocarditis with heart valve replacement and atrial fibrillation posing a treatment challenge: A case report. ( Cao, S; Ding, C; Wang, R; Xia, M; Zhu, X, 2020) |
| "We describe the microbiological characterization and clinical presentation of two fungemia cases caused by fluconazole-resistant Candida auris in neonatal intensive care unit of a hospital in Beijing, China." | 3.88 | Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. ( Chen, J; Chen, Y; Fan, W; Han, L; Liu, J; Qi, L; Wang, Z; Xia, X; Zhang, L; Zhao, J, 2018) |
| "Fluconazole (FLC) is the drug of choice when it comes to treat fungal infections such as invasive candidiasis in humans." | 3.85 | Novel alkylated azoles as potent antifungals. ( Garneau-Tsodikova, S; Garzan, A; Shrestha, SK, 2017) |
| "Rampant use of fluconazole in Candida infections has led to predominance of less susceptible non-albicans Candida over Candida albicans." | 3.85 | Regression analysis and categorical agreement of fluconazole disk zone diameters and minimum inhibitory concentration by broth microdilution of clinical isolates of Candida. ( Aggarwal, P; Kashyap, B, 2017) |
| " A second opinion at our institute resulted in the diagnosis of hepatic candidiasis without prior documented candidemia, for which she was treated successfully with fluconazole." | 3.85 | Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis? ( Bomers, MK; de Rooij, ML; Meijer, E; Menke-van der Houven van Oordt, CW; van Dijk, K; van Prehn, J, 2017) |
| "The serum Fungitell assay was used to trend (1→3)-β-D-glucan in a patient with Candida endocarditis to determine treatment effectiveness with fluconazole, to provide an appropriate end date for antifungal therapy, and to survey infection suppression while off treatment." | 3.85 | (1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis. ( Brown, M; Goldfarb, I; Johnson, T; Saling, C; Slim, J; Szabela, M, 2017) |
| "Fluconazole is an antifungal agent used for the treatment of invasive candidiasis, a leading cause of morbidity and mortality in premature infants." | 3.85 | External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models. ( Beechinor, RJ; Benjamin, DK; Capparelli, EV; Cohen-Wolkowiez, M; Duara, S; Gonzalez, D; Hornik, CP; Hwang, MF; Kennedy, KA; Smith, PB; Wade, KC, 2017) |
| " Long-term or repeated use of oral administration of fluconazole for treating chronic candidiasis in the patient and partially abandoned treatment lead to the resistant strains of the fungus Candida albicans and severity of the disease." | 3.85 | Investigating the performance of drug delivery system of fluconazole made of nano-micro fibers coated on cotton/polyester fabric. ( Afrashi, M; Alihosseini, F; Dehghan, P; Maherolnaghsh, M; Semnani, D, 2017) |
| "Detection by PCR of all Candida species and of most fluconazole-resistant Candida species could improve the cost-effectiveness of fluconazole and echinocandin given to non-neutropenic patients with suspected peritoneal candidiasis in ICUs." | 3.85 | Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit. ( Berry, A; Georges, B; Iriart, X; Juillard-Condat, B; Massip, P; Molinier, L; Pagès, A, 2017) |
| " Fluconazole is the agent of choice for most Candida urinary tract infections." | 3.85 | Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients. ( Campbell-Bright, S; Caylor, MM; Lin, FC; Sullivan, KA, 2017) |
| "Low-dose fluconazole is used commonly to treat vulvovaginal candidiasis, a condition occurring frequently during pregnancy." | 3.83 | Fluconazole use and birth defects in the National Birth Defects Prevention Study. ( Browne, ML; Carter, TC; Cunniff, CM; Druschel, CM; Howley, MM; Romitti, PA, 2016) |
| " Candida albicans has been the species most often associated with neonatal infections, but recently, there has been a changing pattern in the isolates recovered from neonates with invasive candidiasis, which poses resistance to the existing class of azoles such as fluconazole antifungals along with cross resistance to newer triazoles, which results in a therapeutic challenge in invasive fungal infections causing high incidence of mortality." | 3.81 | Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host. ( Kumar, A; Kumar, D; Singh, S; Tilak, R, 2015) |
| " Clinical features and outcome were compared in 25 (41%) Candida-positive patients (6 (22%) fluconazole-resistant Candida glabrata) and 36 patients without Candida infection." | 3.81 | Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery. ( Chochillon, C; Desmard, M; Houze, S; Marmuse, JP; Montravers, P; Ribeiro-Parenti, L; Zappella, N, 2015) |
| "Fluconazole is the standard treatment for oropharyngeal candidiasis, which is the third most common opportunistic infection in human immunodeficiency virus (HIV)/AIDS patients in Indonesia." | 3.81 | Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia. ( Lestari, DC; Rosana, Y; Yasmon, A, 2015) |
| " We used the neutropenic mice model of disseminated candidiasis to challenge the therapeutic equivalence of three generic products of fluconazole compared with the innovator in terms of concentration of the active pharmaceutical ingredient, analytical chemistry (liquid chromatography/mass spectrometry), in vitro susceptibility testing, single-dose serum pharmacokinetics in infected mice, and in vivo pharmacodynamics." | 3.81 | Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis. ( Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF, 2015) |
| "Fluconazole could be used as thefirst-line antifungal for candidiasis at HRH Princess Maha Chakri Sirindhorn Medical Center." | 3.81 | Epidemiology of Candida Infections in HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University. ( Santiwattanakul, S; Tantisiriwat, W, 2015) |
| "We studied the prevalence of fluconazole resistance in esophageal candidiasis." | 3.80 | Is empiric therapy with fluconazole appropriate for esophageal candidiasis? ( Chacko, A; Dutta, AK; Esakimuthu, S; Sahni, RD; Sajith, KG, 2014) |
| "To report a case of a woman in whom alopecia appeared after several months of treatment with anidulafungin." | 3.80 | Anidulafungin-induced alopecia. ( Gil-Gómez, I; Lorente-Fernández, L; Monte-Boquet, E; Poveda-Andrés, JL; Ruiz-Ramos, J; Salavert-Lleti, M, 2014) |
| "Fluconazole is recommended as first-line treatment in invasive candidiasis in children and infants." | 3.80 | Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children. ( Alffenaar, JW; Kosterink, JG; Pereboom, M; Schölvinck, EH; van den Heuvel, ER; van der Elst, KC, 2014) |
| "The fungal pathogen Candida glabrata is an emerging cause of candidiasis in part owing to its robust ability to acquire tolerance to the major clinical antifungal drug fluconazole." | 3.80 | Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells. ( Bair, TB; Moye-Rowley, WS; Paul, S, 2014) |
| " Patients receiving low-dose fluconazole prior to the positive BCx with a known indication for prophylaxis including neutropenia, ICU exposure or history of organ transplantation were classified as prophylaxis." | 3.80 | Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. ( Chaudhari, P; Emons, MF; Khandelwal, N; Shorr, AF; Yu, HT; Zilberberg, M, 2014) |
| "To study the clinical effect of a topical controlled-release ophthalmic fluconazole liposomal formulation on patients with Candida keratitis." | 3.78 | A new long-acting liposomal topical antifungal formula: human clinical study. ( Abdel-Rhaman, MS; Fathalla, D; Habib, F; Soliman, W, 2012) |
| " It can be used as an alternative therapy for candidiasis, either alone or in combination with fluconazole." | 3.78 | Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis. ( Belmonte, R; Borelli, P; Carvalho, DD; Daffre, S; Faintuch, B; Miranda, A; Muñoz, JE; Rossi, DC; Taborda, CP, 2012) |
| " In infants on ECMO, a fluconazole dose of 25 mg/kg weekly provides adequate exposure for prophylaxis against Candida infections." | 3.78 | Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation. ( Benjamin, DK; Brouwer, KL; Capparelli, EV; Cheifetz, IM; Cohen-Wolkowiez, M; Moorthy, G; Smith, PB; Wade, KC; Watt, KM, 2012) |
| "Fluconazole is the first line of therapy for the management of candidiasis." | 3.77 | The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients. ( Coleman, JJ; Kourkoumpetis, TK; Manolakaki, D; Mylonakis, E; Tampakakis, E; Velmahos, GC; Ziakas, PD, 2011) |
| " We report a case of spinal osteomyelitis and epidural abscess caused by Candida glabrata occurring in a patient who had been diagnosed with candidemia 3 months before that patient was treated with fluconazole." | 3.77 | Candida glabrata spinal osteomyelitis. ( Dailey, NJ; Young, EJ, 2011) |
| "The efficacy of allicin compared with fluconazole in alleviating systemic Candida albicans infections was evaluated both in vitro and in vivo through a systemic candidiasis mouse model." | 3.77 | Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model. ( Alizadeh, F; Chong, PP; Harmal, NS; Jahromi, MA; Khodavandi, A; Ng, KP; Othman, F; Sekawi, Z; Sidik, SM, 2011) |
| "To report a case of bilateral endogenous candida endophthalmitis treated with intravenous fluconazole." | 3.77 | Intravenous fluconazole for bilateral endogenous Candida endophthalmitis. ( Annamalai, T; Choo, MM; Fong, KC, 2011) |
| "Systemic Candida infections are a major cause of infectious morbidity and mortality during chemotherapy-induced neutropenia." | 3.77 | The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. ( Wingard, JR, 1992) |
| " In an experimental model of vaginal candidiasis, the two candidate compounds were as active as a therapeutic dose of fluconazole." | 3.76 | Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds. ( Arancia, S; Cassone, A; Cauda, R; De Bernardis, F; Guarna, A; Machetti, F; Mannino, C; Trabocchi, A, 2010) |
| " We evaluated the trailing effect of Candida isolates tested with itraconazole in a guinea pig model of systemic candidiasis." | 3.76 | Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis. ( Chen, E; Leitz, GJ; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rex, JH; Rodriguez, JR, 2010) |
| "To describe the clinical management of a case of Candida albicans peritonitis in a dog and discuss the pathogenicity of Candida peritonitis along with treatment using the fungistatic agent, fluconazole." | 3.76 | Candida albicans peritonitis in a dog. ( Ong, RK; Raisis, AL; Swindells, KL, 2010) |
| "In this study, we investigated the in vivo efficacy of anidulafungin during the early phase of disseminated candidiasis in a neutropenic murine model and compared the results with those obtained for fluconazole." | 3.76 | Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model. ( Chandrasekar, PH; Cutright, JL; Krishnan-Natesan, S; Manavathu, EK, 2010) |
| " Treatment of Candida infections is becoming increasingly difficult due to antifungal drug resistance, especially with fluconazole (FLC), which is a commonly used azole." | 3.76 | In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. ( Ahmad, A; Khan, A; Khan, LA; Manzoor, N, 2010) |
| "Voriconazole is used for treating invasive Aspergillosis, Fusarium and Scedosporium infections as well as resistant candidiasis." | 3.75 | [In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp]. ( Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R, 2009) |
| " The aim of the present study was to investigate the effects of ascorbic acid (AA) on the antifungal activity of fluconazole (FCZ) in a systemic murine candidiasis model as well as in vitro." | 3.75 | Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis. ( Cao, YB; Cao, YY; Gao, PH; Jia, JH; Jia, XM; Jiang, YY; Li, MB; Liao, WQ; Wang, Y, 2009) |
| " Fluconazole is increasingly used to prevent and treat invasive candidiasis in infants." | 3.75 | Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants. ( Adamson, PC; Barrett, JS; Benjamin, DK; Gastonguay, MR; Jayaraman, B; Kaufman, DA; Smith, PB; Wade, KC; Ward, RM, 2009) |
| " Patients bearing the Y238X polymorphism in the DECTIN-1 gene were more likely to be colonized with Candida species, compared with patients bearing wild-type DECTIN-1, necessitating more frequent use of fluconazole in the prevention of systemic Candida infection." | 3.75 | Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. ( Adema, G; Blijlevens, NM; Brown, GD; Donnelly, JP; Ferwerda, B; Feuth, T; Kullberg, BJ; Netea, MG; Plantinga, TS; van der Velden, WJ; van Spriel, AB, 2009) |
| "Prior analyses suggest that empiric fluconazole for ICU patients with sepsis is cost-effective." | 3.75 | Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little? ( Golan, Y, 2009) |
| "Recent studies of nonneutropenic patients with candidemia or candidiasis suggest that fluconazole pharmacodynamic parameters correlate with clinical outcomes; however, additional data of correlation to mortality in patients with candidemia would be valuable." | 3.74 | Association of fluconazole pharmacodynamics with mortality in patients with candidemia. ( Andes, DR; Baddley, JW; Bhavnani, SM; Moser, SA; Patel, M, 2008) |
| "Fluconazole (FLC) remains the antifungal drug of choice for non-life-threatening Candida infections, but drug-resistant strains have been isolated during long-term therapy with azoles." | 3.74 | ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. ( Cannon, RD; Holmes, AR; Keniya, M; Lamping, E; Lin, YH; Monk, BC; Niimi, K; Niimi, M; Tanabe, K, 2008) |
| "Fluconazole is being increasingly used to prevent and treat invasive candidiasis in neonates, yet dosing is largely empirical due to the lack of adequate pharmacokinetic (PK) data." | 3.74 | Population pharmacokinetics of fluconazole in young infants. ( Adamson, PC; Barrett, JS; Benjamin, DK; Gastonguay, MR; Hoppu, K; Jayaraman, B; Kaufman, DA; Ramey, N; Sullivan, JE; Wade, KC; Ward, RM; Wu, D, 2008) |
| ", with that of amphotericin B, caspofungin and fluconazole, in an immunocompetent murine model of haematogenously disseminated candidiasis caused by a fluconazole-resistant Candida albicans." | 3.74 | Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis. ( Ghannoum, MA; Kim, HG; Long, L, 2007) |
| "To evaluate the efficacy of subconjunctival injection of micafungin in the treatment of experimental Candida albicans keratitis in rabbits compared with fluconazole." | 3.74 | Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. ( Hiraoka, T; Kaji, Y; Nanbu, PN; Okamoto, F; Oshika, T; Wakabayashi, T, 2007) |
| "To determine the cost-effectiveness of using empiric high-dose fluconazole in intensive care unit (ICU) with suspected invasive candidiasis." | 3.74 | High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. ( Bearden, DT; Chen, H; Garey, KW; Pai, MP; Suda, KJ; Turpin, RS, 2007) |
| "We report on the correlation of the outcomes for two cohorts of patients who had been treated for candidemia (126 episodes) or oropharyngeal candidiasis (110 episodes) with various doses of fluconazole and the MIC of fluconazole obtained by using the EUCAST standard for fermentative yeasts." | 3.74 | Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. ( Almirante, B; Cuenca-Estrella, M; Donnelly, JP; Laguna, F; Mouton, JW; Pahissa, A; Rodríguez-Pardo, D; Rodríguez-Tudela, JL, 2007) |
| " We report an informative case of endogenous endophthalmitis related to injection of cocaine mixed with lemon juice." | 3.74 | Endophthalmitis associated with intravenous drug use. ( Keyashian, K; Malani, PN, 2007) |
| " On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas." | 3.74 | Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008) |
| " albicans is the major cause of candidiasis in non-AIDS patients, and some isolates that are resistant to fluconazole have G487T and T916C mutations in ERG11 that are associated with fluconazole resistance." | 3.74 | Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. ( Chen, L; Li, C; Xu, Y, 2008) |
| "The efficacy of fluconazole prophylaxis to prevent invasive candida infections in patients with acute leukaemia receiving chemotherapy is not clear." | 3.74 | Effect of fluconazole prophylaxis on the incidence of invasive candida infections and bacteraemias in patients with acute leukaemia. ( Anttila, VJ; Elonen, E; Juvonen, E; Nihtinen, A; Ruutu, T; Volin, L, 2008) |
| "We evaluated the impact of fluconazole prophylaxis for extremely low birth weight infants on invasive candidiasis incidence, invasive candidiasis-related mortality rates, and fluconazole susceptibility of Candida isolates." | 3.74 | Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. ( Baker, CJ; Campbell, JR; Healy, CM; Zaccaria, E, 2008) |
| "Fluconazole is widely used for the treatment of candidiasis." | 3.74 | Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. ( Erichsen, R; Gislum, M; Nørgaard, M; Pedersen, L; Schønheyder, HC; Søgaard, KK; Sørensen, HT, 2008) |
| "We investigated the effects of fluconazole and micafungin for the therapy of deep-seated candidiasis in a cyclophosphamide-induced immunosuppressed mouse model." | 3.73 | Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice. ( Mikamo, H; Ninomiya, M; Tamaya, T; Tanaka, K; Watanabe, K, 2005) |
| "An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 3.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
| "To evaluate the therapeutic potential of FX0685, a new triazole antifungal agent, for the treatment of opportunistic fungal infections, particularly systemic candidiasis and aspergillosis, in vitro and in vivo studies were performed using fluconazole (FLC), itraconazole (ITC) and/or amphotericin B (AMB) as reference drugs." | 3.73 | In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans. ( Hoshiko, S; Ohtsuka, K; Okutomi, T; Takahata, S; Uchida, K; Yamaguchi, H, 2005) |
| ", with that of amphotericin B and fluconazole in a temporarily immunocompromised murine model of disseminated candidiasis." | 3.73 | Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis. ( Denning, DW; Morrissey, G; Sharp, A; Warn, PA, 2005) |
| "We assessed the impact of intravenous fluconazole prophylaxis (FP) in extremely low birth weight (ELBW [<1000 g]) infants on the incidence of and outcome from invasive candidiasis (IC) in all infants admitted to a neonatal intensive care unit (NICU)." | 3.73 | Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. ( Baker, CJ; Campbell, JR; Healy, CM; Zaccaria, E, 2005) |
| "We report a case of breakthrough invasive zygomycosis in a stem cell transplant recipient who was receiving caspofungin for treatment of a breakthrough Candida krusei fungemia that occurred during fluconazole prophylaxis." | 3.73 | Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. ( Barberi, W; Foà, R; Girmenia, C; Iori, AP; Martino, P; Micozzi, A; Moleti, ML, 2005) |
| "To investigate the relative pathogenicity of Candida albicans treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis." | 3.73 | Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. ( Duhamel, GE; Hoerrmann, N; Hornby, JM; Navarathna, DH; Nickerson, KW; Parkhurst, AM, 2005) |
| " The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for candida endocarditis." | 3.73 | Survival of candida sepsis in extracorporeal membrane oxygenation. ( Ibsen, LM; Minette, MS, 2005) |
| "Empirical fluconazole therapy is reasonable for likelihoods of invasive candidiasis greater than 2." | 3.73 | Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. ( Golan, Y; Hadley, S; Pauker, SG; Wolf, MP; Wong, JB, 2005) |
| " To assess fluconazole efficacy in a murine model of disseminated candidiasis, inoculum sizes of the control and the erg3 homozygote were chosen which provided a similar organ burden." | 3.73 | Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance. ( Bennett, JE; Izumikawa, K; Kakeya, H; Kohno, S; Miyakoshi, S; Miyazaki, T; Miyazaki, Y, 2006) |
| "A 7-year retrospective analysis of candidemia in patients with hematologic malignancies demonstrated that ten patients, who received itraconazole and fluconazole during neutropenia, developed breakthrough fungemia caused by fluconazole-resistant Candida albicans (C." | 3.73 | Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies. ( Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T, 2006) |
| "We evaluated whether the likelihood of developing invasive candidiasis (IC) differed depending upon the anatomic site of Candida colonization in 182 surgical intensive care unit (SICU) patients who participated in a randomized trial of fluconazole to prevent candidiasis." | 3.73 | The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. ( Hendrix, CW; Johnson, EA; Lipsett, PA; Magill, SS; Merz, WG; Pelz, RK; Swoboda, SM, 2006) |
| "Fluconazole is an antifungal agent that is widely used for the treatment of Candida infection." | 3.73 | Effect of fluconazole consumption on long-term trends in candidal ecology. ( Blot, S; Buyle, F; Claeys, G; De Waele, JJ; Hoste, E; Janssens, R; Peleman, R; Vandewoude, K; Vogelaers, D, 2006) |
| "A 49-year-old Japanese woman treated with oral corticosteroids, methotrexate, and infliximab for malignant rheumatoid arthritis was admitted because of fever and low back pain." | 3.73 | Infectious myositis involving the piriformis in a patient with rheumatoid arthritis. ( Fujinaga, H; Oda, S; Takahashi, K, 2006) |
| "In an established Candida albicans murine keratitis model, combination therapy with ophthalmic preparations of fluconazole and cyclosporine A (CsA) demonstrated in vivo drug synergy and effectively resolved wild-type C." | 3.73 | Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy. ( Afshari, NA; Heitman, J; Onyewu, C, 2006) |
| "Although a fluconazole prophylaxis regimen for ELBW infants was effective in preventing invasive candidiasis, an increase in the incidence of conjugated hyperbilirubinemia was observed." | 3.73 | Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. ( Aghai, ZH; Amendolia, B; Kaki, S; Kemble, N; Longo, D; Mudduluru, M; Nakhla, TA; Saslow, JG; Stahl, GE; Sutsko, R, 2006) |
| " We performed 24-h pharmacodynamic studies to compare the efficacies of anidulafungin, fluconazole, and amphotericin B in neutropenic mice with disseminated candidiasis caused by one of three strains of Candida glabrata." | 3.73 | Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis. ( Deziel, MR; Drusano, GL; Drusano, MF; Gumbo, T; Liu, W; Louie, A; Ma, L, 2006) |
| "Several clinical trials have demonstrated the efficacy of fluconazole as empiric antifungal therapy in cancer patients with fever and neutropenia." | 3.73 | Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia. ( Bates, DW; Kumar, RN; Peterson, JF; Seger, DL; Yu, DT, 2006) |
| " The drug is available for intravenous or oral administration and has been shown to be effective in invasive aspergillosis, fluconazole-susceptible and -resistant candidiasis, and infections caused by various other fungal pathogens, including some formerly refractory organisms." | 3.73 | Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections. ( Haas, A; Maschmeyer, G, 2006) |
| "The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole." | 3.72 | Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice. ( Fukuoka, T; Hosokawa, T; Kamai, Y; Kubota, M; Kuwahara, S; Maeda, N; Shibayama, T; Uchida, K; Yamaguchi, H, 2003) |
| "To determine if failure of recurrent Candida albicans vulvovaginitis to respond clinically to fluconazole is related to in vitro mycologic resistance." | 3.72 | Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. ( Carey, JC; MacNeill, C; Weisz, J, 2003) |
| "To determine the most efficient time point and concentration of topical corticosteroids in Candida albicans keratitis treated with fluconazole." | 3.72 | Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. ( Behrens-Baumann, W; König, W; Olbrisch, A; Schreiber, W; Vorwerk, CK, 2003) |
| "A 22-yr-old male with acute lymphoblastic leukemia and Candida krusei fungemia failed therapy with fluconazole and amphotericin B." | 3.72 | Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent. ( McGee, WT; Tereso, GJ, 2003) |
| " In neutropenic mouse models of disseminated candidiasis and pulmonary aspergillosis, the efficacy of MCFG was superior to that of fluconazole and itroconazole, but comparable to that of amphotericin B." | 3.72 | [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)]. ( Ikeda, F, 2003) |
| " We encountered a tuboovarian abscess caused by Candida glabrata after chemotherapy with an anticancer drug, methotrexate, in a febrile neutropenic patient." | 3.72 | Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient. ( Mikamo, H; Ninomiya, M; Tamaya, T, 2003) |
| "(1) The reference treatment for invasive candidiasis in patients without neutropenia is standard amphotericin B." | 3.72 | Caspofungin: new indication. No progress in invasive candidiasis. ( , 2004) |
| " Chronic disseminated candidiasis had developed and was treated with amphotericin B, initially, and fluconazol." | 3.72 | [The 'bull's eye' pattern in hepatic tomography]. ( Cortés, JA; Cuervo, SI; Hernández, LF; Potdevin, G; Urdaneta, AM, 2004) |
| " We studied the activity of PLD-118 in escalating dosages against experimental oropharyngeal and esophageal candidiasis (OPEC) caused by fluconazole (FLC)-resistant Candida albicans in immunocompromised rabbits." | 3.72 | Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. ( Bacher, J; Groll, AH; Kelaher, AM; Mickiene, D; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ, 2004) |
| "The aim of this study was to determine the retinal toxicity and intraocular pharmacokinetics of vitrectomy with fluconazole infusion in rabbit eyes and to study its efficacy in the treatment of experimental candidal endophthalmitis." | 3.72 | Vitrectomy with fluconazole infusion: retinal toxicity, pharmacokinetics, and efficacy in the treatment of experimental candidal endophthalmitis. ( Cheng, CK; Hsueh, PR; Liu, CM; Lu, HY; Yang, CH, 2004) |
| "This study aimed to test the MICs (minimal inhibitory concentrations) to fluconazole of Candida species isolated from mouthwash specimens of 54 HIV positive patients with oral candidiasis." | 3.71 | Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients. ( Bussaratid, V; Howe, P; Phonrat, B; Pitisuttithum, P; Simpson, A; Tansupasawasdikul, S; White, NJ, 2002) |
| " He received broad-spectrum antibiotics, fluconazole for oral candidiasis, and cotrimoxazole for possible Pneumocystis carinii." | 3.71 | Pneumonia due to Candida krusei. ( Costopoulos, H; Georgilis, K; Kontoyannis, D; Nanas, J; Petrocheilou-Paschou, V; Prifti, H; Stamatelopoulos, S, 2002) |
| " We studied the antifungal efficacy, the concentrations in saliva and tissue, and the safety of VER-002 at escalating dosages against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant Candida albicans in immunocompromised rabbits." | 3.71 | Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, J; Francesconi, A; Groll, AH; Lyman, CA; Petraitiene, R; Petraitis, V; Piscitelli, SC; Schaufele, RL; Sein, T; Walsh, TJ, 2001) |
| "To present a case of fluconazole-associated torsade de pointes (TDP) and discuss fluconazole's role in causing TDP." | 3.71 | Fluconazole-induced torsade de pointes. ( Hanley, JF; Merliss, AD; Potti, A; Tholakanahalli, VN, 2001) |
| "Although fluconazole is the therapy of choice for patients in the intensive care setting with Candida infections, two patients with multiple organ failure who received high-dose fluconazole appeared to develop adrenal insufficiency." | 3.71 | Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients. ( Albert, SG; DeLeon, MJ; Silverberg, AB, 2001) |
| " The fungal infection was successfully controlled using fluconazole, and the patient has been disease-free for more than 11 months after antileukemic chemotherapy without any recurrence of Candida infections." | 3.71 | Successful treatment of hepatosplenic candidiasis in an elderly patient with acute myeloid leukemia using liposomal daunorubicin and fluconazole. ( Barbera, V; Gambino, R; Mariani, G; Minardi, V; Quintini, G; Spadola, V, 2001) |
| "Fluconazole was reported to be an effective alternative to Amphotericin B for candidal endophthalmitis." | 3.71 | Clinicopathological report of Candida granuloma from an endogenous candidal endophthalmitis. ( Chang, KC; Kou, HK; Lin, JW, 2001) |
| "Random amplified polymorphic DNA analysis was used to detect genotype relatedness among clinical fluconazole-resistant and -sensitive strains of Candida albicans recovered from twenty HIV-infected patients having oropharyngeal candidiasis." | 3.71 | Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and -sensitive strains of Candida albicans. ( Bhattacharya, E; Jain, P; Khan, ZK; Ranade, SA, 2001) |
| "The development of new azoles with a better ocular bioavailability (fluconazole), and the improvement of vitrectomy has recently influenced the treatment of fungal endophthalmitis." | 3.71 | [Mycotic endophthalmitis: management and treatment (9 year study)]. ( Bovey, EH; Guex-Crosier, Y; Mora, P, 2002) |
| "Signs and symptoms of oropharyngeal candidiasis (OPC) were correlated with microbiology and clinical response to fluconazole in a cohort of patients with advanced human immunodeficiency virus (HIV) infection and recurrent OPC." | 3.70 | Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients. ( Dib, OP; Fothergill, AW; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Redding, SW; Revankar, SG; Rinaldi, MG, 1998) |
| "A murine model of systemic candidiasis was used to assess the virulence of serial Candida albicans strains for which fluconazole MICs were increasing." | 3.70 | Fluconazole versus Candida albicans: a complex relationship. ( Graybill, JR; Kirkpatrick, WR; Luther, MF; Montalbo, E; Patterson, TF; Revankar, SG, 1998) |
| "From each of two AIDS patients with oropharyngeal candidiasis, five Candida albicans isolates from recurrent episodes of infection which became gradually resistant against fluconazole during antimycotic treatment were analyzed for molecular changes responsible for drug resistance." | 3.70 | Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. ( Franz, R; Kelly, DE; Kelly, SL; Lamb, DC; Morschhäuser, J; Ruhnke, M, 1998) |
| "To assess efficacy and safety of fluconazole in neonates with Candida fungemia." | 3.70 | Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. ( Filka, J; Hartmanova, I; Huttova, M; Kralinsky, K; Krcmery, V; Krizan, S; Kurak, J; Uher, J, 1998) |
| "Few data exist concerning the combined use of fluconazole systemically and as an irrigant for nephrostomy tubes in a patient with renal candidiasis." | 3.70 | The use of fluconazole as a local irrigant for nephrostomy tubes. ( Clark, MA; Czachor, JS; Gaunt, T, 1999) |
| "We determined the pharmacodynamic parameter and the magnitude of that parameter that was predictive of the efficacy of fluconazole in the treatment of disseminated candidiasis." | 3.70 | Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model. ( Andes, D; van Ogtrop, M, 1999) |
| "The most widely used drug for treatment of candidiasis is fluconazole (FCZ)." | 3.70 | A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cells. ( Barluzzi, R; Bistoni, F; Fringuelli, R; Perito, S; Pitzurra, L; Schiaffella, F; Vecchiarelli, A, 1999) |
| "The purpose of this histological study was to present postmortem findings in both eyes of a 53-year-old male with liver dysfunction 2 weeks after short-time oral treatment with 200 mg/day fluconazole for metastatic Candida endophthalmitis due to intravenous hyperalimentation for 18 days." | 3.70 | Postmortem findings two weeks after oral treatment for metastatic Candida endophthalmitis with fluconazole. ( Arakawa, T; Ishibashi, T; Murata, T; Ohnishi, Y; Sakamoto, T; Tawara, A, 1999) |
| "We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 3.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
| "The interaction between fluconazole (Flu) and amphotericin B (AmB) was evaluated in a murine model of systemic candidiasis for one Flu-susceptible strain (MIC, 0." | 3.70 | Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans. ( Banerjee, P; Drusano, GL; Louie, A; Miller, MH; Shayegani, M, 1999) |
| "In immunocompetent mice with candidiasis, successful therapy with amphotericin B and fluconazole relies on the induction of protective, T helper (Th) type 1 responses, an effect potentiated by concomitant interleukin (IL)-4 neutralization." | 3.70 | Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis. ( Bacci, A; Bistoni, F; Cenci, E; Mencacci, A; Romani, L, 2000) |
| "To study the efficacy of intravitreally injected plain and liposome encapsulated fluconazole in the doses of 100 and 200 microg in Candidal endophthalmitis in rabbit eyes." | 3.70 | Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes. ( Dhingra, N; Gupta, SK; Jaiswal, J; Velpandian, T, 2000) |
| "We compared four doses of amphotericin B lipid complex (ABLC) with three doses of fluconazole in temporarily neutropenic mice in a murine model of disseminated candidiasis due to four different isolates of Candida tropicalis." | 3.70 | In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. ( Denning, DW; Moore, CB; Morrissey, J; Warn, PA, 2000) |
| "5 mg/kg/day or fluconazole > or =6 mg/kg/day) of systemic antifungal therapy predicts focal infectious complication(s) or death from infection, we compared neonatal intensive care unit infants who had persistent (P+) or nonpersistent (P-) positive cultures with invasive candidiasis (clinical signs of infection and recovery of Candida from a normally sterile site) at this center from January 1, 1981, through June 30, 1999." | 3.70 | Persistently positive cultures and outcome in invasive neonatal candidiasis. ( Chapman, RL; Faix, RG, 2000) |
| "Candida peritonitis was treated with fluconazole in ten continuous ambulatory peritoneal dialysis (CAPD) patients without immediate removal of the peritoneal catheter." | 3.69 | Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter. ( Aguirre, R; González, O; Martinez, I; Montenegro, J; Saracho, R, 1995) |
| "Candida krusei is a cause of invasive candidiasis (IC), with numerous cases reported among leukemia patients after bone marrow transplantation and treatment with fluconazole." | 3.69 | Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole. ( Hinrichs, SH; Iwen, PC; Kelly, DM; Reed, EC, 1995) |
| "We investigated the efficacy of oral fluconazole, alone or in combination with oral flucytosine (5FC), in treating Candida endophthalmitis using a rabbit model." | 3.69 | Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole. ( Baker, AS; D'Amico, DJ; Park, SS; Paton, B, 1995) |
| "Although fluconazole is increasingly utilized for the therapy of Candida oesophagitis in patients with AIDS, the time course of response has not been adequately defined." | 3.69 | Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. ( Wilcox, CM, 1994) |
| "A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole." | 3.69 | The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994) |
| "Two pediatric leukemic patients with hepatosplenic candidiasis during multidrug antileukemic chemotherapy successfully underwent bone marrow transplantation (BMT) after aggressive antifungal chemotherapy employing fluconazole and amphotericin B with or without splenectomy." | 3.69 | Successful peritransplant therapy in children with active hepatosplenic candidiasis. ( Ichihara, T; Katayama, K; Koizumi, S; Konishi, M; Maekawa, S; Seki, H; Tamaru, Y; Taniguchi, N; Yamagami, M, 1994) |
| "Models of acute and chronic candidiasis were developed in Fischer 344 rats to evaluate the therapeutic efficacy of recombinant human macrophage colony-stimulating factor (rhM-CSF) alone and in combination with the antifungal agent fluconazole." | 3.69 | Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. ( Ando, D; Aukerman, SL; Fidler, JM; Vitt, CR; Zimmerman, RJ, 1994) |
| " One patient had developed a chronic systemic candidiasis during consolidation chemotherapy and received prophylactic oral or iv fluconazole (200 mg daily) throughout BMT." | 3.69 | Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. ( Altés, A; Brunet, S; Domingo-Albós, A; Martínez, C; Martino, R; Nomdedéu, J; Sureda, A, 1994) |
| "Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B 1-2 mg and oral flucytosine or fluconazole 50 mg b." | 3.69 | Successful treatment of fungal peritonitis with intracatheter antifungal retention. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
| "The present studies were performed to determine whether any beneficial interaction results from combination therapy with recombinant human granulocyte colony-stimulating factor (GCSF) and fluconazole in disseminated candidiasis in mice." | 3.69 | Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. ( Bocanegra, R; Graybill, JR; Luther, M, 1995) |
| "Since fluconazole achieves high urine concentrations, we assessed its usefulness in the treatment of urinary candidiasis." | 3.69 | [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]. ( Castrillón, MA; del Canto, E; Pino, M; Schenone, D; Thompson, L, 1995) |
| "Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis." | 3.69 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996) |
| "Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C." | 3.69 | Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996) |
| "To investigate the efficacy of pars plana vitrectomy and oral fluconazole without injection of intravitreal antimycotic agents in the treatment of vitritis resulting from Candida endophthalmitis." | 3.69 | Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. ( Christmas, NJ; Smiddy, WE, 1996) |
| "Infections with fluconazole-resistant Candida albicans isolate have rarely been described in clinical settings other than oropharyngeal candidiasis in patients with late-stage AIDS." | 3.69 | Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. ( Dix, S; Falconer, DJ; Geller, R; Gilmore, C; Nolte, FS; Parkinson, T; Williams, J; Wingard, JR, 1997) |
| "The clinical records of those patients with invasive candidiasis that cured with fluconazole were retrospectively reviewed." | 3.69 | [Curative treatment with fluconazole in 5 cases of invasive candidiasis]. ( Caballero-Granado, J; Jiménez-Mejías, ME; Martínez-Marcos, FJ; Moreno-Maqueda, I; Pachón-Díaz, J; Rodríguez-Hernández, MJ, 1996) |
| "To evaluate the role of Fluconazole in the management of neonatal systemic candidiasis." | 3.69 | Fluconazole in the management of neonatal systemic candidiasis. ( Agrawal, P; Chakraborti, A; Kumar, P; Narang, A, 1996) |
| "We describe a patient with bilateral, delayed endophthalmitis who underwent bilateral pars plana vitrectomy, total capsulectomy, intraocular lens exchange, intravitreal injection of amphotericin B, and oral fluconazole therapy." | 3.69 | Bilateral Candida parapsilosis endophthalmitis. ( Eagle, RC; Rodriguez, A; Tasman, W; Wong, VK, 1997) |
| "In this study, oral administration of the triazole D0870 was compared to oral administration of fluconazole in the treatment of experimental vaginal candidiasis." | 3.69 | Efficacy of D0870 treatment of experimental Candida vaginitis. ( Cutright, JL; Fidel, PL; Sobel, JD, 1997) |
| "We report on two children with malignancy who showed fungemia despite the antifungal treatment with fluconazole." | 3.69 | [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole]. ( Ebihara, Y; Hosoya, R; Manabe, A; Saito, A; Takahashi, K, 1997) |
| " Since topoisomerases are present in eukaryotic cells, it was of interest to evaluate the antifungal activities of two clinically available quinolones, ciprofloxacin and trovafloxacin, alone and in combination with amphotericin B or fluconazole, in vitro against Candida albicans and in a murine model of invasive candidiasis." | 3.69 | Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs. ( Chen, RJ; Liu, XP; Sugar, AM, 1997) |
| "We report three cases of deep-seated and systemic Candida albicans infection in which inadequate dosages of fluconazole were used, leading to breakthrough fungaemia, candidal osteomyelitis and endocarditis." | 3.69 | Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection. ( Barnes, RA; Flanagan, PG, 1997) |
| "Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C." | 3.68 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 3.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "A 29-year-old former drug addict with candida albicans endophthalmitis determined by cultivation was treated with vitrectomy and systemic fluconazole." | 3.68 | Fluconazole in the treatment of candida albicans endophthalmitis. ( Degn, T; Urbak, SF, 1992) |
| "A patient with acute cholecystitis due to Candida albicans and Candida parapsilosis was treated with a percutaneous cholecystostomy and daily intravenous fluconazole." | 3.68 | Biliary concentrations of fluconazole in a patient with candidal cholecystitis: case report. ( Bozzette, SA; Fierer, J; Gordon, RL; Ito, MK; Rinaldi, M; Yen, A, 1992) |
| " Fluconazole has been proposed as alternative therapy for the treatment of systemic candidiasis including candidemia." | 3.68 | Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis. ( Blumberg, HM; Hendershot, EF; Lott, TJ, 1992) |
| "An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B." | 3.68 | Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992) |
| "The effect of intravenous fluconazole on endogenous Candida endophthalmitis in rabbits was investigated." | 3.68 | Study of suppressive effect of intravenous fluconazole on endogenous Candida endophthalmitis in rabbits. ( Hatano, H; Isobe, Y, 1992) |
| " We report a case of hepatosplenic candidiasis in a patient with acute myelogenous leukemia who had clinical and radiographic improvement during fluconazole therapy." | 3.68 | Fluconazole in the treatment of hepatosplenic candidiasis. ( Adelman, HM; Altus, P; Flannery, MT; Saba, H; Simmons, DB; Wallach, PM, 1992) |
| "To determine if fluconazole is effective treatment for hepatosplenic candidiasis that has not resolved with amphotericin B and flucytosine treatment." | 3.68 | Hepatosplenic candidiasis: successful treatment with fluconazole. ( Bradley, SF; Kauffman, CA; Ross, SC; Weber, DR, 1991) |
| "We compared the efficacy of intravenous fluconazole (80 mg/kg of body weight per day) with that of amphotericin B (1 mg/kg/day) for the long-term treatment of endophthalmitis in rabbits with disseminated candidiasis." | 3.68 | Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. ( Crislip, MA; Edwards, JE; Filler, SG; Mayer, CL, 1991) |
| "Fluconazole, a new triazole derivative, was evaluated in a pilot study of 34 episodes of candidiasis in 24 children." | 3.68 | Fluconazole in the treatment of candidiasis in immunocompromised children. ( Barigione, G; Castagnola, E; Ciravegna, B; Fioredda, F; Terragna, A; Viscoli, C, 1991) |
| "The therapeutic effect of intravenous fluconazole against endogenous candida endophthalmitis was investigated in rabbits." | 3.68 | [The suppressive effect of intravenous fluconazole against endogenous candida endophthalmitis in rabbits]. ( Hatano, H; Isobe, Y, 1990) |
| "We have reviewed the efficacy of the use of fluconazole in patients with definitely proven Candida esophagitis (CE) associated with human immunodeficiency virus (HIV) infection, using a single 400 mg oral dose of fluconazole and evaluating the patient three days afterwards." | 3.68 | [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases]. ( Carrasco, R; Martínez, A; Medina, E; Navarro, V; Nieto, A; Roig, P; Salavert, M, 1990) |
| "To investigate the potential use of fluconazole for prevention and treatment of disseminated candidiasis in granulocytopenic patients, its in vivo antifungal activity was studied in three models of disseminated candidiasis in persistently granulocytopenic rabbits: acute, subacute, and chronic disseminated candidiasis." | 3.68 | Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. ( Aoki, S; Bacher, J; Lee, J; Mechinaud, F; Pizzo, PA; Rubin, M; Walsh, TJ, 1990) |
| "The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis." | 3.68 | Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. ( Hector, RF; Yee, E, 1990) |
| "Using a reproducible model of Candida albicans keratitis in rabbits we studied the effect of topical fluconazole, a new triazole." | 3.68 | Topical fluconazole for experimental candida keratitis in rabbits. ( Behrens-Baumann, W; Klinge, B; Rüchel, R, 1990) |
| "The clinical efficacy of fluconazole at doses of 100-400 mg daily given intravenously in the treatment of 6 cases of deep mycosis complicated with leukemia was evaluated." | 3.67 | [Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia]. ( Fukawa, H; Kodama, F; Maruta, A; Matsuzaki, M, 1989) |
| "Clinical evaluation of fluconazole was performed on 12 cases of mycotic infections (7 cases of Candida esophagitis; one each case of cryptococcal meningitis with AIDS, Candida tropicalis fungemia and disseminated cryptococcosis in kidney transplant patient; 2 cases of Candida pneumonia)." | 3.67 | [Clinical evaluation of fluconazole]. ( Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M, 1989) |
| "Efficacies of fluconazole, a new triazole antifungal agent, were evaluated in 11 cases of systemic mycoses (1 case each of candiduria, pulmonary cryptococcosis, pulmonary aspergillosis, pulmonary penicilliosis and suspected fungal pulmonary infection, and 3 cases each of candidemia and Candida endophthalmitis)." | 3.67 | [Fluconazole treatment of systemic mycoses]. ( Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K, 1989) |
| "We compared the efficacies of the new triazole antifungal drugs fluconazole and itraconazole with that of amphotericin B in vitro and in an animal model of systemic candidiasis in normal and neutropenic mice." | 3.67 | Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. ( Mattie, H; van Furth, R; Van t Wout, JW, 1989) |
| "20 patients (18 men, 2 women), 10 of whom were HIV +, were given Fluconazole (F) for either systemic candidiasis (13 cases), histoplasmosis (1), or cryptococcosis (6)." | 3.67 | [Value of fluconazole in the treatment of systemic yeast infection]. ( Bernard, E; Carles, M; Dellamonica, P; Fournier, JP; Toussaint-Gari, M, 1989) |
| " In the treatment of experimental cryptococcal meningitis, SCH39304 was as effective as fluconazole in reducing yeast counts in the subarachnoid space." | 3.67 | Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. ( Durack, DT; Hobbs, MM; Perfect, JR; Wright, KA, 1989) |
| "Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios." | 3.67 | Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987) |
| " Dosing instructions in product labels appear to be inconsistent with the emerging scientific evidence." | 2.87 | Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial. ( Aurich, B; Barin-Le Guellec, C; Biran, V; Coopman, S; Dusang, B; Elie, V; Garcia Sanchez, R; Goudjil, S; Jacqz-Aigrain, E; Legrand, F; Leroux, S; Manzoni, P; Zhao, W, 2018) |
| "Pyelonephritis was associated with caliectasis and obstruction due to possible fungus ball formation." | 2.82 | Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature. ( Kolonitsiou, F; Lekkou, A; Paliogianni, F; Spiliopoulou, A; Tsoupra, S; Vrioni, G, 2022) |
| "Invasive candidiasis is a serious, progressive, and potentially deadly infection that can affect the brain, heart, bones, eyes, and other parts of the body." | 2.82 | Invasive candidiasis in Africa, what is the current picture? ( Ibe, C; Nweze, E; Okoye, CA, 2022) |
| "Isavuconazole is a novel, broad-spectrum antifungal developed for the treatment of opportunistic fungal infections." | 2.80 | A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis. ( Azie, N; Ghannoum, M; Schmitt-Hoffmann, AH; Viljoen, J, 2015) |
| " In 234 episodes, initial antifungal treatment consisted of amphotericin B [as monotherapy, n = 193; median dosage (range) of amphotericin B deoxycholate 0." | 2.73 | Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93. ( Creutzig, U; Groll, AH; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Ritter, J; Schwabe, D; Varwig, D, 2007) |
| "Fluconazole plasma levels were determined to evaluate whether this dosage is adequate to reach the advised fluconazole levels." | 2.72 | Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg. ( Bergner, R; Haefeli, WE; Henrich, DM; Hoffmann, M; Mikus, G; Riedel, KD; Uppenkamp, M; Walter-Sack, I, 2006) |
| "Fluconazole prophylaxis was defined by a minimum of 5 prophylactic doses." | 2.69 | The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. ( Bowden, RA; Hackman, RC; Leisenring, W; McDonald, GB; Myerson, D; Sale, GE; Shulman, HM; van Burik, JH, 1998) |
| "Fluconazole (FLU) is an alternative to amphotericin B (AMB) for the treatment of candidemia in non-neutropenic patients." | 2.69 | Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients. ( Conly, J; Dranitsaris, G; Garber, G; Ioannou, S; Miller, M; Phillips, P; Puodziunas, A; Rotstein, C; Salit, I; Shafran, S; Singer, J; Smaill, F; Williams, K, 1998) |
| "The test is applied on AIDS prophylaxis and paediatric trials." | 2.69 | Combining mortality and longitudinal measures in clinical trials. ( Finkelstein, DM; Schoenfeld, DA, 1999) |
| "Although fungal urinary tract infections are an increasing nosocomial problem, the significance of funguria is still not clear." | 2.69 | Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. ( Dismukes, WE; Gallis, HA; Karchmer, AW; Kauffman, CA; Lee, JY; Mangi, R; McKinsey, DS; Mosher, A; Sharkey, PK; Sobel, JD; Sugar, AM; Vazquez, JA; Wise, GJ, 2000) |
| "Oral fluconazole was safe and effective for short-term eradication of candiduria, especially following catheter removal." | 2.69 | Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. ( Dismukes, WE; Karchmer, AW; Kauffman, CA; Lee, J; McKinsey, D; Panzer, H; Sobel, JD; Thomas, C; Vazquez, JA; Zervos, M, 2000) |
| "54-1) and the elimination half-life (t1/2) was 14." | 2.69 | Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole. ( Bruch, HP; Iven, H; Martens, T; Muhl, E; Rob, P, 2000) |
| " Prophylactic fluconazole was safe and significantly reduced systemic fungal infections with other benefits, including improved survival at day 110 after marrow transplantation." | 2.68 | Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. ( Adams, R; Bowden, RA; Feldman, AR; Levenstein, MJ; Meyers, JD; Osborne, B; Schoch, HG; Slavin, MA, 1995) |
| "Disseminated candidiasis is a serious infectious complication with a mortality as high as 50%." | 2.68 | An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. ( de Pauw, BE; Donnelly, JP; Kullberg, BJ; Meis, JF; Raemaekers, JM, 1995) |
| "fluconazole for treatment of candidemia in nonneutropenic patients, data on the management of intravascular catheters were collected." | 2.68 | Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. ( Bennett, JE; Edwards, JE; Pappas, PG; Rex, JH; Serody, J; Sugar, AM; Washburn, RG, 1995) |
| "Fluconazole was given 100-200 mg daily for 3 days to 8 months." | 2.68 | [A multiple center clinical trial on fluconazole for deep-seated fungal infections]. ( Liang, D; Xu, N; Zhang, H, 1995) |
| "Amphotericin B was prescribed therapeutically in 25 patients, in seven together with fluconazole." | 2.68 | Management of candida septicaemia in a regional burn unit. ( Belcher, K; Law, EJ; Still, JM, 1995) |
| "Fungal urinary tract infections are increasingly prevalent in the elderly in acute and chronic care settings." | 2.68 | Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. ( Fox, N; Freeman, K; Jacobs, LG; Lipschultz, D; Skidmore, EA, 1996) |
| "Fluconazole alone was given to 27 patients, amphotericin B alone to 10, and sequential therapy to 6." | 2.68 | Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. ( Ibáñez-Lucía, P; León-Gil, C; León-Regidor, MA; Martínez-González, J; Nolla-Salas, J; Sitges-Serra, A; Torres-Rodríguez, JM, 1997) |
| "Fungal urinary tract infections are increasingly prevalent in hospitalized patients." | 2.68 | Oral fluconazole for Candida urinary tract infection. ( Castin, A; Moskovitz, B; Nativ, O; Potasman, I; Srugo, I, 1997) |
| "Oral candidiasis is a frequent opportunistic infection in AIDS patients." | 2.67 | [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)]. ( Coll-Seck, AM; Diop, BM; Faye, MA; Ndiaye, I; Sow, PS, 1993) |
| "Fluconazole was evaluated prospectively in 173 children aged between 4 months and 16 years in whom conventional antifungal therapy was ineffective or contraindicated." | 2.67 | Fluconazole treatment of children with severe fungal infections not treatable with conventional agents. ( Fasano, C; Gibbs, D; O'Keeffe, J, 1994) |
| " No treatment-related adverse events required termination of treatment." | 2.67 | Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group. ( Graninger, W; Presterl, E, 1994) |
| "Fluconazole was evaluated prospectively in 40 neonates and infants between the ages of 2 days and 3 months in whom conventional antifungal therapy was ineffective or contraindicated." | 2.67 | Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents. ( Fasano, C; Gibbs, D; O'Keeffe, J, 1994) |
| "Fluconazole was particularly effective in reducing the carriage of C." | 2.67 | The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team. ( Chandrasekar, PH; Gatny, CM, 1994) |
| "Fluconazole (FLCZ) is an antifungal agent of triazole class and has been proven to be effective against deep-seated mycosis caused by Candida spp." | 2.67 | [Experience of fluconazole granules and injection in pediatric patients]. ( Azuma, E; Ido, M; Ihara, T; Ito, M; Kamiya, H; Nakano, T; Sakurai, M; Yasuda, N, 1994) |
| "Fluconazole (FLCZ) is a novel antifungal agent and available both in oral and intravenous forms." | 2.67 | [Pharmacokinetic and clinical evaluations of fluconazole in pediatric patients]. ( Aoki, S; Miyake, M; Murata, T; Nishimura, T; Sugita, K; Takitani, K, 1994) |
| " Pharmacokinetic characteristics of fluconazole were determined after the first, third, and fifth doses." | 2.67 | Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. ( Hoppu, K; Pohjavuori, M; Saxén, H, 1993) |
| "Fluconazole treatment was successful in 53% of the patients." | 2.67 | Efficacy of fluconazole in the treatment of systemic fungal infections. ( Milatovic, D; Voss, A, 1992) |
| "Fluconazole or placebo was administered prophylactically from the start of the conditioning regimen until the neutrophil count returned to 1000 per microliter, toxicity was suspected, or a systemic fungal infection was suspected or proved." | 2.67 | A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. ( Chandrasekar, PH; Fox, B; Friedman, DJ; Goodman, JL; Greenfield, RA; Kaizer, H; Shadduck, RK; Shea, TC; Stiff, P; Winston, DJ, 1992) |
| "Fluconazole is a bis-triazole antifungal agent with a long serum half-life." | 2.67 | Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs. ( Hales, M; Kernoff, PB; Lee, CA; Lim, SG; O'Doherty, M; Winter, M, 1991) |
| "Fluconazole is a new antifungal agent from the class of triazoles for systemic treatment of fungal infections caused by Candida or Cryptococcus." | 2.67 | [Collection of cases in relation to clinical trials of fluconazole in Germany]. ( Krisch, H; Sarnow, E, 1990) |
| "Invasive fungal infections are a potentially life-threatening complication in immunocompromised patients." | 2.66 | Efficacy and safety of posaconazole for the prevention of invasive fungal infections in immunocompromised patients: a systematic review with meta-analysis and trial sequential analysis. ( Ching, SM; Divya, G; Loo, YS; Menon, RK; Veettil, SK; Wong, PS; Wong, TY, 2020) |
| "Fluconazole is a novel antifungal agent, available in oral and intravenous forms, which was developed by Pfizer Central Research." | 2.66 | [Clinical study of fluconazole on deep-seated fungal infections]. ( Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T, 1989) |
| "Fungal otomastoiditis is a rare disease, but can be fatal for immunocompromised patients." | 2.55 | Otomastoiditis caused by Candida auris: Case report and literature review. ( An, J; Choi, HI; Hwang, JJ; Moon, SY; Son, JS, 2017) |
| "Neonatal liver abscess is an uncommon seen condition in neonatology and it holds a very high neonatal mortality because of difficulty in diagnosis and treatment." | 2.52 | Neonatal liver abscesses due to Candida infection in a preterm infant, secondary to malpositioned umbilical lines--a rare entity. ( Choudhary, M; Sharma, D; Sharma, PK; Shastri, S, 2015) |
| "Fluconazole resistance was present in 16 of 32 cases of C." | 2.49 | Background changing patterns of neonatal fungal sepsis in a developing country. ( Ballot, DE; Bosman, N; Cooper, PA; Nana, T; Ramdin, T, 2013) |
| "Amphotericin B deoxycholate has been favored for many years, but fluconazole has the most data supporting its use in neonatal Candida infections and is often employed for prophylaxis as well as treatment." | 2.49 | Old and new: appropriate dosing for neonatal antifungal drugs in the nursery. ( Benjamin, DK; Ericson, J; Manzoni, P, 2013) |
| "Candida osteomyelitis is a rare infection." | 2.48 | Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature. ( Horn, DL; Keith, SW; Slenker, AK, 2012) |
| "We report a patient with acute myeloid leukemia who developed HSC during post-remission consolidation chemotherapy and was treated with a prolonged course of caspofungin followed by fluconazole." | 2.45 | Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature. ( Chia, HY; Koh, LP; Liu, TC; Poon, LM; Tan, LK, 2009) |
| "In most people, untreated candidiasis persists for months or years unless associated risk factors are treated or eliminated." | 2.45 | Candidiasis (oropharyngeal). ( Pankhurst, CL, 2009) |
| " Sensitivity analyses included dosage forms of amphotericin B and fluconazole compared to other azoles." | 2.45 | Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis. ( Cooper, C; Mills, EJ; Nachega, JB; Perri, D; Phillips, P; Tleyjeh, I; Wu, P, 2009) |
| "Invasive candidiasis is a common nosocomial infection among critically ill patients, constitutes an important cause of sepsis, and is associated with significant morbidity and mortality." | 2.44 | Invasive candidiasis in the ICU: evidence based and on the edge of evidence. ( Hollenbach, E, 2008) |
| "Micafungin was comparable to liposomal amphotericin B in mortality." | 2.44 | Treatment of invasive candidal infections: systematic review and meta-analysis. ( Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L, 2008) |
| "Invasive candidiasis is diagnosed by combination of clinical manifestation, laboratory findings and isolation of Candida spp." | 2.44 | [Candidiasis]. ( Imamura, Y; Izumikawa, K; Kohno, S, 2008) |
| "Fungal peritonitis is a rare but serious complication in children on peritoneal dialysis (PD)." | 2.44 | Fungal peritonitis in children on peritoneal dialysis. ( Cornelissen, E; Monnens, L; Raaijmakers, R; Schröder, C; Warris, A, 2007) |
| "Endogenous fungal endophthalmitis is a potentially blinding condition that can signal an underlying systemic infection." | 2.44 | Presumed Candida endogenous fungal endophthalmitis: a case report and literature review. ( Najmi, NG; Ober, RR; Song, HF, 2007) |
| "Candida endophthalmitis is a sight-threatening manifestation of disseminated candidiasis." | 2.44 | Candida endophthalmitis: focus on current and future antifungal treatment options. ( Khakoo, RA; Khan, FA; Slain, D, 2007) |
| "Voriconazole is a second-generation triazole antifungal agent, structurally derived from fluconazole with an extended spectrum of activity against a wide variety of yeasts and moulds." | 2.43 | Voriconazole: review of a broad spectrum triazole antifungal agent. ( Kofla, G; Ruhnke, M, 2005) |
| "The incidence of candidiasis has risen in neonatal intensive care units as advances in medical therapy have allowed for increased survival of extremely preterm neonates." | 2.43 | Neonatal candidiasis: prophylaxis and treatment. ( Benjamin, DK; Smith, PB; Tiffany, KF, 2005) |
| "Candida species rarely cause spondylodiscitis." | 2.42 | An unusual cause of vertebral osteomyelitis: Candida species. ( Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Rohner, P; Schnyder, I, 2003) |
| " This article reviews recent pertinent data with regard to dosing guidelines, efficacy, and toxicities of available systemic antifungal agents in the newborn." | 2.42 | Antifungal pharmacotherapy for neonatal candidiasis. ( Bliss, JM; Gigliotti, F; Wellington, M, 2003) |
| "Fluconazole has the most neonatal pharmacokinetic data, which show slightly less variability than the other antifungals." | 2.42 | Antifungals in systemic neonatal candidiasis. ( Aranda, JV; Frattarelli, DA; Giacoia, GP; Reed, MD, 2004) |
| "Fosfluconazole is a phosphate prodrug of fluconazole that has been developed to reduce the volume of fluid required to administer fluconazole by the intravenous route." | 2.42 | [Nonclinical studies and clinical studies on fosfluconazole, a triazole antifungal agent (Prodif)]. ( Abe, M; Ishiko, J; Kawakami, Y; Nagino, K; Shinkai, K; Sobue, S, 2004) |
| " Oral bioavailability is more than 90% after a 50 mg dose, peak levels are reached after 0." | 2.41 | Fluconazole: optimized antifungal therapy based on pharmacokinetics. ( Silling, G, 2002) |
| "Fluconazole is approved for the treatment of candidal UTIs, but dosage recommendations are not consistent." | 2.41 | Fluconazole dose recommendation in urinary tract infection. ( Boedeker, KS; Kilzer, WJ, 2001) |
| "Invasive candidiasis is a frequent infection in compromised patient." | 2.41 | [Visceral candidiasis]. ( Herbrecht, R; Letscher-Bru, V; Zamfir, A, 2001) |
| "Amphotericin B has a broad spectrum and has remained the drug of choice for these life threatening invasive fungal infections." | 2.41 | [Choice and use of antifungal drugs]. ( Dupont, B, 2001) |
| "Opportunistic mycoses have emerged as important causes for morbidity and mortality in pediatric cancer patients, particularly in those with intensively treated hematological malignancies, allogeneic hematopoetic stem cell transplantation, and aplastic anemia." | 2.41 | [Prevention of fungal infections in children and adolescents with cancer]. ( Groll, AH; Müller, FM; Ritter, J, 2001) |
| "Fluconazole has become a mainstay of therapy; however, when to treat, whom to treat, and how long to treat are still largely unanswered questions." | 2.41 | Management of candiduria. ( Lundstrom, T; Sobel, JD, 2001) |
| "Focal hepatosplenic candidiasis has been increasingly recognized as a variant of disseminated candidiasis in immunocompromised patients." | 2.40 | Candida splenic abscess in the absence of obvious immunodeficiency. ( Howden, CW; Kapur, A; Vasudeva, R, 1997) |
| "However, Candida infections are predominantly caused by colonizing fungi; therefore drug prophylaxis is more promising." | 2.40 | Prophylaxis of fungal infections. ( Haag, C; Schuler, US, 1997) |
| " Whilst this pharmacokinetic profile is valuable in the treatment of fungal infections of the urinary tract, it also means that the dosage may need to be decreased in patients with renal impairment." | 2.40 | Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility. ( Laufen, H; Schmalreck, AF; Wildfeuer, A; Yeates, RA; Zimmermann, T, 1997) |
| " The range of fluconazole dosage was 2-50 mg/kg/day with 162 days as maximum duration of treatment." | 2.40 | [Use of fluconazole in children less than 1 year old: review]. ( Penk, A; Pittrow, L; Schwarze, R, 1998) |
| " The mean duration of therapy was 6-8 weeks (maximum duration: lifelong) with an average dosage of 200-400 mg/d (maximum dosage: 800 mg/d and 14 mg/kg BW, resp." | 2.40 | [Status of fluconazole in the therapy of endogenous Candida endophthalmitis]. ( Penk, A; Pittrow, L, 1998) |
| "Fluconazole was effective and safe in acute therapy alone or in combination with surgery as well as in long term suppression therapy." | 2.40 | [Fungal arthritis--a rare complication of systemic candidiasis or orthopedic intervention. Review of therapeutic experience with fluconazole]. ( Penk, A; Pittrow, L, 1998) |
| "krusei fungemia from our cancer institute." | 2.40 | Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review. ( Grausova, S; Grey, E; Krcmery, V; Krupova, I; Kunova, A; Mateicka, F; Pichnova, E; Sabo, A; Spanik, S; Trupl, J, 1999) |
| " The range of fluconazole dosage was 2-50 mg kg-1 day-1, with 162 days being the maximum duration of treatment." | 2.40 | Administration of fluconazole in children below 1 year of age. ( Penk, A; Pittrow, L; Schwarze, R, 1999) |
| " and Cryptococcus neoformans at a dosage of up to 800 mg day-1." | 2.40 | Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD). ( Penk, A; Pittrow, L, 1999) |
| " However, bioavailability of itraconazole is reduced in patients with raised gastric pH and no i." | 2.39 | [Prophylaxis against mycoses in neutropenic patients]. ( Arning, M; Aul, C, 1994) |
| "Ketoconazole tablets were used with good success in previous years of the AIDS epidemics." | 2.39 | [Therapy of candidiasis and cryptococcosis in AIDS]. ( Just-Nübling, G, 1994) |
| "Fluconazole has been shown effective as prophylaxis of candidosis including in patients undergoing bone marrow transplantation as well as in treatment of oropharyngeal candidosis and for candidaemia occurring in non-neutropenic patients." | 2.39 | [Therapy of systemic candidiasis]. ( Meunier, F, 1994) |
| "Fluconazole is a bis-triazole antifungal drug which has a pharmacokinetic profile characterised by its high water solubility, low affinity for plasma proteins, and metabolic stability." | 2.39 | Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis. ( McTavish, D; Perry, CM; Whittington, R, 1995) |
| "Fluconazole appears to be a safe and effective alternative or addition to conventional treatments for the management of candidal endophthalmitis." | 2.39 | Use of fluconazole in the treatment of candidal endophthalmitis. ( Akler, ME; Gold, WL; McNeely, DM; Vellend, H; Walmsley, SL, 1995) |
| "There is a wide range of drugs to treat or suppress Candida infections." | 2.39 | Resistant candidiasis. ( Powderly, WG, 1994) |
| "Amphotericin B has routinely been used to treat this infection." | 2.39 | Problems and controversies in the management of hematogenous candidiasis. ( Anaissie, EJ; Uzun, O, 1996) |
| "In 60% of the cases, candidal spondylodiskitis was a late complication of candidemia (mean delay, 5." | 2.39 | Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature. ( Bourée, P; Charpentier, B; Dupont, B; Hennequin, C; Hiesse, C, 1996) |
| " However, successful therapy with long-term administration of oral fluconazole has been reported for five patients." | 2.39 | Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. ( Amidi, M; Keys, TF; McMahon, D; Nguyen, MH; Nguyen, ML; Yu, VL, 1996) |
| "Strategies for treating invasive Candida infections must consider the relative rates of non-C." | 2.39 | Resistance to antifungal agents in the critical care setting: problems and perspectives. ( Martins, MD; Rex, JH, 1996) |
| " Besides the proven susceptibility of the fungus, clinical response to antifungal therapy with fluconazole also depends to a great extent on the daily dosage and the corresponding plasma and tissue concentrations as well as the immunological status and the underlying disease of the patient." | 2.39 | [Plasma and tissue concentrations of fluconazole: discussion of the breakpoint problem]. ( Penk, A; Pittrow, L, 1996) |
| "Over a 12 year period 19 children treated for leukemia at our institution developed C." | 2.38 | Candida tropicalis infections in children with leukemia. ( Flynn, PM; Hughes, WT; Marina, NM; Rivera, GK, 1993) |
| "Treatment with fluconazole led to mycologic cure and symptom improvement, although he subsequently underwent above-the-knee amputation due to continued joint instability." | 2.38 | Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. ( Thomas, CY; Tunkel, AR; Wispelwey, B, 1993) |
| "Fluconazole (Diflucan) is a new triazole antifungal agent that is effective against a wide range of fungi and has a favourable pharmacokinetic profile." | 2.38 | [Fluconazole--a new antifungal agent]. ( Dobloug, JH, 1992) |
| "Fluconazole is a new triazole antifungal agent with good activity against Candida and cryptococcal meningitis." | 2.38 | Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis. ( Garber, GE, 1992) |
| "Fluconazole is a recently approved agent for the treatment of certain fungal infections." | 2.38 | Fluconazole: a new triazole antifungal agent. ( Morrow, JD, 1991) |
| "Invasive fungal infections are common in immunocompromised patients." | 2.38 | [Systemic mycotic infections]. ( Meunier, F, 1990) |
| " Wet-lab validation of the four shortlisted peptidomimetics revealed that two molecules, when used in combination with fluconazole, could significantly reduce the dosage of fluconazole required for 50% inhibition of Candida albicans." | 1.91 | Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases. ( Chakraborty, S; Idicula-Thomas, S; Kumar, C; Rahate, K, 2023) |
| "Oral candidiasis is an infection of the oral cavity commonly caused by Candida albicans." | 1.91 | Anticandidal Activity of Capsaicin and Its Effect on Ergosterol Biosynthesis and Membrane Integrity of ( Behbehani, JM; Irshad, M; Karched, M; Shreaz, S, 2023) |
| "Candidiasis is the most common cause of fungal sepsis, and new agents are of interest to ameliorate current deficiencies in therapy." | 1.91 | Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates. ( Larwood, DJ; Martinez, M; Sass, G; Stevens, DA, 2023) |
| "Congenital systemic candidiasis is a rare disease observed in both full-term and preterm infants." | 1.91 | Congenital candidiasis in a full-term infant: A case report. ( Ding, YX; Lu, L; Yang, LJ; Zhao, HH; Zhao, YZ, 2023) |
| "Candidemia is a life-threatening invasive fungal infection in immunocompromised patients." | 1.91 | Alarming Increase of Azole-Resistant Candida Causing Blood Stream Infections in Oncology Patients in Egypt. ( Abdel-Hamid, RM; Abdelfattah, NE; El-Mahallawy, HA; Wassef, MA, 2023) |
| "Oral candidiasis is a common but most harmful oral cavity infection caused by yeast-like fungus, this condition is called Oropharyngeal candidiasis." | 1.91 | Human Oropharyngeal Candidiasis: From Etiology to Current Treatment. ( Ahmad, MH; Bashir, H; Qadir, MI, 2023) |
| "Fluconazole resistance was found in 248 (38." | 1.91 | Screening of C. auris among Candida isolates from various tertiary care institutions in Lahore by VITEK 2 and real time PCR based molecular technique. ( Amar, A; Arshad, F; Huma, ZE; Imran, M; Jabeen, K; Saleem, S, 2023) |
| "Although "Candida pneumonia" is rarely being reported in critically ill patients, Candida airway colonization mainly by Candida albicans is common especially among patients with diabetes, malignancies, and kidney disorders." | 1.72 | Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia. ( Amiri, S; Erami, M; Fakhrehi, M; Getso, MI; Hashemi, SJ; Mehri, N; Momen-Heravi, M; Raiesi, O; Raissi, V; Yarahmadi, M, 2022) |
| "When mycoses are diagnosed early and treated with the appropriate drugs, favorable therapeutic outcomes can be achieved." | 1.72 | Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report. ( de Lima-Neto, RG; de Melo, HRL; de Sousa, BR; Neves, RP; Silva, GM; Torres, KB, 2022) |
| "Candidiasis is reported to be the most common fungal infection in the critical care setting." | 1.72 | Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of ( Lao, AR; Moron-Espiritu, LS; Yu, PK, 2022) |
| " Although there was a 40% increase in the volume of distribution for fluconazole relative to healthy volunteers, the pharmacodynamic targets for prophylaxis were still met." | 1.62 | Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO: a case report. ( Abdul-Aziz, MH; Dhanani, JA; Lipman, J; Livermore, A; Pincus, J; Roberts, JA; Townsend, S; Wallis, SC, 2021) |
| "Piperine inhibit Candida albicans growth (planktonic and biofilm) significantly in our study." | 1.62 | Oxidative stress induced by piperine leads to apoptosis in Candida albicans. ( Jadhav, V; Karuppayil, SM; Kazi, R; Kharat, K; Patil, R; Shelar, A; Thakre, A; Zore, G, 2021) |
| "Fluconazole tolerance was strongly associated with death for patients treated with fluconazole within 24 h of candidemia onset (33." | 1.62 | Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection. ( Ben-Ami, R; Berman, J; Dahan, A; Levinson, T; Novikov, A; Paran, Y, 2021) |
| " This study investigated the activity of Asiatic acid (AA) alone and in combination with fluconazole (FLC) against C." | 1.62 | Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans. ( Liu, Y; Lu, C; Sun, S; Wang, D; Wang, Y; Zhao, X, 2021) |
| "Fluconazole resistance was 13." | 1.62 | Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years. ( Arikan-Akdagli, S; Demirci-Duarte, S; Gülmez, D, 2021) |
| "Esophageal candidiasis is the most frequent form of esophagitis." | 1.62 | Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis. ( Gharaghani, M; Jafarian, H; Mahmoudabadi, AZ; Seyedian, SS, 2021) |
| "Bloodstream Candida infection is a life-threatening event among ICU admitted patients." | 1.56 | Necessity to identify candida species accurately with minimum inhibitory concentration determination in each case of bloodstream infections. ( Gupta, MK; Pandey, N; Paul, P; Tilak, R, 2020) |
| " In vitro studies indicated that the drug combination had a synergistic effect on C." | 1.56 | The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms. ( Chen, X; Li, X; Li, Y; Su, S; Sun, S; Yang, J, 2020) |
| "Fluconazole was administrated for one year." | 1.56 | Candidal Prosthetic Hip Infection in a Patient with Previous Candidal Sepsis - A Case Report. ( Murata, Y; Ohnishi, H; Okabe, S; Sakai, A; Tamagawa, S, 2020) |
| "Identification of infected cysts should be pursued in such cases, particularly with PET-CT, and when technically possible followed by cyst aspiration and culture to guide treatment." | 1.51 | Two cases of fungal cyst infection in ADPKD: is this really a rare complication? ( Balbo, BEP; Chocair, PR; de Abreu Testagrossa, L; de Almeida, MCS; de Menezes Neves, PDM; Ferreira, FT; Onuchic, L; Onuchic, LF; Portela-Neto, AA; Sato, VAH; Watanabe, A; Watanabe, EH, 2019) |
| "Oropharyngeal candidiasis is caused by opportunistic fungal pathogen candida." | 1.51 | Pediatric oropharyngeal candidiasis: A comprehensive study on risk factors and most prevalent species of Candida. ( Akhtar, Z; Ali, MI; Jamal, A; Rashid, A; Shirazi, JH, 2019) |
| "We experienced a rare case of acute pancreatitis caused by Candida infection." | 1.51 | A rare case of acute pancreatitis caused by Candida Albicans. ( Aono, M; Hiasa, Y; Hida, AI; Joko, K; Kumagi, T; Mashiba, T; Ochi, H; Oshiro, Y; Sunago, K; Takechi, S; Tange, K; Yokota, T, 2019) |
| "Invasive candidiasis is a common and serious infection in premature newborns." | 1.51 | [Results of the use of micafungin in newborns]. ( Çakır, SÇ; Çelebi, S; Dorum, BA; Hacımustafaoğlu, M; Köksal, N; Özkan, H; Yeşil, E, 2019) |
| " As the Ost concentration-time curve showed, Ost-S100-NP can increase the plasma concentration and relative bioavailability of Ost compared with Ost-suspension by oral administration." | 1.48 | Antifungal activity of osthol in vitro and enhancement in vivo through Eudragit S100 nanocarriers. ( Cao, YB; Gu, LQ; Han, B; Jiang, YY; Li, LP; Shen, CY; Wang, XJ; Yang, QL; Yu, YQ; Zhang, JY; Zhang, LL, 2018) |
| "There predominant combinations of mixed infection were 14 Candida albicans/Candida glabrata, 13 C." | 1.48 | Mixed yeast infections in Taiwan. ( Chen, PN; Chu, WL; Lin, CC; Lo, HJ; Yang, YL; Zhou, ZL, 2018) |
| "Candidiasis is a major opportunistic fungal infection in humans." | 1.48 | Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae. ( da Rocha Curvelo, JA; Ferreira-Pereira, A; Moraes, DC; Reis de Sá, LF; Soares, RM, 2018) |
| "Fungal pneumonia is considered as one of the most serious forms of pneumonia, the number of which has recently increased despite the use of new antimycotic drugs in pulmonology." | 1.48 | [CASE REPORT OF CANDIDA PNEUMONIA]. ( Beysenbekova, Z; Tayzhanova, D; Toleuova, A; Toyynbekova, R, 2018) |
| "Thymol was found to have a fungicidal effect on Candida species and a synergistic effect when combined with FLZ." | 1.48 | Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei. ( Khosravi, AR; Sharifzadeh, A; Shirzadi, H; Shokri, H, 2018) |
| " We developed a novel and flexible approach that uses physiologically based pharmacokinetic (PBPK) modeling to translate results from ECMO ex vivo experiments into bedside dosing recommendations." | 1.48 | Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO. ( Barrett, JS; Brouwer, KLR; Cohen-Wolkowiez, M; Edginton, AN; Sevestre, M; Watt, KM; Zhao, P, 2018) |
| "The amphotericin B MICs were slightly higher for some C." | 1.46 | Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients. ( Čurová, K; Hrabovská, Z; Hrabovský, V; Pastvová, L; Schréterová, E; Siegfried, L; Takáčová, V, 2017) |
| "Gallic acid (GA) is a polyphenol natural compound found in many medicinal plant species, including pomegranate rind (Punica granatum L." | 1.46 | Antifungal Activity of Gallic Acid In Vitro and In Vivo. ( Aibai, S; Dawuti, G; Dou, Q; Li, ZJ; Liu, HG; Liu, M; Ma, Y, 2017) |
| "Osthole is a natural coumarin that exhibits wide biological and pharmacological activities such as neuroprotective, osteogenic, immunomodulation, antitumor, and anti-inflammatory effects." | 1.46 | Potent ( Chai, D; Du, J; Guan, SX; Huang, XW; Jiang, YY; Li, DD; Sun, Y; Zhang, HY, 2017) |
| "We established that Chr4 trisomy contributes significantly to fluconazole resistance, whereas Chr6 trisomy has no discernible effect on resistance." | 1.46 | A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans. ( Anderson, MZ; Bennett, RJ; Haseeb, A; Saha, A, 2017) |
| " The in vivo efficacy of this drug combination was evaluated using a Galleria mellonella model by determining survival rate, fungal burden and histological damage." | 1.46 | Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence. ( Huang, X; Li, X; Sun, S; Sun, W; Wang, D; Yu, C, 2017) |
| "Bacterial pneumonia is a common cause of death worldwide." | 1.46 | Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia. ( Du, L; Jin, Y; Li, M; Liu, B; Zhang, T; Zhu, L, 2017) |
| "Fluconazole is an alternative for candidemic patients who are not critically ill." | 1.46 | Fluconazole-containing agar Sabouraud dextrose plates are not useful when screening for susceptibility in Candida albicans. ( Bordallo-Cardona, MA; Bouza, E; Cantón, R; Escribano, P; Gómez G de la Pedrosa, E; Guinea, J; Marcos-Zambrano, LJ, 2017) |
| "Isavuconazole is a novel, broad-spectrum, antifungal azole." | 1.43 | Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. ( Coste, AT; Sanglard, D, 2016) |
| " Noncompartmental pharmacokinetic analysis was performed." | 1.43 | In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis. ( Lassig-Smith, M; Lipman, J; Peake, SL; Roberts, JA; Roberts, MS; Robertson, T; Sinnollareddy, MG; Starr, T, 2016) |
| "Treatment with fluconazole was successful." | 1.43 | Community acquired fungemia caused by Candida pulcherrima: diagnostic contribution of MALDI-TOF mass spectrometry. ( Deconinck, L; Melliez, H; Meybeck, A; Patoz, P; Pradier, M; Senneville, E, 2016) |
| "The 8 patients with septicemia caused by Candida haemulonii had similar clinical chariacteristics to those of other neonatal candidemia, such as apnea, fever, abdominal distension, jaundice etc." | 1.43 | [Clinical analysis of 8 cases of neonatal septicemia caused by Candida haemulonii in neonatal intensive care unit]. ( Chen, S; Hu, Y; Huang, X; Jie, Q; Lin, S; Lin, Z; Zhang, H, 2016) |
| "Candida esophagitis was suspected." | 1.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
| "Candidiasis has increased significantly recently that threatens patients with low immunity." | 1.43 | Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans. ( Gu, W; Li, X; Liu, S; Sun, S; Yue, L; Zhang, L, 2016) |
| "Berberine is a protoberberine-type isoquinoline alkaloid isolated from the roots, rhizomes, and stem bark of natural herbs, such as Berberis aquifolium, Berberis vulgaris, Berberis aristata, and Hydrastis canadensis, and of Phellodendron amurense Berberine has been proven to have broad antibacterial and antifungal activity." | 1.43 | Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp. ( Campos, Rde S; Cavalcanti, BC; Costa Silva, RA; da Silva, AR; da Silva, CR; de Andrade Neto, JB; de Andrade, LN; de Moraes, MO; do Nascimento, FB; Freitas, DD; Grangeiro, TB; Magalhães, HI; Nobre Júnior, HV; Sampaio, LS, 2016) |
| "Fluconazole is a renally-eliminated antifungal commonly used to treat Candida species infections." | 1.43 | Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach. ( Gharibian, KN; Mueller, BA, 2016) |
| "Fluconazole treatment in utero decreased intestinal C." | 1.43 | Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine. ( Hornef, MW; Jacobs, EM; Janssen, LE; Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Newnham, JP; Nikiforou, M; Payne, MS; Saito, M; Wolfs, TG, 2016) |
| "Although infective esophagitis is encountered sporadically in pediatric age group, but it should always be considered in high risk individuals and when conventional medication fails to resolve the symptoms." | 1.43 | Fungal Esophagitis in a Child with Insulin Dependent Diabetes Mellitus. ( Alsheikh, A; Assiri, A; Saeed, A; Zaidi, Z, 2016) |
| " Previous in vitro data suggest that, in combination with certain antifungals, farnesol may have an adjuvant anti-biofilm agent." | 1.43 | The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model. ( Bozó, A; Domán, M; Kardos, G; Kovács, R; Majoros, L; Varga, I, 2016) |
| "Fluconazole treatment temporarily decreased the pulmonary and chorioamnion inflammatory responses." | 1.42 | Fluconazole treatment of intrauterine Candida albicans infection in fetal sheep. ( Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Maneenil, G; Miura, Y; Newnham, JP; Payne, MS; Senthamarai Kannan, P, 2015) |
| "Because morbid obesity may confer a relative immunodeficiency, morbidly obese patients may develop unusual infections such as opportunistic fungal abscesses." | 1.42 | Tubo-Ovarian Abscess Caused by Candida Albicans in an Obese Patient. ( Gurberg, J; Krishnamurthy, S; To, V, 2015) |
| "Candidiasis has become an important concern for clinical practice, especially with the increasing incidence of immunocompromised patients." | 1.42 | Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil. ( Cartágenes-Pinto, AC; de Sá, LF; Ferreira-Pereira, A; Junqueira, Mde L; Neves-Junior, A; Rocha, DA, 2015) |
| "Candida albicans osteomyelitis is a rare disease that occurs in immunocompromised individuals, sometimes with a late diagnosis related to the mismatch between symptoms and candidemia." | 1.42 | Candida albicans osteomyelitis as a cause of chest pain and visual loss. ( Cortez, J; Magano, R; Ramos, E; Trindade, L, 2015) |
| "Candida Osteomyelitis is uncommon." | 1.40 | A case of rib fungal osteomyelitis. ( Eves, S; Potter, M; Sayeed, R, 2014) |
| "One patient developed Fusarium infection." | 1.40 | Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country. ( Adil, SN; Ali, N; Shaikh, MU, 2014) |
| "Malignancy was independently associated with the development of candidemia by non-albicans Candida species (odds ratio 3." | 1.40 | Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia. ( Al Amri, AF; Al Harbi, MI; Al Thaqafi, AH; Farahat, FM; Perfect, JR, 2014) |
| "Fluconazole (FLCZ) is a first-line drug for treating Candida albicans infections, but clinical failure due to reduced sensitivity is a growing concern." | 1.40 | Potent drugs that attenuate anti-Candida albicans activity of fluconazole and their possible mechanisms of action. ( Fukazawa, H; Inoue, M; Kaneko, Y; Miyazaki, Y; Niki, M; Ohno, H; Tanabe, K; Umeyama, T; Urai, M, 2014) |
| " After 7 days of exposure to 200 mg of ketoconazole once daily, the AUC0-t and Cmax of the parent drug were not affected significantly." | 1.40 | Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects. ( Chen, X; Gao, R; Pang, X; Zhang, Y; Zhong, D; Zhong, K, 2014) |
| "Fungal endocarditis was confirmed by culturing of the resected vegetation showing mixed growth of Candida albicans and Candida tropicalis, although three consecutive blood cultures were negative for Candida species." | 1.39 | Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. ( Abbasi, K; Anvari, MS; Badali, H; Boroumand, M; Fesharaki, SH; Haghani, I; Kargar, ML; Meis, JF; Mousavi, B, 2013) |
| "Graft site candidiasis is a rare but life-threatening complication of renal transplant." | 1.39 | Candida arteritis in a pair of renal transplant recipients. ( Ashley, S; Barwell, J; Chinai, N; Cunningham, R; Guy, A; Rowe, P, 2013) |
| "The pharmacokinetic (PK) property of fluconazole might be significantly altered in major burn patients by medical interventions and physiologic changes." | 1.39 | Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection. ( Han, S; Hong, T; Hur, J; Jeon, S; Kim, J; Lee, J; Song, W; Woo, H; Yim, DS; Yim, H, 2013) |
| "A standardized broth microdilution method was used to test the antifungal activity of geldanamycin (GA), an inhibitor of heat shock protein 90 (Hsp90), alone or in combination with the antifungal agent fluconazole (FLC) against 32 clinical isolates of Candida spp." | 1.39 | Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species. ( Li, R; Liu, W; Sun, Y; Tan, J; Wan, Z; Zhang, J, 2013) |
| "Intra-amniotic Candida infection is associated with preterm rupture of membranes, preterm labor, severe neonatal infection, and fetal death." | 1.39 | Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection. ( Bean, LM; Beiswenger, TR; Dobak, WJ; Jackson, JR; Thorp, JA, 2013) |
| "Candidiasis is still of major concern in neonates with accompanying risk factors." | 1.38 | Candidiasis caused by Candida kefyr in a neonate: case report. ( Dietz, A; Geginat, G; Kilian, AK; Reinshagen, K; Schroten, H; Tenenbaum, T; Weichert, S; Zahn, K, 2012) |
| "Candida endocarditis is extremely rare in term neonates, and gall bladder involvement due to candidemia has never been reported amongst neonates and infants." | 1.38 | Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis. ( Garg, A; Goyal, VK; Jajoo, M; Kumar, V, 2012) |
| "Fluconazole prophylaxis was associated with a significant decrease in candidal BSI (odds ratio, 0." | 1.38 | Targeted fluconazole prophylaxis for high-risk very low birth weight infants. ( Klinger, G; Levy, I; Rolnitsky, A; Shalit, I; Sirota, L, 2012) |
| " The occurrence of LAMB-attributable renal toxicity was investigated; infants withdrawn from treatment for development of adverse effects or toxicity were identified." | 1.38 | Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates. ( Antonucci, R; Fanos, V; Farina, D; Franco, C; Galletto, P; Gallo, E; Manzoni, P; Rizzollo, S, 2012) |
| "Candida infections are a permanent threat to immunocompromised individuals such as cancer patients, and Candida glabrata has emerged as a major problem in recent years." | 1.38 | Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates. ( Knobloch, M; Ruhnke, M; Schulz, B; Weber, K, 2012) |
| " Therefore, free plasma levels are a good surrogate to estimate free FCZ renal concentrations in systemic candidiasis and can be used to optimize dosing regimens for this drug." | 1.38 | Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats. ( Azeredo, FJ; Dalla Costa, T; de Andrade, C; de Araújo, BV; Haas, SE; Pigatto, M; Torres, B, 2012) |
| "A case of allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans in a 48 year old man was discussed." | 1.38 | A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans. ( Datau, EA, 2012) |
| "Fluconazole has been used extensively with an unknown impact on susceptibility." | 1.37 | Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades. ( Bulik, CC; Nailor, MD; Sobel, JD, 2011) |
| " No adverse events were thought to be related to fluconazole therapy." | 1.37 | Fluconazole loading dose pharmacokinetics and safety in infants. ( Barrett, JS; Benjamin, DK; Cheifetz, IM; Cohen-Wolkowiez, M; Hope, WW; Hornik, CP; Moorthy, G; Piper, L; Smith, PB; Wade, KC, 2011) |
| "Candida bloodstream infections are associated with high intensive care unit and hospital mortality rates and resource use." | 1.37 | Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. ( Azoulay, E; Echeverria, PM; Kett, DH; Vincent, JL, 2011) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 1.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Fungal spondylodiscitis is often because of Candida albicans or other common Candida species, whereas unusual strains such as Candida sake are often thought to be nonpathogenic." | 1.37 | Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient. ( Benecchi, M; Buzio, C; De Filippo, M; Maggiore, U; Palmisano, A; Vaglio, A, 2011) |
| "Pulmonary aspergillosis was the most common causative agent, and no patients showed candidemia, or hepatosplenic candidiasis." | 1.37 | Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole. ( Kato, K; Kojima, S; Matsumoto, K; Watanabe, N, 2011) |
| "Linalool and citral were the most effective ones, inhibiting all the isolates at ≤0." | 1.37 | Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle. ( Jadhav, S; Karuppayil, SM; Thakre, AD; Zore, GB, 2011) |
| "For the treatment of candidiasis in patients with atrophic or erosive oral lichen planus, the value of nystatin should be addressed." | 1.37 | [Antifungal susceptibility test of genotypes of Candida albicans from patients with atrophic or erosive oral lichen planus]. ( Li, JY; Sun, HY; Zhang, QQ, 2011) |
| "We describe two patients with acute myelogenous leukemia who developed cervical lymphadenitis and chronic disseminated infection due to Candida albicans." | 1.37 | Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia. ( Alsan, MM; Baden, LR; DeAngelo, DJ; Hammond, SP; Issa, NC; Milner, DA, 2011) |
| "Discitis or epidural abscess after discogram is a rare but known complication." | 1.37 | Candida lusitaniae discitis after discogram in an immunocompetent patient. ( Hogan, MV; Shen, FH; Werner, BC, 2011) |
| "Fluconazole resistance was a rare finding in our study." | 1.37 | Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period. ( França, EJ; Furlaneto, MC; Furlaneto-Maia, L; Oda, S; Oliveira, MT; Quesada, RM; Rodrigues, R; Rota, JF; Serpa, R, 2011) |
| "Fluconazole resistance was detected in C." | 1.36 | The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. ( Chee, CW; Ng, LS; Tan, AL; Tan, TY; Tee, NW, 2010) |
| " However, when allicin was used in combination with fluconazole or ketoconazole, the MICs were decreased in some isolates." | 1.36 | In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species. ( Aala, F; Alizadeh, F; Chong, PP; Khodavandi, A; Sekawi, Z, 2010) |
| "parapsilosis infection without recurrence was confirmed." | 1.36 | Candida parapsilosis meningitis associated with shunt infection in an adult male. ( Bagheri, F; Cervellione, KL; Marino, W; Maruf, M; Santucci, T, 2010) |
| "glabrata fungemia were systematically recorded." | 1.36 | Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. ( Adrie, C; Clec'h, C; Cohen, Y; Gauzit, R; Karoubi, P; Marsepoil, T; Zarka, D, 2010) |
| "Micafungin was started, patient responded, and fungemia cleared." | 1.36 | Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy. ( Afonso, L; Bhargava, A; Chopra, A; Chopra, T; Dhar, S; Kumar, S; Sobel, JD, 2010) |
| "Candidaemia in cancer patients is associated with increasing fluconazole resistance." | 1.36 | Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. ( Chen, SC; Ellis, DH; Marriott, D; Morrissey, CO; Nguyen, Q; Slavin, MA; Sorrell, TC; Thursky, KA, 2010) |
| "Voriconazole was more active than fluconazole (range, 82." | 1.36 | Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. ( Barton, R; Bijie, H; Bille, J; Chang, SC; da Luz Martins, M; Diekema, DJ; Duse, A; Dzierzanowska, D; Ellis, D; Finquelievich, J; Gibbs, DL; Gould, I; Gur, D; Hoosen, A; Lee, K; Mallatova, N; Mallie, M; Newell, VA; Peng, NG; Petrikos, G; Pfaller, MA; Santiago, A; Trupl, J; VanDen Abeele, AM; Wadula, J; Zaidi, M, 2010) |
| "Fluconazole was administered in 3 mg/kg doses, given every 48 hours, starting on day 3 of life, for a period of 6 weeks." | 1.36 | Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country. ( Espinosa, M; Moreno, MT; Rueda, K; Sáez-Llorens, X, 2010) |
| "Fluconazole has been a new option for treatment however, expanded use of the drug brought up the development of resistance." | 1.36 | [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. ( Akman, I; Altuncu, E; Bakır, M; Bilgen, H; Cerikçioğlu, N; Ilki, A; Ozek, E; Ulger, N, 2010) |
| "Fluconazole was considered to inhibit Candida growth and caspofungin to stimulate Candida death according to an Emax pharmacodynamic model." | 1.35 | Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans. ( Couet, W; Grégoire, N; Marliat, M; Venisse, N, 2008) |
| "Candida infection is a relatively common cause of nosocomial bloodstream infection in immunosuppressed patients." | 1.35 | [Candidemia and granulomatous tubulointerstitial nephritis]. ( Benoit, G; Faucher, C; Madore, F; Mandalenakis, N, 2008) |
| "Fungal peritonitis is a relatively uncommon complication of peritoneal dialysis that contributes significantly to morbidity, drop out from the continuous ambulatory peritoneal dialysis (CAPD) program, and mortality." | 1.35 | First case of continuous ambulatory peritoneal dialysis peritonitis due to Candida sake. ( Guclu, E; Kucukbayrak, A; Ozdemir, D; Soypacaci, Z; Yildirim, M, 2009) |
| "Fluconazole (100 mg/day) was administered from April 8, 2006." | 1.35 | [A case of nail candidiasis with severe deformities treated with oral fluconazole]. ( Ito, Y; Kobayashi, M; Sei, Y; Soude, E; Sukegawa, N; Takahashi, E, 2008) |
| " We compared patients who received 50 mg of caspofungin per day in a double-blind trial that used fluconazole as the comparator with patients who received the corresponding dosage in 2 similar earlier studies that used amphotericin as the comparator." | 1.35 | Double-blind active-control trials: beware the comparator you keep. ( Dinubile, MJ, 2008) |
| "027), inadequate initial fluconazole dosing (AOR, 3." | 1.35 | Treatment-related risk factors for hospital mortality in Candida bloodstream infections. ( Kollef, MH; Labelle, AJ; Micek, ST; Roubinian, N, 2008) |
| "No fluconazole resistance was observed in C." | 1.35 | Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility. ( Al-Sweih, N; Devarajan, LV; Khan, S; Khan, Z, 2009) |
| "The aim of this study was to assess the dose-response of isavuconazole, voriconazole and fluconazole in disseminated Candida tropicalis and Candida krusei infections." | 1.35 | Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. ( Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA, 2009) |
| "Fluconazole was discontinued in two patients due to non-severe adverse events (acute eosinophilia, elevated transaminases)." | 1.35 | Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. ( Campos, T; Faiz, S; Neale, B; Ostrosky-Zeichner, L; Parsley, E; Patel, B; Rios, E, 2009) |
| "To observe the effect of Qishen Huoxue Granule (QHG) combined with Fluconazole on the survival rate of mice with systemic C." | 1.35 | [Effect of qishen huoxue granule combined with fluconazole on survival rate of mice with systemic C. albaicans infection]. ( Li, SR; Wang, H; Zhang, SW, 2008) |
| "Fluconazole resistance was more frequent among isolates of Candida tropicalis (46." | 1.35 | Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. ( Chan, CH; Chang, YW; Chen, TC; Cheng, MF; Cheung, BM; Chi, H; Ho, YH; Lee, SC; Lin, JY; Lo, HJ; Shi, ZY; Tseng, FC; Yang, YL; Young, TG, 2008) |
| "Here, we present a Fournier's gangrene case caused by Candida albicans." | 1.35 | [Fournier's gangrene caused by Candida albicans]. ( Aslan, A; Cetin, M; Temiz, M, 2008) |
| "Micafungin (MCFG) is an echinocandin antifungal agent that exhibits potent activity against most species of Candida and Aspergillus." | 1.35 | In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. ( Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M, 2009) |
| "05) or inadequately dosed fluconazole (32% versus 8%, P < 0." | 1.35 | Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection. ( Diekema, DJ; Horn, DL; Klevay, MJ; Neofytos, D; Pfaller, MA, 2009) |
| "Hematologic malignancy and neutropenia were significantly more frequent in children than in neonates and adults." | 1.35 | Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. ( Blyth, CC; Chen, SC; Ellis, D; Marriott, D; Meyer, W; Nguyen, Q; Serena, C; Slavin, MA; Sorrell, TC, 2009) |
| "However, invasive candidiasis is difficult to diagnose owing to its non-specific clinical features, and delayed therapy is a major contributor to poor outcomes." | 1.35 | Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region. ( Graybill, JR; Hsueh, PR; Huang, S; Ja'alam, K; Kurup, A; Nangia, V; Oh, MD; Padiglione, AA; Playford, EG; Watcharananan, SP, 2009) |
| "Ibuprofen was described as being able to revert resistance related to efflux activity in Candida." | 1.35 | Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. ( Costa-de-Oliveira, S; Dias, AS; Guerra, J; Pina-Vaz, C; Ricardo, E; Rodrigues, AG, 2009) |
| "Fluconazole was the most commonly administered antimicrobial, followed by the echinocandins, and amphotericin B products were infrequently administered." | 1.35 | Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. ( Anaissie, EJ; Chang, CH; Fishman, JA; Horn, DL; Marr, KA; Neofytos, D; Olyaei, AJ; Pfaller, MA; Steinbach, WJ; Webster, KM, 2009) |
| "Endocarditis is uncommon in infants and is exceptionally related to Candida albicans on pulmonary banding." | 1.35 | [Candida albicans endocarditis after pulmonary artery banding]. ( Acar, P; Dulac, Y; Kreitmann, B; Mansir, T; Paranon, S; Talvard, M, 2009) |
| "Mice treated with voriconazole or fluconazole administered intravaginally at >or=0." | 1.35 | Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model. ( Andrade, SE; Elizondo, M; González, GM; Portillo, OJ; Robledo, M; Rodríguez, C; Uscanga, GI, 2009) |
| "Invasive candidiasis is associated with high morbidity and mortality." | 1.35 | Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne. ( Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S, 2009) |
| "Fluconazole was used as prophylaxis in critically ill patients until 2002; from January 2003 infectious disease consultants strongly discouraged its use." | 1.35 | Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. ( Ansaldi, F; Bassetti, M; Bobbio Pallavicini, F; Icardi, G; Malfatto, E; Molinari, MP; Mussap, M; Nicolini, L; Rebesco, B; Viscoli, C, 2009) |
| "Fluconazole is an antifungal medication that has been reported to cause prolongation of the QT interval and Torsades de Pointes (TdP) ventricular tachycardia in adults." | 1.35 | Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole. ( Esch, JJ; Kantoch, MJ, 2008) |
| "Voriconazole was very active in vitro against C." | 1.35 | Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. ( Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M, 2008) |
| "Fluconazole was given to 17 paitents, intraconazole was given to 21 patients, and intraconazole to the other 9 patients after they had no effect with fluconazole." | 1.35 | [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies]. ( Chen, SP; Shu, YG; Xu, YJ; Zhu, Y, 2008) |
| "Fungal necrotizing otitis externa is rare, although its frequency has increased over the last few years." | 1.35 | [Fungal necrotizing external otitis]. ( Abdelkefi, M; Belcadhi, M; Ben Said, M; Bouzouita, K; Krifa, N; Mani, R, 2008) |
| "Candidal cholecystitis is seen especially in patients with malignancies." | 1.35 | Acute calculous cholecystitis caused by Candida lusitaniae: an unusual causative organism in a patient without underlying malignancy. ( Ozaydin, I; Sahin, I; Yasar, M; Yildirim, M, 2008) |
| " Information was requested on the prophylactic agents used, dosing schedules and duration of therapy." | 1.35 | Antifungal prophylaxis for the prevention of neonatal candidiasis? ( Dempsey, EM; O'Grady, MJ, 2008) |
| "Neutropenia was the leading risk factor for all candidemia, whereas the catheter was the leading risk factor for C." | 1.35 | The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. ( Hachem, R; Hanna, H; Jiang, Y; Kontoyiannis, D; Raad, I, 2008) |
| "Fluconazole MICs were highest against C." | 1.34 | Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia. ( Garey, KW; Pai, MP; Turpin, RS, 2007) |
| "In the present study on animal model of ulcerative colitis the influence of fungal colonization on the severity of inflammatory lesions in the colon and the course of their healing was evaluated." | 1.34 | [Candidiasis in the experimental model of ulcerative colitis]. ( Brzozowski, T; Budak, A; Drozdowicz, D; Konturek, SJ; Kwiecień, S; Mach, T; Mazurkiewicz-Janik, M; Pawlik, WW; Rudnicka-Sosin, L; Sliwowski, Z; Trojanowska, D; Zwolińska-Wcisło, M, 2007) |
| "The fungal septic arthritis was not diagnosed until Candida tropicalis, a rare species of Candida, was isolated in the synovial fluid." | 1.34 | An unusual case of Candida tropicalis and Candida krusei arthritis in a patient with acute myelogenous leukemia before chemotherapy. ( Chang, HN; Chen, WS; Chou, CT; Chou, YL; Tsai, CY; Wang, HP; Yen, YF, 2007) |
| " However, the extent to which inappropriate antifungal therapy is due to improper dosing or drug selection has not been well investigated." | 1.34 | Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. ( Bearden, DT; Garey, KW; Mingo, DE; Pai, MP; Rege, MD; Suda, KJ; Turpin, RS, 2007) |
| "Voriconazole MICs were much low for all isolates tested." | 1.34 | Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital. ( Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R, 2007) |
| "Posaconazole (POS) is a newer triazole with activity against yeasts and moulds." | 1.34 | Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods. ( Falusi, E; Gergely, L; Kardos, G; Majoros, L; McNicholas, PM; Sóczó, G, 2007) |
| "These were patients of septicemia who had undergone ocular examination as part of their initial assessment." | 1.34 | Ocular lesions in disseminated candidiasis. ( Desai, M; Jiandani, P; Mehta, S, 2007) |
| "Present-day methods of successful treatment of inflammatory bowel diseases (IBD) result from a better understanding of their pathophysiology due to advances in preclinical studies in this area of knowledge." | 1.34 | [Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model]. ( Brzozowski, T; Budak, A; Drozdowicz, D; Konturek, SJ; Kwiecień, S; Mach, T; Pawlik, WW; Rudnicka-Sosin, L; Sliwowski, Z; Targosz, A; Trojanowska, D; Zwolińska-Wcisło, M, 2007) |
| "The in vitro activity of the peptide IB-367, alone or combined with either fluconazole (FLU) or amphotericin B (AMB), was investigated against 25 Candida isolates belonging to five species." | 1.34 | In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. ( Arzeni, D; Barchiesi, F; Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Licci, A; Marigliano, A; Nadolski, P; Scalise, G; Silvestri, C; Łukasiak, J, 2007) |
| "Fluconazole was therefore continued orally for a total of 60 days, and the patient remained asymptomatic for 2 years." | 1.33 | Recurrent Candida tropicalis meningitis. ( Alvarez, S; Dawson, NL; Robles, HA, 2005) |
| "Fluconazole prophylaxis has been used to control the problem." | 1.33 | Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. ( Koukila-Kähkölä, P; Luukkainen, P; Lyytikäinen, O; Pfaller, MA; Pujol, C; Richardson, M; Sarvikivi, E; Saxén, H; Soll, DR, 2005) |
| "Treatment with fluconazole inactived the chorio-retinal lesion and resolved the vitritis, but developed an inner limiting membrane contraction over the macula." | 1.33 | [Posterior retinal hole secondary to a candida retinitis]. ( Alvarez-Suárez, ML; Fernández-Alvarez, MA; Sánchez-Tabar, L; Viescas-Fernández, MJ, 2005) |
| "Fluconazole (Diflucan R) was administered for 28 days at a dose of 6 mg/kg every third day during the first week and daily after the first week." | 1.33 | Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. ( Bertini, G; Dani, C; Filippi, L; Perugi, S; Pratesi, S; Rubaltelli, FF, 2005) |
| "Fluconazole was a viable therapy for C glabrata fungemia, with bloodstream eradication in 65% of patients and mortality rates of 24% to 40% in this retrospective chart review." | 1.33 | A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia. ( Micek, ST; Ritchie, DJ; Wilson, AG, 2005) |
| "Fungal peritonitis is a rare cause of peritonitis, but it is associated to poorer prognosis and higher mortality than bacterial peritonitis." | 1.33 | [Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases]. ( Aparicio, M; García Ramón, R; Miguel, A; Molina, P; Puchades, MJ, 2005) |
| "Anidulafungin is an echinocandin antifungal agent with potent activity against Candida spp." | 1.33 | In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. ( Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S, 2005) |
| "Because of cardiac tamponade, the pericardium was surgically drained." | 1.33 | [A man with Candida pyopneumopericarditis and cardiac tamponade in conjunction with gastric tube infection]. ( Landman, JJ; van Beek, LM; Verheught, FW, 2005) |
| "Fluconazole, 400 mg/day, was given as EPT." | 1.33 | Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. ( Lee, JC; Lin, PW; Shan, YS; Sy, ED; Wang, ST, 2006) |
| "The spectrum of candidiasis has changed with the emergence of non-albicans Candida spp." | 1.33 | Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. ( Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Srivastava, L; Verma, PK, 2005) |
| "Fluconazole used for the treatment of mice infected with C." | 1.33 | Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice. ( Khan, A; Khan, MA; Owais, M, 2006) |
| "Micafungin is a new echinocandin exhibiting broad-spectrum activity against Candida spp." | 1.33 | Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. ( Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S, 2006) |
| "Fluconazole was adsorbed in higher amounts by the most hydrophilic polymers and its release was influenced by the degree of polymer swelling in water." | 1.33 | Pore formers promoted release of an antifungal drug from functionalized polyurethanes to inhibit Candida colonization. ( D'Ilario, L; Donelli, G; Francolini, I; Guaglianone, E; Piozzi, A; Ruggeri, V, 2006) |
| "Oesophageal candidiasis is an epithelial infection which requires an immune deficiency." | 1.33 | [Oesophageal candidiasis: clinical and mycological analysis]. ( Araya, V; Cahn, P; Concetti, H; Guelfand, L; Kaufman, S; Olmos, MA; Pérez, H; Piskorz, E; Ramallo, J, 2005) |
| "Fluconazole was administered to 81% of ELBW infants, who received a median of 8 doses, and 41% of larger infants, who received a median of 5 doses." | 1.33 | Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. ( Brion, LP; Dave, VA; Herring, L; Marsh, J; Nafday, S; Reinersman, GT; Soghier, LM; Uko, S; Vega, M, 2006) |
| "Fluconazole was the most frequently prescribed antifungal (1846 patient-days) followed by amphotericin B deoxycholate (251 patient-days), lipid formulations of amphotericin B (201 patient-days), itraconazole (71 patient-days), and caspofungin (42 patient-days)." | 1.33 | Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. ( Bearden, DT; Cannon, JP; Garey, KW; Gentry, LO; Kontoyiannis, DP; Lewis, RE; Neuhauser, MM, 2006) |
| "Treatment with posaconazole resulted in clinical improvement and the patient had only intermittently positive fungal cultures for 6 weeks." | 1.33 | Control of a Candida glabrata prosthetic endovascular infection with posaconazole. ( Anstead, GM; Graybill, JR; Martinez, M, 2006) |
| "A 47-year-old man with diabetic nephropathy and alcoholic liver disease developed disseminated candidiasis, with the initial presentation of pyomyositis." | 1.33 | Pyomyositis with hepatic and perinephric abscesses caused by Candida albicans in a diabetic nephropathy patient. ( Peng, YJ; Tsai, SH; Wang, NC, 2006) |
| "Posaconazole was active against isolates of Candida and Aspergillus spp." | 1.33 | In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. ( Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F, 2006) |
| "Azoles are safe, effective agents to treat esophageal candidiasis." | 1.33 | Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. ( Cappello, D; Di Mare, M; Fiamingo, P; Gagliano, M; Giuffrida, G; Macarone, M; Severino, V; Sorbello, M; Spataro, M; Veroux, M; Veroux, P; Vizcarra, D, 2006) |
| " One variable under the control of the prescriber is the drug dosing regimen." | 1.33 | Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. ( Andes, D; Forrest, A; Lepak, A; Lincoln, L; Marchillo, K; Nett, J, 2006) |
| " The studies also demonstrated a striking relationship between fluconazole pharmacodynamic exposures and the mRNA abundance of drug resistance-associated efflux pumps." | 1.33 | In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling. ( Andes, D; Lepak, A; Lincoln, L; Marchillo, K; Nett, J, 2006) |
| "Fluconazole resistance was detected in one isolate of C." | 1.33 | Epidemiology of candidemia in a Turkish tertiary care hospital. ( Bakir, M; Barton, R; Cerikcioglu, N; Yagci, A, 2006) |
| "Fluconazole was least active against isolates from dermatology (58%) and surgical (69%) services and against isolates associated with skin and soft tissue infection (68%, compared to 85% susceptible for bloodstream isolates)." | 1.33 | Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. ( Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA, 2006) |
| "Voriconazole was also active against C." | 1.32 | Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. ( Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA, 2003) |
| "The isolation of Candida sp in nosocomial infections is on the increase and over the past 10 years many guidelines for "good" practices and recommendations have been published on the modalities for the management of systemic candidiasis." | 1.32 | [Infections by Candida sp. in intensive care. Survey of French practices]. ( Blin, P; Chevalier, E; Cohen, Y; Dupont, H; Gauzit, R; Hennequin, C; Montravers, P; Palestro, B; Timsit, JF; Veber, B, 2003) |
| "Fungal infections have become one of the emerging complications in intensive care patients and the morbidity and mortality linked to these infections underlines the importance of managing these pathologies." | 1.32 | High-dose fluconazole therapy in Intensive Care Unit. ( Bacigalupo, P; Bonfiglio, M; Buscaglia, G; De Bellis, P; Gerbi, G; Guido, P; Massobrio, B, 2003) |
| "In vivo studies have described the pharmacodynamic (PD) characteristics of several triazoles." | 1.32 | In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. ( Andes, D; Conklin, R; Marchillo, K; Stamstad, T, 2003) |
| "Candidiasis was treated with flucostat: 50 mg and 150 mg capsules per os and solution (100-50 ml) intravenously by dropper." | 1.32 | [Treatment of patients with visceral candidiasis]. ( Kurbatova, IV; Makova, GN, 2003) |
| "Candidemia cases in cancer patients from 1998 to 2001 (n = 144) were analyzed retrospectively along with their in vitro susceptibility to amphotericin B, fluconazole, and itraconazole (National Committee for Clinical and Laboratory Standards M27-A method)." | 1.32 | Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. ( Antoniadou, A; Bodey, GP; Han, XY; Kontoyiannis, DP; Lewis, RE; Raad, II; Rolston, KV; Safdar, A; Tarrand, JP; Thornby, J; Torres, HA, 2003) |
| "Cervical lymphadenitis caused by Candida albicans developed in an 8-year-old Chinese child." | 1.32 | Cervical lymphadenitis caused by Candida albicans. ( Sang, H; Wu, B; Zhang, X, 2003) |
| " The histological examination showed no morphological changing, no reduction or extinction of the yeast cells under fluconazole therapy with a dosage of 6 mg kg(-1) body weight (400 mg daily)." | 1.32 | Prosthetic joint infections with osteomyelitis due to Candida albicans. ( Grifka, J; Kalteis, T; Lehn, N; Lerch, K; Schubert, T, 2003) |
| "Anderson Cancer Center (1998-2002)." | 1.32 | High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. ( Kontoyiannis, DP; Rolston, KV; Torres, HA, 2004) |
| "Voriconazole was quite active in vitro against all the isolates with a MIC90% of < or =1 microg ml(-1) and we conclude that it may be useful in the treatment of non-albicans bloodstream infections." | 1.32 | In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study). ( Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M, 2004) |
| "Fluconazole was the antifungal agent most frequently used, both in infected and colonized patients." | 1.32 | [Indications for antifungal treatment in intensive care unit patients]. ( Alvarez-Lerma, F; Bermejo, B; Cerdá, E; León, C; Olaechea, P; Palomar, M, 2004) |
| "Candidiasis is a significant cause of morbidity and mortality in immunosuppressed individuals." | 1.32 | Candida albicans switch phenotypes display differential levels of fitness. ( Holke, A; Joly, S; Morris, R; Sifri, T; Srikantha, R; Vargas, K, 2004) |
| "Ravuconazole was active against the majority of fluconazole-resistant isolates; but for 102 of 562 (18%) resistant isolates, mainly Candida tropicalis, Candida glabrata, and Cryptococcus neoformans, ravuconazole MICs were > or =1 microg/ml." | 1.32 | In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. ( Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL, 2004) |
| "Fluconazole patients were significantly more likely to have Candida cultured from sites associated with colonization (43% vs 2%; p < 0." | 1.32 | Impact of fluconazole administration on outcomes in critically ill patients. ( Garrelts, JC; Harrison, PB; Schroeder, TR, 2004) |
| "Candida infections are difficult to manage due to their persistent nature and associated drug resistance." | 1.32 | Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. ( Albrecht, R; Andes, D; Marchillo, K; Nett, J; Oschel, P; Pitula, A, 2004) |
| "Fluconazole prophylaxis was not used during the study period." | 1.32 | Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. ( Anttila, VJ; Jantunen, E; Juvonen, E; Nihtinen, A; Parkkali, T; Ruutu, T; Volin, L, 2004) |
| "Fungal peritonitis is rare among end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis (CAPD), but when it occurs, it is associated with a high risk of mortality and peritoneal membrane failure." | 1.32 | Risk factors for poor outcome of fungal peritonitis in Chinese patients on continuous ambulatory peritoneal dialysis. ( Chan, CK; Chow, VC; Lo, SH; Mo, KL; Shum, HP; Wong, KS, 2003) |
| "Treatment with fluconazole at 10 mg/kg of body weight/day for 12 weeks not only reduced the numbers of viable organisms within the chambers compared to those in untreated mice (mean +/- standard deviation of log(10) CFU of 0." | 1.31 | Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice. ( Hahn, BL; Sohnle, PG, 2002) |
| "Fluconazole resistance was more common among C." | 1.31 | Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (C ( Armstrong, D; Chaturvedi, V; Koll, BS; Larone, DH; Perlin, DS; Safdar, A, 2002) |
| "Disseminated candidiasis is difficult to diagnose and treat, and often becomes life-threatening in critically ill patients." | 1.31 | Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan. ( Aikawa, N; Hirasawa, H; Kusachi, S; Oda, S; Sumiyama, Y; Yamazaki, Y, 2002) |
| "Fluconazole MICs were 16 (3 SDD strains) and 128 microg/ml (1 resistant strain), respectively." | 1.31 | Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole. ( Alcalá, L; Bouza, E; Fernández-Turégano, CP; Muñoz, P; Peláez, T; Rodríguez-Créixems, M, 2002) |
| " The level of resistance to fungal infections was superior to that given by fluconazole (FLC) treatment alone and highly enhanced by the combination with FLC." | 1.31 | Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections. ( Endo, M; Ino-Ue, T; Kato, I; Kurasawa, M; Mizutani, S; Saito, H; Takesako, K; Uno, Y, 2000) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 1.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| " The concentrations of fluconazole in plasma were maintained above the MICs for FS isolates throughout the dosing interval." | 1.31 | Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. ( Bacher, JD; Gonzalez, CE; Katsov, V; Kligys, K; Lyman, CA; Peter, J; Piscitelli, S; Shetti, D; Torres, R; Walsh, TJ, 2000) |
| "Treatment with fluconazole at 5 or 10 mg kg(-1) per day were equivalent to each other and efficacious in reducing the fungal burden from all four tissues compared with no treatment or lower doses of fluconazole (P < 0." | 1.31 | Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma. ( Clemons, KV; Stevens, DA, 2000) |
| "Oral fluconazole is an alternative to parenteral amphotericin B in the treatment of premature infants, but proof of absorption and an extended treatment period according to prematurity might be warranted." | 1.31 | Candida arthritis in a premature infant treated successfully with oral fluconazole for six months. ( Weigl, JA, 2000) |
| " Long-term use of fluconazole may explain the outcome of the resistant stipple phenotype." | 1.31 | Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients. ( Akgün, Y; Anğ, O; Erturan, Z; Kiraz, N, 2000) |
| "Mucosal candidiasis is common in human immunodeficiency virus (HIV) infection." | 1.31 | In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. ( Arribas, A; Fichtenbaum, C; Fidel, PL; Powderly, W; Saavedra, M; Slavinsky III, J; Swoboda, R; Taylor, BN; Wozniak, K, 2000) |
| "Voriconazole is a promising azole effective against a variety of fungi, including yeasts." | 1.31 | Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. ( Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O, 2000) |
| "Endocarditis is an uncommon complication of invasive candidiasis." | 1.31 | Candida endocarditis in a premature infant. ( Mogyorósy, G; Nagy, A; Soós, G, 2000) |
| "Fluconazole was administered as the first line agent in 6 episodes and successfully cleared candidemia in 5 episodes." | 1.31 | Fluconazole therapy in neonatal candidemia. ( Chou, YH; Hsieh, WS; Huang, YC; Kuo, CY; Lien, RI; Lin, TY; Yang, PH, 2000) |
| "Endogenous fungal endophthalmitis is mostly seen as opportunistic infection, particularly in immunocompromised patients and under special risk factors." | 1.31 | [Candida endophthalmitis in drug abuse. case report. ( Faulborn, J; Haller-Schober, EM; Klein, A, 2000) |
| "Fluconazole was effective as a single agent in 3 patients with solid tumors." | 1.31 | Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. ( Hachem, R; Minari, A; Raad, I, 2001) |
| "Diagnosis and treatment of fungal infections in medical and surgical intensive care units are controversial issues." | 1.31 | [Fungal infections in intensive care units: a cross-survey]. ( Dupont, H, 2001) |
| "Fluconazole utilization was determined by the number of fluconazole treatment-days per 100 hospitalization days (penetration index)." | 1.31 | Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies. ( Aho, S; Bonnin, A; Caillot, D; Chavanet, P; Dalle, F; Durnet-Archeray, MJ; Lopez, J; Pernot, C; Vagner, O, 2001) |
| "Fluconazole, which has been available since the early 1990s, is a relatively atoxic intravenously applicable antimycotic agent." | 1.31 | [Retrospective analysis of fluconazole efficacy in Candida-colonized, non-neutropenic, surgical patients in long-term intensive care]. ( Böhrer, H; Kappe, R; Streitzig, S, 2001) |
| "Treatment of recurrence or persistence was again most commonly nystatin for both mother and infant, followed by oral nystatin for the infant and oral fluconazole for the mother or oral fluconazole for both." | 1.31 | Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment. ( Brent, NB, 2001) |
| "Oral fluconazole was continued for 6 months." | 1.31 | Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole). ( Antoniadou, A; Dosios, T; Giamarellou, H; Petrikkos, G; Sabatakou, H; Skiada, A, 2001) |
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 1.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| "Fluconazole was effective with both administration methods." | 1.31 | Effects of fluconazole on viable cell count in experimental intraperitoneal Candida abscesses. ( Hayasaki, Y; Hua, YX; Mikamo, H; Sato, Y; Tamaya, T, 2000) |
| "isolates from HIV seropositive or AIDS patients with syntomatic oropharyngeal Candida infection." | 1.31 | "In vitro" antifungal activity of protease inhibitors. ( Deibis, L; Hartung de Capriles, C; Magaldi, S; Mata-Essayag, S; Perez, C; Verde, G, 2001) |
| "Fluconazole was less effective against C." | 1.31 | The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. ( Abbas, J; Bodey, GP; Boktour, M; Girgawy, E; Hachem, RY; Hanna, HA; Kontoyiannis, DP; Mardani, M; Raad, II, 2002) |
| "Fluconazole was labelled with (99m)Tc and radiochemical analysis showed less than 5% impurities." | 1.31 | Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. ( Lupetti, A; Mazzi, U; Nibbering, PH; Pauwels, EK; Welling, MM, 2002) |
| "Fluconazole was used before the onset of candidemia in only two patients." | 1.31 | Nosocomial candidemia in a tertiary care hospital in Saudi Arabia. ( Bukharie, HA, 2002) |
| " This process of continuous in vitro exposure to antifungal drug may be useful as a model for studying the effects of different antifungal agents and dosing regimens on the development of resistance and for defining the mechanism(s) of reversible resistance." | 1.30 | Reversible fluconazole resistance in Candida albicans: a potential in vitro model. ( Calvet, HM; Filler, SG; Yeaman, MR, 1997) |
| "Fluconazole seems to be an effective and well-tolerated agent in the treatment of severe life-threatening systemic candidiasis, and a very good alternative to amphotericin B, in cardiac surgery patients." | 1.30 | Systemic candidiasis in cardiac surgery patients. ( Geroulanos, S; Kriaras, J; Michalopoulos, A, 1997) |
| " These results indicate that successful antifungal therapy alone or in combination with cytokine antagonists may rely on the induction of an appropriate Th antifungal cell response." | 1.30 | Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. ( Bistoni, F; Cenci, E; Del Sero, G; Mencacci, A; Romani, L, 1997) |
| "Medical treatment of fungal endocarditis on prosthetic valves can be successful in selected cases." | 1.30 | A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone. ( Kozelj, M; Lejko-Zupanc, T, 1997) |
| "Systemic Candida infections are usually encountered as opportunistic infections in a setting of immunologic depression." | 1.30 | Systemic candidiasis with acute Epstein-Barr virus infection. ( Ener, B; Hacimustafaoglu, M; Ildirim, I; Kiliç, S; Tanritanir, A; Tarim, O, 1997) |
| "Voriconazole was more active than amphotericin B and 5FC against all species except C." | 1.30 | In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. ( Jones, RN; Marco, F; Messer, S; Pfaller, MA, 1998) |
| "Treatment with fluconazole resulted in full recovery." | 1.30 | Synovial fluid levels of fluconazole in a patient with Candida parapsilosis prosthetic joint infection who had an excellent clinical response. ( Cushing, RD; Fulgenzi, WR, 1997) |
| "Laryngeal candidiasis is very rare in the absence of other more proximal diseases in the aerodigestive tract." | 1.30 | [Exophytic papillomatous space-occupying lesions of the larynx as a rare manifestation of candidiasis. Diagnostic and therapeutic consequences]. ( Lorenz, KJ; Maier, H; Wallner, F, 1998) |
| "A 57-year-old male was treated for fungal endocarditis caused by Candida parapsilosis which precipitated severe cardiac valve vegetation and insufficiency." | 1.30 | A case report of Candida parapsilosis endocarditis. ( Inoue, Y; Kawada, S; Ueda, T; Yozu, R, 1998) |
| "In this study we defined the pharmacodynamic parameter that optimizes outcome in deep-seated Candida albicans infections treated with fluconazole." | 1.30 | Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. ( Banerjee, P; Drusano, GL; Kaw, P; Liu, QF; Liu, W; Louie, A; Miller, MH; Shayegani, M; Taber, H, 1998) |
| "Oral fluconazole seems to be a safe and effective treatment for Candida albicans septicaemia even in premature infants." | 1.30 | Pharmacokinetics of oral fluconazole in premature infants. ( Hörnchen, H; Schefels, J; Skopnik, H; Wenzl, TG, 1998) |
| "albicans endophthalmitis was diagnosed for 15 IVDAs." | 1.30 | Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. ( Bordón, J; de la Fuente, J; Fernández-Ulloa, J; Martínez-Vázquez, C; Ocampo, A; Rubianes, M; Sopeña, B, 1998) |
| "parapsilosis in a cancer center within 10 years, with the aim to compare risk factors and the outcome with fungemias caused by C." | 1.30 | Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome. ( Grausová, S; Krcméry, V; Krupová, I; Mardiak, J; Roidová, A; Sálek, T; Spánik, S; Sufliarsky, J; Trupl, J, 1998) |
| "A case of Candida albicans spondylodiscitis in a 20-year-old female liver transplant recipient is reported." | 1.30 | Fluconazole therapy in Candida albicans spondylodiscitis. ( Nielsen, H; Rössel, P; Schønheyder, HC, 1998) |
| "Voriconazole (UK-109,496) is a new triazole with in vitro activity against a wide spectrum of fungi including yeasts intrinsically resistant to fluconazole such as Candida krusei." | 1.30 | Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. ( Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H, 1999) |
| "Fluconazole was most frequently utilized (n = 42, 52." | 1.30 | Clinicians' reaction to positive urine culture for Candida organisms. ( Ayeni, O; Khatib, R; Riederer, KM; Wilson, FM, 1999) |
| "Yeast fungemia has increased markedly in the last few years." | 1.30 | [A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)]. ( Cuenca-Estrella, M; Rodríguez-Tudela, JL, 1999) |
| " The times spent above the MIC during the experimental dosing interval of 24 h were 4 h for LY at 0." | 1.30 | Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits. ( Bacher, J; Bell, A; Candelario, M; Groll, AH; Lyman, CA; McMillian, CL; Petraitiene, R; Petraitis, V; Sein, T; Walsh, TJ, 1999) |
| "Systemic candidiasis affects 1." | 1.30 | Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. ( McGinnis, MR; Nordoff, N; Passarell, L; Rowen, JL; Tate, JM, 1999) |
| "(NAC) in a single National Cancer Institution within 10 years were analysed for aetiology, risk factors and outcome." | 1.30 | Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. ( Grey, E; Jurga, L; Krcmery, V; Kunova, A; Mardiak, J; Mateicka, F; Mrazova, M; Novotny, J; Sabo, A; Sevcikova, L; Sorkovska, D; Sufliarsky, J; Trupl, J; West, D, 1999) |
| " Since lactoferrin is one of the nonspecific host defense factors present in saliva that exhibit antifungal activity, we studied the antifungal effects of human, bovine, and iron-depleted lactoferrin in combination with fluconazole, amphotericin B, and 5-fluorocytosine in vitro against clinical isolates of Candida species." | 1.30 | Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. ( de Vries, HG; Eikelboom, MC; Kuipers, ME; Meijer, DK; Swart, PJ, 1999) |
| "Fungal peritonitis is a rare event in patients receiving peritoneal dialysis." | 1.30 | Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. ( Blowey, DL; Garg, UC; Kearns, GL; Warady, BA, 1998) |
| "Amphotericin B (amp B) was added when clinical sepsis was present." | 1.30 | Fungal peritonitis in pediatric patients. ( Abitbol, C; Coakley, S; Diaz, R; Mazza, I; Montane, BS; Strauss, J; Zilleruelo, G, 1998) |
| " When combined with amphotericin B (AmB), however, DU-6859a clearly enhanced the in vitro antifungal activity of AmB against Candida albicans, Candida tropicalis, Candida krusei, Candida glabrata, and Cryptococcus neoformans in microdilution checkerboard studies." | 1.29 | In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. ( Kitamura, A; Nakajima, R; Sato, K; Someya, K; Tanaka, M, 1995) |
| "This syndrome has a favorable prognosis." | 1.29 | A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis. ( Hussein, A; Meisenberg, B; Mudad, R; Paulson, EK; Peters, WP; Ross, M; Vredenburgh, J, 1994) |
| "Treatment with fluconazole, flucytosine, amphotericin B or a combination was begun one day after infection." | 1.29 | Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice. ( Atkinson, BA; Bocanegra, R; Bouthet, C; Correa, A; Graybill, JR; Luther, MF, 1995) |
| "Fluconazole treatment was started after the diagnosis of systemic candidiasis." | 1.29 | Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient. ( Bause, H; Höver, S; Scholz, J; Schulz, M; Steinfath, M, 1995) |
| "After this treatment, pneumonia deteriorated." | 1.29 | [Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report]. ( Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Shiba, K; Shindou, N; Yoshida, M; Yoshikawa, K, 1993) |
| "Fluconazole appears to be a safe and effective antifungal agent that can be administered orally and may be a useful agent for treating some intraocular fungal infections." | 1.29 | Treatment of ocular fungal infections with oral fluconazole. ( Kubak, BM; Luttrull, JK; Oster, HA; Smith, MD; Wan, WL, 1995) |
| "Fluconazole was less effective for treatment of resistant C." | 1.29 | Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice. ( Graybill, JR; Holmberg, JD; Luther, MF; Najvar, LK, 1995) |
| "Treatment with fluconazole (100 mg/kg/day orally) had no effect." | 1.29 | SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice. ( Anaissie, EJ; Dignani, MC; Karyotakis, NC, 1995) |
| "Deep Candida infections are increasing in incidence, especially in non-neutropenic, intensive care patients including neonates." | 1.29 | Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party. ( , 1994) |
| "Almost all patients with acquired immunodeficiency syndrome and successfully treated esophageal candidiasis develop a recurrence, usually within 2-3 months." | 1.29 | The natural history of esophageal candidiasis after successful treatment in patients with AIDS. ( Laine, L, 1994) |
| "Candida endophthalmitis is a good indicator of systemic candidiasis in hospitalized patients." | 1.29 | Mortality of hospitalized patients with Candida endophthalmitis. ( Demajo, WA; Devenyi, RG; Menezes, AV; Sigesmund, DA, 1994) |
| " In immunocompetent mice, the dosage of AmB-DOC was limited by toxicity, resulting in a maximum tolerated dosage (MTD) of 0." | 1.29 | Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. ( Bakker-Woudenberg, IA; van den Heuvel-de Groot, C; van Etten, EW, 1993) |
| "Fungal endocarditis is considered an absolute indication for valve replacement surgery." | 1.29 | Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. ( Hinthorn, DR; Klotz, SA; Zahid, MA, 1994) |
| "Case 2 was a boy with candida pneumonitis." | 1.29 | [Fluconazole therapy for pediatric patients with severe candidal infections]. ( Hisakawa, H; Kurashige, T; Misaki, Y; Morita, H; Okada, T; Sinohara, M; Tomoda, T; Wakiguchi, H; Watanabe, S, 1994) |
| "Fluconazole is an effective and less toxic alternative to prolonged courses of amphotericin B in the treatment of neonatal renal candidiasis." | 1.29 | Neonatal renal candidiasis. ( Bailey, CJ; Cartledge, JM; Morris, SA, 1994) |
| "Fluconazole was a potent inhibitor of cytochrome P-450-dependent 14 alpha-sterol demethylase (P-450DM) in lysates of cells from both susceptible and resistant cultures (50% inhibitory concentration, 0." | 1.29 | Fluconazole resistance in Candida glabrata. ( Hitchcock, CA; Johnson, EM; Pye, GW; Troke, PF; Warnock, DW, 1993) |
| "Amphotericin B is the treatment of choice for acute and chronic hematogenously disseminated candidiasis." | 1.29 | Severe candidal infections in neutropenic patients. ( Edwards, JE; Filler, SG; Swerdloff, JN, 1993) |
| "Hepatosplenic candidiasis is increasingly observed in patients with a haematological malignancy who have received chemotherapy." | 1.29 | [Hepatosplenic candidiasis in patients treated for hemato-oncological disorders]. ( Huijgens, PC; Sibinga, L; Zweegman, S, 1994) |
| "Fluconazole was reasonably well tolerated." | 1.29 | Treatment of Candida albicans fungaemia with fluconazole. ( Georgopoulos, A; Graninger, W; Presteril, E; Schneeweiss, B; Teleky, B, 1993) |
| "Treatment by fluconazole for six months, in the first case in the beginning also by amphotericin B, lead to the healing of fungal spondylitis, accompanied by partial osseous consolidation." | 1.29 | [Candida albicans spondylitis: successful treatment with fluconazole. 2 case reports]. ( Brunner-La Rocca, HP; Rösler-Meier, D; Schlumpf, U; Senn, P, 1996) |
| "Fungal peritonitis is rare in our CPD population, and although it leads to significant CPD drop-out, it can be managed in many patients with antifungal therapy, early catheter removal, and temporary hemodialysis." | 1.29 | Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. ( Dunne, D; Finkelstein, FO; Goldie, SJ; Gorban-Brennan, N; Kiernan-Tridle, L; Kliger, AS; Torres, C, 1996) |
| "Treatment with fluconazole was ineffective, but amphotericin B was curative." | 1.29 | Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole. ( Arranz-Caso, JA; García-Altozano, J; Gomez-Herruz, P; Lopez-Pizarro, VM; Martinez-Martinez, J, 1996) |
| "Fluconazole is an effective alternative to amphotericin B for the treatment of serious infections caused by Candida albicans." | 1.29 | Fluconazole treatment of candidal infections caused by non-albicans Candida species. ( van 't Wout, JW, 1996) |
| "Fluconazole is an effective oral or intravenous anti-fungal agent." | 1.29 | Fluconazole infused via a nephrostomy tube: a novel and effective route of delivery. ( Oliver, SE; Walker, RJ; Woods, DJ, 1995) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 1.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "The drug proved effective and safe." | 1.29 | [Use of Diflucan in the treatment of chronic and recurrent candidosis with involvement of the esophagus]. ( Antonov, VV; Barantsevich, EP; Nizamutdinova, AS, 1996) |
| "Fluconazole was superior to oral amphotericin B in the treatment of C." | 1.28 | Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. ( Bordone, G; Colledan, M; Malaspina, C; Pagano, A; Paone, G; Rossi, G; Tortorano, AM; Viviani, MA, 1992) |
| "Treatment with fluconazole alone also significantly lowered the number of C." | 1.28 | Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. ( Kullberg, BJ; Poell, RJ; van 't Wout, JW; van Furth, R, 1992) |
| "esophagitis is common in HIV-infected patients." | 1.28 | Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. ( Aguado, AG; Khamashta, MA; López-Dupla, M; Mora Sanz, P; Pintado García, V; Uriol, PL; Valencia Ortega, E, 1992) |
| "Amphotericin B was the most effective agent in this study of disseminated Candida tropicalis (C." | 1.28 | The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice. ( Bannatyne, RM; Cheng, PC; Fong, IW, 1992) |
| " Dosage was 5 mg/kg/day." | 1.28 | Candida albicans septicemia in a premature infant successfully treated with oral fluconazole. ( Bodé, S; Hjelt, K; Pedersen-Bjergaard, L, 1992) |
| "Fluconazole was administered to these patients for a mean of 20 days at doses ranging from 100 to 200 mg/d." | 1.28 | Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. ( León, C; Martín, E; Nolla-Salas, J; Sitges-Serra, A; Torres-Rodríguez, JM, 1992) |
| "Fluconazole was continued orally later on." | 1.28 | [Isolated Candida albicans meningitis after treatment of B lymphoma]. ( Chevalier, MC; Damay, M; Gouraud, F; Jabado, N; Landman-Parker, J; Leverger, G; Varache, C, 1992) |
| "Fluconazole was well tolerated in all the patients." | 1.28 | [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla, P; López Dupla, M; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1992) |
| "For fluconazole, activity was restricted to inhibition of fungal growth, even after the inoculum size was reduced." | 1.28 | Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans. ( Bakker-Woudenberg, IA; van de Rhee, NE; van Etten, EW; van Kampen, KM, 1991) |
| "fluconazole (50 mg/kg) was begun 24 or 60 h postinfection and continued daily for 9 or 12 days." | 1.28 | Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis. ( Bayer, AS; Witt, MD, 1991) |
| "Fluconazole is a recently licensed antifungal agent that has gained widespread use in the medical community." | 1.28 | Fluconazole failure in the treatment of invasive mycoses. ( Carroll, K; Classen, D; Cohen, S; Evans, TG; Mayer, J, 1991) |
| "An AIDS patient with a subdural empyema as a complication of candida sinusitis is presented." | 1.28 | Successfully treated candida sinusitis in an AIDS patient. ( Castro, A; Colmenero, C; Moñux, A; Valencia, E, 1990) |
| "Fluconazole was administered orally at a daily dose of 100 mg and 200 mg, respectively (n = 29), or intravenously at a dose of 100 mg and 400 mg (n = 2)." | 1.28 | [Prophylaxis and therapy of fungal infections with fluconazole in patients after bone marrow transplantation]. ( Beelen, DW; Dermoumi, H; Kölbel, M; Kraft, J; Müller, KD; Quabeck, K; Schaefer, UW, 1990) |
| "Fluconazole was markedly effective against septicemia due to Candida and oral candidiasis accompanied with lingual ulcer in spite of seriousness of these underlying disease." | 1.28 | [Clinical evaluation of fluconazole in patients with mycotic infection]. ( Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S, 1989) |
| "Fluconazole is a triazole agent and possesses a potent antifungal activity against fungi such as Candida, Cryptococcus and Aspergillus." | 1.28 | [Experience of fluconazole in pediatric patients]. ( Arai, S; Iguchi, K; Kamiya, H; Sakurai, M, 1989) |
| "Fluconazole was given either orally (4 patients) or intravenously (3 patients) in a dose of 50 mg per day." | 1.28 | [Clinical efficacy of fluconazole in urinary tract fungal infections]. ( Nito, H, 1989) |
| " No significant adverse reactions nor abnormality in clinical laboratory tests related with the dosing of fluconazole were observed in any of the patients." | 1.28 | [A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy]. ( Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O, 1989) |
| "Fluconazole (UK-49,858) is a new oral bis-triazole antifungal agent with demonstrated activity against Candida albicans." | 1.28 | Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei. ( Fisher, MA; Haddad, J; Shen, SH; Tarry, WF, 1989) |
| "Oral treatment with fluconazole resulted in much higher serum and extravascular concentrations of this antifungal agent than did comparable doses of ketoconazole." | 1.27 | Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. ( Beggs, WH; Bennett, RL; Hughes, CE; Tuna, IC, 1988) |
| "Fluconazole was well tolerated by all patients and there were no significant changes in haematological or hepatic parameters that could be attributed to the drug." | 1.27 | Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. ( Drouhet, E; Dupont, B, 1988) |
| " In a 10-day dosage regimen, UK-49,858 was far more active than ketoconazole against systemic infections with C." | 1.27 | Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice. ( Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (1.88) | 18.7374 |
| 1990's | 584 (29.75) | 18.2507 |
| 2000's | 754 (38.41) | 29.6817 |
| 2010's | 469 (23.89) | 24.3611 |
| 2020's | 119 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Dolle, RE | 1 |
| Allaudeen, HS | 1 |
| Kruse, LI | 1 |
| Bartroli, J | 3 |
| Turmo, E | 3 |
| Algueró, M | 3 |
| Boncompte, E | 3 |
| Vericat, ML | 3 |
| García-Rafanell, J | 3 |
| Forn, J | 3 |
| Conte, L | 2 |
| Ramis, J | 2 |
| Merlos, M | 2 |
| Fujie, A | 1 |
| Iwamoto, T | 1 |
| Sato, B | 1 |
| Muramatsu, H | 1 |
| Kasahara, C | 1 |
| Furuta, T | 1 |
| Hori, Y | 1 |
| Hino, M | 1 |
| Hashimoto, S | 1 |
| Barrett, D | 2 |
| Tanaka, A | 2 |
| Harada, K | 2 |
| Ohki, H | 1 |
| Watabe, E | 3 |
| Maki, K | 3 |
| Ikeda, F | 4 |
| Ebiike, H | 1 |
| Masubuchi, M | 1 |
| Liu, P | 2 |
| Kawasaki, K | 2 |
| Morikami, K | 1 |
| Sogabe, S | 1 |
| Hayase, M | 1 |
| Fujii, T | 1 |
| Sakata, K | 1 |
| Shindoh, H | 1 |
| Shiratori, Y | 1 |
| Aoki, Y | 1 |
| Ohtsuka, T | 1 |
| Shimma, N | 1 |
| Meulbroek, JA | 1 |
| Nilius, AM | 1 |
| Li, Q | 1 |
| Wang, W | 4 |
| Hasvold, L | 1 |
| Steiner, B | 1 |
| Dickman, DA | 1 |
| Ding, H | 1 |
| Frost, D | 1 |
| Goldman, RC | 1 |
| Lartey, P | 1 |
| Plattner, JJ | 1 |
| Bennani, YL | 1 |
| Lal, B | 1 |
| Gund, VG | 1 |
| Pai, MP | 6 |
| Turpin, RS | 5 |
| Garey, KW | 6 |
| Vandeputte, P | 3 |
| Tronchin, G | 2 |
| Bergès, T | 2 |
| Hennequin, C | 6 |
| Chabasse, D | 3 |
| Bouchara, JP | 3 |
| Venkatesh, MP | 1 |
| Pham, D | 1 |
| Fein, M | 1 |
| Kong, L | 2 |
| Weisman, LE | 1 |
| Yao, B | 1 |
| Ji, H | 1 |
| Cao, Y | 1 |
| Zhou, Y | 1 |
| Zhu, J | 1 |
| Lü, J | 1 |
| Li, Y | 5 |
| Chen, J | 3 |
| Zheng, C | 1 |
| Jiang, Y | 4 |
| Liang, R | 1 |
| Tang, H | 1 |
| Spreghini, E | 3 |
| Maida, CM | 2 |
| Milici, ME | 2 |
| Scalise, G | 8 |
| Barchiesi, F | 9 |
| Fritsche, TR | 1 |
| Rhomberg, PR | 2 |
| Sader, HS | 3 |
| Jones, RN | 9 |
| Venisse, N | 1 |
| Grégoire, N | 1 |
| Marliat, M | 1 |
| Couet, W | 1 |
| Mitsuyama, J | 2 |
| Nomura, N | 2 |
| Hashimoto, K | 1 |
| Yamada, E | 2 |
| Nishikawa, H | 3 |
| Kaeriyama, M | 1 |
| Kimura, A | 1 |
| Todo, Y | 1 |
| Narita, H | 2 |
| Gomez-Lopez, A | 2 |
| Alastruey-Izquierdo, A | 1 |
| Rodriguez, D | 2 |
| Almirante, B | 5 |
| Pahissa, A | 4 |
| Rodriguez-Tudela, JL | 13 |
| Cuenca-Estrella, M | 12 |
| Cleary, JD | 2 |
| Garcia-Effron, G | 4 |
| Chapman, SW | 3 |
| Perlin, DS | 7 |
| Tomassetti, S | 1 |
| Orlando, F | 1 |
| Giannini, D | 2 |
| Larcher, G | 1 |
| Ernoult, E | 1 |
| Kontoyiannis, DP | 14 |
| Lewis, RE | 8 |
| Lamping, E | 2 |
| Ranchod, A | 1 |
| Nakamura, K | 1 |
| Tyndall, JD | 1 |
| Niimi, K | 2 |
| Holmes, AR | 3 |
| Niimi, M | 2 |
| Cannon, RD | 2 |
| Arendrup, MC | 5 |
| Buzina, W | 1 |
| Mortensen, KL | 1 |
| Reiter, N | 1 |
| Lundin, C | 1 |
| Jensen, HE | 1 |
| Lass-Flörl, C | 4 |
| Bruun, B | 1 |
| Aher, NG | 1 |
| Pore, VS | 1 |
| Mishra, NN | 1 |
| Kumar, A | 8 |
| Shukla, PK | 1 |
| Sharma, A | 1 |
| Bhat, MK | 1 |
| Dimopoulos, G | 1 |
| Velegraki, A | 2 |
| Falagas, ME | 1 |
| Ostrosky-Zeichner, L | 6 |
| Paetznick, VL | 3 |
| Rodriguez, J | 1 |
| Chen, E | 2 |
| Sheehan, DJ | 4 |
| Florent, M | 1 |
| Noël, T | 2 |
| Ruprich-Robert, G | 1 |
| Da Silva, B | 1 |
| Fitton-Ouhabi, V | 1 |
| Chastin, C | 1 |
| Papon, N | 2 |
| Chapeland-Leclerc, F | 2 |
| Mann, PA | 2 |
| McNicholas, PM | 3 |
| Chau, AS | 1 |
| Patel, R | 3 |
| Mendrick, C | 1 |
| Ullmann, AJ | 1 |
| Cornely, OA | 2 |
| Patino, H | 1 |
| Black, TA | 2 |
| Heilmann, CJ | 1 |
| Schneider, S | 2 |
| Barker, KS | 6 |
| Rogers, PD | 8 |
| Morschhäuser, J | 8 |
| Girard, A | 1 |
| Socié, G | 2 |
| Ribaud, P | 3 |
| Lacroix, C | 3 |
| MacCallum, DM | 2 |
| Coste, A | 2 |
| Ischer, F | 5 |
| Jacobsen, MD | 2 |
| Odds, FC | 8 |
| Sanglard, D | 12 |
| Miyazaki, T | 3 |
| Yamauchi, S | 1 |
| Inamine, T | 1 |
| Nagayoshi, Y | 1 |
| Saijo, T | 2 |
| Izumikawa, K | 5 |
| Seki, M | 1 |
| Kakeya, H | 2 |
| Yamamoto, Y | 1 |
| Yanagihara, K | 2 |
| Miyazaki, Y | 4 |
| Kohno, S | 4 |
| Trabocchi, A | 2 |
| Mannino, C | 1 |
| Machetti, F | 1 |
| De Bernardis, F | 7 |
| Arancia, S | 2 |
| Cauda, R | 4 |
| Cassone, A | 9 |
| Guarna, A | 2 |
| Kucharíková, S | 3 |
| Tournu, H | 1 |
| Holtappels, M | 1 |
| Van Dijck, P | 3 |
| Lagrou, K | 3 |
| Kuroyanagi, J | 1 |
| Kanai, K | 1 |
| Sugimoto, Y | 1 |
| Fujisawa, T | 1 |
| Morita, C | 1 |
| Suzuki, T | 1 |
| Kawakami, K | 1 |
| Takemura, M | 1 |
| Tichotová, L | 1 |
| Matoušová, E | 1 |
| Spulák, M | 1 |
| Kuneš, J | 1 |
| Votruba, I | 1 |
| Buchta, V | 2 |
| Pour, M | 1 |
| De Vita, D | 1 |
| Scipione, L | 1 |
| Tortorella, S | 1 |
| Mellini, P | 1 |
| Di Rienzo, B | 1 |
| Simonetti, G | 1 |
| D'Auria, FD | 1 |
| Panella, S | 1 |
| Cirilli, R | 1 |
| Di Santo, R | 1 |
| Palamara, AT | 4 |
| Shi, LP | 1 |
| Jiang, KM | 1 |
| Jiang, JJ | 1 |
| Jin, Y | 2 |
| Tao, YH | 1 |
| Li, K | 1 |
| Wang, XH | 1 |
| Lin, J | 1 |
| Soni, JN | 1 |
| Soman, SS | 1 |
| Bardiot, D | 1 |
| Thevissen, K | 2 |
| De Brucker, K | 2 |
| Peeters, A | 1 |
| Cos, P | 2 |
| Taborda, CP | 2 |
| McNaughton, M | 1 |
| Maes, L | 1 |
| Chaltin, P | 1 |
| Cammue, BP | 2 |
| Marchand, A | 1 |
| Zaheer, Z | 1 |
| Khan, FA | 2 |
| Sangshetti, JN | 1 |
| Patil, RH | 1 |
| Lohar, KS | 1 |
| Shrestha, SK | 1 |
| Garzan, A | 1 |
| Garneau-Tsodikova, S | 1 |
| Lino, CI | 2 |
| Gonçalves de Souza, I | 1 |
| Borelli, BM | 1 |
| Silvério Matos, TT | 1 |
| Santos Teixeira, IN | 1 |
| Ramos, JP | 1 |
| Maria de Souza Fagundes, E | 1 |
| de Oliveira Fernandes, P | 1 |
| Maltarollo, VG | 1 |
| Johann, S | 2 |
| de Oliveira, RB | 2 |
| Emami, S | 2 |
| Ghobadi, E | 1 |
| Saednia, S | 1 |
| Hashemi, SM | 2 |
| Montoir, D | 1 |
| Guillon, R | 1 |
| Gazzola, S | 1 |
| Ourliac-Garnier, I | 1 |
| Soklou, KE | 1 |
| Tonnerre, A | 1 |
| Picot, C | 1 |
| Planchat, A | 1 |
| Pagniez, F | 3 |
| Le Pape, P | 4 |
| Logé, C | 2 |
| Han, G | 3 |
| Liu, N | 5 |
| Li, C | 4 |
| Tu, J | 5 |
| Li, Z | 5 |
| Sheng, C | 5 |
| Xu, H | 1 |
| Yan, ZZ | 1 |
| Guo, MB | 1 |
| An, R | 1 |
| Wang, X | 7 |
| Zhang, R | 4 |
| Mou, YH | 1 |
| Hou, Z | 2 |
| Guo, C | 2 |
| Yin, W | 1 |
| Wu, T | 1 |
| Liu, L | 4 |
| Jiang, H | 1 |
| Zhang, Y | 3 |
| Cui, H | 1 |
| Sun, Y | 6 |
| Qin, Q | 1 |
| Gao, Z | 1 |
| Zhao, L | 1 |
| Su, X | 1 |
| Zhao, D | 2 |
| Cheng, M | 1 |
| Zhang, X | 3 |
| Wang, M | 1 |
| Zhu, X | 2 |
| Peng, Y | 1 |
| Fu, T | 1 |
| Hu, CH | 1 |
| Cai, J | 1 |
| Liao, G | 1 |
| Dhanani, JA | 1 |
| Lipman, J | 3 |
| Pincus, J | 1 |
| Townsend, S | 1 |
| Livermore, A | 1 |
| Wallis, SC | 1 |
| Abdul-Aziz, MH | 1 |
| Roberts, JA | 4 |
| Wang, T | 2 |
| Pan, M | 1 |
| Xiao, N | 1 |
| Wu, J | 2 |
| Wang, Q | 5 |
| Cheng, T | 1 |
| Yan, G | 1 |
| Wu, D | 4 |
| Li, N | 1 |
| Shao, J | 2 |
| Escandón, P | 1 |
| Cáceres, DH | 1 |
| Lizarazo, D | 1 |
| Lockhart, SR | 5 |
| Lyman, M | 1 |
| Duarte, C | 1 |
| Hagras, M | 1 |
| Abutaleb, NS | 1 |
| Sayed, AM | 1 |
| Salama, EA | 1 |
| Seleem, MN | 1 |
| Mayhoub, AS | 1 |
| Santana, DJ | 1 |
| O'Meara, TR | 1 |
| Spiliopoulou, A | 3 |
| Kolonitsiou, F | 2 |
| Vrioni, G | 1 |
| Tsoupra, S | 1 |
| Lekkou, A | 1 |
| Paliogianni, F | 1 |
| Kumari, S | 2 |
| Kumar, M | 2 |
| Esquivel, BD | 1 |
| Wasi, M | 2 |
| Pandey, AK | 1 |
| Kumar Khandelwal, N | 1 |
| Mondal, AK | 2 |
| White, TC | 4 |
| Prasad, R | 3 |
| Gaur, NA | 2 |
| Engbers, AGJ | 1 |
| Flint, RB | 1 |
| Voeller, S | 1 |
| Reiss, I | 1 |
| Liem, KD | 1 |
| Alffenaar, JC | 1 |
| Tibboel, D | 1 |
| Simons, S | 1 |
| Knibbe, CAJ | 1 |
| Brüggemann, RJ | 2 |
| López Peña, C | 1 |
| Barrientos Delgado, A | 1 |
| Soler Góngora, M | 1 |
| Atiencia-Carrera, MB | 1 |
| Cabezas-Mera, FS | 1 |
| Tejera, E | 1 |
| Machado, A | 1 |
| Kraisit, P | 1 |
| Yonemochi, E | 1 |
| Furuishi, T | 1 |
| Mahadlek, J | 1 |
| Limmatvapirat, S | 1 |
| López-Medrano, F | 1 |
| Muñoz de la Espada, M | 1 |
| Pérez-Jacoiste Asín, MA | 1 |
| Fernández-Ruiz, M | 1 |
| Herrero-Martínez, JM | 1 |
| Alonso-Carrillo, J | 1 |
| San Juan, R | 1 |
| Rodríguez-Goncer, I | 1 |
| Andrés, A | 1 |
| González, E | 1 |
| Manrique, A | 1 |
| Justo, I | 1 |
| Marcacuzco, A | 1 |
| Loinaz, C | 1 |
| Jiménez, C | 1 |
| Lumbreras, C | 2 |
| Aguado, JM | 2 |
| Pohl, CH | 1 |
| Song, N | 1 |
| Zhou, X | 2 |
| Li, D | 2 |
| Li, X | 6 |
| Liu, W | 8 |
| Erami, M | 2 |
| Raiesi, O | 1 |
| Momen-Heravi, M | 1 |
| Getso, MI | 1 |
| Fakhrehi, M | 1 |
| Mehri, N | 1 |
| Yarahmadi, M | 1 |
| Amiri, S | 1 |
| Raissi, V | 1 |
| Hashemi, SJ | 1 |
| Mwassi, HA | 1 |
| Yahav, D | 1 |
| Ayada, G | 1 |
| Matsri, S | 1 |
| Margalit, I | 1 |
| Shargian, L | 1 |
| Bishara, J | 3 |
| Atamna, A | 1 |
| Alcoceba, E | 1 |
| Gómez, A | 1 |
| Lara-Esbrí, P | 1 |
| Oliver, A | 1 |
| Beltrán, AF | 1 |
| Ayestarán, I | 1 |
| Muñoz, P | 6 |
| Escribano, P | 3 |
| Guinea, J | 6 |
| Okoye, CA | 1 |
| Nweze, E | 1 |
| Ibe, C | 1 |
| Wang, B | 1 |
| Wang, Y | 12 |
| Zhang, L | 4 |
| Lu, F | 1 |
| Zhang, M | 4 |
| Xu, Y | 2 |
| Dougue, AN | 1 |
| El-Kholy, MA | 2 |
| Giuffrè, L | 1 |
| Galeano, G | 1 |
| D Aleo, F | 1 |
| Kountchou, CL | 1 |
| Nangwat, C | 1 |
| Dzoyem, JP | 1 |
| Giosa, D | 1 |
| Pernice, I | 1 |
| Shawky, SM | 2 |
| Ngouana, TK | 1 |
| Boyom, FF | 1 |
| Romeo, O | 1 |
| Tartor, YH | 1 |
| Elmowalid, GA | 1 |
| Hassan, MN | 1 |
| Shaker, A | 1 |
| Ashour, DF | 1 |
| Saber, T | 1 |
| Lona-Reyes, JC | 1 |
| Gómez-Ruiz, LM | 1 |
| Cordero-Zamora, A | 1 |
| Cortés-González, SI | 1 |
| Quiles-Corona, M | 1 |
| Pérez-Ramírez, RO | 1 |
| Pinto-Macedo, H | 1 |
| Dunaiski, CM | 1 |
| Kock, MM | 1 |
| Jung, H | 1 |
| Peters, RPH | 1 |
| Sutar, Y | 1 |
| Nabeela, S | 1 |
| Singh, S | 3 |
| Alqarihi, A | 1 |
| Solis, N | 1 |
| Ghebremariam, T | 1 |
| Filler, S | 1 |
| Ibrahim, AS | 1 |
| Date, A | 1 |
| Uppuluri, P | 1 |
| Billmyre, RB | 1 |
| Branco, J | 1 |
| Ryan, AP | 1 |
| Pinto E Silva, A | 1 |
| Butler, G | 2 |
| Miranda, IM | 3 |
| Rodrigues, AG | 6 |
| Bilal, H | 1 |
| Shafiq, M | 1 |
| Hou, B | 1 |
| Islam, R | 1 |
| Khan, MN | 1 |
| Khan, RU | 1 |
| Zeng, Y | 1 |
| Spruijtenburg, B | 1 |
| Badali, H | 5 |
| Abastabar, M | 2 |
| Mirhendi, H | 1 |
| Khodavaisy, S | 2 |
| Sharifisooraki, J | 1 |
| Taghizadeh Armaki, M | 1 |
| de Groot, T | 2 |
| Meis, JF | 14 |
| Tsukamoto, H | 1 |
| Higashi, T | 1 |
| Kodawara, T | 1 |
| Watanabe, K | 5 |
| Hida, Y | 1 |
| Iwasaki, H | 1 |
| Goto, N | 1 |
| Silva, GM | 1 |
| de Sousa, BR | 1 |
| Torres, KB | 1 |
| Neves, RP | 2 |
| de Melo, HRL | 1 |
| de Lima-Neto, RG | 1 |
| Yu, PK | 3 |
| Moron-Espiritu, LS | 3 |
| Lao, AR | 3 |
| Chakraborty, S | 3 |
| Rahate, K | 3 |
| Kumar, C | 3 |
| Idicula-Thomas, S | 3 |
| Yazdanpanah, S | 3 |
| Ahmadi, M | 2 |
| Zare, Z | 2 |
| Nikoupour, H | 2 |
| Arabsheybani, S | 2 |
| Jabrodini, A | 2 |
| Eghtedarnejad, E | 2 |
| Chamanpara, P | 2 |
| Geramizadeh, B | 2 |
| Anbardar, MH | 2 |
| Malekizadeh, Z | 2 |
| Gashtasebi, M | 2 |
| Mohsenzadeh, M | 2 |
| Shafiekhani, M | 2 |
| Zomorodian, K | 4 |
| Xiao, H | 2 |
| Miao, Y | 2 |
| Feng, W | 3 |
| Liu, S | 5 |
| Guo, L | 2 |
| Guo, X | 3 |
| Chen, T | 2 |
| Hu, B | 2 |
| Hu, H | 2 |
| Xu, F | 2 |
| Han, L | 3 |
| Ren, L | 2 |
| Li, W | 2 |
| Liu, G | 2 |
| do Rosário Esteves Guimarães, C | 2 |
| de Freitas, HF | 2 |
| Barros, TF | 2 |
| Badr-Eldin, SM | 1 |
| Aldawsari, HM | 1 |
| Fahmy, UA | 1 |
| Ahmed, OAA | 1 |
| Alhakamy, NA | 1 |
| Elfaky, MA | 1 |
| Sirwi, A | 1 |
| Hawsawi, SA | 1 |
| Alzahrani, AH | 1 |
| Yaseen, AY | 1 |
| Qassim, M | 1 |
| Kotta, S | 1 |
| Behbehani, JM | 1 |
| Irshad, M | 1 |
| Shreaz, S | 2 |
| Karched, M | 1 |
| Sass, G | 2 |
| Larwood, DJ | 2 |
| Martinez, M | 3 |
| Stevens, DA | 5 |
| Derkacz, D | 1 |
| Krasowska, A | 2 |
| Huang, Y | 2 |
| Yang, W | 3 |
| Zhao, HH | 1 |
| Lu, L | 1 |
| Zhao, YZ | 1 |
| Yang, LJ | 1 |
| Ding, YX | 1 |
| Mannala, GK | 1 |
| Rupp, M | 1 |
| Walter, N | 1 |
| Scholz, KJ | 1 |
| Simon, M | 1 |
| Riool, M | 1 |
| Alt, V | 1 |
| Yang, S | 1 |
| Peng, X | 2 |
| Ren, B | 2 |
| Luo, Y | 1 |
| Xu, X | 2 |
| Fonseca, MS | 1 |
| Deegan, KR | 1 |
| Tomé, LM | 1 |
| Mendonça, MA | 1 |
| Sokolonski, AR | 1 |
| Gondim, LQ | 1 |
| Azevedo, V | 1 |
| Meyer, R | 1 |
| Tasic, L | 1 |
| Góes-Neto, A | 1 |
| Portela, RW | 1 |
| Sharifi, M | 1 |
| Badiee, P | 1 |
| Morovati, H | 1 |
| Haghani, I | 2 |
| Noorbakhsh, M | 1 |
| Mohammadi, R | 1 |
| Scott, NE | 1 |
| Edwin Erayil, S | 1 |
| Kline, SE | 1 |
| Selmecki, A | 2 |
| Liang, T | 1 |
| Helaly, GF | 1 |
| El Ghazzawi, EF | 1 |
| El-Sawaf, G | 1 |
| Zhang, H | 5 |
| Yi, X | 1 |
| Chen, M | 1 |
| Shi, H | 1 |
| Tan, L | 1 |
| Lu, H | 4 |
| Yang, F | 1 |
| Yan, Z | 1 |
| Guo, M | 1 |
| Wei, Y | 1 |
| Mou, Y | 1 |
| Song, S | 1 |
| Zhao, S | 1 |
| Sun, X | 1 |
| Meng, L | 1 |
| Wang, Z | 3 |
| Tan, H | 1 |
| Liu, J | 4 |
| Deng, Y | 1 |
| El-Mahallawy, HA | 1 |
| Abdelfattah, NE | 1 |
| Wassef, MA | 1 |
| Abdel-Hamid, RM | 1 |
| Sztafrowski, D | 1 |
| Muraszko, J | 1 |
| Jasiura, A | 1 |
| Bryk, P | 1 |
| Urbanek, AK | 1 |
| Qadir, MI | 1 |
| Bashir, H | 1 |
| Ahmad, MH | 1 |
| Huma, ZE | 1 |
| Saleem, S | 1 |
| Imran, M | 2 |
| Jabeen, K | 1 |
| Arshad, F | 1 |
| Amar, A | 1 |
| Feng, Y | 1 |
| Whiteway, M | 2 |
| Ong, CW | 1 |
| Chen, SC | 3 |
| Clark, JE | 1 |
| Halliday, CL | 1 |
| Kidd, SE | 1 |
| Marriott, DJ | 1 |
| Marshall, CL | 1 |
| Morris, AJ | 3 |
| Morrissey, CO | 2 |
| Roy, R | 1 |
| Slavin, MA | 5 |
| Stewardson, AJ | 1 |
| Worth, LJ | 1 |
| Heath, CH | 1 |
| Usher, J | 1 |
| Haynes, K | 1 |
| Toh, J | 1 |
| Snowball, V | 1 |
| Bamidele, OF | 1 |
| Olokoba, AB | 1 |
| Bojuwoye, MO | 1 |
| Barde, AA | 1 |
| Köklü, S | 1 |
| Köklü, H | 1 |
| Castanheira, M | 1 |
| Deshpande, LM | 1 |
| Messer, SA | 22 |
| Pfaller, MA | 48 |
| Yan, H | 1 |
| Lu, M | 1 |
| Wang, D | 5 |
| Sun, S | 11 |
| Ahmad, S | 5 |
| Khan, Z | 5 |
| Al-Sweih, N | 3 |
| Alfouzan, W | 1 |
| Joseph, L | 3 |
| Onuchic, L | 1 |
| Sato, VAH | 1 |
| de Menezes Neves, PDM | 1 |
| Balbo, BEP | 1 |
| Portela-Neto, AA | 1 |
| Ferreira, FT | 1 |
| Watanabe, EH | 1 |
| Watanabe, A | 1 |
| de Almeida, MCS | 1 |
| de Abreu Testagrossa, L | 1 |
| Chocair, PR | 1 |
| Onuchic, LF | 1 |
| Morare, NMT | 1 |
| Rose, DM | 1 |
| Appels, O | 1 |
| Brunetti, G | 1 |
| Navazio, AS | 1 |
| Giuliani, A | 1 |
| Giordano, A | 1 |
| Proli, EM | 1 |
| Antonelli, G | 1 |
| Raponi, G | 1 |
| Korem, M | 1 |
| Geffen, Y | 1 |
| Amit, S | 2 |
| Yang, D | 1 |
| Lv, X | 1 |
| Xue, L | 1 |
| Yang, N | 1 |
| Hu, Y | 2 |
| Weng, L | 1 |
| Fu, N | 1 |
| Wang, L | 1 |
| Dong, X | 1 |
| Chatterjee, S | 2 |
| Ghosh, R | 1 |
| Mandal, NC | 1 |
| Ganan, M | 1 |
| Lorentzen, SB | 1 |
| Aam, BB | 1 |
| Eijsink, VGH | 1 |
| Gaustad, P | 3 |
| Sørlie, M | 1 |
| Pandey, N | 2 |
| Gupta, MK | 2 |
| Paul, P | 2 |
| Tilak, R | 3 |
| Castelo-Branco, DSCM | 1 |
| Paiva, MAN | 1 |
| Teixeira, CEC | 1 |
| Caetano, ÉP | 1 |
| Guedes, GMM | 1 |
| Cordeiro, RA | 3 |
| Brilhante, RSN | 1 |
| Rocha, MFG | 1 |
| Sidrim, JJC | 1 |
| Muscianese, M | 1 |
| Magri, F | 1 |
| Pranteda, G | 2 |
| Shirazi, JH | 1 |
| Ali, MI | 1 |
| Akhtar, Z | 1 |
| Jamal, A | 1 |
| Rashid, A | 1 |
| Tripathi, M | 1 |
| Rojas, AE | 1 |
| Pérez, JE | 1 |
| Hernández, JS | 1 |
| Zapata, Y | 1 |
| Dalla Lana, DF | 1 |
| Kaminski, TFA | 1 |
| Lavorato, SN | 1 |
| Merkel, S | 1 |
| Zanette, RA | 1 |
| da Rosa, PD | 1 |
| Staudt, KJ | 1 |
| de Araújo, BV | 2 |
| da Costa, B | 1 |
| Quatrin, PM | 1 |
| Bazana, LCG | 1 |
| Ferreira, FA | 1 |
| Caurio, CFB | 1 |
| de Andrade, SF | 2 |
| Alves, RJ | 1 |
| Fuentefria, AM | 2 |
| Osman, M | 1 |
| Al Bikai, A | 1 |
| Rafei, R | 1 |
| Mallat, H | 1 |
| Dabboussi, F | 1 |
| Hamze, M | 1 |
| Yang, J | 2 |
| Su, S | 1 |
| Chen, X | 3 |
| Iraji, A | 1 |
| Alizadeh, F | 3 |
| Mirzamohammadi, S | 1 |
| Ghasemi, Y | 1 |
| Pakshir, K | 1 |
| Yang, Y | 3 |
| Antoran, A | 1 |
| Aparicio-Fernandez, L | 1 |
| Pellon, A | 1 |
| Buldain, I | 1 |
| Martin-Souto, L | 1 |
| Rementeria, A | 1 |
| Ghannoum, MA | 10 |
| Fuchs, BB | 3 |
| Mylonakis, E | 6 |
| Hernando, FL | 1 |
| Ramirez-Garcia, A | 1 |
| Akroum, S | 1 |
| Song, KY | 1 |
| Park, C | 1 |
| Byun, JH | 2 |
| Chun, HS | 1 |
| Choi, JH | 1 |
| Han, EH | 1 |
| Lee, SO | 1 |
| Jeong, Y | 1 |
| Kim, YJ | 2 |
| Kim, SH | 8 |
| Fejes, I | 1 |
| Garcia-Hermosa, P | 1 |
| Bodin, A | 1 |
| Gerstein, AC | 1 |
| Berman, J | 5 |
| do Nascimento Dias, J | 1 |
| de Souza Silva, C | 1 |
| de Araújo, AR | 1 |
| Souza, JMT | 1 |
| de Holanda Veloso Júnior, PH | 1 |
| Cabral, WF | 1 |
| da Glória da Silva, M | 1 |
| Eaton, P | 1 |
| de Souza de Almeida Leite, JR | 1 |
| Nicola, AM | 1 |
| Albuquerque, P | 1 |
| Silva-Pereira, I | 1 |
| Thakre, A | 1 |
| Jadhav, V | 1 |
| Kazi, R | 1 |
| Shelar, A | 1 |
| Patil, R | 1 |
| Kharat, K | 1 |
| Zore, G | 1 |
| Karuppayil, SM | 3 |
| Liu, Y | 3 |
| Ren, H | 1 |
| Zhao, Y | 4 |
| Krishnamoorthy, M | 1 |
| Othman, NAN | 1 |
| Hassan, NEB | 1 |
| Hitam, SB | 1 |
| Muilwijk, EW | 1 |
| de Lange, DW | 1 |
| Schouten, JA | 1 |
| Wasmann, RE | 1 |
| Ter Heine, R | 1 |
| Burger, DM | 1 |
| Colbers, A | 1 |
| Haas, PJ | 2 |
| Verweij, PE | 4 |
| Pickkers, P | 1 |
| Wong, TY | 1 |
| Loo, YS | 1 |
| Veettil, SK | 1 |
| Wong, PS | 1 |
| Divya, G | 1 |
| Ching, SM | 1 |
| Menon, RK | 1 |
| Alvendal, C | 1 |
| Mohanty, S | 1 |
| Bohm-Starke, N | 1 |
| Brauner, A | 1 |
| Singh, A | 2 |
| Kumar, P | 2 |
| Rudramurthy, SM | 2 |
| Chakrabarti, A | 3 |
| Gow, NAR | 2 |
| Levinson, T | 1 |
| Dahan, A | 1 |
| Novikov, A | 2 |
| Paran, Y | 1 |
| Ben-Ami, R | 3 |
| Bal, AM | 1 |
| Navarro-Rodríguez, P | 1 |
| López-Fernández, L | 1 |
| Martin-Vicente, A | 1 |
| Guarro, J | 6 |
| Capilla, J | 2 |
| Tian, S | 1 |
| Han, X | 1 |
| Chu, Y | 1 |
| Zhou, B | 1 |
| Shang, H | 1 |
| Sheikh, T | 1 |
| Tomcho, JC | 1 |
| Awad, MT | 1 |
| Zaidi, SR | 1 |
| Darma, S | 1 |
| Ambara, A | 1 |
| Aman, AT | 1 |
| Annisa, L | 1 |
| Nuryastuti, T | 1 |
| Wibawa, T | 2 |
| Cao, S | 1 |
| Xia, M | 1 |
| Ding, C | 1 |
| Wang, R | 1 |
| Murata, Y | 1 |
| Okabe, S | 1 |
| Tamagawa, S | 1 |
| Ohnishi, H | 1 |
| Sakai, A | 1 |
| Biermann, AR | 2 |
| Demers, EG | 2 |
| Hogan, DA | 2 |
| Vega-Chacón, Y | 1 |
| de Albuquerque, MC | 1 |
| Pavarina, AC | 2 |
| Goldman, GH | 2 |
| Mima, EGO | 1 |
| Sunny, S | 1 |
| Episcopia, B | 1 |
| Boudourakis, L | 1 |
| Xavier, G | 1 |
| Quale, J | 1 |
| Shrivastava, M | 1 |
| Ji, C | 1 |
| Li, J | 1 |
| Bhagali, R | 1 |
| Prabhudesai, NP | 1 |
| Prabhudesai, MN | 1 |
| Lu, C | 2 |
| Zhao, X | 1 |
| Pedaci, FA | 1 |
| Filippeschi, C | 1 |
| Giovannini, M | 1 |
| Dolce, D | 1 |
| Oranges, T | 1 |
| Demirci-Duarte, S | 1 |
| Arikan-Akdagli, S | 1 |
| Gülmez, D | 1 |
| Jafarian, H | 1 |
| Gharaghani, M | 1 |
| Seyedian, SS | 1 |
| Mahmoudabadi, AZ | 1 |
| Nobrega de Almeida, J | 1 |
| Brandão, IB | 1 |
| Francisco, EC | 1 |
| de Almeida, SLR | 1 |
| de Oliveira Dias, P | 1 |
| Pereira, FM | 1 |
| Santos Ferreira, F | 1 |
| de Andrade, TS | 1 |
| de Miranda Costa, MM | 1 |
| de Souza Jordão, RT | 1 |
| Colombo, AL | 14 |
| Jia, D | 1 |
| Sun, W | 2 |
| Fattouh, N | 1 |
| Hdayed, D | 1 |
| Geukgeuzian, G | 1 |
| Tokajian, S | 1 |
| Khalaf, RA | 1 |
| Siscar-Lewin, S | 1 |
| Gabaldón, T | 1 |
| Aldejohann, AM | 1 |
| Kurzai, O | 1 |
| Hube, B | 1 |
| Brunke, S | 1 |
| Maras, B | 2 |
| Maggiore, A | 1 |
| Mignogna, G | 2 |
| D'Erme, M | 1 |
| Angiolella, L | 3 |
| Sung, JY | 1 |
| Kim, JM | 2 |
| Lee, JU | 1 |
| Lee, YH | 1 |
| Lee, SB | 1 |
| da Rocha, LF | 1 |
| Pippi, B | 1 |
| Joaquim, AR | 1 |
| Hernández-Carreón, O | 1 |
| Hernández-Howell, C | 1 |
| Hernández-Hernández, G | 1 |
| Herrera-Basurto, MS | 1 |
| González-Gómez, BE | 1 |
| Gutiérrez-Escobedo, G | 1 |
| García-Calderón, NI | 1 |
| Barrón-Pastor, D | 1 |
| De Las Peñas, A | 1 |
| Castaño, I | 1 |
| Papadimitriou-Olivgeris, M | 2 |
| Fligou, F | 2 |
| Tsiata, E | 1 |
| Nikolopoulou, A | 1 |
| Papamichail, C | 1 |
| Spiliopoulou, I | 2 |
| Marangos, M | 3 |
| Christofidou, M | 3 |
| Asadzadeh, M | 1 |
| Hrabovský, V | 1 |
| Takáčová, V | 1 |
| Schréterová, E | 1 |
| Pastvová, L | 1 |
| Hrabovská, Z | 1 |
| Čurová, K | 1 |
| Siegfried, L | 1 |
| Aggarwal, P | 3 |
| Kashyap, B | 1 |
| Kusanovic, JP | 1 |
| Romero, R | 1 |
| Martinovic, C | 1 |
| Silva, K | 1 |
| Erez, O | 1 |
| Maymon, E | 1 |
| Díaz, F | 1 |
| Ferrer, F | 1 |
| Valdés, R | 1 |
| Córdova, V | 1 |
| Vargas, P | 1 |
| Nilo, ME | 1 |
| Le Cerf, P | 1 |
| Choi, HI | 1 |
| An, J | 1 |
| Hwang, JJ | 1 |
| Moon, SY | 2 |
| Son, JS | 2 |
| Huang, X | 4 |
| Yu, C | 3 |
| van Prehn, J | 1 |
| Menke-van der Houven van Oordt, CW | 1 |
| de Rooij, ML | 1 |
| Meijer, E | 1 |
| Bomers, MK | 1 |
| van Dijk, K | 1 |
| Bouklas, T | 1 |
| Alonso-Crisóstomo, L | 1 |
| Székely, T | 1 |
| Diago-Navarro, E | 1 |
| Orner, EP | 1 |
| Smith, K | 1 |
| Munshi, MA | 1 |
| Del Poeta, M | 2 |
| Balázsi, G | 1 |
| Fries, BC | 1 |
| Jamil, B | 1 |
| Mukhtar Bokhari, MT | 1 |
| Saeed, A | 2 |
| Mukhtar Bokhari, MZ | 1 |
| Hussain, Z | 1 |
| Khalid, T | 1 |
| Bokhari, H | 1 |
| Abbasi, SA | 1 |
| Sławińska, M | 1 |
| Barańska-Rybak, W | 1 |
| Wilkowska, A | 1 |
| Nowicki, R | 1 |
| Li, ZJ | 1 |
| Liu, M | 1 |
| Dawuti, G | 1 |
| Dou, Q | 1 |
| Ma, Y | 2 |
| Liu, HG | 1 |
| Aibai, S | 1 |
| Pourakbari, B | 1 |
| Teymuri, M | 1 |
| Mahmoudi, S | 1 |
| Valian, SK | 1 |
| Movahedi, Z | 1 |
| Eshaghi, H | 1 |
| Mamishi, S | 1 |
| Ježíková, Z | 1 |
| Pagáč, T | 1 |
| Pfeiferová, B | 1 |
| Bujdáková, H | 2 |
| Dižová, S | 1 |
| Jančíková, I | 1 |
| Gášková, D | 1 |
| Olejníková, P | 1 |
| Li, DD | 1 |
| Chai, D | 1 |
| Huang, XW | 1 |
| Guan, SX | 1 |
| Du, J | 1 |
| Zhang, HY | 1 |
| Jiang, YY | 7 |
| Yang, Q | 1 |
| Chen, L | 2 |
| Hao, R | 1 |
| Zhang, T | 2 |
| Lei, J | 1 |
| Xie, J | 1 |
| Dong, Y | 1 |
| Anderson, MZ | 1 |
| Saha, A | 1 |
| Haseeb, A | 1 |
| Bennett, RJ | 1 |
| Khadka, S | 1 |
| Sherchand, JB | 1 |
| Pokhrel, BM | 1 |
| Parajuli, K | 1 |
| Mishra, SK | 1 |
| Sharma, S | 1 |
| Shah, N | 1 |
| Kattel, HP | 1 |
| Dhital, S | 1 |
| Khatiwada, S | 1 |
| Parajuli, N | 1 |
| Pradhan, M | 1 |
| Rijal, BP | 1 |
| Lo, HJ | 16 |
| Tsai, SH | 2 |
| Chu, WL | 3 |
| Chen, YZ | 1 |
| Zhou, ZL | 2 |
| Chen, HF | 1 |
| Lee, CF | 1 |
| Yang, YL | 14 |
| Shi, G | 1 |
| Wang, C | 2 |
| Zida, A | 1 |
| Yacouba, A | 1 |
| Bamba, S | 1 |
| Sangare, I | 1 |
| Sawadogo, M | 1 |
| Guiguemde, T | 1 |
| Kone, S | 1 |
| Traore, LK | 1 |
| Ouedraogo-Traore, R | 1 |
| Guiguemde, RT | 1 |
| Tasneem, U | 1 |
| Siddiqui, MT | 1 |
| Faryal, R | 1 |
| Shah, AA | 1 |
| Li, LP | 1 |
| Wang, XJ | 1 |
| Zhang, JY | 1 |
| Zhang, LL | 1 |
| Cao, YB | 5 |
| Gu, LQ | 1 |
| Yu, YQ | 1 |
| Yang, QL | 1 |
| Shen, CY | 1 |
| Han, B | 1 |
| Li, M | 1 |
| Zhu, L | 2 |
| Liu, B | 1 |
| Du, L | 1 |
| Slim, J | 1 |
| Saling, C | 1 |
| Szabela, M | 1 |
| Brown, M | 1 |
| Johnson, T | 1 |
| Goldfarb, I | 1 |
| Sony, P | 1 |
| Kalyani, M | 1 |
| Jeyakumari, D | 1 |
| Kannan, I | 1 |
| Sukumar, RG | 1 |
| Cebeci Güler, N | 1 |
| Tosun, I | 1 |
| Aydin, F | 1 |
| Adler, NR | 1 |
| Lin, MJ | 1 |
| Cameron, R | 1 |
| Gin, D | 1 |
| Hwang, MF | 1 |
| Beechinor, RJ | 1 |
| Wade, KC | 6 |
| Benjamin, DK | 9 |
| Smith, PB | 5 |
| Hornik, CP | 2 |
| Capparelli, EV | 2 |
| Duara, S | 1 |
| Kennedy, KA | 1 |
| Cohen-Wolkowiez, M | 5 |
| Gonzalez, D | 1 |
| Armstrong, MJ | 1 |
| Ahmed, R | 1 |
| Boulton, R | 1 |
| Furukawa, D | 1 |
| Ohtani, K | 1 |
| Kawahara, T | 1 |
| Yakabe, D | 1 |
| Tsutsui, H | 1 |
| Semnani, D | 1 |
| Afrashi, M | 1 |
| Alihosseini, F | 1 |
| Dehghan, P | 1 |
| Maherolnaghsh, M | 1 |
| Tu, EY | 2 |
| Majmudar, PA | 1 |
| Rivoisy, C | 1 |
| Vena, A | 1 |
| Schaeffer, L | 1 |
| Charlier, C | 2 |
| Fontanet, A | 2 |
| Delahaye, F | 1 |
| Bouza, E | 7 |
| Lortholary, O | 6 |
| Lefort, A | 3 |
| Lin, CC | 3 |
| Chen, PN | 1 |
| Salazar, SB | 1 |
| Münsterkötter, M | 1 |
| Okamoto, M | 1 |
| Takahashi-Nakaguchi, A | 1 |
| Chibana, H | 2 |
| Lopes, MM | 1 |
| Güldener, U | 1 |
| Mira, NP | 1 |
| Yamamoto, S | 2 |
| Ikeda, M | 1 |
| Fujimoto, F | 1 |
| Okamoto, K | 1 |
| Wakabayashi, Y | 1 |
| Sato, T | 1 |
| Tatsuno, K | 1 |
| Kaburaki, T | 1 |
| Yoshida, S | 1 |
| Okugawa, S | 1 |
| Koike, K | 1 |
| Moriya, K | 1 |
| Pathirana, RU | 1 |
| Friedman, J | 1 |
| Norris, HL | 1 |
| Salvatori, O | 1 |
| McCall, AD | 1 |
| Kay, J | 1 |
| Edgerton, M | 1 |
| Gu, W | 2 |
| Yu, Q | 1 |
| da Rocha Curvelo, JA | 1 |
| Reis de Sá, LF | 1 |
| Moraes, DC | 1 |
| Soares, RM | 1 |
| Ferreira-Pereira, A | 2 |
| Pagès, A | 1 |
| Iriart, X | 1 |
| Molinier, L | 1 |
| Georges, B | 1 |
| Berry, A | 1 |
| Massip, P | 1 |
| Juillard-Condat, B | 1 |
| Lima, GME | 1 |
| Nunes, MO | 1 |
| Chang, MR | 1 |
| Tsujisaki, RAS | 1 |
| Nunes, JO | 1 |
| Taira, CL | 1 |
| Thomaz, DY | 1 |
| Negro, GMBD | 1 |
| Mendes, RP | 1 |
| Paniago, AMM | 1 |
| d'Aleo, F | 1 |
| Bonanno, R | 1 |
| Midiri, A | 1 |
| Mancuso, G | 1 |
| Cordaro, S | 1 |
| Warm, A | 1 |
| Verduci, E | 1 |
| Beninati, C | 2 |
| Biondo, C | 1 |
| Shokohi, T | 2 |
| Aslani, N | 1 |
| Ahangarkani, F | 1 |
| Meyabadi, MF | 1 |
| Hagen, F | 3 |
| Boekhout, T | 2 |
| Kolecka, A | 1 |
| Mellinghoff, SC | 1 |
| Hoenigl, M | 1 |
| Koehler, P | 1 |
| Menon, V | 1 |
| Rautemaa-Richardson, R | 1 |
| Hsieh, YH | 1 |
| Zhang, JH | 1 |
| Chuang, WC | 1 |
| Yu, KH | 1 |
| Huang, XB | 1 |
| Lee, YC | 2 |
| Lee, CI | 1 |
| Madhavan, P | 1 |
| Jamal, F | 1 |
| Pei, CP | 1 |
| Othman, F | 2 |
| Karunanidhi, A | 1 |
| Ng, KP | 5 |
| Huang, MC | 1 |
| Shen, M | 1 |
| Huang, YJ | 1 |
| Lin, HC | 1 |
| Chen, CT | 1 |
| Alobaid, K | 1 |
| Faty, M | 1 |
| El-Nahas, A | 1 |
| Al-Terki, A | 1 |
| Liu, X | 3 |
| Ma, Z | 1 |
| Zhang, J | 7 |
| Yang, L | 2 |
| Sun, L | 1 |
| Liao, K | 1 |
| Hang, C | 1 |
| Vande Velde, G | 1 |
| Himmelreich, U | 1 |
| Toleuova, A | 1 |
| Tayzhanova, D | 1 |
| Toyynbekova, R | 1 |
| Beysenbekova, Z | 1 |
| Crane, JK | 1 |
| Fortmann, I | 1 |
| Hartz, A | 1 |
| Pulzer, F | 1 |
| Müller, A | 1 |
| Böttger, R | 1 |
| Proquitté, H | 1 |
| Dawczynski, K | 1 |
| Simon, A | 1 |
| Rupp, J | 1 |
| Herting, E | 1 |
| Göpel, W | 1 |
| Härtel, C | 1 |
| Król, J | 1 |
| Nawrot, U | 2 |
| Bartoszewicz, M | 1 |
| Sharifynia, S | 1 |
| Rezaie, S | 1 |
| Mohamadnia, A | 1 |
| Mortezaee, V | 1 |
| Hadian, A | 1 |
| Seyedmousavi, S | 1 |
| Jin, L | 1 |
| Cao, Z | 1 |
| Chen, H | 2 |
| Wang, H | 4 |
| Rizzato, C | 1 |
| Poma, N | 1 |
| Zoppo, M | 1 |
| Posteraro, B | 10 |
| Mello, E | 1 |
| Bottai, D | 1 |
| Lupetti, A | 4 |
| Sanguinetti, M | 10 |
| Tavanti, A | 1 |
| Sharifzadeh, A | 3 |
| Khosravi, AR | 1 |
| Shokri, H | 2 |
| Shirzadi, H | 1 |
| de Assis, DN | 1 |
| Araújo, RS | 1 |
| Fuscaldi, LL | 1 |
| Fernandes, SOA | 1 |
| Mosqueira, VCF | 1 |
| Cardoso, VN | 1 |
| Motahari, K | 1 |
| Fakhim, H | 1 |
| Mirzaei, H | 1 |
| Vaezi, A | 1 |
| Shokrzadeh, M | 1 |
| de Sá, NP | 1 |
| de Paula, LFJ | 1 |
| Lopes, LFF | 1 |
| Cruz, LIB | 1 |
| Matos, TTS | 1 |
| de Souza-Fagundes, EM | 1 |
| Leroux, S | 1 |
| Jacqz-Aigrain, E | 2 |
| Elie, V | 1 |
| Legrand, F | 1 |
| Barin-Le Guellec, C | 1 |
| Aurich, B | 1 |
| Biran, V | 1 |
| Dusang, B | 1 |
| Goudjil, S | 1 |
| Coopman, S | 1 |
| Garcia Sanchez, R | 1 |
| Zhao, W | 1 |
| Manzoni, P | 9 |
| Lee, JH | 2 |
| Kim, YG | 1 |
| Lee, J | 7 |
| Ko, JH | 2 |
| Peck, KR | 2 |
| Jung, DS | 1 |
| Lee, JY | 3 |
| Kim, HA | 1 |
| Ryu, SY | 1 |
| Jung, SI | 3 |
| Joo, EJ | 1 |
| Cheon, S | 1 |
| Kim, YS | 2 |
| Kim, SW | 3 |
| Cho, SY | 1 |
| Ha, YE | 1 |
| Kang, CI | 1 |
| Chung, DR | 1 |
| Lee, NY | 3 |
| Song, JH | 2 |
| Cojutti, PG | 1 |
| Lugano, M | 1 |
| Righi, E | 3 |
| Della Rocca, G | 1 |
| Bassetti, M | 7 |
| Hope, W | 2 |
| Pea, F | 2 |
| Watt, KM | 2 |
| Barrett, JS | 5 |
| Sevestre, M | 1 |
| Zhao, P | 1 |
| Brouwer, KLR | 1 |
| Edginton, AN | 1 |
| Shi, J | 1 |
| Li, S | 2 |
| Gao, A | 1 |
| Zhu, K | 1 |
| Choi, YJ | 1 |
| Yong, D | 1 |
| Kim, TS | 1 |
| Chang, YS | 1 |
| Choi, MJ | 2 |
| Byeon, SA | 1 |
| Won, EJ | 2 |
| Shin, MG | 6 |
| Shin, JH | 9 |
| Tange, K | 1 |
| Yokota, T | 2 |
| Sunago, K | 1 |
| Aono, M | 1 |
| Ochi, H | 1 |
| Takechi, S | 1 |
| Mashiba, T | 1 |
| Hida, AI | 1 |
| Oshiro, Y | 1 |
| Joko, K | 1 |
| Kumagi, T | 1 |
| Hiasa, Y | 1 |
| Lee, Y | 1 |
| Lee, KT | 1 |
| Lee, SJ | 1 |
| Beom, JY | 1 |
| Hwangbo, A | 1 |
| Jung, JA | 1 |
| Song, MC | 1 |
| Yoo, YJ | 1 |
| Kang, SH | 1 |
| Averette, AF | 1 |
| Heitman, J | 3 |
| Yoon, YJ | 1 |
| Cheong, E | 1 |
| Bahn, YS | 1 |
| Chen, Y | 2 |
| Zhao, J | 1 |
| Qi, L | 1 |
| Fan, W | 1 |
| Xia, X | 1 |
| Astvad, KMT | 1 |
| Delarze, E | 2 |
| Hare, RK | 1 |
| Abdeljaleel, OA | 1 |
| Alnadhari, I | 1 |
| Mahmoud, S | 1 |
| Khachatryan, G | 1 |
| Salah, M | 1 |
| Ali, O | 1 |
| Shamsodini, A | 1 |
| Challa, K | 1 |
| Edlind, T | 1 |
| Katiyar, S | 1 |
| Masonjones, S | 1 |
| Crocker, AW | 1 |
| Ashare, A | 1 |
| Stajich, JE | 1 |
| Okmen, F | 1 |
| Ekici, H | 1 |
| Ari, SA | 1 |
| Raj, AT | 1 |
| Patil, S | 1 |
| Sujatha, G | 1 |
| Seetharam, C | 1 |
| Kader, NA | 1 |
| Minematsu, A | 1 |
| Shimamura, S | 1 |
| Nakayama, H | 2 |
| Takazono, T | 1 |
| Yamamoto, K | 2 |
| Imamura, Y | 3 |
| Mukae, H | 1 |
| Çakır, SÇ | 1 |
| Çelebi, S | 1 |
| Özkan, H | 1 |
| Köksal, N | 1 |
| Dorum, BA | 1 |
| Yeşil, E | 1 |
| Hacımustafaoğlu, M | 2 |
| Rybak, JM | 1 |
| Doorley, LA | 1 |
| Nishimoto, AT | 1 |
| Palmer, GE | 1 |
| Paul, S | 2 |
| Ghosh, AK | 1 |
| Singh, PK | 2 |
| Mathur, P | 1 |
| Tarai, B | 1 |
| Sachdeva, N | 1 |
| Upadhyaya, G | 1 |
| Sarma, S | 1 |
| Chowdhary, A | 2 |
| Arastehfar, A | 1 |
| Daneshnia, F | 1 |
| Salehi, MR | 1 |
| Zarrinfar, H | 1 |
| Roudbary, M | 1 |
| Najafzadeh, MJ | 2 |
| Charsizadeh, A | 1 |
| Brouwer, C | 1 |
| Pan, W | 1 |
| Wan, K | 1 |
| Khoo, CK | 1 |
| Kathirvel, R | 1 |
| Bastianpillai, J | 1 |
| Chaudhry, S | 1 |
| Vijendren, A | 1 |
| Yang, DL | 1 |
| Hu, YL | 1 |
| Yin, ZX | 1 |
| Zeng, GS | 1 |
| Zhang, YQ | 2 |
| Xu, ZH | 1 |
| Guan, XM | 1 |
| Weng, LX | 1 |
| Wang, LH | 1 |
| Matveev, AL | 1 |
| Krylov, VB | 1 |
| Khlusevich, YA | 1 |
| Baykov, IK | 1 |
| Yashunsky, DV | 1 |
| Emelyanova, LA | 1 |
| Tsvetkov, YE | 1 |
| Karelin, AA | 1 |
| Bardashova, AV | 1 |
| Wong, SSW | 1 |
| Aimanianda, V | 1 |
| Latgé, JP | 1 |
| Tikunova, NV | 1 |
| Nifantiev, NE | 1 |
| Ishchuk, OP | 2 |
| Ahmad, KM | 2 |
| Wee, J | 1 |
| Piskur, J | 2 |
| Shapiro, JA | 1 |
| Gu, Z | 1 |
| Khan, AT | 1 |
| Dhorajiya, P | 1 |
| Lung, E | 1 |
| Woodworth, MH | 1 |
| Dynerman, D | 1 |
| Crawford, ED | 1 |
| Doernberg, SB | 1 |
| Ramirez-Avila, L | 1 |
| Serpa, PH | 1 |
| Nichols, A | 1 |
| Li, LM | 1 |
| Lyden, A | 1 |
| Tato, CM | 1 |
| Miller, S | 1 |
| Derisi, JL | 1 |
| Langelier, C | 1 |
| Roberts, SC | 1 |
| Zembower, TR | 1 |
| Bolon, MK | 1 |
| Kadakia, AR | 1 |
| Gilley, JH | 1 |
| Clark, J | 1 |
| Ward-Fore, S | 1 |
| Taiwo, BO | 1 |
| Lu, Y | 1 |
| Zhou, Z | 1 |
| Mo, L | 1 |
| Guo, Q | 1 |
| Hu, T | 1 |
| Bilgin, E | 1 |
| Ökten, Aİ | 1 |
| Gezercan, Y | 1 |
| Çavuş, G | 1 |
| Açık, V | 1 |
| Arslan, A | 1 |
| Altıntaş, S | 1 |
| Luparia, M | 1 |
| Landi, F | 1 |
| Mesini, A | 1 |
| Militello, MA | 1 |
| Galletto, P | 4 |
| Farina, D | 7 |
| Castagnola, E | 3 |
| Iguchi, S | 1 |
| Itakura, Y | 1 |
| Yoshida, A | 2 |
| Kamada, K | 1 |
| Mizushima, R | 1 |
| Arai, Y | 1 |
| Uzawa, Y | 1 |
| Kikuchi, K | 1 |
| Romera, D | 1 |
| Aguilera-Correa, JJ | 1 |
| Gadea, I | 1 |
| Viñuela-Sandoval, L | 1 |
| García-Rodríguez, J | 2 |
| Esteban, J | 1 |
| Xu, J | 4 |
| Liu, R | 1 |
| Sun, F | 1 |
| An, L | 1 |
| Shang, Z | 1 |
| Yang, M | 1 |
| Fang, H | 1 |
| Huang, L | 1 |
| Xie, D | 1 |
| Sun, H | 1 |
| Zeng, C | 1 |
| Cai, D | 1 |
| Agnelli, C | 1 |
| Valerio, M | 1 |
| Alrumaihi, F | 1 |
| Allemailem, KS | 1 |
| Almatroudi, A | 1 |
| Alsahli, MA | 1 |
| Khan, A | 5 |
| Khan, MA | 3 |
| Uthayakumar, N | 1 |
| Bates, J | 1 |
| Pérez-Lanzac, A | 1 |
| Soto-Villalva, J | 1 |
| Ledo-Cepero, MJ | 1 |
| Garcia-Baquero, R | 1 |
| Rosety-Rodriguez, J | 1 |
| Madurga-Patuel, B | 1 |
| Alvarez-Ossorio-Fernández, JL | 1 |
| Hamada, Y | 1 |
| Okuma, R | 1 |
| Katori, Y | 1 |
| Takahashi, S | 1 |
| Hirayama, T | 1 |
| Ichibe, Y | 1 |
| Kuroyama, M | 1 |
| Camacho-Gonzalez, A | 1 |
| Spearman, PW | 1 |
| Stoll, BJ | 1 |
| Ying, Y | 1 |
| Hu, X | 1 |
| Cai, Z | 1 |
| Jin, G | 1 |
| Dreyfuss, D | 1 |
| Ricard, JD | 1 |
| Gaudry, S | 1 |
| Ferreira, AV | 1 |
| Prado, CG | 1 |
| Carvalho, RR | 1 |
| Dias, KS | 1 |
| Dias, AL | 1 |
| Hernández-Torres, A | 1 |
| García-Vázquez, E | 1 |
| Laso-Ortiz, A | 1 |
| Herrero-Martínez, JA | 1 |
| Gómez-Gómez, J | 1 |
| Scorzoni, L | 1 |
| de Lucas, MP | 1 |
| Mesa-Arango, AC | 1 |
| Fusco-Almeida, AM | 2 |
| Lozano, E | 1 |
| Mendes-Giannini, MJ | 2 |
| Zaragoza, O | 1 |
| Eddouzi, J | 1 |
| Parker, JE | 4 |
| Vale-Silva, LA | 3 |
| Kelly, S | 1 |
| Manai, M | 1 |
| Fennelly, AM | 1 |
| Slenker, AK | 2 |
| Murphy, LC | 1 |
| Moussouttas, M | 1 |
| DeSimone, JA | 1 |
| Jang, MJ | 1 |
| Lee, WG | 6 |
| Kim, MN | 5 |
| Lee, K | 7 |
| Lee, HS | 5 |
| Lee, MK | 6 |
| Chang, CL | 3 |
| Jang, HC | 1 |
| Song, ES | 1 |
| Suh, SP | 5 |
| Ryang, DW | 5 |
| Hellborg, L | 1 |
| Jørgensen, G | 1 |
| Skvarc, M | 1 |
| Stenderup, J | 1 |
| Jørck-Ramberg, D | 1 |
| Polakova, S | 1 |
| Osawa, K | 1 |
| Shigemura, K | 1 |
| Yoshida, H | 1 |
| Fujisawa, M | 1 |
| Arakawa, S | 1 |
| Ballot, DE | 1 |
| Bosman, N | 1 |
| Nana, T | 1 |
| Ramdin, T | 1 |
| Cooper, PA | 1 |
| Ericson, J | 1 |
| Rebibo, L | 1 |
| Dupont, H | 3 |
| Levrard, M | 1 |
| Cosse, C | 1 |
| Dhahri, A | 1 |
| Verhaeghe, P | 1 |
| Regimbeau, JM | 1 |
| Fesharaki, SH | 1 |
| Mousavi, B | 1 |
| Kargar, ML | 1 |
| Boroumand, M | 1 |
| Anvari, MS | 1 |
| Abbasi, K | 1 |
| Garcia, J | 1 |
| Soch, K | 1 |
| Matthew, E | 1 |
| Surani, S | 1 |
| Horseman, MA | 1 |
| Masterton, RG | 1 |
| Casamayor, M | 1 |
| Musingarimi, P | 1 |
| van Engen, A | 1 |
| Zinck, R | 1 |
| Odufowora-Sita, O | 1 |
| Odeyemi, IA | 1 |
| Prevost, N | 1 |
| English, JC | 1 |
| Sharma, C | 1 |
| Duggal, S | 1 |
| Agarwal, K | 1 |
| Prakash, A | 1 |
| Jain, S | 1 |
| Kathuria, S | 1 |
| Randhawa, HS | 1 |
| Morio, F | 3 |
| Besse, M | 1 |
| Gay-andrieu, F | 1 |
| Miegeville, M | 2 |
| Anil Kumar, V | 1 |
| Francis, E | 1 |
| Sreehari, S | 1 |
| Raj, B | 1 |
| Eves, S | 1 |
| Sayeed, R | 1 |
| Potter, M | 2 |
| Luhmann, A | 1 |
| Moses, A | 1 |
| Maly, J | 1 |
| Szarszoi, O | 1 |
| Netuka, I | 1 |
| Dorazilova, Z | 1 |
| Pirk, J | 1 |
| Guy, A | 1 |
| Chinai, N | 1 |
| Ashley, S | 1 |
| Rowe, P | 1 |
| Cunningham, R | 1 |
| Barwell, J | 1 |
| Sandoval-Denis, M | 1 |
| Pastor, FJ | 4 |
| Sutton, DA | 2 |
| Fothergill, AW | 8 |
| Blennow, O | 1 |
| Ljungman, P | 1 |
| Sparrelid, E | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Ali, N | 1 |
| Adil, SN | 1 |
| Shaikh, MU | 1 |
| Sajith, KG | 1 |
| Dutta, AK | 1 |
| Sahni, RD | 1 |
| Esakimuthu, S | 1 |
| Chacko, A | 1 |
| Al Thaqafi, AH | 1 |
| Farahat, FM | 1 |
| Al Harbi, MI | 1 |
| Al Amri, AF | 1 |
| Perfect, JR | 9 |
| Hou, Y | 2 |
| Gao, Y | 2 |
| Li, H | 2 |
| Vazquez, J | 1 |
| Reboli, AC | 2 |
| Pappas, PG | 6 |
| Patterson, TF | 13 |
| Reinhardt, J | 1 |
| Chin-Hong, P | 1 |
| Tobin, E | 1 |
| Kett, DH | 5 |
| Biswas, P | 2 |
| Swanson, R | 1 |
| Ruiz-Ramos, J | 1 |
| Salavert-Lleti, M | 2 |
| Monte-Boquet, E | 1 |
| Lorente-Fernández, L | 1 |
| Gil-Gómez, I | 1 |
| Poveda-Andrés, JL | 1 |
| Tringali, G | 1 |
| Greco, MC | 1 |
| Ragazzoni, E | 1 |
| Calugi, C | 1 |
| Sandini, S | 1 |
| Graziani, S | 1 |
| Navarra, P | 1 |
| Massanet, P | 1 |
| Jung, B | 1 |
| Molinari, N | 1 |
| Villiet, M | 1 |
| Moulaire, V | 1 |
| Roch-Torreilles, I | 1 |
| Jaber, S | 1 |
| Reynes, J | 6 |
| Corne, P | 1 |
| Kaufman, DA | 10 |
| Morris, A | 1 |
| Gurka, MJ | 3 |
| Kapik, B | 1 |
| Hetherington, S | 1 |
| Afzali, H | 1 |
| Heravi, MM | 1 |
| Rezaei-Matehkolaei, A | 1 |
| Moazeni, M | 2 |
| Dolatabadi, S | 1 |
| Hosseinpour, L | 1 |
| Ho, MW | 1 |
| Chi, CY | 1 |
| Chen, HT | 1 |
| Lin, PC | 1 |
| Hsieh, LY | 1 |
| Chou, CH | 1 |
| Wu, CP | 1 |
| Lauderdale, TL | 1 |
| Saravu, K | 1 |
| Vishwanath, S | 1 |
| Shastry, BA | 1 |
| Vandana, KE | 1 |
| Corzo-Leon, DE | 1 |
| Alvarado-Matute, T | 1 |
| Cornejo-Juarez, P | 1 |
| Cortes, J | 1 |
| Echevarria, JI | 1 |
| Guzman-Blanco, M | 1 |
| Macias, AE | 1 |
| Nucci, M | 4 |
| Ponce-de-Leon, A | 1 |
| Queiroz-Telles, F | 1 |
| Santolaya, ME | 1 |
| Thompson-Moya, L | 1 |
| Tiraboschi, IN | 1 |
| Zurita, J | 1 |
| Sifuentes-Osornio, J | 1 |
| Cojutti, P | 1 |
| Carnelutti, A | 1 |
| Baccarani, U | 1 |
| Soardo, G | 1 |
| Zhang, C | 1 |
| Ricardo, E | 3 |
| Faria-Ramos, I | 1 |
| Silva, RM | 1 |
| Pina-Vaz, C | 5 |
| Vavala, E | 1 |
| Macone, A | 1 |
| Colone, M | 2 |
| Pitari, G | 1 |
| Stringaro, A | 1 |
| Dupré, S | 1 |
| Nobile, CJ | 1 |
| Fox, EP | 1 |
| Hartooni, N | 1 |
| Mitchell, KF | 1 |
| Hnisz, D | 1 |
| Andes, DR | 4 |
| Kuchler, K | 1 |
| Johnson, AD | 1 |
| Oliveira-Carvalho, V | 1 |
| Del Negro, GM | 1 |
| Szweda, P | 1 |
| Gucwa, K | 1 |
| Naumiuk, L | 1 |
| Romanowska, E | 1 |
| Dzierzanowska-Fangrat, K | 1 |
| Brillowska-Dabrowska, A | 1 |
| Wojciechowska-Koszko, I | 1 |
| Milewski, S | 1 |
| Rivera, NT | 1 |
| Bray, N | 1 |
| Zelnick, K | 1 |
| Osman, A | 1 |
| Vicuña, R | 1 |
| De Rosa, FG | 1 |
| Motta, I | 1 |
| Corcione, S | 1 |
| Cattel, F | 1 |
| Di Perri, G | 2 |
| D'Avolio, A | 1 |
| Chakraborty, PP | 1 |
| Pulai, D | 1 |
| Urai, M | 1 |
| Kaneko, Y | 1 |
| Niki, M | 1 |
| Inoue, M | 1 |
| Tanabe, K | 2 |
| Umeyama, T | 1 |
| Fukazawa, H | 1 |
| Ohno, H | 1 |
| Arichi, N | 1 |
| Yasumoto, H | 1 |
| Ogawa, K | 1 |
| Nagami, T | 1 |
| Anjiki, H | 1 |
| Nakamura, S | 1 |
| Mitsui, Y | 1 |
| Hiraoka, T | 2 |
| Sumura, M | 1 |
| Shiina, H | 1 |
| Massolt, ET | 1 |
| Rijneveld, AW | 1 |
| Vernooij, MW | 1 |
| Kevenaar, ME | 1 |
| van Kemenade, FJ | 1 |
| Peeters, RP | 1 |
| Hou, J | 1 |
| Pang, X | 1 |
| Gao, R | 1 |
| Zhong, K | 1 |
| Zhong, D | 1 |
| van der Elst, KC | 1 |
| Pereboom, M | 1 |
| van den Heuvel, ER | 1 |
| Kosterink, JG | 1 |
| Schölvinck, EH | 1 |
| Alffenaar, JW | 1 |
| Dufour, DR | 1 |
| Manolopoulou, P | 1 |
| Vrettos, T | 1 |
| Dodou, V | 1 |
| Filos, KS | 1 |
| Anastassiou, ED | 1 |
| Vasicek, EM | 1 |
| Berkow, EL | 2 |
| Bruno, VM | 1 |
| Mitchell, AP | 1 |
| Wiederhold, NP | 3 |
| Sławiński, J | 1 |
| Pogorzelska, A | 1 |
| Zołnowska, B | 1 |
| Kędzia, A | 1 |
| Ziółkowska-Klinkosz, M | 1 |
| Kwapisz, E | 1 |
| Tyczkowska-Sieron, E | 2 |
| Gaszynski, W | 1 |
| Tyczkowski, J | 1 |
| Glowacka, A | 1 |
| Gøtzsche, PC | 1 |
| Johansen, HK | 1 |
| Bair, TB | 1 |
| Moye-Rowley, WS | 1 |
| Sharma, R | 1 |
| Garg, T | 1 |
| Goyal, AK | 1 |
| Rath, G | 1 |
| Lopez, R | 1 |
| Hunter, AR | 1 |
| Geoghegan, O | 1 |
| Demertzi, E | 1 |
| Zilberberg, M | 1 |
| Yu, HT | 1 |
| Chaudhari, P | 1 |
| Emons, MF | 1 |
| Khandelwal, N | 1 |
| Shorr, AF | 4 |
| De Cremer, K | 1 |
| Lanckacker, E | 1 |
| Cools, TL | 1 |
| Bax, M | 1 |
| Flowers, SA | 1 |
| Colón, B | 1 |
| Whaley, SG | 1 |
| Schuler, MA | 1 |
| Ellepola, AN | 1 |
| Joseph, BK | 1 |
| Samaranayake, LP | 2 |
| Bandara, HM | 1 |
| Khan, ZU | 3 |
| Tan, J | 2 |
| Chen, W | 1 |
| Wan, Z | 3 |
| Li, R | 3 |
| Neirinck, B | 1 |
| Sharma, N | 2 |
| Vleugels, J | 1 |
| Goff, TA | 1 |
| Kanakaris, NK | 1 |
| Trabasso, P | 1 |
| Matsuzawa, T | 1 |
| Fagnani, R | 1 |
| Muraosa, Y | 1 |
| Tominaga, K | 1 |
| Resende, MR | 1 |
| Kamei, K | 1 |
| Mikami, Y | 5 |
| Schreiber, AZ | 1 |
| Moretti, ML | 1 |
| Kim, HY | 1 |
| Huh, HJ | 1 |
| Choi, R | 1 |
| Ki, CS | 1 |
| Viljoen, J | 2 |
| Azie, N | 1 |
| Schmitt-Hoffmann, AH | 1 |
| Ghannoum, M | 2 |
| Kumar, D | 2 |
| Ford, CB | 1 |
| Funt, JM | 1 |
| Abbey, D | 1 |
| Issi, L | 1 |
| Guiducci, C | 1 |
| Martinez, DA | 1 |
| Delorey, T | 1 |
| Li, BY | 1 |
| Cuomo, C | 1 |
| Rao, RP | 1 |
| Thompson, DA | 1 |
| Regev, A | 1 |
| Kanoshiki, RL | 1 |
| de Paula, SB | 1 |
| Santos, JP | 1 |
| Morey, AT | 1 |
| Souza, NB | 1 |
| Yamauchi, LM | 1 |
| Dias Filho, BP | 1 |
| Yamada-Ogatta, SF | 1 |
| Kirpal, H | 1 |
| Gathwala, G | 1 |
| Chaudhary, U | 2 |
| Sharma, D | 2 |
| Aljarbou, AN | 1 |
| Younus, H | 1 |
| Mertas, A | 1 |
| Garbusińska, A | 1 |
| Szliszka, E | 1 |
| Jureczko, A | 1 |
| Kowalska, M | 1 |
| Król, W | 1 |
| Choudhary, M | 1 |
| Shastri, S | 1 |
| Sharma, PK | 1 |
| Toyoda, S | 1 |
| Tajima, E | 1 |
| Fukuda, R | 1 |
| Masawa, T | 1 |
| Inami, S | 1 |
| Amano, H | 1 |
| Arikawa, T | 1 |
| Hishinuma, A | 1 |
| Inoue, T | 1 |
| Maneenil, G | 1 |
| Payne, MS | 2 |
| Senthamarai Kannan, P | 1 |
| Kallapur, SG | 2 |
| Kramer, BW | 2 |
| Newnham, JP | 2 |
| Miura, Y | 1 |
| Jobe, AH | 2 |
| Kemp, MW | 2 |
| Baly, I | 1 |
| Daeli, PR | 1 |
| Kartasasmita, G | 1 |
| Wijayanti, N | 1 |
| Bressieux-Degueldre, S | 1 |
| Sekarski, N | 1 |
| Di Bernardo, S | 1 |
| Spierer, O | 1 |
| Dugar, J | 1 |
| Miller, D | 1 |
| OʼBrien, TP | 1 |
| Dhieb, C | 1 |
| Normand, AC | 2 |
| Al-Yasiri, M | 1 |
| Chaker, E | 1 |
| El Euch, D | 1 |
| Vranckx, K | 1 |
| Hendrickx, M | 1 |
| Sadfi, N | 1 |
| Piarroux, R | 3 |
| Ranque, S | 2 |
| Ding, CH | 1 |
| Wahab, AA | 1 |
| Muttaqillah, NA | 1 |
| Tzar, MN | 1 |
| Costa-de-Oliveira, S | 4 |
| Silva-Dias, A | 1 |
| Silva, AP | 1 |
| Ferreira, D | 1 |
| Grenouillet, F | 2 |
| Blasco, G | 2 |
| Samain, E | 1 |
| Hénon, T | 1 |
| Dussaucy, A | 1 |
| Millon, L | 2 |
| Mercier, M | 1 |
| Pili-Floury, S | 1 |
| Zappella, N | 1 |
| Desmard, M | 1 |
| Chochillon, C | 1 |
| Ribeiro-Parenti, L | 1 |
| Houze, S | 1 |
| Marmuse, JP | 1 |
| Montravers, P | 3 |
| Leon, C | 3 |
| Timsit, JF | 2 |
| Liew, YX | 1 |
| Teo, J | 1 |
| Too, IA | 1 |
| Ngan, CC | 1 |
| Tan, AL | 3 |
| Chlebicki, MP | 1 |
| Kwa, AL | 1 |
| Lee, W | 1 |
| To, V | 1 |
| Gurberg, J | 1 |
| Krishnamurthy, S | 1 |
| Manigaba, K | 1 |
| Kelly, SL | 5 |
| Moreira, A | 1 |
| Silva, S | 2 |
| Botelho, C | 1 |
| Sampaio, P | 1 |
| Pais, C | 1 |
| Henriques, M | 3 |
| Maatouk, I | 1 |
| Hajjar, MA | 1 |
| Moutran, R | 1 |
| Neufeld, PM | 1 |
| Melhem, Mde S | 1 |
| Szeszs, MW | 2 |
| Ribeiro, MD | 1 |
| Amorim, Ede L | 1 |
| da Silva, M | 1 |
| Lazéra, Mdos S | 1 |
| Rosana, Y | 1 |
| Yasmon, A | 1 |
| Lestari, DC | 1 |
| Coste, AT | 3 |
| Neves-Junior, A | 1 |
| Cartágenes-Pinto, AC | 1 |
| Rocha, DA | 1 |
| de Sá, LF | 1 |
| Junqueira, Mde L | 1 |
| Liu, JY | 1 |
| Shi, C | 1 |
| Li, WJ | 1 |
| Yan, L | 1 |
| Xiang, MJ | 1 |
| Magano, R | 1 |
| Cortez, J | 1 |
| Ramos, E | 1 |
| Trindade, L | 1 |
| Gonzalez, JM | 1 |
| Rodriguez, CA | 1 |
| Zuluaga, AF | 1 |
| Agudelo, M | 1 |
| Vesga, O | 1 |
| Toner, L | 1 |
| Papa, N | 1 |
| Aliyu, SH | 1 |
| Dev, H | 1 |
| Lawrentschuk, N | 1 |
| Al-Hayek, S | 1 |
| Phan, CM | 1 |
| Bajgrowicz, M | 1 |
| McCanna, DJ | 1 |
| Subbaraman, LN | 1 |
| Jones, L | 1 |
| Sinnollareddy, MG | 1 |
| Roberts, MS | 2 |
| Lassig-Smith, M | 1 |
| Starr, T | 1 |
| Robertson, T | 1 |
| Peake, SL | 2 |
| Howley, MM | 1 |
| Carter, TC | 1 |
| Browne, ML | 1 |
| Romitti, PA | 1 |
| Cunniff, CM | 1 |
| Druschel, CM | 1 |
| Mane, A | 1 |
| Vidhate, P | 1 |
| Kusro, C | 1 |
| Waman, V | 1 |
| Saxena, V | 1 |
| Kulkarni-Kale, U | 1 |
| Risbud, A | 1 |
| Ahmad, A | 2 |
| Wani, MY | 1 |
| Manzoor, N | 4 |
| Molepo, J | 1 |
| Adjapong, G | 1 |
| Bartlett, M | 1 |
| Hale, M | 1 |
| Garrill, A | 1 |
| Saúl-García, Y | 1 |
| Humbría-García, L | 1 |
| Hernández-Valles, R | 1 |
| Meleddu, R | 1 |
| Distinto, S | 1 |
| Corona, A | 1 |
| Maccioni, E | 1 |
| Arridu, A | 1 |
| Melis, C | 1 |
| Bianco, G | 1 |
| Matyus, P | 1 |
| Cottiglia, F | 1 |
| Sanna, A | 1 |
| De Logu, A | 1 |
| Kaplan, YC | 1 |
| Koren, G | 1 |
| Ito, S | 1 |
| Bozzo, P | 1 |
| Ahmadi, MS | 1 |
| Lee, HH | 1 |
| Sanchez, DA | 1 |
| Friedman, AJ | 1 |
| Tar, MT | 1 |
| Davies, KP | 1 |
| Nosanchuk, JD | 1 |
| Martinez, LR | 1 |
| Tantisiriwat, W | 1 |
| Santiwattanakul, S | 1 |
| Wang, P | 1 |
| Fan, ZQ | 1 |
| Fan, RQ | 1 |
| Nishikawa, JL | 1 |
| Boeszoermenyi, A | 1 |
| Torelli, R | 4 |
| Sohn, YJ | 1 |
| Ji, F | 1 |
| Gelev, V | 1 |
| Sadreyev, RI | 1 |
| Mukherjee, G | 1 |
| Bhyravabhotla, J | 1 |
| Buhrlage, SJ | 1 |
| Gray, NS | 1 |
| Wagner, G | 1 |
| Näär, AM | 1 |
| Arthanari, H | 1 |
| Jones, N | 1 |
| Garcez, T | 1 |
| Newman, W | 1 |
| Denning, D | 1 |
| Deconinck, L | 1 |
| Meybeck, A | 1 |
| Pradier, M | 1 |
| Patoz, P | 1 |
| Melliez, H | 1 |
| Senneville, E | 1 |
| Jie, Q | 1 |
| Lin, S | 1 |
| Chen, S | 3 |
| Lin, Z | 1 |
| Querques, G | 1 |
| Modorati, G | 1 |
| Miserocchi, E | 1 |
| Baruffaldi Preis, F | 1 |
| Bandello, F | 1 |
| Chen, KH | 1 |
| Weng, MT | 1 |
| Chou, YH | 2 |
| Lu, YF | 1 |
| Hsieh, CH | 1 |
| Yue, L | 1 |
| da Silva, AR | 1 |
| de Andrade Neto, JB | 1 |
| da Silva, CR | 1 |
| Campos, Rde S | 1 |
| Costa Silva, RA | 1 |
| Freitas, DD | 1 |
| do Nascimento, FB | 1 |
| de Andrade, LN | 1 |
| Sampaio, LS | 1 |
| Grangeiro, TB | 1 |
| Magalhães, HI | 1 |
| Cavalcanti, BC | 1 |
| de Moraes, MO | 1 |
| Nobre Júnior, HV | 1 |
| Im, YJ | 1 |
| Dufresne, SF | 1 |
| Vinh, DC | 1 |
| Aubin, MJ | 1 |
| Sullivan, KA | 1 |
| Caylor, MM | 1 |
| Lin, FC | 1 |
| Campbell-Bright, S | 1 |
| Liu, ZH | 1 |
| Su, MQ | 1 |
| Ma, YY | 1 |
| Xin, YJ | 1 |
| Han, RB | 1 |
| Wen, J | 1 |
| Hao, XK | 1 |
| Sharma, V | 1 |
| De, A | 1 |
| Ahuja, A | 1 |
| Lamoria, S | 1 |
| Lamba, BM | 1 |
| Calandra, T | 5 |
| Antonelli, M | 1 |
| Vincent, JL | 2 |
| Nelwan, EJ | 1 |
| Indrasanti, E | 1 |
| Sinto, R | 1 |
| Nurchaida, F | 1 |
| Sosrosumihardjo, R | 1 |
| Dagi, HT | 1 |
| Findik, D | 2 |
| Senkeles, C | 1 |
| Arslan, U | 2 |
| Gharibian, KN | 1 |
| Mueller, BA | 1 |
| Durnaś, B | 1 |
| Wnorowska, U | 1 |
| Pogoda, K | 1 |
| Deptuła, P | 1 |
| Wątek, M | 1 |
| Piktel, E | 1 |
| Głuszek, S | 1 |
| Gu, X | 1 |
| Savage, PB | 1 |
| Niemirowicz, K | 1 |
| Bucki, R | 1 |
| Jia, W | 1 |
| Li, G | 1 |
| Wei, J | 1 |
| Kozlova, IV | 1 |
| Lekareva, LI | 1 |
| Bykova, AP | 1 |
| Myalina, JN | 1 |
| Ostrovskàja, LJ | 1 |
| Kim, M | 1 |
| Bae, EH | 2 |
| Ma, SK | 2 |
| Das, PP | 1 |
| Saikia, L | 1 |
| Nath, R | 1 |
| Phukan, SK | 1 |
| Nikiforou, M | 1 |
| Jacobs, EM | 1 |
| Hornef, MW | 1 |
| Saito, M | 1 |
| Janssen, LE | 1 |
| Wolfs, TG | 1 |
| Toka Özer, T | 1 |
| Durmaz, S | 1 |
| Yula, E | 1 |
| Zimmerman, O | 1 |
| Finn, T | 1 |
| Wertheimer, N | 1 |
| Lurie-Weinberger, M | 1 |
| Goel, S | 1 |
| Mittal, S | 1 |
| Assiri, A | 1 |
| Zaidi, Z | 1 |
| Alsheikh, A | 1 |
| Veerappan, M | 1 |
| Seider, M | 1 |
| Fekrat, S | 1 |
| Kadosh, D | 1 |
| Najvar, LK | 7 |
| Bocanegra, R | 5 |
| Olivo, M | 1 |
| Kirkpatrick, WR | 11 |
| Sardi, JC | 1 |
| Gullo, FP | 1 |
| Freires, IA | 1 |
| Pitangui, NS | 1 |
| Segalla, MP | 1 |
| Rosalen, PL | 1 |
| Regasini, LO | 1 |
| Aneja, B | 1 |
| Irfan, M | 1 |
| Kapil, C | 1 |
| Jairajpuri, MA | 1 |
| Maguire, R | 1 |
| Kavanagh, K | 1 |
| Rizvi, MM | 1 |
| Azam, A | 1 |
| Abid, M | 1 |
| Gohar, AA | 1 |
| Nabili, M | 1 |
| Amirrajab, N | 1 |
| Xu, YC | 1 |
| Hsueh, PR | 9 |
| Al-Yasiri, MH | 1 |
| L'Ollivier, C | 1 |
| Lachaud, L | 2 |
| Bourgeois, N | 2 |
| Rebaudet, S | 1 |
| Mauffrey, JF | 1 |
| Cooper, LG | 1 |
| Heydemann, J | 1 |
| Misenhimer, G | 1 |
| Antony, S | 1 |
| Haghdoost, NS | 1 |
| Salehi, TZ | 1 |
| Khosravi, A | 1 |
| Bozó, A | 1 |
| Domán, M | 1 |
| Majoros, L | 2 |
| Kardos, G | 2 |
| Varga, I | 1 |
| Kovács, R | 1 |
| Rammaert, B | 1 |
| Candon, S | 1 |
| Maunoury, C | 1 |
| Bougnoux, ME | 1 |
| Jouvion, G | 1 |
| Braun, T | 1 |
| Correas, JM | 1 |
| Cretella, D | 1 |
| Barber, KE | 1 |
| King, ST | 1 |
| Stover, KR | 1 |
| Rodolico, V | 1 |
| Di Carlo, P | 1 |
| Gulotta, G | 1 |
| D'Arpa, F | 1 |
| Salamone, G | 1 |
| Cocorullo, G | 1 |
| Agrusa, A | 1 |
| Giammanco, A | 1 |
| Sergi, C | 1 |
| Xi, Z | 1 |
| Qiao, Z | 1 |
| Lv, Y | 1 |
| Cen, W | 1 |
| Patel, PN | 1 |
| Sah, P | 1 |
| Chandrashekar, C | 1 |
| Vidyasagar, S | 1 |
| Venkata Rao, J | 1 |
| Tiwari, M | 1 |
| Radhakrishnan, R | 1 |
| Bordallo-Cardona, MA | 1 |
| Marcos-Zambrano, LJ | 1 |
| Gómez G de la Pedrosa, E | 1 |
| Cantón, R | 1 |
| Wu, JY | 1 |
| Guo, H | 1 |
| Wang, HM | 1 |
| Yi, GH | 1 |
| Zhou, LM | 1 |
| He, XW | 1 |
| Szabó, Z | 1 |
| Sóczó, G | 2 |
| Miszti, C | 1 |
| Hermann, P | 1 |
| Rozgonyi, F | 2 |
| Benoit, G | 1 |
| Mandalenakis, N | 1 |
| Faucher, C | 1 |
| Madore, F | 1 |
| Playford, EG | 5 |
| Marriott, D | 4 |
| Nguyen, Q | 3 |
| Ellis, D | 4 |
| Slavin, M | 1 |
| Sorrell, TC | 4 |
| van Asbeck, E | 1 |
| Clemons, KV | 3 |
| Tong, AJ | 1 |
| Lo, JS | 1 |
| Lo, JO | 1 |
| Hunter, AJ | 1 |
| Baddley, JW | 2 |
| Patel, M | 2 |
| Bhavnani, SM | 1 |
| Moser, SA | 3 |
| Leonessa, M | 2 |
| Latino, MA | 2 |
| Arisio, R | 3 |
| Maule, M | 2 |
| Agriesti, G | 2 |
| Gastaldo, L | 1 |
| Gallo, E | 2 |
| Mostert, M | 4 |
| Schuster, MG | 1 |
| Edwards, JE | 12 |
| Sobel, JD | 14 |
| Darouiche, RO | 4 |
| Karchmer, AW | 6 |
| Hadley, S | 5 |
| Slotman, G | 1 |
| Panzer, H | 3 |
| Rex, JH | 18 |
| Fekete, T | 1 |
| Guclu, E | 1 |
| Soypacaci, Z | 1 |
| Yildirim, M | 2 |
| Kucukbayrak, A | 1 |
| Ozdemir, D | 1 |
| González, GM | 3 |
| Elizondo, M | 2 |
| Ayala, J | 1 |
| Panizo, MM | 1 |
| Reviákina, V | 1 |
| Dolande, M | 1 |
| Selgrad, S | 1 |
| Kim, EC | 3 |
| Uh, Y | 2 |
| Jeong, SH | 1 |
| Park, KH | 1 |
| Lee, JS | 2 |
| Salemis, NS | 1 |
| Tsolakis, K | 1 |
| Aloizos, S | 1 |
| Tsohataridis, E | 1 |
| Arendse, T | 1 |
| Orth, H | 1 |
| Kobayashi, M | 2 |
| Soude, E | 1 |
| Takahashi, E | 1 |
| Sukegawa, N | 1 |
| Sei, Y | 1 |
| Ito, Y | 1 |
| Lin, YH | 2 |
| Keniya, M | 1 |
| Monk, BC | 1 |
| Hollenbach, E | 1 |
| Saha, R | 1 |
| Das Das, S | 1 |
| Kaur, IR | 1 |
| Gafter-Gvili, A | 1 |
| Vidal, L | 1 |
| Goldberg, E | 1 |
| Leibovici, L | 1 |
| Paul, M | 1 |
| Dinubile, MJ | 3 |
| Kappe, R | 2 |
| Fuchs, E | 1 |
| Gorges, A | 1 |
| Rimek, D | 1 |
| Tumbarello, M | 2 |
| Trecarichi, EM | 1 |
| La Sorda, M | 2 |
| Rossi, M | 1 |
| de Carolis, E | 3 |
| de Gaetano Donati, K | 1 |
| Fadda, G | 6 |
| Pasqualotto, AC | 1 |
| Zimerman, RA | 1 |
| Alves, SH | 4 |
| Aquino, VR | 2 |
| Branco, D | 1 |
| Wiltgen, D | 1 |
| do Amaral, A | 1 |
| Cechinel, R | 1 |
| Colares, SM | 1 |
| da Rocha, IG | 1 |
| Severo, LC | 1 |
| Sukiennik, TC | 1 |
| Johnson, E | 1 |
| Espinel-Ingroff, A | 10 |
| Szekely, A | 1 |
| Hockey, H | 1 |
| Troke, P | 3 |
| Vervaeke, S | 1 |
| Vandamme, K | 1 |
| Boone, E | 1 |
| De Laere, E | 1 |
| Swinne, D | 2 |
| Surmont, I | 1 |
| Diekema, DJ | 23 |
| Alexander, BD | 1 |
| Andes, D | 9 |
| Brown, SD | 2 |
| Chaturvedi, V | 3 |
| Knapp, CC | 1 |
| Walsh, TJ | 13 |
| Ward, RM | 2 |
| Sullivan, JE | 1 |
| Ramey, N | 1 |
| Jayaraman, B | 2 |
| Hoppu, K | 3 |
| Adamson, PC | 2 |
| Gastonguay, MR | 2 |
| Yoo, JI | 1 |
| Choi, CW | 1 |
| Lee, KM | 2 |
| Kim, YK | 1 |
| Kim, TU | 1 |
| Joo, SI | 1 |
| Yun, SH | 1 |
| Lee, YS | 1 |
| Kim, BS | 1 |
| Labelle, AJ | 1 |
| Micek, ST | 2 |
| Roubinian, N | 1 |
| Kollef, MH | 3 |
| Brecht, M | 1 |
| Clerihew, L | 1 |
| McGuire, W | 3 |
| Findling, O | 1 |
| Meier, N | 1 |
| Sellner, J | 1 |
| Nedeltchev, K | 1 |
| Arnold, M | 1 |
| Kuzucu, C | 1 |
| Durmaz, R | 1 |
| Otlu, B | 1 |
| Aktas, E | 2 |
| Gulcan, H | 1 |
| Cizmeci, Z | 1 |
| Guery, BP | 1 |
| Auzinger, G | 1 |
| Azoulay, E | 2 |
| Borges Sá, M | 2 |
| Johnson, EM | 7 |
| Müller, E | 1 |
| Putensen, C | 1 |
| Rotstein, C | 5 |
| Sganga, G | 1 |
| Venditti, M | 4 |
| Zaragoza Crespo, R | 1 |
| Kullberg, BJ | 6 |
| Peláez, T | 3 |
| Rodríguez-Créixems, M | 2 |
| Torres-Narbona, M | 1 |
| Alcalá, L | 2 |
| Kaufman, D | 5 |
| Eggimann, P | 3 |
| Khan, S | 3 |
| Devarajan, LV | 1 |
| Pozzatti, P | 1 |
| Scheid, LA | 1 |
| Spader, TB | 1 |
| Atayde, ML | 1 |
| Santurio, JM | 3 |
| Majithiya, J | 1 |
| Sharp, A | 2 |
| Parmar, A | 1 |
| Denning, DW | 15 |
| Warn, PA | 3 |
| Faiz, S | 1 |
| Neale, B | 1 |
| Rios, E | 1 |
| Campos, T | 1 |
| Parsley, E | 1 |
| Patel, B | 1 |
| Cubillos, GF | 1 |
| Soares, BM | 1 |
| da Silva, DL | 1 |
| Sousa, GR | 1 |
| Amorim, JC | 1 |
| de Resende, MA | 2 |
| Pinotti, M | 1 |
| Cisalpino, PS | 1 |
| Ruan, SY | 2 |
| Chien, JY | 2 |
| Vandijck, DM | 1 |
| Blot, SI | 2 |
| Vandekerckhove, L | 1 |
| Vogelaers, DP | 1 |
| Huang, S | 2 |
| Cao, YY | 4 |
| Dai, BD | 1 |
| Sun, XR | 1 |
| Zhu, ZY | 1 |
| Gao, PH | 4 |
| Hirshoren, N | 1 |
| Eliashar, R | 1 |
| Weinberger, JM | 1 |
| Zwolińska-Wcisło, M | 2 |
| Sliwowski, Z | 3 |
| Drozdowicz, D | 3 |
| Kwiecień, S | 3 |
| Mazurkiewicz-Janik, M | 1 |
| Trojanowska, D | 3 |
| Rudnicka-Sosin, L | 3 |
| Mach, T | 3 |
| Budak, A | 3 |
| Brzozowski, T | 3 |
| Konturek, SJ | 3 |
| Pawlik, WW | 3 |
| Wheeler, RT | 1 |
| Kombe, D | 1 |
| Agarwala, SD | 1 |
| Fink, GR | 1 |
| Li, SR | 1 |
| Zhang, SW | 1 |
| Cheng, MF | 3 |
| Chang, YW | 1 |
| Young, TG | 2 |
| Chi, H | 2 |
| Lee, SC | 3 |
| Cheung, BM | 1 |
| Tseng, FC | 1 |
| Chen, TC | 1 |
| Ho, YH | 1 |
| Shi, ZY | 1 |
| Chan, CH | 1 |
| Lin, JY | 1 |
| Healy, CM | 3 |
| Baker, CJ | 3 |
| Shelburne, SA | 1 |
| Lee, DH | 1 |
| Nowicka, J | 1 |
| Wlodarczyk, K | 1 |
| Ferrari, S | 2 |
| Calabrese, D | 1 |
| Rohde, B | 1 |
| Bauser, C | 1 |
| Bader, O | 2 |
| Temiz, M | 1 |
| Cetin, M | 1 |
| Aslan, A | 1 |
| Tuon, FF | 1 |
| Amato, VS | 1 |
| Penteado Filho, SR | 1 |
| Vendettuoli, V | 1 |
| Vento, G | 1 |
| Tirone, C | 1 |
| Romagnoli, C | 1 |
| Girão, E | 1 |
| Levin, AS | 1 |
| Basso, M | 1 |
| Gobara, S | 1 |
| Gomes, LB | 1 |
| Medeiros, EA | 1 |
| Costa, SF | 1 |
| Pérez-Parra, A | 1 |
| Martín-Rabadán, P | 1 |
| Guembe, M | 1 |
| Poon, LM | 1 |
| Chia, HY | 1 |
| Tan, LK | 1 |
| Liu, TC | 1 |
| Koh, LP | 2 |
| Marti, J | 1 |
| Bland, CM | 1 |
| Thomas, S | 1 |
| Nishi, I | 1 |
| Sunada, A | 1 |
| Toyokawa, M | 1 |
| Asari, S | 1 |
| Iwatani, Y | 1 |
| Magill, SS | 4 |
| Swoboda, SM | 5 |
| Shields, CE | 1 |
| Colantuoni, EA | 1 |
| Merz, WG | 8 |
| Lipsett, PA | 4 |
| Hendrix, CW | 4 |
| Lam, SW | 2 |
| Eschenauer, GA | 2 |
| Carver, PL | 1 |
| Parikh, SV | 1 |
| Memon, N | 1 |
| Echols, M | 1 |
| Shah, J | 1 |
| McGuire, DK | 1 |
| Keeley, EC | 1 |
| Enwuru, CA | 1 |
| Ogunledun, A | 1 |
| Idika, N | 1 |
| Enwuru, NV | 1 |
| Ogbonna, F | 1 |
| Aniedobe, M | 1 |
| Adeiga, A | 1 |
| Ricciardi, AM | 1 |
| Ricciardi, R | 1 |
| Danzi, M | 1 |
| Mungiguerra, M | 1 |
| Pisano, L | 1 |
| Marino, A | 1 |
| Klevay, MJ | 1 |
| Horn, DL | 3 |
| Neofytos, D | 2 |
| Pérez Melón, C | 1 |
| Conde Rivera, O | 1 |
| Novoa Fernández, E | 1 |
| Borrajo Prol, M | 1 |
| Blyth, CC | 1 |
| Serena, C | 3 |
| Meyer, W | 1 |
| Martucci, R | 1 |
| Fiori, B | 2 |
| Florio, AR | 1 |
| Graybill, JR | 14 |
| Watcharananan, SP | 1 |
| Oh, MD | 1 |
| Ja'alam, K | 1 |
| Nangia, V | 1 |
| Kurup, A | 2 |
| Padiglione, AA | 1 |
| Moon, CJ | 1 |
| Kim, DW | 1 |
| Kee, SJ | 1 |
| Jia, XM | 1 |
| Jia, JH | 1 |
| Li, MB | 1 |
| Liao, WQ | 1 |
| Dias, AS | 1 |
| Guerra, J | 1 |
| Cuesta, I | 2 |
| Bielza, C | 2 |
| Larrañaga, P | 2 |
| Laguna, F | 3 |
| Rodriguez-Pardo, D | 2 |
| Zwolinska-Wcislo, M | 1 |
| Anaissie, EJ | 8 |
| Fishman, JA | 1 |
| Steinbach, WJ | 1 |
| Olyaei, AJ | 1 |
| Marr, KA | 10 |
| Chang, CH | 1 |
| Webster, KM | 1 |
| Pankhurst, CL | 1 |
| Yenişehirli, G | 1 |
| Bulut, Y | 1 |
| Güven, M | 1 |
| Günday, E | 1 |
| Donnelly, JP | 5 |
| Zaragoza-Crespo, R | 1 |
| Deuschle, P | 1 |
| Hou, YC | 1 |
| Odabasi, Z | 2 |
| Rodriguez, JR | 1 |
| Leitz, GJ | 1 |
| Talvard, M | 1 |
| Paranon, S | 1 |
| Dulac, Y | 1 |
| Mansir, T | 1 |
| Kreitmann, B | 1 |
| Acar, P | 1 |
| Chen, CG | 1 |
| Tseng, KY | 1 |
| Shih, HI | 1 |
| Liou, CH | 1 |
| Teyton, P | 1 |
| Baillet, G | 1 |
| Hindié, E | 1 |
| Filmont, JE | 1 |
| Sarandi, F | 1 |
| Toubert, ME | 1 |
| Moretti, JL | 1 |
| Zilberberg, MD | 1 |
| Kothari, S | 1 |
| Mills, EJ | 1 |
| Perri, D | 1 |
| Cooper, C | 1 |
| Nachega, JB | 1 |
| Wu, P | 1 |
| Tleyjeh, I | 1 |
| Phillips, P | 3 |
| Bulik, CC | 1 |
| Nailor, MD | 1 |
| Portillo, OJ | 1 |
| Uscanga, GI | 1 |
| Andrade, SE | 1 |
| Robledo, M | 1 |
| Rodríguez, C | 1 |
| Pemán, J | 7 |
| Garnacho Montero, J | 1 |
| Avolio, M | 1 |
| Grosso, S | 1 |
| Bruschetta, G | 1 |
| De Rosa, R | 1 |
| Camporese, A | 1 |
| Fung, CP | 2 |
| Lee, N | 2 |
| See, LC | 2 |
| Plantinga, TS | 1 |
| van der Velden, WJ | 1 |
| Ferwerda, B | 1 |
| van Spriel, AB | 1 |
| Adema, G | 1 |
| Feuth, T | 1 |
| Brown, GD | 1 |
| Blijlevens, NM | 1 |
| Netea, MG | 3 |
| Tan, TY | 1 |
| Tee, NW | 1 |
| Ng, LS | 1 |
| Chee, CW | 1 |
| Savini, V | 1 |
| Catavitello, C | 1 |
| Bianco, A | 1 |
| Balbinot, A | 1 |
| D'Antonio, F | 1 |
| D'Antonio, D | 2 |
| Ansaldi, F | 1 |
| Nicolini, L | 1 |
| Malfatto, E | 1 |
| Molinari, MP | 3 |
| Mussap, M | 2 |
| Rebesco, B | 1 |
| Bobbio Pallavicini, F | 1 |
| Icardi, G | 1 |
| Viscoli, C | 5 |
| Hollis, RJ | 17 |
| Boyken, L | 9 |
| Tendolkar, S | 7 |
| Kroeger, J | 2 |
| Habib, FS | 1 |
| Fouad, EA | 1 |
| Abdel-Rhaman, MS | 2 |
| Fathalla, D | 2 |
| Costa, CR | 2 |
| Jesuíno, RS | 1 |
| de Aquino Lemos, J | 1 |
| de Fátima Lisboa Fernandes, O | 1 |
| Hasimoto e Souza, LK | 1 |
| Passos, XS | 2 |
| do Rosário Rodrigues Silva, M | 1 |
| Chandran, SK | 1 |
| Lyons, KM | 2 |
| Divi, V | 1 |
| Geyer, M | 1 |
| Sataloff, RT | 4 |
| Hasosah, MY | 1 |
| Showail, M | 1 |
| Al-Sahafi, A | 1 |
| Satti, M | 1 |
| Jacobson, K | 1 |
| Choi, HK | 1 |
| Jeong, SJ | 1 |
| Chin, BS | 1 |
| Choi, SH | 1 |
| Han, SH | 1 |
| Kim, MS | 1 |
| Kim, CO | 1 |
| Choi, JY | 1 |
| Song, YG | 1 |
| Golan, Y | 4 |
| Li, SY | 4 |
| Ko, HC | 1 |
| Wang, AH | 3 |
| Chen, KW | 2 |
| Wang, CW | 3 |
| Paul, DJ | 1 |
| Reedy, JL | 1 |
| Filler, SG | 6 |
| Austin, N | 1 |
| Darlow, BA | 1 |
| Negri, M | 2 |
| Martins, M | 1 |
| Svidzinski, TI | 1 |
| Azeredo, J | 1 |
| Oliveira, R | 2 |
| Guo, N | 3 |
| Wu, X | 2 |
| Yu, L | 3 |
| Meng, R | 1 |
| Jin, J | 3 |
| Yan, S | 1 |
| Deng, X | 4 |
| Iwazaki, RS | 1 |
| Endo, EH | 1 |
| Ueda-Nakamura, T | 1 |
| Nakamura, CV | 1 |
| Garcia, LB | 1 |
| Filho, BP | 1 |
| Dovigo, LN | 1 |
| Mima, EG | 1 |
| Giampaolo, ET | 1 |
| Vergani, CE | 1 |
| Bagnato, VS | 1 |
| Dehandschoewercker, L | 1 |
| Bertout, S | 1 |
| Bousquet, PJ | 1 |
| Rispail, P | 1 |
| Michot, C | 1 |
| Guillot, B | 1 |
| Dereure, O | 1 |
| Minces, LR | 1 |
| Ho, KS | 1 |
| Veldkamp, PJ | 1 |
| Clancy, CJ | 4 |
| Khodavandi, A | 2 |
| Aala, F | 1 |
| Sekawi, Z | 2 |
| Chong, PP | 3 |
| Aziz, M | 1 |
| Patel, AL | 1 |
| Losavio, J | 1 |
| Iyengar, A | 1 |
| Berven, M | 1 |
| Schloemer, N | 1 |
| Jakubowicz, A | 1 |
| Mathai, T | 1 |
| McAuley, JB | 1 |
| Myoken, Y | 4 |
| Binning, MJ | 1 |
| Thorell, EA | 1 |
| Riva-Cambrin, JK | 1 |
| Bagheri, F | 1 |
| Cervellione, KL | 1 |
| Maruf, M | 1 |
| Marino, W | 1 |
| Santucci, T | 1 |
| Cohen, Y | 2 |
| Karoubi, P | 1 |
| Adrie, C | 1 |
| Gauzit, R | 2 |
| Marsepoil, T | 1 |
| Zarka, D | 1 |
| Clec'h, C | 1 |
| Kelesidis, T | 1 |
| Tsiodras, S | 1 |
| Chopra, T | 1 |
| Bhargava, A | 1 |
| Kumar, S | 1 |
| Chopra, A | 1 |
| Dhar, S | 1 |
| Afonso, L | 1 |
| Coleman, JJ | 2 |
| Okoli, I | 1 |
| Tegos, GP | 2 |
| Holson, EB | 1 |
| Wagner, FF | 1 |
| Hamblin, MR | 2 |
| Lezrek, M | 1 |
| Nadah, M | 1 |
| El Moussaif, H | 1 |
| Karmane, A | 1 |
| Daoudi, R | 1 |
| Lyon, GM | 2 |
| Karatela, S | 1 |
| Sunay, S | 1 |
| Adiri, Y | 1 |
| Kim, TH | 1 |
| Cheng, WT | 2 |
| Hospitals, T | 1 |
| Kludze-Forson, M | 1 |
| Kubin, CJ | 1 |
| Della-Latta, P | 3 |
| Macêdo, DP | 1 |
| Oliveira, NT | 1 |
| Farias, AM | 1 |
| Silva, VK | 1 |
| Wilheim, AB | 1 |
| Couto, FM | 1 |
| Gibbs, DL | 7 |
| Newell, VA | 5 |
| Tullio, V | 4 |
| Rodloff, A | 1 |
| Fu, W | 1 |
| Ling, TA | 1 |
| Yampolsky, C | 1 |
| Corti, M | 1 |
| Negroni, R | 1 |
| Hata, M | 1 |
| Yoshida, K | 2 |
| Ishii, C | 1 |
| Otani, T | 1 |
| Ando, A | 1 |
| Gamarra, S | 1 |
| Rocha, EM | 1 |
| Park, S | 4 |
| Rao, R | 1 |
| Fleischhacker, M | 1 |
| Pasligh, J | 1 |
| Moran, G | 1 |
| Ruhnke, M | 8 |
| Thursky, KA | 1 |
| Ellis, DH | 1 |
| Besse, B | 1 |
| Ong, RK | 1 |
| Raisis, AL | 1 |
| Swindells, KL | 1 |
| Barton, R | 2 |
| Bijie, H | 1 |
| Bille, J | 7 |
| Chang, SC | 5 |
| da Luz Martins, M | 1 |
| Duse, A | 1 |
| Dzierzanowska, D | 1 |
| Finquelievich, J | 3 |
| Gould, I | 1 |
| Gur, D | 2 |
| Hoosen, A | 1 |
| Mallatova, N | 1 |
| Mallie, M | 5 |
| Peng, NG | 1 |
| Petrikos, G | 1 |
| Santiago, A | 1 |
| Trupl, J | 6 |
| VanDen Abeele, AM | 1 |
| Wadula, J | 2 |
| Zaidi, M | 1 |
| Stolk, MJ | 1 |
| King, AL | 1 |
| Massey, HD | 1 |
| Hebert, C | 1 |
| Villaran, R | 1 |
| Tolentino, J | 2 |
| Best, L | 1 |
| Boonlayangoor, S | 1 |
| Pitrak, D | 1 |
| Lin, M | 1 |
| Weber, SG | 2 |
| Westbrook, SD | 2 |
| Vallor, AC | 1 |
| Kotara, S | 1 |
| Bernardo, S | 2 |
| Lee, SA | 2 |
| Toro, JJ | 2 |
| Freytes, C | 1 |
| Redding, SW | 7 |
| Lee, I | 2 |
| Zaoutis, TE | 2 |
| Fishman, NO | 2 |
| Morales, KH | 2 |
| Nachamkin, I | 2 |
| Lautenbach, E | 2 |
| Nimmo, GR | 1 |
| Tilse, M | 1 |
| Krishnan-Natesan, S | 1 |
| Manavathu, EK | 1 |
| Cutright, JL | 2 |
| Chandrasekar, PH | 3 |
| Kothavade, RJ | 1 |
| Kura, MM | 1 |
| Valand, AG | 1 |
| Panthaki, MH | 1 |
| Oxman, DA | 1 |
| Chow, JK | 2 |
| Frendl, G | 1 |
| Hershkovitz, S | 1 |
| Ireland, P | 1 |
| McDermott, LA | 1 |
| Tsai, K | 1 |
| Marty, FM | 1 |
| Alburquenque, C | 1 |
| Bucarey, SA | 1 |
| Neira-Carrillo, A | 1 |
| Urzúa, B | 1 |
| Hermosilla, G | 1 |
| Tapia, CV | 1 |
| Sidrim, JJ | 2 |
| Maia, DC | 1 |
| Brilhante, RS | 2 |
| Soares, GD | 1 |
| Monteiro, AJ | 2 |
| Rocha, MF | 2 |
| Nett, JE | 2 |
| Sanchez, H | 2 |
| Cain, MT | 2 |
| Garnacho-Montero, J | 1 |
| Díaz-Martín, A | 1 |
| García-Cabrera, E | 1 |
| Ruiz Pérez de Pipaón, M | 1 |
| Hernández-Caballero, C | 1 |
| Aznar-Martín, J | 1 |
| Cisneros, JM | 1 |
| Ortiz-Leyba, C | 1 |
| Zaoutis, T | 1 |
| Rueda, K | 1 |
| Moreno, MT | 1 |
| Espinosa, M | 1 |
| Sáez-Llorens, X | 2 |
| Abbes, S | 2 |
| Sellami, H | 2 |
| Sellami, A | 2 |
| Makni, F | 2 |
| Mahfoudh, N | 2 |
| Makni, H | 2 |
| Khaled, S | 1 |
| Ayadi, A | 2 |
| Cervera, C | 1 |
| Linares, L | 1 |
| Reverté, E | 1 |
| Escorsell, A | 1 |
| Moreno, A | 2 |
| Khan, LA | 2 |
| Hyun, JJ | 1 |
| Chun, HJ | 1 |
| Keum, B | 1 |
| Seo, YS | 1 |
| Jeen, YT | 1 |
| Um, SH | 1 |
| Kim, CD | 1 |
| Ryu, HS | 1 |
| Wu, MH | 1 |
| Hsu, KY | 1 |
| Ding, Y | 1 |
| Tang, X | 1 |
| Liang, J | 1 |
| Li, L | 1 |
| de Boer, MG | 1 |
| Erba, P | 1 |
| Campa, M | 2 |
| Nibbering, PH | 3 |
| Sharon, V | 1 |
| Eisen, DB | 1 |
| Fung, MA | 1 |
| Kourkoumpetis, TK | 1 |
| Velmahos, GC | 1 |
| Ziakas, PD | 1 |
| Tampakakis, E | 1 |
| Manolakaki, D | 1 |
| Mansfield, BE | 1 |
| Oltean, HN | 1 |
| Oliver, BG | 1 |
| Hoot, SJ | 1 |
| Leyde, SE | 1 |
| Hedstrom, L | 1 |
| Burton, MJ | 1 |
| Shah, P | 1 |
| Swiatlo, E | 1 |
| Weingart, V | 1 |
| Allescher, HD | 2 |
| Poikonen, E | 1 |
| Lyytikäinen, O | 2 |
| Anttila, VJ | 3 |
| Koivula, I | 1 |
| Lumio, J | 1 |
| Kotilainen, P | 1 |
| Syrjälä, H | 1 |
| Ruutu, P | 1 |
| Dailey, NJ | 1 |
| Young, EJ | 1 |
| Schwentner, L | 1 |
| Wulff, C | 1 |
| Kreienberg, R | 1 |
| Herr, D | 1 |
| Sheehan, D | 1 |
| Altuncu, E | 1 |
| Bilgen, H | 1 |
| Cerikçioğlu, N | 4 |
| Ilki, A | 1 |
| Ulger, N | 1 |
| Bakır, M | 2 |
| Akman, I | 1 |
| Ozek, E | 1 |
| Agarwal, V | 1 |
| Lal, P | 1 |
| Pruthi, V | 1 |
| Piper, L | 1 |
| Cheifetz, IM | 2 |
| Moorthy, G | 2 |
| Hope, WW | 1 |
| Matsumoto, Y | 1 |
| Murat, D | 1 |
| Kojima, T | 1 |
| Shimazaki, J | 1 |
| Tsubota, K | 1 |
| Ko, KS | 2 |
| Cuff, AL | 1 |
| Wamstad, JB | 1 |
| Boyle, R | 4 |
| Grossman, LB | 3 |
| Patrick, P | 1 |
| Echeverria, PM | 1 |
| Gallieni, M | 1 |
| Chiarelli, G | 1 |
| Olivi, L | 1 |
| Cozzolino, M | 1 |
| Cusi, D | 1 |
| Azevedo, AC | 2 |
| Bizerra, FC | 1 |
| da Matta, DA | 2 |
| de Almeida, LP | 2 |
| Rosas, R | 2 |
| Kristóf, K | 1 |
| Janik, L | 1 |
| Komka, K | 1 |
| Harmath, A | 1 |
| Hajdú, J | 1 |
| Nobilis, A | 1 |
| Nagy, K | 1 |
| Rigó, J | 1 |
| Szabó, D | 1 |
| Mulu, A | 1 |
| Diro, E | 1 |
| Tekleselassie, H | 1 |
| Belyhun, Y | 1 |
| Anagaw, B | 1 |
| Alemayehu, M | 1 |
| Gelaw, A | 1 |
| Biadglegne, F | 1 |
| Desalegn, K | 1 |
| Yifiru, S | 1 |
| Tiruneh, M | 1 |
| Kassu, A | 1 |
| Nishikawa, T | 1 |
| Isogai, E | 1 |
| Ito, M | 2 |
| Yokoi, T | 1 |
| Sugita, S | 1 |
| Shinohara, N | 1 |
| Nishina, S | 1 |
| Azuma, N | 1 |
| Harmal, NS | 1 |
| Sidik, SM | 1 |
| Jahromi, MA | 1 |
| Annamalai, T | 1 |
| Fong, KC | 1 |
| Choo, MM | 1 |
| Kim, S | 1 |
| Lee, MS | 1 |
| Lee, MY | 1 |
| Lopatin, AS | 1 |
| Ovchinnikov, AIu | 1 |
| Otsuru, M | 1 |
| Aoki, T | 1 |
| Ota, Y | 1 |
| Karakida, K | 1 |
| Yamazaki, H | 1 |
| Sasaki, M | 2 |
| Yüksekkaya, S | 1 |
| Motyl, M | 1 |
| de Vasconcelos, AA | 1 |
| Menezes, EA | 1 |
| Cunha, FA | 1 |
| Palmisano, A | 1 |
| Benecchi, M | 1 |
| De Filippo, M | 1 |
| Maggiore, U | 1 |
| Buzio, C | 1 |
| Vaglio, A | 1 |
| Vinekar, A | 1 |
| Avadhani, K | 1 |
| Maralusiddappa, P | 1 |
| Prabhu, VM | 1 |
| Mahendradas, P | 1 |
| Indumathi, VA | 1 |
| García-Oltra, E | 1 |
| García-Ramiro, S | 1 |
| Martínez, JC | 1 |
| Tibau, R | 1 |
| Bori, G | 1 |
| Bosch, J | 1 |
| Mensa, J | 2 |
| Soriano, A | 1 |
| Cantón, E | 5 |
| Sheikh, Z | 1 |
| Khan, AS | 1 |
| Takakura, S | 2 |
| Watanabe, N | 1 |
| Matsumoto, K | 2 |
| Kojima, S | 1 |
| Kato, K | 1 |
| Shieh, HH | 1 |
| Ibidi, SM | 1 |
| Gilio, AE | 1 |
| Motloch, LJ | 1 |
| Rottlaender, D | 1 |
| Darabi, T | 1 |
| Joost, I | 1 |
| Erdmann, E | 1 |
| Hoppe, UC | 1 |
| Fisher, JF | 1 |
| Kauffman, CA | 8 |
| Newman, CA | 1 |
| Zore, GB | 2 |
| Thakre, AD | 1 |
| Jadhav, S | 1 |
| Hadrich, I | 1 |
| Amouri, I | 1 |
| Neji, S | 1 |
| Schulz, B | 2 |
| Weber, K | 2 |
| Schmidt, A | 1 |
| Borg-von Zepelin, M | 1 |
| Basu, S | 1 |
| Ross, KM | 1 |
| Smego, RA | 2 |
| Ahmad, H | 2 |
| Bhatia, R | 1 |
| Khan, N | 1 |
| Muralidhar, S | 1 |
| Basir, SF | 1 |
| Ramírez, E | 1 |
| Borobia, AM | 1 |
| Ortega, JM | 1 |
| Lei, S | 1 |
| Barrios-Fernández, A | 1 |
| Sánchez, M | 1 |
| Carcas, AJ | 1 |
| Herrero, A | 1 |
| de la Puente, JM | 1 |
| Frías, J | 1 |
| Li, JY | 1 |
| Sun, HY | 1 |
| Zhang, QQ | 1 |
| Alsan, MM | 1 |
| Issa, NC | 1 |
| Hammond, SP | 1 |
| Milner, DA | 1 |
| DeAngelo, DJ | 1 |
| Baden, LR | 1 |
| Lott, TJ | 2 |
| Frade, JP | 2 |
| Iqbal, N | 1 |
| Sinnollareddy, M | 1 |
| Ling, G | 1 |
| Liang, X | 1 |
| Fan, J | 1 |
| Qiu, J | 1 |
| Song, Y | 1 |
| Huang, N | 1 |
| Taramasso, L | 1 |
| Nicco, E | 1 |
| Ozhak-Baysan, B | 1 |
| Ogunc, D | 1 |
| Colak, D | 1 |
| Ongut, G | 1 |
| Donmez, L | 1 |
| Vural, T | 1 |
| Gunseren, F | 1 |
| Werner, BC | 1 |
| Hogan, MV | 1 |
| Shen, FH | 1 |
| Furlaneto, MC | 1 |
| Rota, JF | 1 |
| Quesada, RM | 1 |
| Furlaneto-Maia, L | 1 |
| Rodrigues, R | 1 |
| Oda, S | 3 |
| Oliveira, MT | 1 |
| Serpa, R | 1 |
| França, EJ | 1 |
| Sundi, D | 1 |
| Tseng, K | 1 |
| Mullins, JK | 1 |
| Hyndman, ME | 1 |
| Soliman, W | 1 |
| Habib, F | 1 |
| Springer, J | 1 |
| Pinto, E | 1 |
| Sampaio-Marques, B | 1 |
| Barbosa, M | 1 |
| Ludovico, P | 1 |
| Wilkins, MR | 1 |
| Olshtain-Pops, K | 1 |
| Krieger, M | 1 |
| Oren, I | 1 |
| Dan, M | 2 |
| Wiener-Well, Y | 2 |
| Weinberger, M | 1 |
| Zimhony, O | 1 |
| Chowers, M | 1 |
| Weber, G | 1 |
| Potasman, I | 3 |
| Chazan, B | 1 |
| Kassis, I | 1 |
| Shalit, I | 2 |
| Block, C | 1 |
| Keller, N | 2 |
| Giladi, M | 1 |
| Khan, MS | 1 |
| Ahmad, I | 1 |
| Chartier, L | 1 |
| Sendid, B | 2 |
| Wolff, M | 1 |
| Mainardi, JL | 1 |
| Podglajen, I | 1 |
| Desnos-Ollivier, M | 2 |
| Bretagne, S | 2 |
| Miyamoto, H | 1 |
| Miura, T | 1 |
| Morita, E | 1 |
| Morizaki, Y | 1 |
| Uehara, K | 1 |
| Ohe, T | 1 |
| Tanaka, S | 1 |
| Rossi, DC | 1 |
| Muñoz, JE | 1 |
| Carvalho, DD | 1 |
| Belmonte, R | 1 |
| Faintuch, B | 1 |
| Borelli, P | 1 |
| Miranda, A | 1 |
| Daffre, S | 1 |
| Chandy, R | 2 |
| Weichert, S | 1 |
| Reinshagen, K | 1 |
| Zahn, K | 1 |
| Geginat, G | 1 |
| Dietz, A | 1 |
| Kilian, AK | 1 |
| Schroten, H | 2 |
| Tenenbaum, T | 1 |
| Grandesso, S | 1 |
| Sapino, B | 1 |
| Mazzuccato, S | 1 |
| Solinas, M | 1 |
| Bedin, M | 1 |
| D'Angelo, M | 1 |
| Gion, M | 1 |
| Köse, S | 1 |
| Türken, M | 1 |
| Akkoçlu, G | 1 |
| Karaca, C | 1 |
| Senger, SS | 1 |
| Leibovitz, E | 1 |
| Gammelsrud, KW | 1 |
| Lindstad, BL | 1 |
| Ingebretsen, A | 1 |
| Høiby, EA | 1 |
| Brandtzaeg, P | 1 |
| Sandven, P | 7 |
| Alves, IA | 1 |
| Bandeira, LA | 1 |
| Mario, DA | 1 |
| Denardi, LB | 1 |
| Neves, LV | 1 |
| Jajoo, M | 1 |
| Kumar, V | 1 |
| Goyal, VK | 1 |
| Garg, A | 1 |
| Kim, JS | 2 |
| Park, YH | 1 |
| Keith, SW | 1 |
| Brouwer, KL | 1 |
| Rolnitsky, A | 1 |
| Levy, I | 1 |
| Sirota, L | 1 |
| Klinger, G | 1 |
| Rizzollo, S | 1 |
| Franco, C | 1 |
| Antonucci, R | 1 |
| Fanos, V | 1 |
| Knobloch, M | 1 |
| Teixeira, CE | 1 |
| Castelo-Branco, DS | 1 |
| Paiva, MA | 1 |
| Giffoni Leite, JJ | 1 |
| Lima, DT | 1 |
| Nagao, J | 1 |
| Cho, T | 1 |
| Uno, J | 1 |
| Ueno, K | 2 |
| Imayoshi, R | 1 |
| Kaminishi, H | 1 |
| Singla, N | 1 |
| Gulati, N | 1 |
| Kaistha, N | 1 |
| Chander, J | 1 |
| Malton, A | 1 |
| DeFatta, RA | 1 |
| Chang, W | 1 |
| Cheng, A | 1 |
| Lou, H | 1 |
| Mandras, N | 2 |
| Allizond, V | 1 |
| Nostro, A | 1 |
| Roana, J | 2 |
| Merlino, C | 2 |
| Banche, G | 1 |
| Scalas, D | 1 |
| Cuffini, AM | 2 |
| Buschart, A | 1 |
| Burakowska, A | 1 |
| Bilitewski, U | 1 |
| Sasse, C | 1 |
| Dunkel, N | 2 |
| Schäfer, T | 1 |
| Dierolf, F | 1 |
| Ohlsen, K | 1 |
| Azeredo, FJ | 1 |
| Haas, SE | 1 |
| Torres, B | 1 |
| Pigatto, M | 1 |
| de Andrade, C | 1 |
| Dalla Costa, T | 1 |
| Samaranayake, YH | 1 |
| Cheung, BPK | 1 |
| Yau, JYY | 1 |
| Yeung, KWS | 1 |
| Hull, CM | 1 |
| Weig, M | 1 |
| Gross, U | 1 |
| Warrilow, AG | 1 |
| Kelly, DE | 3 |
| Tchernev, G | 1 |
| Penev, PK | 1 |
| Nenoff, P | 1 |
| Zisova, LG | 1 |
| Cardoso, JC | 1 |
| Taneva, T | 1 |
| Ginter-Hanselmayer, G | 1 |
| Ananiev, J | 1 |
| Gulubova, M | 1 |
| Hristova, R | 1 |
| Nocheva, D | 1 |
| Guarneri, C | 1 |
| Martino, G | 1 |
| Kanazawa, N | 1 |
| Tashiro, M | 1 |
| Murakami, H | 1 |
| Yoshizawa, S | 1 |
| Tateda, K | 1 |
| Yamaguchi, K | 1 |
| Kato, IT | 1 |
| Prates, RA | 1 |
| Sabino, CP | 1 |
| Ribeiro, MS | 2 |
| Choi, HJ | 1 |
| Ju, MY | 1 |
| Park, YJ | 2 |
| Silva, LV | 1 |
| Rochat, B | 1 |
| Beam, E | 1 |
| Mansfield, AS | 1 |
| Thompson, CA | 1 |
| Dubert, M | 1 |
| Loi, V | 1 |
| Tligui, M | 1 |
| Hertig, A | 1 |
| Han, S | 1 |
| Kim, J | 1 |
| Yim, H | 1 |
| Hur, J | 1 |
| Song, W | 2 |
| Jeon, S | 1 |
| Hong, T | 1 |
| Woo, H | 1 |
| Yim, DS | 1 |
| Datau, EA | 1 |
| Bean, LM | 1 |
| Jackson, JR | 1 |
| Dobak, WJ | 1 |
| Beiswenger, TR | 1 |
| Thorp, JA | 1 |
| Pereira, O | 1 |
| Figueira-Coelho, J | 1 |
| Picado, B | 1 |
| Costa, JN | 1 |
| Oberoi, JK | 1 |
| Wattal, C | 1 |
| Goel, N | 1 |
| Raveendran, R | 1 |
| Datta, S | 1 |
| Prasad, K | 1 |
| Arthington-Skaggs, BA | 4 |
| Lee-Yang, W | 1 |
| Ciblak, MA | 1 |
| Brandt, ME | 2 |
| Hajjeh, RA | 2 |
| Harrison, LH | 1 |
| Sofair, AN | 1 |
| Warnock, DW | 11 |
| Biancofiore, G | 1 |
| Bindi, ML | 1 |
| Baldassarri, R | 1 |
| Romanelli, AM | 1 |
| Catalano, G | 1 |
| Filipponi, F | 1 |
| Vagelli, A | 1 |
| Mosca, F | 2 |
| Oliveira, JS | 1 |
| Kerbauy, FR | 1 |
| Bahia, DM | 1 |
| Pinheiro, GS | 1 |
| Silva, MR | 1 |
| Raineri, G | 1 |
| Kerbauy, J | 1 |
| Maebashi, K | 1 |
| Kudoh, M | 1 |
| Nishiyama, Y | 1 |
| Makimura, K | 1 |
| Uchida, K | 5 |
| Mori, T | 3 |
| Yamaguchi, H | 5 |
| Da Matta, D | 1 |
| Morace, G | 3 |
| Amato, G | 1 |
| Bistoni, F | 5 |
| Marone, P | 1 |
| Montagna, MT | 2 |
| Oliveri, S | 1 |
| Polonelli, L | 2 |
| Rigoli, R | 1 |
| Mancuso, I | 1 |
| La Face, S | 1 |
| Masucci, L | 1 |
| Romano, L | 1 |
| Napoli, C | 1 |
| Tatò, D | 1 |
| Buscema, MG | 1 |
| Belli, CM | 1 |
| Piccirillo, MM | 1 |
| Conti, S | 2 |
| Covan, S | 1 |
| Fanti, F | 1 |
| Cavanna, C | 1 |
| D'Alò, F | 1 |
| Pitzurra, L | 2 |
| Bauters, TG | 1 |
| Moerman, M | 1 |
| Vermeersch, H | 1 |
| Nelis, HJ | 1 |
| Oon, LL | 1 |
| Yeo, MG | 1 |
| Triolo, V | 1 |
| Gari-Toussaint, M | 2 |
| Casagrande, F | 1 |
| Garraffo, R | 1 |
| Dageville, C | 1 |
| Boutté, P | 1 |
| Bérard, E | 1 |
| James, JS | 1 |
| Ratip, S | 1 |
| Karti, S | 1 |
| Cetiner, M | 1 |
| Yeğen, C | 1 |
| Bayik, M | 1 |
| Korten, V | 2 |
| Sohnle, PG | 1 |
| Hahn, BL | 1 |
| Safdar, A | 3 |
| Koll, BS | 1 |
| Larone, DH | 1 |
| Armstrong, D | 1 |
| Bussaratid, V | 1 |
| Tansupasawasdikul, S | 1 |
| Simpson, A | 1 |
| Pitisuttithum, P | 1 |
| Phonrat, B | 1 |
| Howe, P | 2 |
| White, NJ | 1 |
| Turgut, B | 1 |
| Vural, O | 1 |
| Demir, M | 1 |
| Kaldir, M | 1 |
| Aikawa, N | 1 |
| Sumiyama, Y | 1 |
| Kusachi, S | 1 |
| Hirasawa, H | 1 |
| Yamazaki, Y | 1 |
| Raad, II | 4 |
| Prince, RA | 1 |
| Kartsonis, N | 1 |
| Bartizal, K | 1 |
| Hicks, PS | 1 |
| Ryan, D | 1 |
| Sable, CA | 1 |
| Zer, Y | 1 |
| Balci, I | 1 |
| Meriç, G | 1 |
| Garbino, J | 5 |
| Kolarova, L | 1 |
| Rohner, P | 3 |
| Lew, D | 3 |
| Pichna, P | 2 |
| Pittet, D | 3 |
| Lew, DP | 1 |
| Romand, JA | 1 |
| Hugonnet, S | 1 |
| Auckenthaler, R | 1 |
| Goh, YT | 1 |
| Fook-Chong, SM | 1 |
| Tan, PH | 1 |
| Fernández-Turégano, CP | 1 |
| Wroblewska, MM | 1 |
| Swoboda-Kopec, E | 1 |
| Rokosz, A | 1 |
| Krawczyk, E | 1 |
| Marchel, H | 1 |
| Luczak, M | 1 |
| Paya, CV | 2 |
| Nuevo, JA | 1 |
| Hijano, A | 1 |
| Eimil, M | 1 |
| Valdivia, A | 1 |
| Candel, FJ | 1 |
| Núñez, MJ | 1 |
| Roca, V | 1 |
| Petrocheilou-Paschou, V | 1 |
| Georgilis, K | 1 |
| Kontoyannis, D | 1 |
| Nanas, J | 1 |
| Prifti, H | 1 |
| Costopoulos, H | 1 |
| Stamatelopoulos, S | 1 |
| Shepherd, J | 1 |
| Hawkins, JL | 1 |
| Baddour, LM | 1 |
| Teng, LJ | 1 |
| Yang, PC | 1 |
| Ho, SW | 1 |
| Luh, KT | 3 |
| Kamai, Y | 3 |
| Kubota, M | 1 |
| Fukuoka, T | 2 |
| Maeda, N | 1 |
| Hosokawa, T | 1 |
| Shibayama, T | 2 |
| Kuwahara, S | 2 |
| Prenzel, KL | 1 |
| Isenberg, J | 1 |
| Helling, HJ | 1 |
| Rehm, KE | 1 |
| Saville, S | 1 |
| Coco, BJ | 2 |
| White, W | 1 |
| Fothergill, A | 2 |
| Rinaldi, M | 4 |
| Eng, T | 1 |
| Lopez-Ribot, J | 1 |
| Marchetti, O | 4 |
| Viudes, A | 3 |
| López-Ribot, JL | 4 |
| Gobernado, M | 3 |
| El-Zaatari, MM | 1 |
| Hulten, K | 1 |
| Fares, Y | 1 |
| Baassiri, A | 1 |
| Balkis, M | 1 |
| Almashhrawi, A | 1 |
| El-Zaatari, FA | 1 |
| Ozkutuk, A | 2 |
| Ergon, C | 2 |
| Yulug, N | 4 |
| Alvarez-Lerma, F | 2 |
| Nolla, J | 1 |
| Palomar, M | 2 |
| León, MA | 1 |
| Islam, S | 1 |
| Zaidi, AK | 1 |
| Wilson, J | 1 |
| García de Hombre, AM | 1 |
| Pineda Salguedo, A | 1 |
| Seravalli, L | 1 |
| Van Linthoudt, D | 1 |
| Bernet, C | 1 |
| de Torrenté, A | 1 |
| Porchet, F | 1 |
| Genné, D | 1 |
| MacNeill, C | 1 |
| Weisz, J | 1 |
| Carey, JC | 1 |
| Brown, AL | 1 |
| Greig, JR | 1 |
| Kaygusuz, I | 1 |
| Mulazimoglu, L | 1 |
| Toprak, A | 1 |
| Oktay, A | 1 |
| Spellberg, B | 1 |
| Rieg, G | 1 |
| Bayer, A | 1 |
| Silling, G | 1 |
| Maesaki, S | 1 |
| Yamaguchi, T | 1 |
| Baglivo, E | 2 |
| Seghelmeble, C | 1 |
| Bagnoud, M | 2 |
| Leuenberger, PM | 1 |
| Safran, AB | 2 |
| Veber, B | 1 |
| Chevalier, E | 1 |
| Blin, P | 1 |
| Palestro, B | 1 |
| Snydman, DR | 3 |
| Kusaka, S | 1 |
| Hayashi, N | 1 |
| Ohji, M | 1 |
| Ikuno, Y | 1 |
| Gomi, F | 1 |
| Tano, Y | 2 |
| Sobel, J | 1 |
| Brass, C | 1 |
| Vazquez, JA | 7 |
| Horowitz, HW | 2 |
| Zervos, M | 2 |
| McKinsey, D | 2 |
| Babinchak, T | 1 |
| Bradsher, RW | 1 |
| Cohen, DM | 1 |
| Danziger, L | 1 |
| Goldman, M | 1 |
| Goodman, J | 1 |
| Hilton, E | 1 |
| Hyslop, NE | 1 |
| Lutz, J | 1 |
| Rubin, RH | 2 |
| Scheld, WM | 2 |
| Schuster, M | 1 |
| Simmons, B | 1 |
| Stein, DK | 1 |
| Washburn, RG | 3 |
| Mautner, L | 1 |
| Chu, TC | 1 |
| Rosenstein, RB | 1 |
| Booth, J | 1 |
| Van Saene, HK | 1 |
| Silvestri, L | 1 |
| Petros, A | 1 |
| Viviani, M | 1 |
| de la Cal, MA | 1 |
| Zandstra, DF | 1 |
| Schreiber, W | 1 |
| Olbrisch, A | 1 |
| Vorwerk, CK | 1 |
| König, W | 1 |
| Behrens-Baumann, W | 2 |
| Kyo, T | 2 |
| Kohara, T | 2 |
| Fujihara, M | 1 |
| Sugata, T | 2 |
| McGee, WT | 1 |
| Tereso, GJ | 1 |
| Chen, YC | 3 |
| Hsieh, WC | 1 |
| Rodríguez-Adrián, LJ | 1 |
| King, RT | 1 |
| Tamayo-Derat, LG | 1 |
| Miller, JW | 1 |
| Garcia, CA | 1 |
| De Bellis, P | 1 |
| Bonfiglio, M | 1 |
| Gerbi, G | 1 |
| Bacigalupo, P | 1 |
| Buscaglia, G | 1 |
| Guido, P | 1 |
| Massobrio, B | 1 |
| Hernandez, S | 2 |
| Larsen, RA | 2 |
| Wald, M | 1 |
| Lawrenz, K | 1 |
| Kretzer, V | 1 |
| Weninger, M | 1 |
| Pumberger, W | 1 |
| Pollak, A | 1 |
| Zaknun, D | 1 |
| Gottfredsson, M | 1 |
| Vredenburgh, JJ | 1 |
| Schell, WA | 1 |
| Schnyder, I | 1 |
| Bouchuiguir-Wafa, K | 1 |
| De Pasquale, K | 1 |
| Girmenia, C | 9 |
| Martino, P | 10 |
| Giacchino, F | 1 |
| Comune, L | 1 |
| Carlone, NA | 1 |
| Jiménez-Alonso, J | 1 |
| Estev, D | 1 |
| Vera, C | 1 |
| Sabio, JM | 1 |
| Aaron, L | 1 |
| Therby, A | 1 |
| Viard, JP | 1 |
| Lahoulou, R | 1 |
| Dupont, B | 7 |
| Tapia, C | 1 |
| González, P | 1 |
| Pereira, A | 1 |
| Pérez, J | 1 |
| Noriega, LM | 1 |
| Palavecino, E | 1 |
| Shanmugam, N | 1 |
| Isenmann, R | 1 |
| Barkin, JS | 1 |
| Beger, HG | 1 |
| Zielińska, E | 1 |
| Vegner, EE | 1 |
| Beloborodova, EI | 1 |
| Siianov, VS | 1 |
| Zhivotiagin, VN | 1 |
| Penkin, AV | 1 |
| Kvach, EA | 1 |
| Hamill, RJ | 1 |
| Powderly, W | 2 |
| Hyslop, N | 1 |
| Mangino, JE | 2 |
| Chapman, S | 2 |
| Dismukes, WE | 3 |
| Gökahmetoglu, S | 1 |
| Nedret Koç, A | 1 |
| Patiroglu, T | 1 |
| Nakagawa, Z | 1 |
| Valdetaro, F | 1 |
| Branchini, ML | 2 |
| Kussano, EJ | 1 |
| Rubio Calvo, MC | 1 |
| Gil, J | 1 |
| Ramírez de Ocáriz, I | 1 |
| Benito, R | 1 |
| Rezusta, A | 1 |
| Kolbin, AS | 1 |
| Ivanov, DO | 1 |
| Shabalov, NP | 1 |
| Klimko, NN | 1 |
| Karpov, OI | 1 |
| Leisenring, W | 2 |
| Crippa, F | 1 |
| Slattery, JT | 1 |
| Corey, L | 2 |
| Boeckh, M | 2 |
| McDonald, GB | 2 |
| Marchillo, K | 4 |
| Stamstad, T | 1 |
| Conklin, R | 1 |
| Heseltine, JC | 1 |
| Panciera, DL | 1 |
| Saunders, GK | 1 |
| Solomkin, JS | 2 |
| Umanskiy, K | 1 |
| Mikamo, H | 3 |
| Ninomiya, M | 2 |
| Tamaya, T | 3 |
| Makova, GN | 1 |
| Kurbatova, IV | 1 |
| Antoniadou, A | 2 |
| Torres, HA | 2 |
| Thornby, J | 1 |
| Bodey, GP | 7 |
| Tarrand, JP | 1 |
| Han, XY | 1 |
| Rolston, KV | 3 |
| Gudlaugsson, O | 1 |
| Gillespie, S | 1 |
| Vande Berg, J | 1 |
| Hu, J | 1 |
| Messer, S | 2 |
| Herwaldt, L | 1 |
| Pfaller, M | 1 |
| Diekema, D | 1 |
| Kaloterakis, A | 1 |
| Rizos, I | 1 |
| Goumas, G | 1 |
| Filiotou, A | 1 |
| Barbetseas, J | 1 |
| Papathanasiou, S | 1 |
| Toutouzas, P | 1 |
| Leone, M | 1 |
| Albanèse, J | 1 |
| Antonini, F | 1 |
| Michel-Nguyen, A | 1 |
| Blanc-Bimar, MC | 1 |
| Martin, C | 1 |
| Cheng, HH | 4 |
| Ho, YA | 3 |
| Hsiao, CF | 1 |
| Garg, P | 1 |
| Mahesh, S | 1 |
| Bansal, AK | 1 |
| Gopinathan, U | 1 |
| Rao, GN | 1 |
| Schelenz, S | 1 |
| Gransden, WR | 1 |
| Sang, H | 1 |
| Wu, B | 1 |
| Bliss, JM | 1 |
| Wellington, M | 1 |
| Gigliotti, F | 1 |
| Lerch, K | 1 |
| Kalteis, T | 1 |
| Schubert, T | 1 |
| Lehn, N | 1 |
| Grifka, J | 1 |
| Hazen, KC | 4 |
| Baron, EJ | 1 |
| Sanchez-Sousa, A | 4 |
| del Palacio, A | 5 |
| de Bedout, C | 1 |
| Michalopoulos, AS | 1 |
| Geroulanos, S | 3 |
| Mentzelopoulos, SD | 1 |
| Williams, LE | 1 |
| Goldstein, MH | 1 |
| Lim, M | 1 |
| Driebe, WT | 1 |
| Thanka, J | 1 |
| Kuruvilla, S | 1 |
| Abraham, G | 2 |
| Shroff, S | 1 |
| Kumar, BA | 1 |
| Ranjitham, M | 1 |
| Fluckiger, U | 1 |
| Ruef, C | 1 |
| Glauser, MP | 7 |
| Täuber, MG | 1 |
| Ho, M | 2 |
| Yu, KW | 1 |
| Tang, RB | 1 |
| Fan, YH | 1 |
| Hsieh, KS | 1 |
| Austin, NC | 1 |
| Darlow, B | 1 |
| Ozdemir, S | 1 |
| Lipsetta, PA | 1 |
| Frattarelli, DA | 1 |
| Reed, MD | 1 |
| Giacoia, GP | 1 |
| Aranda, JV | 1 |
| Bennett, JE | 6 |
| Fujihara, N | 1 |
| Saito, T | 1 |
| Kudo, T | 1 |
| Iinuma, Y | 1 |
| Ichiyama, S | 1 |
| Legrand, M | 1 |
| Lephart, P | 1 |
| Forche, A | 2 |
| Mueller, FM | 1 |
| Walsh, T | 1 |
| Magee, PT | 1 |
| Magee, BB | 1 |
| Watelle, M | 1 |
| Van der Flaes, M | 1 |
| Nolard, N | 1 |
| Crisp, S | 1 |
| Wiederhold, N | 1 |
| Bareither, B | 1 |
| Eckstein, J | 1 |
| Barbuch, R | 1 |
| Bard, M | 1 |
| Olaechea, P | 1 |
| Cerdá, E | 1 |
| Bermejo, B | 1 |
| Molina, L | 1 |
| Hernando, S | 1 |
| Puthanakit, T | 1 |
| Carson, KA | 1 |
| Salvatori, R | 1 |
| McCarthy, DI | 3 |
| Bocanegera, R | 1 |
| Kawakami, Y | 1 |
| Nagino, K | 1 |
| Shinkai, K | 1 |
| Sobue, S | 1 |
| Abe, M | 1 |
| Ishiko, J | 1 |
| Vargas, K | 1 |
| Srikantha, R | 1 |
| Holke, A | 1 |
| Sifri, T | 1 |
| Morris, R | 1 |
| Joly, S | 3 |
| Cortés, JA | 1 |
| Cuervo, SI | 1 |
| Hernández, LF | 1 |
| Potdevin, G | 1 |
| Urdaneta, AM | 1 |
| Noguchi, M | 1 |
| Takai, H | 1 |
| Eishi, K | 1 |
| Atogami, S | 1 |
| Yoder, BA | 1 |
| Winter, V | 1 |
| Coalson, JJ | 1 |
| Solomon, R | 1 |
| Biser, SA | 1 |
| Donnenfeld, ED | 1 |
| Perry, HD | 1 |
| Doshi, SJ | 1 |
| Lee, CC | 1 |
| Yeaman, MR | 2 |
| Cheng, D | 1 |
| Desai, B | 1 |
| Kupferwasser, LI | 1 |
| Xiong, YQ | 1 |
| Gank, KD | 1 |
| Bayer, AS | 5 |
| Mellado, E | 3 |
| Silva, V | 2 |
| Alvarado, D | 2 |
| Diaz, MC | 2 |
| Melkusová, S | 1 |
| Volleková, A | 1 |
| Bernhardt, J | 1 |
| Bernhardt, H | 2 |
| Knoke, M | 1 |
| Ludwig, K | 1 |
| Garrelts, JC | 1 |
| Schroeder, TR | 1 |
| Harrison, PB | 1 |
| Wang, JL | 1 |
| Singh-Parikshak, R | 1 |
| Bothun, ED | 1 |
| Superstein, R | 1 |
| Del Monte, M | 1 |
| Archer, S | 1 |
| Johnson, MW | 1 |
| Takesue, Y | 2 |
| Kakehashi, M | 1 |
| Ohge, H | 1 |
| Murakami, Y | 1 |
| Morifuji, M | 1 |
| Yokoyama, Y | 1 |
| Kouyama, M | 1 |
| Yokoyama, T | 1 |
| Sueda, T | 1 |
| da Silva Ferreira, ME | 1 |
| dos Reis Marques, E | 1 |
| Savoldi, M | 1 |
| Perlin, D | 2 |
| Godoy Martinez, PC | 1 |
| Goldman, MH | 1 |
| Nett, J | 3 |
| Oschel, P | 1 |
| Albrecht, R | 1 |
| Pitula, A | 1 |
| Petraitis, V | 4 |
| Petraitiene, R | 4 |
| Kelaher, AM | 1 |
| Sarafandi, AA | 1 |
| Sein, T | 3 |
| Mickiene, D | 1 |
| Bacher, J | 6 |
| Groll, AH | 7 |
| Baldassarri, I | 1 |
| Marigliano, A | 2 |
| Arzeni, D | 5 |
| Krause, DS | 2 |
| Simjee, AE | 1 |
| van Rensburg, C | 1 |
| Goldstein, BP | 2 |
| Wible, M | 2 |
| Henkel, T | 1 |
| de Wet, N | 1 |
| Llanos-Cuentas, A | 1 |
| Suleiman, J | 1 |
| Baraldi, E | 1 |
| Krantz, EF | 1 |
| Della Negra, M | 1 |
| Diekmann-Berndt, H | 1 |
| Jones, M | 1 |
| Cloud, G | 1 |
| Smith, AC | 1 |
| Cha, R | 1 |
| Prabhu, RM | 1 |
| Orenstein, R | 1 |
| Kobayashi, CC | 1 |
| de Fernandes, OF | 1 |
| Miranda, KC | 1 |
| de Sousa, ED | 1 |
| Silva, Mdo R | 2 |
| Jones, AL | 1 |
| Di Bonaventura, G | 1 |
| Spedicato, I | 1 |
| Picciani, C | 1 |
| Piccolomini, R | 1 |
| Jantunen, E | 1 |
| Nihtinen, A | 2 |
| Volin, L | 2 |
| Juvonen, E | 2 |
| Parkkali, T | 1 |
| Ruutu, T | 2 |
| Mondal, RK | 1 |
| Singhi, SC | 1 |
| M, J | 1 |
| Testore, GP | 1 |
| Dori, L | 1 |
| Buonomini, AR | 1 |
| Schito, GC | 1 |
| Soro, O | 1 |
| Fortina, G | 1 |
| Andreoni, S | 1 |
| Carlone, N | 1 |
| Andreoni, M | 1 |
| Rudensky, B | 2 |
| Broidie, E | 1 |
| Yinnon, AM | 2 |
| Weitzman, T | 1 |
| Paz, E | 1 |
| Raveh, D | 2 |
| Yoshida, M | 3 |
| Pancholi, P | 1 |
| Kubin, C | 1 |
| Balvay, P | 1 |
| Tran, V | 1 |
| Boillot, A | 1 |
| Kakuta, M | 1 |
| del Castillo, M | 1 |
| Wainsztein, N | 1 |
| Klein, F | 1 |
| Manganello, S | 1 |
| Orellana, N | 1 |
| Cheng, CK | 1 |
| Yang, CH | 1 |
| Liu, CM | 1 |
| Lu, HY | 1 |
| Braun, JP | 1 |
| Schneider, M | 1 |
| Dohmen, P | 1 |
| Döpfmer, U | 1 |
| Marr, K | 1 |
| Ranno, S | 1 |
| Borst, A | 1 |
| Raimer, MT | 1 |
| Morrison, CJ | 2 |
| Avila-Aguero, ML | 1 |
| Canas-Coto, A | 1 |
| Ulloa-Gutierrez, R | 1 |
| Caro, MA | 1 |
| Alfaro, B | 1 |
| Paris, MM | 1 |
| Nevado, J | 1 |
| De Alarcón, A | 1 |
| Hernández, A | 1 |
| Doğan, A | 1 |
| Irmak, H | 1 |
| Harman, M | 1 |
| Ceylan, A | 1 |
| Akpinar, F | 1 |
| Tosun, N | 1 |
| Tanaka, K | 1 |
| Rahhal, RM | 1 |
| Ramkumar, DP | 1 |
| Pashankar, DS | 1 |
| Ergon, MC | 1 |
| Gülay, Z | 1 |
| Masood, A | 1 |
| Sallah, S | 1 |
| de Wet, NT | 1 |
| Bester, AJ | 1 |
| Viljoen, JJ | 1 |
| Filho, F | 1 |
| Suleiman, JM | 1 |
| Ticona, E | 1 |
| Llanos, EA | 1 |
| Fisco, C | 1 |
| Lau, W | 1 |
| Buell, D | 1 |
| Westling, K | 1 |
| Thalme, A | 1 |
| Julander, I | 1 |
| Tan, GL | 1 |
| Peterson, EM | 1 |
| Park, BJ | 2 |
| Planes, AM | 1 |
| Almela, M | 1 |
| Sanchez, F | 1 |
| Ayats, J | 1 |
| Gimenez, M | 1 |
| Saballs, P | 1 |
| Fridkin, SK | 2 |
| Morgan, J | 1 |
| Dawson, NL | 1 |
| Robles, HA | 1 |
| Alvarez, S | 1 |
| Yamamoto, T | 1 |
| Ueta, E | 1 |
| Kamatani, T | 1 |
| Osaki, T | 1 |
| Vianna, RN | 1 |
| Souza Filho, JP | 1 |
| Deschênes, J | 1 |
| Burnier, MN | 1 |
| Arikan, S | 5 |
| Sancak, B | 3 |
| Hascelik, G | 1 |
| Hsieh, WB | 1 |
| Leung, C | 1 |
| Liolios, A | 1 |
| Gressens, B | 1 |
| Leonard, I | 1 |
| Coche, E | 1 |
| Hantson, P | 1 |
| Vázquez-Tsuji, O | 1 |
| Campos-Rivera, T | 1 |
| Ahumada-Mendoza, H | 1 |
| Rondán-Zárate, A | 1 |
| Martínez-Barbabosa, I | 1 |
| Staib, P | 1 |
| Köhler, G | 1 |
| Devkatte, AN | 1 |
| Sarvikivi, E | 1 |
| Soll, DR | 4 |
| Pujol, C | 3 |
| Richardson, M | 1 |
| Koukila-Kähkölä, P | 1 |
| Luukkainen, P | 1 |
| Saxén, H | 3 |
| Kofla, G | 1 |
| Takahata, S | 1 |
| Okutomi, T | 1 |
| Ohtsuka, K | 2 |
| Hoshiko, S | 1 |
| Giusiano, G | 1 |
| Mangiaterra, M | 1 |
| Rojas, F | 1 |
| Gómez, V | 1 |
| Ahmed, IM | 1 |
| Gupta, A | 1 |
| Gould, K | 1 |
| Clark, SC | 1 |
| Laupland, KB | 1 |
| Gregson, DB | 1 |
| Church, DL | 1 |
| Ross, T | 1 |
| Elsayed, S | 1 |
| Morrissey, G | 1 |
| Yu, VL | 3 |
| Nguyen, MH | 5 |
| Alvarez-Suárez, ML | 1 |
| Sánchez-Tabar, L | 1 |
| Viescas-Fernández, MJ | 1 |
| Fernández-Alvarez, MA | 1 |
| Hsu, HH | 1 |
| Chang, YL | 1 |
| Chen, JS | 1 |
| Tiffany, KF | 1 |
| Gamma, R | 1 |
| Carrel, T | 1 |
| Schmidli, J | 1 |
| Zimmerli, S | 1 |
| Tanner, H | 1 |
| Hullin, R | 1 |
| Mohacsi, PJ | 1 |
| Hariya, A | 1 |
| Naruse, Y | 1 |
| Kobayashi, T | 1 |
| Endo, M | 2 |
| Ikeda, Y | 1 |
| Yoshii, T | 1 |
| Momomura, S | 1 |
| Ishiwata, S | 1 |
| Maehara, A | 1 |
| Kumar, CP | 1 |
| Sundararajan, T | 1 |
| Menon, T | 2 |
| Venkatadesikalu, M | 1 |
| Kamaliah, MD | 1 |
| Bhajan, MA | 1 |
| Dzarr, GA | 1 |
| Long, SS | 1 |
| Stevenson, DK | 1 |
| Bertini, G | 1 |
| Perugi, S | 1 |
| Dani, C | 1 |
| Filippi, L | 1 |
| Pratesi, S | 1 |
| Rubaltelli, FF | 1 |
| Zaccaria, E | 2 |
| Campbell, JR | 2 |
| Patrie, JT | 2 |
| Robinson, M | 3 |
| Torfoss, D | 1 |
| Chung, K | 1 |
| Jackson, WL | 2 |
| Waterman, PE | 1 |
| Brncić, N | 1 |
| Mijandrusić-Sincić, B | 1 |
| Visković, I | 1 |
| Samra, Z | 1 |
| Yardeni, M | 1 |
| Peled, N | 1 |
| Cowen, LE | 1 |
| Lindquist, S | 1 |
| Zhao, Q | 1 |
| Liao, J | 1 |
| Qin, H | 1 |
| Wang, J | 2 |
| Wilson, AG | 1 |
| Ritchie, DJ | 1 |
| Moleti, ML | 1 |
| Micozzi, A | 3 |
| Iori, AP | 1 |
| Barberi, W | 1 |
| Foà, R | 1 |
| Luzzati, R | 1 |
| Allegranzi, B | 1 |
| Antozzi, L | 1 |
| Masala, L | 1 |
| Pegoraro, E | 1 |
| Azzini, A | 1 |
| Concia, E | 2 |
| Natarajan, G | 1 |
| Lulic-Botica, M | 1 |
| Rongkavilit, C | 1 |
| Pappas, A | 1 |
| Bedard, M | 1 |
| Angel-Moreno, A | 1 |
| Boronat, M | 1 |
| Bolaños, M | 1 |
| Carrillo, A | 2 |
| González, S | 1 |
| Pérez Arellano, JL | 1 |
| Molina, P | 1 |
| Puchades, MJ | 1 |
| Aparicio, M | 1 |
| García Ramón, R | 1 |
| Miguel, A | 1 |
| Navarathna, DH | 1 |
| Hornby, JM | 1 |
| Hoerrmann, N | 1 |
| Parkhurst, AM | 1 |
| Duhamel, GE | 1 |
| Nickerson, KW | 1 |
| Lin, MY | 1 |
| Carmeli, Y | 2 |
| Zumsteg, J | 1 |
| Flores, EL | 1 |
| Sreeramoju, P | 1 |
| Mariné, M | 2 |
| Fernández-Torres, B | 1 |
| Freydiere, AM | 1 |
| Piens, MA | 1 |
| Andre, JM | 1 |
| Putet, G | 1 |
| Picot, S | 1 |
| Minette, MS | 1 |
| Ibsen, LM | 1 |
| Lye, DC | 1 |
| Hughes, A | 1 |
| O'Brien, D | 1 |
| Athan, E | 1 |
| van Beek, LM | 1 |
| Landman, JJ | 1 |
| Verheught, FW | 1 |
| Bergner, R | 1 |
| Hoffmann, M | 1 |
| Riedel, KD | 1 |
| Mikus, G | 1 |
| Henrich, DM | 1 |
| Haefeli, WE | 1 |
| Uppenkamp, M | 1 |
| Walter-Sack, I | 1 |
| Esposito, R | 2 |
| Uberti Foppa, C | 1 |
| Cernuschi, M | 2 |
| Gomirato, G | 2 |
| Al-Assiri, A | 1 |
| Al-Jastaneiah, S | 1 |
| Al-Khalaf, A | 1 |
| Al-Fraikh, H | 1 |
| Wagoner, MD | 1 |
| Jabbour, K | 1 |
| Spellberg, BJ | 1 |
| Wolf, MP | 1 |
| Pauker, SG | 1 |
| Wong, JB | 1 |
| Arend, SM | 1 |
| Kuijper, EJ | 2 |
| de Vaal, BJ | 1 |
| de Fijter, JW | 1 |
| van't Wout, JW | 1 |
| Shan, YS | 1 |
| Sy, ED | 1 |
| Wang, ST | 1 |
| Lee, JC | 1 |
| Lin, PW | 1 |
| Capoor, MR | 2 |
| Nair, D | 2 |
| Deb, M | 2 |
| Verma, PK | 1 |
| Srivastava, L | 1 |
| Kul'ko, AB | 1 |
| Mitrokhin, SD | 1 |
| Moroz, AM | 1 |
| Fanaroff, AA | 1 |
| Shen, Q | 1 |
| Song, XM | 1 |
| Xu, XP | 1 |
| Wang, JM | 1 |
| Lunardi, LW | 1 |
| Goldani, LZ | 1 |
| Barth, AL | 1 |
| Owais, M | 1 |
| Ho, KM | 1 |
| Miyakoshi, S | 2 |
| Allotey, J | 1 |
| Duncan, H | 1 |
| Williams, H | 1 |
| Marik, PE | 1 |
| Hart, E | 1 |
| Dromer, F | 1 |
| Shields, C | 1 |
| Sears, CL | 1 |
| Choti, M | 1 |
| Murayama, SY | 1 |
| Lattif, AA | 1 |
| Banerjee, U | 1 |
| Gupta, N | 1 |
| Mohammad, S | 1 |
| Baquer, NZ | 1 |
| Costa, A | 1 |
| Fasce, R | 1 |
| Rosso, R | 1 |
| Pallavicini, FB | 1 |
| Donelli, G | 1 |
| Francolini, I | 1 |
| Ruggeri, V | 1 |
| Guaglianone, E | 1 |
| D'Ilario, L | 1 |
| Piozzi, A | 1 |
| Quan, H | 1 |
| Xu, Z | 3 |
| Zhao, JX | 1 |
| Qin, XF | 1 |
| Olmos, MA | 1 |
| Araya, V | 1 |
| Concetti, H | 1 |
| Ramallo, J | 1 |
| Piskorz, E | 1 |
| Pérez, H | 1 |
| Cahn, P | 1 |
| Kaufman, S | 1 |
| Guelfand, L | 1 |
| Rinaldi, MG | 16 |
| Chamilos, G | 1 |
| Lionakis, MS | 1 |
| Saville, SP | 1 |
| Albert, ND | 1 |
| Halder, G | 1 |
| Rao, S | 2 |
| Ali, U | 1 |
| Kon, Y | 1 |
| Bohgaki, M | 1 |
| Notoya, A | 1 |
| Mukai, M | 1 |
| Kohno, M | 1 |
| Sato, H | 1 |
| Chieng, DC | 1 |
| Low, LY | 1 |
| Hafeez, A | 1 |
| Shamsudin, MN | 1 |
| Seow, HF | 1 |
| Skiest, DJ | 2 |
| Nieto, L | 1 |
| Northland, R | 1 |
| Sanne, I | 1 |
| Gogate, J | 1 |
| Greaves, W | 1 |
| Isaacs, R | 2 |
| Uko, S | 1 |
| Soghier, LM | 1 |
| Vega, M | 1 |
| Marsh, J | 1 |
| Reinersman, GT | 1 |
| Herring, L | 1 |
| Dave, VA | 1 |
| Nafday, S | 1 |
| Brion, LP | 2 |
| Saiman, L | 3 |
| Rothe, C | 1 |
| Ignatius, R | 1 |
| Zeitz, M | 1 |
| Schneider, T | 1 |
| Cheng, YR | 1 |
| Lin, LC | 1 |
| Liu, CE | 1 |
| Chen, CH | 1 |
| Tsay, RW | 1 |
| Even-Tov, E | 1 |
| Niv, A | 1 |
| Kraus, M | 1 |
| Nash, M | 1 |
| Edwards, JR | 1 |
| Shetty, S | 1 |
| Horan, T | 1 |
| Cotteau, A | 1 |
| François, N | 1 |
| D'Haveloose, A | 1 |
| Standaert, A | 1 |
| Camus, D | 1 |
| Poulain, D | 1 |
| Panackal, AA | 1 |
| Gribskov, JL | 1 |
| Staab, JF | 1 |
| Kirby, KA | 1 |
| Loreto, ES | 1 |
| Boff, E | 1 |
| Neuhauser, MM | 1 |
| Bearden, DT | 5 |
| Cannon, JP | 1 |
| Gentry, LO | 2 |
| Johnson, EA | 1 |
| Pelz, RK | 2 |
| Lyon, JP | 2 |
| da Costa, SC | 1 |
| Totti, VM | 1 |
| Munhoz, MF | 1 |
| Rogers, TR | 1 |
| Anstead, GM | 2 |
| Peng, YJ | 1 |
| Wang, NC | 1 |
| Sabatelli, F | 1 |
| Mendrick, CA | 1 |
| Norris, CC | 1 |
| Hare, R | 2 |
| Loebenberg, D | 2 |
| Sahin, GO | 1 |
| Akova, M | 2 |
| Tascini, C | 1 |
| Ferranti, S | 1 |
| Leonildi, A | 1 |
| Menichetti, F | 1 |
| Veroux, M | 2 |
| Macarone, M | 2 |
| Fiamingo, P | 1 |
| Cappello, D | 1 |
| Gagliano, M | 2 |
| Di Mare, M | 1 |
| Vizcarra, D | 1 |
| Spataro, M | 1 |
| Giuffrida, G | 1 |
| Sorbello, M | 1 |
| Severino, V | 1 |
| Veroux, P | 2 |
| Blot, S | 1 |
| Janssens, R | 1 |
| Claeys, G | 1 |
| Hoste, E | 1 |
| Buyle, F | 1 |
| De Waele, JJ | 1 |
| Peleman, R | 1 |
| Vogelaers, D | 1 |
| Vandewoude, K | 1 |
| Bevanger, L | 1 |
| Digranes, A | 2 |
| Haukland, HH | 1 |
| Mannsåker, T | 1 |
| Rege, M | 1 |
| Mingo, DE | 2 |
| Suda, KJ | 4 |
| Wang, HP | 1 |
| Yen, YF | 1 |
| Chen, WS | 2 |
| Chou, YL | 1 |
| Tsai, CY | 1 |
| Chang, HN | 1 |
| Chou, CT | 1 |
| Zhang, LX | 1 |
| Zhang, JD | 2 |
| Yu, YY | 1 |
| Wang, DJ | 1 |
| Ying, K | 1 |
| Forrest, A | 1 |
| Lepak, A | 2 |
| Lincoln, L | 2 |
| Vermitsky, JP | 1 |
| Earhart, KD | 1 |
| Smith, WL | 1 |
| Homayouni, R | 2 |
| Edlind, TD | 1 |
| Yang, SC | 1 |
| Shao, PL | 1 |
| Lin, KH | 1 |
| Huang, LM | 1 |
| Nakamura, T | 2 |
| Takahashi, H | 1 |
| Park, JC | 1 |
| Taguchi, H | 2 |
| Fukushima, K | 1 |
| Hyon, SH | 1 |
| Takatori, K | 1 |
| Ribeiro, MA | 1 |
| Paula, CR | 1 |
| Al-Fattani, MA | 1 |
| Douglas, LJ | 1 |
| Zaragoza, R | 1 |
| Arcaya, NM | 1 |
| Mesa, LM | 1 |
| Pineda, MR | 1 |
| Beltrán-Luengo, H | 1 |
| Milagros Calvo, B | 1 |
| Legout, L | 1 |
| Assal, M | 1 |
| Bernard, L | 1 |
| Hoffmeyer, P | 1 |
| Kupś, J | 1 |
| Woźniakowska-Gesicka, T | 1 |
| Grzegorczyk, W | 1 |
| Borowska-Rybus, B | 1 |
| Fujinaga, H | 1 |
| Takahashi, K | 2 |
| Vonk, AG | 2 |
| van der Meer, JW | 2 |
| Onyewu, C | 1 |
| Afshari, NA | 1 |
| Aghai, ZH | 1 |
| Mudduluru, M | 1 |
| Nakhla, TA | 1 |
| Amendolia, B | 1 |
| Longo, D | 1 |
| Kemble, N | 1 |
| Kaki, S | 1 |
| Sutsko, R | 1 |
| Saslow, JG | 1 |
| Stahl, GE | 1 |
| Yagci, A | 1 |
| Gumbo, T | 1 |
| Drusano, GL | 4 |
| Ma, L | 1 |
| Deziel, MR | 1 |
| Drusano, MF | 1 |
| Louie, A | 5 |
| Dóczi, I | 1 |
| Mestyán, G | 1 |
| Puskás, E | 1 |
| Nikolova, R | 1 |
| Barcs, I | 1 |
| Nagy, E | 1 |
| Sánchez-Somolinos, M | 1 |
| Cuevas, O | 1 |
| Voigt, C | 1 |
| Lill, H | 1 |
| Bynens, BG | 1 |
| Ampe, JF | 1 |
| Denys, H | 1 |
| Oyen, PM | 1 |
| Morales-Molina, JA | 1 |
| Mateu-de Antonio, J | 1 |
| Grau, S | 1 |
| Luque, S | 1 |
| Berenguer, N | 1 |
| Staley, B | 1 |
| Manfredi, R | 1 |
| Sabbatani, S | 1 |
| Mendez, M | 1 |
| Kibbler, C | 2 |
| Erzsebet, P | 1 |
| Kennedy, HF | 1 |
| Shankland, GS | 1 |
| Bagg, J | 1 |
| Chalmers, EA | 1 |
| Gibson, BE | 1 |
| Williams, CL | 1 |
| Aoufi, S | 1 |
| Agoumi, A | 1 |
| Joung, YH | 1 |
| Kim, HR | 2 |
| Park, AJ | 1 |
| Stronati, M | 2 |
| Decembrino, L | 2 |
| Sastre, M | 1 |
| Valentín, A | 3 |
| Bosch, M | 1 |
| Raaijmakers, R | 1 |
| Schröder, C | 1 |
| Monnens, L | 2 |
| Cornelissen, E | 1 |
| Warris, A | 1 |
| Crawford, JT | 1 |
| Pereira, L | 1 |
| Buckmaster, J | 1 |
| Gravett, MG | 1 |
| Tolosa, JE | 1 |
| Yu, DT | 1 |
| Seger, DL | 1 |
| Peterson, JF | 1 |
| Kumar, RN | 1 |
| Bates, DW | 1 |
| Garcia-Vidal, C | 1 |
| Carratalà, J | 3 |
| Shen, H | 1 |
| An, MM | 1 |
| Wang, de J | 1 |
| Corona, D | 1 |
| Giuffida, G | 1 |
| Procop, GW | 1 |
| Uko, SE | 1 |
| Goldman, DL | 1 |
| Kim, HG | 1 |
| Long, L | 1 |
| Ward, D | 1 |
| Boparai, N | 1 |
| Pagano, R | 1 |
| Rege, MD | 1 |
| Comert, F | 1 |
| Kulah, C | 1 |
| Eroglu, O | 1 |
| Ozlu, N | 1 |
| Kang, JO | 1 |
| Kim, JJ | 1 |
| Lee, M | 1 |
| Lee, CK | 1 |
| Lee, HJ | 1 |
| Choi, TY | 1 |
| Lazarus, DR | 1 |
| Sherner, JH | 1 |
| Morrel, M | 1 |
| Fraser, VJ | 1 |
| Araújo, CR | 1 |
| Nascimento, ES | 1 |
| e Souza, LK | 1 |
| Fernandes, Ode F | 1 |
| Sales, WS | 1 |
| Freytes, CO | 1 |
| Horcajada, JP | 1 |
| Fernández-Sampedro, M | 1 |
| García-Palomo, D | 1 |
| Cañal, J | 1 |
| Salesa, R | 1 |
| Farinas, MC | 1 |
| Ramaswamy, K | 1 |
| Correa, M | 1 |
| Koshy, A | 1 |
| Pazos, C | 1 |
| Moragues, MD | 1 |
| Quindós, G | 4 |
| Pontón, J | 2 |
| Drew, RH | 2 |
| Malani, AN | 1 |
| Easley, C | 1 |
| Kirkpatrick, P | 1 |
| Kaji, Y | 1 |
| Wakabayashi, T | 1 |
| Nanbu, PN | 1 |
| Okamoto, F | 1 |
| Oshika, T | 1 |
| Alkhatib, A | 1 |
| Kawji, AS | 1 |
| Adler, DG | 1 |
| Al-Sweih, NA | 1 |
| Al-Kazemi, N | 1 |
| Wang, JS | 1 |
| Chou, HH | 2 |
| Bae, WK | 1 |
| Lee, KS | 1 |
| Park, JW | 1 |
| Kim, NH | 1 |
| Choi, KC | 1 |
| Cho, HH | 1 |
| Cho, YB | 1 |
| Frentiu, E | 1 |
| Petitfrere, M | 1 |
| May, T | 1 |
| Rabaud, C | 1 |
| McCrossan, BA | 1 |
| McHenry, E | 1 |
| O'Neill, F | 1 |
| Ong, G | 1 |
| Sweet, DG | 1 |
| Baixench, MT | 1 |
| Aoun, N | 1 |
| Garcia-Hermoso, D | 1 |
| Ramires, S | 1 |
| Piketty, C | 1 |
| Dannaoui, E | 1 |
| Falusi, E | 1 |
| Gergely, L | 1 |
| Chen, LI | 1 |
| Chang, JM | 1 |
| Kuo, MC | 1 |
| Hwang, SJ | 1 |
| Chen, HC | 1 |
| Liao, MH | 1 |
| Rodríguez, MM | 1 |
| Ruiz, M | 1 |
| du Plessis, FA | 1 |
| Helbing, WA | 1 |
| Bogers, AJ | 1 |
| Etienne, M | 1 |
| Caron, F | 1 |
| Chiew, YF | 1 |
| Inwood, H | 1 |
| Figueiredo, VT | 1 |
| de Assis Santos, D | 1 |
| Resende, MA | 1 |
| Hamdan, JS | 1 |
| Kalavsky, E | 1 |
| Kisac, P | 1 |
| Huttova, M | 4 |
| Benca, J | 1 |
| Krcmery, V | 11 |
| Betts, R | 1 |
| Schranz, J | 1 |
| Stolfi, I | 1 |
| Pugni, L | 1 |
| Magnani, C | 1 |
| Vetrano, G | 1 |
| Tridapalli, E | 1 |
| Corona, G | 1 |
| Giovannozzi, C | 1 |
| Merletti, F | 1 |
| Pedicino, R | 1 |
| Revankar, SG | 4 |
| Salamon, SA | 1 |
| Fuursted, K | 1 |
| Egeblad, H | 1 |
| Petersen, E | 1 |
| Ott, P | 1 |
| Rodríguez, VE | 1 |
| Freuler, CB | 1 |
| Ezcurra, C | 1 |
| Durlach, RA | 1 |
| Hanson, MF | 1 |
| Davidson, AD | 1 |
| Wright, P | 1 |
| Whyte, JA | 1 |
| Jones, BL | 1 |
| Mouton, JW | 1 |
| Chai, YA | 1 |
| Khoo, AL | 1 |
| Chan, FY | 1 |
| Chow, C | 1 |
| Kumarasinghe, G | 1 |
| Singh, K | 1 |
| Tambyah, PA | 1 |
| Maschmeyer, G | 1 |
| Haas, A | 1 |
| Lehrnbecher, T | 1 |
| Kaiser, J | 1 |
| Varwig, D | 1 |
| Ritter, J | 2 |
| Creutzig, U | 1 |
| Klingebiel, T | 1 |
| Schwabe, D | 2 |
| Hüseyin, A | 1 |
| Demirbileki, M | 1 |
| Timurkaynak, F | 1 |
| Can, F | 1 |
| Azap, O | 1 |
| Arslan, H | 1 |
| Hautala, T | 1 |
| Ikäheimo, I | 1 |
| Husu, H | 1 |
| Säily, M | 1 |
| Siitonen, T | 1 |
| Koistinen, P | 1 |
| Vuopio-Varkila, J | 2 |
| Koskela, M | 1 |
| Kujala, P | 1 |
| Jeragh, A | 1 |
| Naseem, J | 1 |
| Najmi, NG | 1 |
| Song, HF | 1 |
| Ober, RR | 1 |
| Zar, T | 1 |
| Zar, R | 1 |
| Kaplan, AA | 1 |
| Esch, JJ | 1 |
| Kantoch, MJ | 1 |
| Sica, G | 1 |
| Meissner, S | 1 |
| Dawas, K | 1 |
| Maynard, N | 1 |
| Vain, NE | 1 |
| Vazquez, LN | 1 |
| Aberegg, SK | 1 |
| O'Brien, JM | 1 |
| Nir-Paz, R | 1 |
| Moses, AE | 1 |
| Procianoy, RS | 1 |
| Silveira, RC | 1 |
| Mehta, S | 1 |
| Jiandani, P | 1 |
| Desai, M | 1 |
| Brouwer, CP | 1 |
| Bogaards, SJ | 1 |
| Welling, MM | 2 |
| de Heer, E | 1 |
| van Dissel, JT | 1 |
| Friesen, RH | 1 |
| Targosz, A | 1 |
| Shin, BM | 1 |
| Lo, SH | 1 |
| Chan, CK | 1 |
| Shum, HP | 1 |
| Chow, VC | 1 |
| Mo, KL | 1 |
| Wong, KS | 1 |
| Iguchi, Y | 1 |
| Matsumoto, S | 2 |
| Tawara, S | 1 |
| Mutoh, S | 1 |
| Slain, D | 1 |
| Khakoo, RA | 1 |
| Sánchez-Vargas, LO | 1 |
| Villar-Vidal, M | 1 |
| Eraso, E | 1 |
| Alkorta, M | 1 |
| Hernández-Almaraz, JL | 1 |
| Parikh, TB | 1 |
| Nanavati, RN | 1 |
| Patankar, CV | 1 |
| Bisure, K | 1 |
| Udani, RH | 1 |
| Mehta, P | 1 |
| Giacometti, A | 2 |
| Cirioni, O | 2 |
| Kamysz, W | 1 |
| Silvestri, C | 1 |
| Licci, A | 1 |
| Della Vittoria, A | 1 |
| Nadolski, P | 1 |
| Łukasiak, J | 1 |
| Monstert, M | 1 |
| Priolo, C | 1 |
| Marol, S | 1 |
| Yücesoy, M | 2 |
| Forrest, GN | 1 |
| Weekes, E | 1 |
| Johnson, JK | 1 |
| Rawat, D | 1 |
| Keyashian, K | 1 |
| Malani, PN | 1 |
| Stringaro, AR | 1 |
| Bonito, M | 1 |
| Toccacieli, L | 1 |
| Torosantucci, A | 1 |
| Guo, XL | 1 |
| Leng, P | 1 |
| Yu, LG | 1 |
| Lou, HX | 1 |
| Colombo, A | 1 |
| Barnes, R | 1 |
| Karatza, AA | 1 |
| Dimitriou, G | 1 |
| Pavlou, V | 1 |
| Giannakopoulos, I | 1 |
| Darzentas, A | 1 |
| Mantagos, SP | 1 |
| Karabak, BI | 1 |
| Popov, SV | 1 |
| Shmel'kov, IIu | 1 |
| Elonen, E | 1 |
| Zhu, Y | 1 |
| Chen, SP | 1 |
| Shu, YG | 1 |
| Xu, YJ | 1 |
| Medlicott, SA | 1 |
| Cox, H | 1 |
| Dupre, M | 1 |
| Lategan, J | 1 |
| Auer, I | 1 |
| Hollaar, G | 1 |
| Debru, E | 1 |
| Conly, J | 2 |
| van Hal, SJ | 1 |
| Stark, D | 1 |
| Harkness, J | 1 |
| Bulatova, NR | 1 |
| Darwish, RM | 1 |
| Kurnatowska, I | 1 |
| Pazurek, M | 1 |
| Nowicki, M | 1 |
| Mathai, AM | 1 |
| Khadilkar, UN | 1 |
| Mani, R | 1 |
| Belcadhi, M | 1 |
| Krifa, N | 1 |
| Abdelkefi, M | 1 |
| Ben Said, M | 1 |
| Bouzouita, K | 1 |
| Nomura, S | 1 |
| Iishii, K | 1 |
| Inami, N | 1 |
| Kimura, E | 1 |
| Urase, F | 1 |
| Ozaydin, I | 1 |
| Sahin, I | 1 |
| Yasar, M | 1 |
| Gerami-Nejad, M | 1 |
| Paulson, C | 1 |
| O'Grady, MJ | 1 |
| Dempsey, EM | 1 |
| Kabbara, N | 1 |
| Peffault de Latour, R | 1 |
| Broide, E | 1 |
| Berko, N | 1 |
| Nørgaard, M | 1 |
| Pedersen, L | 1 |
| Gislum, M | 1 |
| Erichsen, R | 1 |
| Søgaard, KK | 1 |
| Schønheyder, HC | 2 |
| Sørensen, HT | 1 |
| Hachem, R | 4 |
| Hanna, H | 1 |
| Kontoyiannis, D | 1 |
| Raad, I | 3 |
| Kersun, LS | 1 |
| Reilly, AF | 1 |
| Ingram, ME | 1 |
| Nicholaou, MJ | 1 |
| McGowan, KL | 1 |
| Masoud, M | 1 |
| Nasser, NJ | 1 |
| Karban, A | 1 |
| Edelstein, S | 1 |
| Oz, Y | 1 |
| Akşit, F | 1 |
| Kiraz, N | 2 |
| Kiremitçi, A | 1 |
| Ruthazer, R | 1 |
| Lichtenberg, D | 1 |
| Chawla, V | 1 |
| Young, J | 1 |
| Claudino, AL | 1 |
| Peixoto, RF | 1 |
| Melhem, MS | 1 |
| Chavasco, JK | 1 |
| Franco, MC | 1 |
| Carter, JE | 1 |
| Laurini, JA | 1 |
| Evans, TN | 1 |
| Estrada, B | 1 |
| Liu, TT | 1 |
| Huang, CT | 1 |
| Leu, HS | 1 |
| Nakajima, R | 1 |
| Kitamura, A | 1 |
| Someya, K | 1 |
| Tanaka, M | 1 |
| Sato, K | 1 |
| Castiglia, M | 1 |
| Fisher, MA | 3 |
| Jafari, HS | 1 |
| Severien, C | 1 |
| Parras, F | 1 |
| Friedland, I | 1 |
| Rinderknecht, S | 1 |
| Ehrett, S | 1 |
| Olsen, KD | 1 |
| Abramowsky, C | 1 |
| McCracken, GH | 1 |
| Mudad, R | 1 |
| Vredenburgh, J | 1 |
| Paulson, EK | 1 |
| Ross, M | 1 |
| Meisenberg, B | 1 |
| Hussein, A | 1 |
| Peters, WP | 1 |
| Arning, M | 1 |
| Aul, C | 1 |
| Montenegro, J | 1 |
| Aguirre, R | 1 |
| González, O | 1 |
| Martinez, I | 1 |
| Saracho, R | 1 |
| Ansari, SH | 1 |
| Levin, MH | 1 |
| Lipshitz, S | 1 |
| Härtl, A | 1 |
| Hillesheim, HG | 1 |
| Künkel, W | 1 |
| Schrinner, EJ | 1 |
| Kunová, A | 3 |
| Dluholucký, S | 1 |
| Galová, G | 1 |
| Barbaro, G | 5 |
| Barbarini, G | 4 |
| Di Lorenzo, G | 5 |
| Atkinson, BA | 2 |
| Bouthet, C | 1 |
| Correa, A | 3 |
| Luther, MF | 5 |
| Kamitsuka, MD | 1 |
| Nugent, NA | 1 |
| Conrad, PD | 1 |
| Swanson, TN | 1 |
| Just-Nübling, G | 3 |
| Meunier, F | 4 |
| Oldfield, EC | 1 |
| López Onrubia, P | 1 |
| Bastida Vilá, MT | 1 |
| Martínez Martínez, JA | 1 |
| Ribas Montfort, J | 1 |
| Jové Vidal, N | 1 |
| Scholz, J | 1 |
| Schulz, M | 1 |
| Steinfath, M | 1 |
| Höver, S | 1 |
| Bause, H | 1 |
| Perry, CM | 1 |
| Whittington, R | 1 |
| McTavish, D | 1 |
| Struijk, DG | 1 |
| Boeschoten, EW | 1 |
| Krediet, RT | 1 |
| Genet, P | 1 |
| Pulik, M | 1 |
| Lionnet, F | 1 |
| Petitdidier, C | 1 |
| Touahri, T | 1 |
| De Jonghe, B | 2 |
| Kalya, AV | 1 |
| Ahearn, DG | 1 |
| Hitchcock, RJ | 1 |
| Pallett, A | 1 |
| Hall, MA | 1 |
| Malone, PS | 1 |
| Coppola, S | 1 |
| Angarano, G | 1 |
| Congedo, P | 1 |
| Monno, L | 1 |
| Bellisario, A | 1 |
| Pastore, G | 1 |
| McCann, J | 1 |
| Yoshikawa, K | 1 |
| Maezawa, H | 1 |
| Shindou, N | 1 |
| Sakamoto, M | 1 |
| Nakazawa, Y | 1 |
| Shiba, K | 1 |
| Saito, A | 2 |
| Sakai, O | 1 |
| Barry, AL | 4 |
| Nelson, PW | 2 |
| Webb, CD | 1 |
| Hidalgo, M | 1 |
| Ridríguez-Tudela, JL | 1 |
| Luttrull, JK | 1 |
| Wan, WL | 1 |
| Kubak, BM | 1 |
| Smith, MD | 1 |
| Oster, HA | 1 |
| Force, RW | 1 |
| Nahata, MC | 1 |
| Vincent, F | 1 |
| Bensousan, TA | 1 |
| Leclercq, B | 1 |
| Goff, DA | 1 |
| Koletar, SL | 1 |
| Buesching, WJ | 1 |
| Barnishan, J | 1 |
| Fass, RJ | 1 |
| Kung, N | 1 |
| Fisher, N | 1 |
| Gunson, B | 1 |
| Hastings, M | 1 |
| Mutimer, D | 1 |
| Iwen, PC | 1 |
| Kelly, DM | 1 |
| Reed, EC | 1 |
| Hinrichs, SH | 1 |
| Waltzing-Koudine, L | 1 |
| Breville, P | 1 |
| Rajzbaum, G | 1 |
| Waltzing, P | 1 |
| Fujita, H | 1 |
| Masuda, H | 1 |
| Nakajima, T | 1 |
| Nakae, T | 1 |
| Narita, Y | 1 |
| Yada, K | 1 |
| Watanabe, M | 3 |
| Kagitani, Y | 1 |
| Akler, ME | 1 |
| Vellend, H | 1 |
| McNeely, DM | 1 |
| Walmsley, SL | 1 |
| Gold, WL | 1 |
| Osborne, B | 1 |
| Adams, R | 1 |
| Levenstein, MJ | 1 |
| Schoch, HG | 2 |
| Feldman, AR | 1 |
| Meyers, JD | 1 |
| Bowden, RA | 5 |
| Xie, W | 1 |
| Israel, L | 1 |
| Sadigh, M | 1 |
| Holmberg, JD | 2 |
| Park, SS | 1 |
| D'Amico, DJ | 1 |
| Paton, B | 1 |
| Baker, AS | 1 |
| Sugar, AM | 8 |
| Hitchcock, CA | 2 |
| Troke, PF | 5 |
| Picard, M | 1 |
| Karyotakis, NC | 3 |
| Dignani, MC | 3 |
| White, A | 1 |
| Goetz, MB | 1 |
| Waites, KB | 1 |
| Marr, B | 1 |
| Gross, S | 1 |
| Cunningham, C | 1 |
| Weiner, L | 1 |
| Powderly, WG | 2 |
| Enríquez, A | 1 |
| Sewell, DL | 1 |
| Gearhart, MO | 1 |
| Baltch, AL | 1 |
| Smith, RP | 1 |
| Franke, MA | 1 |
| Ritz, WJ | 1 |
| Singh, JK | 1 |
| Gordon, MA | 1 |
| Simşek, U | 1 |
| Akinci, H | 1 |
| Oktay, B | 1 |
| Kavrama, I | 1 |
| Ozyurt, M | 1 |
| Imbert-Bernard, C | 1 |
| Bastide, JM | 4 |
| Montalvo, JA | 1 |
| Montaner, A | 1 |
| Torino, JR | 1 |
| Ribó, JM | 1 |
| Morales, L | 1 |
| Prignet, JM | 1 |
| Galzin, M | 1 |
| Demarquay, JF | 1 |
| Raynard, B | 1 |
| Louvety, S | 1 |
| Künkel, D | 1 |
| de Pauw, BE | 5 |
| Raemaekers, JM | 1 |
| Sow, PS | 1 |
| Diop, BM | 1 |
| Ndiaye, I | 1 |
| Faye, MA | 1 |
| Coll-Seck, AM | 1 |
| Labenne, M | 1 |
| Benkerrou, M | 1 |
| Hambourg, M | 1 |
| Boccanera, M | 2 |
| Weintrub, PS | 1 |
| Chapman, A | 1 |
| Piecuch, R | 1 |
| Cofsky, RD | 1 |
| Tang, CM | 1 |
| Crook, DW | 1 |
| Bart-Delabesse, E | 1 |
| Boiron, P | 1 |
| Carlotti, A | 1 |
| Wilcox, CM | 3 |
| Ellis, ME | 2 |
| Qadri, SM | 1 |
| Spence, D | 2 |
| Halim, MA | 1 |
| Ernst, P | 2 |
| Clink, H | 1 |
| Baillie, F | 1 |
| De Vol, EB | 1 |
| van der Horst, CM | 1 |
| Dine, AP | 1 |
| Sangeorzan, JA | 1 |
| Bradley, SF | 2 |
| He, X | 2 |
| Zarins, LT | 2 |
| Ridenour, GL | 1 |
| Tiballi, RN | 2 |
| Wingard, JR | 7 |
| Nishida, T | 1 |
| Mayumi, H | 1 |
| Kawachi, Y | 1 |
| Tokunaga, S | 1 |
| Maruyama, Y | 1 |
| Nakashima, A | 1 |
| Yasui, H | 1 |
| Tokunaga, K | 1 |
| Agresti, MG | 1 |
| Mondello, F | 2 |
| Bellocco, R | 1 |
| Carosi, GP | 1 |
| Caputo, RM | 1 |
| Milazzo, F | 1 |
| Chiodo, F | 1 |
| Giannini, V | 1 |
| Minoli, L | 1 |
| Angus, B | 1 |
| Gintautas, J | 1 |
| Duvalsaint, F | 1 |
| Abadir, AR | 1 |
| Chubachi, A | 2 |
| Miura, I | 2 |
| Ohshima, A | 2 |
| Nishinari, T | 1 |
| Nimura, T | 2 |
| Niitsu, H | 2 |
| Miura, AB | 2 |
| Takamoto, M | 1 |
| Ishibashi, T | 2 |
| Shinoda, A | 1 |
| Nakanishi, Y | 1 |
| Nomoto, K | 1 |
| Miyahara, T | 1 |
| Oizumi, K | 1 |
| Ichikawa, Y | 1 |
| Corzo Delgado, JE | 1 |
| Lozano de León, F | 1 |
| Aretio Najarro, R | 1 |
| Martín Mazuelos, E | 1 |
| Chung, YM | 1 |
| Lin, JC | 1 |
| Liu, JH | 1 |
| Zadok, D | 1 |
| Karpuch, J | 1 |
| Katayama, K | 1 |
| Koizumi, S | 2 |
| Yamagami, M | 1 |
| Tamaru, Y | 1 |
| Ichihara, T | 1 |
| Konishi, M | 1 |
| Maekawa, S | 1 |
| Seki, H | 2 |
| Taniguchi, N | 2 |
| Paetznick, V | 1 |
| Cabrera, F | 1 |
| Arilla, MC | 1 |
| Burgos, A | 1 |
| Ortiz-Vigón, R | 1 |
| Cañón, JL | 1 |
| Krídl, J | 1 |
| Danisovicová, A | 1 |
| Priel, I | 1 |
| Dubé, MP | 1 |
| Heseltine, PN | 1 |
| Evans, S | 1 |
| Zawacki, B | 1 |
| Vuffray, A | 1 |
| Durussel, C | 2 |
| Boerlin, P | 1 |
| Boerlin-Petzold, F | 1 |
| Chave, JP | 4 |
| Fasano, C | 2 |
| O'Keeffe, J | 2 |
| Gibbs, D | 2 |
| Presterl, E | 3 |
| Graninger, W | 3 |
| Laine, L | 4 |
| Michel, C | 1 |
| Courdavault, L | 1 |
| al Khayat, R | 1 |
| Viron, B | 1 |
| Roux, P | 1 |
| Mignon, F | 1 |
| di Francesco, P | 1 |
| Gaziano, R | 1 |
| Casalinuovo, IA | 1 |
| Belogi, L | 1 |
| Favalli, C | 1 |
| Garaci, E | 1 |
| Baily, GG | 4 |
| Perry, FM | 1 |
| Mandal, BK | 1 |
| Menezes, AV | 1 |
| Sigesmund, DA | 1 |
| Demajo, WA | 1 |
| Devenyi, RG | 1 |
| Huang, TC | 1 |
| Chung, WK | 1 |
| Vitt, CR | 1 |
| Fidler, JM | 1 |
| Ando, D | 1 |
| Zimmerman, RJ | 1 |
| Aukerman, SL | 1 |
| Parente, F | 1 |
| Ardizzone, S | 1 |
| Antinori, S | 1 |
| Moroni, M | 1 |
| Lazzarin, A | 1 |
| Bianchi Porro, G | 1 |
| van Etten, EW | 2 |
| van den Heuvel-de Groot, C | 1 |
| Bakker-Woudenberg, IA | 2 |
| Sarmiento, R | 1 |
| Holubka, J | 1 |
| Khatib, R | 3 |
| Martinez-Suarez, JV | 1 |
| Thakur, RK | 1 |
| Skelcy, KM | 1 |
| Kahn, RN | 1 |
| Cannon, L | 1 |
| Cherukuri, R | 1 |
| Thevenot, T | 1 |
| Colardelle, P | 1 |
| Chochon, M | 1 |
| Andrieu, J | 1 |
| van Belkum, A | 1 |
| Melchers, W | 1 |
| Scherer, S | 1 |
| Quint, W | 1 |
| Zahid, MA | 1 |
| Klotz, SA | 1 |
| Hinthorn, DR | 1 |
| Gatny, CM | 1 |
| Ishikawa, Y | 1 |
| Shimizu, T | 1 |
| Sakiyama, Y | 1 |
| Hatae, Y | 1 |
| Takeda, T | 1 |
| Ishikawa, A | 1 |
| Takase, A | 1 |
| Wagatsuma, Y | 1 |
| Sato, Y | 2 |
| Iwata, S | 1 |
| Akita, H | 1 |
| Sunakawa, K | 1 |
| Seno, A | 1 |
| Sakazume, S | 1 |
| Shinoda, K | 1 |
| Shintani, N | 1 |
| Wada, T | 1 |
| Wada, H | 1 |
| Horita, S | 1 |
| Kamiya, H | 2 |
| Ihara, T | 1 |
| Yasuda, N | 1 |
| Sakurai, M | 2 |
| Azuma, E | 1 |
| Ido, M | 1 |
| Nakano, T | 1 |
| Wakiguchi, H | 1 |
| Hisakawa, H | 1 |
| Sinohara, M | 1 |
| Watanabe, S | 1 |
| Okada, T | 1 |
| Misaki, Y | 1 |
| Tomoda, T | 1 |
| Morita, H | 1 |
| Kurashige, T | 1 |
| Sugita, K | 1 |
| Miyake, M | 1 |
| Takitani, K | 1 |
| Murata, T | 2 |
| Nishimura, T | 1 |
| Aoki, S | 2 |
| Troillet, N | 1 |
| Alter, SJ | 1 |
| Farley, J | 1 |
| Morris, SA | 1 |
| Bailey, CJ | 1 |
| Cartledge, JM | 1 |
| Martino, R | 1 |
| Nomdedéu, J | 1 |
| Altés, A | 1 |
| Sureda, A | 1 |
| Brunet, S | 1 |
| Martínez, C | 2 |
| Domingo-Albós, A | 1 |
| Cancelas, JA | 1 |
| Lopez, J | 2 |
| Cabezudo, E | 2 |
| Navas, E | 3 |
| Garcia Laraña, J | 1 |
| Jimenez Mena, M | 1 |
| Diz, P | 2 |
| Perez de Oteyza, J | 1 |
| Villalon, L | 1 |
| Townsend, DJ | 1 |
| Singer, DI | 1 |
| Doyle, JR | 1 |
| Kliasova, GA | 1 |
| Akiyama, H | 1 |
| Sakamaki, H | 2 |
| Onozawa, Y | 1 |
| Pavia, AT | 1 |
| Riley, DK | 1 |
| Borne, MJ | 1 |
| Elliott, JH | 1 |
| O'Day, DM | 2 |
| Flynn, PM | 1 |
| Marina, NM | 1 |
| Rivera, GK | 1 |
| Hughes, WT | 1 |
| Samonis, G | 3 |
| Reed, PA | 1 |
| Girgis, RM | 1 |
| Ashok, PS | 1 |
| Ravi, J | 1 |
| Agrawal, RM | 1 |
| Brodmerkel, GJ | 1 |
| Miller, CB | 1 |
| Karp, JE | 2 |
| Saral, R | 2 |
| Pye, GW | 1 |
| Witt, MD | 3 |
| Imhoff, T | 1 |
| van der Bijl, P | 1 |
| Arendorf, TM | 1 |
| Johnson, JR | 2 |
| Swerdloff, JN | 1 |
| Guex-Crosier, Y | 2 |
| Herbort, CP | 1 |
| Bjørneklett, A | 1 |
| Maeland, A | 1 |
| Nomura, J | 1 |
| Ruskin, J | 1 |
| Zweegman, S | 1 |
| Sibinga, L | 1 |
| Huijgens, PC | 1 |
| Epelbaum, S | 1 |
| Laurent, C | 1 |
| Morin, G | 1 |
| Berquin, P | 1 |
| Piussan, C | 1 |
| Nassoura, Z | 1 |
| Ivatury, RR | 1 |
| Simon, RJ | 1 |
| Jabbour, N | 1 |
| Stahl, WM | 1 |
| Erbslöh-Möller, B | 1 |
| Steinhoff, J | 1 |
| Sack, K | 1 |
| Ponnuvel, KM | 1 |
| Rama, CP | 1 |
| Ong, ST | 1 |
| Kueh, YK | 1 |
| Neely, D | 1 |
| Pohjavuori, M | 2 |
| Barbara, JA | 1 |
| Clarkson, AR | 1 |
| LaBrooy, J | 1 |
| McNeil, JD | 1 |
| Woodroffe, AJ | 1 |
| Oleinik, EM | 1 |
| Hoch, BS | 1 |
| Namboodiri, NK | 1 |
| Banayat, G | 1 |
| Neiderman, G | 1 |
| Louis, BM | 1 |
| Manohar, NL | 1 |
| Lipner, HI | 1 |
| Tunkel, AR | 1 |
| Thomas, CY | 1 |
| Wispelwey, B | 1 |
| Jiménez-Mejías, ME | 2 |
| Moreno-Maqueda, I | 2 |
| Regordan, C | 1 |
| Artola-Igarza, JL | 1 |
| Holgado, S | 1 |
| Luna, JD | 1 |
| Juárez, CP | 1 |
| Vorreuther, R | 1 |
| Kuss, M | 1 |
| Franzen, W | 1 |
| Engelking, R | 1 |
| Altenburg, A | 1 |
| Tang, C | 1 |
| Ocampo, A | 2 |
| Miralles, C | 1 |
| Otero, I | 1 |
| Iglesias, I | 1 |
| Legg, JJ | 1 |
| Brossier, KA | 1 |
| Goldschmidt, RH | 1 |
| Thio, CL | 1 |
| Rutledge, TM | 1 |
| Ng, TT | 1 |
| Presteril, E | 1 |
| Schneeweiss, B | 1 |
| Teleky, B | 1 |
| Georgopoulos, A | 1 |
| Sanguineti, A | 1 |
| Carmichael, JK | 1 |
| Campbell, K | 1 |
| Akiba, Y | 1 |
| Osanai, S | 1 |
| Nakano, H | 1 |
| Matsumoto, H | 1 |
| Onodera, S | 1 |
| Czerwiec, FS | 1 |
| Bilsker, MS | 1 |
| Kamerman, ML | 1 |
| Bisno, AL | 1 |
| Füssle, R | 1 |
| Sziegoleit, A | 1 |
| Hoogkamp-Korstanje, JA | 2 |
| Ben Hamida, M | 1 |
| Bedrossian, J | 1 |
| Pruna, A | 1 |
| Fouqueray, B | 1 |
| Metivier, F | 1 |
| Idatte, JM | 1 |
| Lee, SH | 1 |
| Chiang, SS | 1 |
| Hseih, SJ | 1 |
| Shen, HM | 1 |
| Virtanen, M | 1 |
| Carlson, P | 1 |
| Vaara, M | 1 |
| Peltola, H | 1 |
| Aust, R | 1 |
| Kruse, FE | 1 |
| Wildfeuer, A | 3 |
| Pfaff, G | 1 |
| Rohrschneider, K | 1 |
| Völcker, HE | 1 |
| Luther, M | 1 |
| Essayag, SM | 2 |
| Burnie, JP | 2 |
| Braegger, CP | 1 |
| Albisetti, M | 1 |
| Nadal, D | 1 |
| Rabeneck, L | 1 |
| Hof, H | 2 |
| Kretschmar, M | 2 |
| Wells, CJ | 1 |
| Leech, GJ | 1 |
| Lever, AM | 1 |
| Wansbrough-Jones, MH | 1 |
| Pujol, F | 1 |
| Angirekula, M | 1 |
| Weiner, M | 1 |
| Jindrak, K | 1 |
| Pachter, BR | 1 |
| Scott, EM | 1 |
| Tariq, VN | 1 |
| McCrory, RM | 1 |
| Haslett, RS | 1 |
| Moriarty, AP | 1 |
| Vijayadurai, P | 1 |
| McGalliard, JN | 1 |
| Chandna, A | 1 |
| Fan-Havard, P | 1 |
| O'Donovan, C | 1 |
| Smith, SM | 1 |
| Oh, J | 1 |
| Bamberger, M | 1 |
| Eng, RH | 1 |
| Serody, J | 1 |
| Balcerska, A | 1 |
| Drozyńska, E | 1 |
| Stefanowicz, J | 1 |
| Bień, E | 1 |
| Szutowicz, E | 1 |
| Czarniak, P | 1 |
| Rösler-Meier, D | 1 |
| Brunner-La Rocca, HP | 1 |
| Senn, P | 1 |
| Schlumpf, U | 1 |
| Jahnson, L | 1 |
| Chryssanthou, E | 2 |
| Petrini, B | 2 |
| Vikerfors, T | 1 |
| Keiser, G | 1 |
| Schmid, M | 1 |
| Ishak, KG | 1 |
| Wirth, W | 1 |
| Vogt, M | 1 |
| Peacock, JE | 1 |
| Tanner, DC | 1 |
| Nguyen, ML | 2 |
| Wagener, MM | 1 |
| Cormican, MG | 1 |
| Stary, A | 1 |
| Soeltz-Szoets, J | 1 |
| Ziegler, C | 1 |
| Kinghorn, GR | 2 |
| Roy, RB | 1 |
| Ganatra, JV | 1 |
| Bostwick, HE | 1 |
| Medow, MS | 1 |
| Beneck, D | 1 |
| Berezin, S | 1 |
| Goldie, SJ | 1 |
| Kiernan-Tridle, L | 1 |
| Torres, C | 1 |
| Gorban-Brennan, N | 1 |
| Dunne, D | 1 |
| Kliger, AS | 1 |
| Finkelstein, FO | 1 |
| Gonzalez, C | 1 |
| Lyman, CA | 4 |
| Chanock, SJ | 1 |
| Pizzo, PA | 3 |
| Uzun, O | 5 |
| Arranz-Caso, JA | 1 |
| Lopez-Pizarro, VM | 1 |
| Gomez-Herruz, P | 1 |
| García-Altozano, J | 1 |
| Martinez-Martinez, J | 1 |
| Medoff, G | 1 |
| Le Guennec, R | 1 |
| Rodriguez, E | 1 |
| Liang, D | 1 |
| Xu, N | 1 |
| Thompson, L | 2 |
| Pino, M | 1 |
| Castrillón, MA | 1 |
| Schenone, D | 1 |
| del Canto, E | 1 |
| van 't Wout, JW | 2 |
| Still, JM | 1 |
| Belcher, K | 1 |
| Law, EJ | 1 |
| Rhine-Chalberg, J | 1 |
| Vartivarian, SE | 1 |
| Abi-Said, D | 3 |
| Pinczowski, H | 1 |
| Khoury, P | 1 |
| Papadakis, K | 1 |
| Gardner, A | 1 |
| Gilbreath, J | 1 |
| Eichel, M | 1 |
| Helm, EB | 1 |
| Stille, W | 1 |
| Laufen, H | 2 |
| Yeates, RA | 2 |
| Zimmermann, T | 2 |
| Péter, Z | 1 |
| Horváth, Z | 1 |
| Makara, M | 1 |
| Telegdy, L | 1 |
| Zala, J | 1 |
| Zágoni, T | 1 |
| Cuervas-Mons, V | 1 |
| Jara, P | 1 |
| Turrión, VS | 1 |
| Barrios, C | 1 |
| Moreno, E | 1 |
| Noriega, AR | 1 |
| Panda, A | 1 |
| Angra, SK | 1 |
| Berrouane, YF | 2 |
| Chemlal, K | 1 |
| Saint-Julien, L | 1 |
| Joly, V | 3 |
| Farinotti, R | 1 |
| Seta, N | 1 |
| Yeni, P | 2 |
| Carbon, C | 3 |
| Klingspor, L | 1 |
| Stintzing, G | 1 |
| Fasth, A | 1 |
| Tollemar, J | 1 |
| Bourée, P | 1 |
| Hiesse, C | 1 |
| Charpentier, B | 1 |
| Jacobs, LG | 1 |
| Skidmore, EA | 1 |
| Freeman, K | 1 |
| Lipschultz, D | 1 |
| Fox, N | 1 |
| Bevilacqua, N | 1 |
| Federico, G | 1 |
| Tacconelli, E | 1 |
| Niazi, ZB | 1 |
| Salzberg, CA | 1 |
| Montecalvo, M | 1 |
| Kim, E | 1 |
| McMahon, D | 1 |
| Keys, TF | 1 |
| Amidi, M | 1 |
| Barnes, AJ | 1 |
| Wardley, AM | 1 |
| Oppenheim, BA | 1 |
| Morgenstern, GR | 1 |
| Scarffe, JH | 1 |
| Benedetti, E | 1 |
| Gruessner, AC | 1 |
| Troppmann, C | 1 |
| Papalois, BE | 1 |
| Sutherland, DE | 1 |
| Dunn, DL | 1 |
| Gruessner, RW | 1 |
| Bartlett, ST | 1 |
| Oliver, SE | 1 |
| Walker, RJ | 1 |
| Woods, DJ | 1 |
| Martins, MD | 1 |
| Rabalais, GP | 1 |
| Samiec, TD | 1 |
| Bryant, KK | 1 |
| Lewis, JJ | 1 |
| Friedland, IR | 1 |
| Tebbe, B | 1 |
| Boyvat, A | 1 |
| Geilen, CC | 1 |
| Wölfer, LU | 1 |
| Seibold, M | 2 |
| Orfanos, CE | 1 |
| Wardle, HM | 1 |
| Law, D | 2 |
| Gürses, N | 1 |
| Kalayci, AG | 1 |
| Le, TP | 1 |
| Tuazon, CU | 1 |
| Levine, M | 1 |
| Borum, M | 1 |
| Rollhauser, C | 1 |
| Bode, CP | 1 |
| Koletzko, S | 1 |
| Lübke, H | 1 |
| Wahn, V | 1 |
| Hata, K | 2 |
| Kimura, J | 2 |
| Miki, H | 2 |
| Toyosawa, T | 2 |
| Katsu, K | 2 |
| Moriyama, M | 1 |
| Melville, C | 2 |
| Kempley, S | 1 |
| Graham, J | 1 |
| Berry, CL | 1 |
| Calderon, W | 1 |
| Grisorio, B | 1 |
| Alcini, P | 1 |
| Nichterlein, T | 1 |
| Kuntz, P | 1 |
| Thadepalli, H | 1 |
| Gollapudi, S | 1 |
| Mera, J | 1 |
| Williams, T | 1 |
| Karl, CL | 1 |
| James, P | 1 |
| McAtee, RK | 3 |
| Taylor, CB | 1 |
| Finlay, R | 1 |
| Richardson, C | 1 |
| Bunting, P | 1 |
| Welch, J | 1 |
| Lamb, DC | 2 |
| Loeffler, J | 1 |
| Einsele, H | 3 |
| Vassallo, J | 1 |
| Galizia, AC | 1 |
| Cuschieri, P | 1 |
| Sweeney, JF | 1 |
| Greene, JN | 1 |
| Hiemenz, JW | 1 |
| Wei, S | 1 |
| Rosemurgy, AS | 1 |
| Djeu, JY | 1 |
| Alexander, LN | 1 |
| Clark, WS | 1 |
| Thompson, SE | 1 |
| Barson, WJ | 1 |
| Marcon, MJ | 1 |
| Christmas, NJ | 1 |
| Smiddy, WE | 1 |
| Yotsuji, A | 1 |
| Shimizu, K | 1 |
| Araki, H | 1 |
| Fujimaki, K | 1 |
| Nishida, N | 1 |
| Hori, R | 1 |
| Annen, N | 1 |
| Hayakawa, H | 1 |
| Imaizumi, H | 1 |
| Watanbe, Y | 1 |
| Nolte, FS | 1 |
| Parkinson, T | 2 |
| Falconer, DJ | 2 |
| Dix, S | 1 |
| Williams, J | 1 |
| Gilmore, C | 1 |
| Geller, R | 1 |
| Greer, W | 1 |
| Papalambrou, D | 1 |
| Soremi, S | 1 |
| Legakis, NJ | 1 |
| Barantsevich, EP | 1 |
| Antonov, VV | 1 |
| Nizamutdinova, AS | 1 |
| Shapiro, BD | 1 |
| Ehrenpreis, ED | 1 |
| Tomaka, FL | 1 |
| Bonner, GF | 1 |
| Secrest, KM | 1 |
| Cheney, LM | 1 |
| Bregenzer, T | 1 |
| Evison-Eckstein, AC | 1 |
| Frei, R | 1 |
| Zimmerli, W | 1 |
| Voss, A | 3 |
| Kluytmans, JA | 1 |
| Koeleman, JG | 1 |
| Spanjaard, L | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Verbrugh, HA | 1 |
| Vos, MC | 1 |
| Weersink, AY | 1 |
| Kernbaum, S | 1 |
| Chiche, R | 1 |
| Desgrez, JP | 1 |
| Le Goaziou, F | 1 |
| Le Houelleur, J | 1 |
| Martínez-Marcos, FJ | 1 |
| Caballero-Granado, J | 1 |
| Rodríguez-Hernández, MJ | 1 |
| Pachón-Díaz, J | 1 |
| Nolla-Salas, J | 2 |
| Sitges-Serra, A | 2 |
| León-Gil, C | 1 |
| Martínez-González, J | 1 |
| León-Regidor, MA | 1 |
| Ibáñez-Lucía, P | 1 |
| Torres-Rodríguez, JM | 2 |
| Orikasa, Y | 1 |
| Inouye, S | 1 |
| Kondo, S | 1 |
| Takeuchi, T | 1 |
| al Soub, H | 1 |
| Estinoso, W | 1 |
| Calvet, HM | 1 |
| Narang, A | 1 |
| Agrawal, P | 1 |
| Chakraborti, A | 1 |
| Kapur, A | 1 |
| Vasudeva, R | 1 |
| Howden, CW | 1 |
| Galgiani, JN | 1 |
| Bartlett, MS | 1 |
| Lancaster, M | 1 |
| López-Jiménez, J | 1 |
| Duarte-Palomino, R | 1 |
| Velasco-Martínez, JJ | 1 |
| Sousa, A | 1 |
| Odriozola, J | 1 |
| Merchant, RH | 1 |
| Sanghvi, KP | 1 |
| Sridhar, N | 1 |
| Sonigara, S | 1 |
| Mehta, KP | 1 |
| Joshi, NC | 1 |
| Kuştimur, S | 1 |
| Memiş, L | 1 |
| Kilinç, M | 1 |
| Ercan, ZS | 1 |
| Michalopoulos, A | 1 |
| Kriaras, J | 1 |
| Wong, VK | 1 |
| Tasman, W | 1 |
| Eagle, RC | 1 |
| Rodriguez, A | 1 |
| McDonald, JA | 1 |
| Saulsbury, FT | 1 |
| Finkelstein, DM | 2 |
| Schoenfeld, DA | 2 |
| Stamenovic, E | 1 |
| Hebart, H | 2 |
| Roller, G | 1 |
| Löffler, J | 2 |
| Rothenhofer, I | 1 |
| Müller, CA | 1 |
| van Burik, J | 1 |
| Engelhard, D | 2 |
| Kanz, L | 1 |
| Schumacher, U | 2 |
| Sanati, H | 2 |
| Ramos, CF | 1 |
| Nilsen, K | 1 |
| Tjade, T | 1 |
| Lassen, J | 1 |
| Hood, SV | 1 |
| Fortún, J | 2 |
| López-San Román, A | 2 |
| Velasco, JJ | 1 |
| de Vicente, E | 2 |
| Nuño, J | 2 |
| Quereda, C | 2 |
| Bárcena, R | 2 |
| Monge, G | 1 |
| Candela, A | 1 |
| Honrubia, A | 2 |
| Guerrero, A | 1 |
| Baud, O | 1 |
| Boithias, C | 1 |
| Lacaze-Masmonteil, T | 1 |
| Ville, Y | 1 |
| Guibert, M | 1 |
| Zupan, V | 1 |
| Chabernaud, JL | 1 |
| André, P | 1 |
| Nordmann, P | 1 |
| Frydman, R | 1 |
| Dehan, M | 1 |
| Filipowicz, J | 1 |
| Kozłowski, M | 1 |
| Irga, N | 1 |
| Szalewska, M | 1 |
| Zurowska, A | 1 |
| Slusarczyk, M | 1 |
| Anaissie, E | 2 |
| Pinzcowski, H | 1 |
| Vartivarian, S | 1 |
| White, MH | 1 |
| Piemonte, P | 1 |
| Conte, G | 1 |
| Flores, C | 1 |
| Barahona, O | 1 |
| Araos, D | 1 |
| Alfaro, J | 1 |
| Fardella, P | 1 |
| Schröder, G | 1 |
| Schulz, K | 1 |
| Blaschke-Hellmessen, R | 2 |
| Schmidt-Westhausen, A | 1 |
| Trautmann, M | 2 |
| Pittrow, L | 11 |
| Penk, A | 12 |
| Cenci, E | 3 |
| Mencacci, A | 3 |
| Del Sero, G | 2 |
| Romani, L | 3 |
| Moskovitz, BL | 1 |
| Mallegol, I | 1 |
| Fidel, PL | 2 |
| Shafran, S | 2 |
| Garber, G | 2 |
| Smaill, F | 2 |
| Fong, I | 1 |
| Salit, I | 2 |
| Miller, M | 2 |
| Williams, K | 2 |
| Conly, JM | 1 |
| Singer, J | 2 |
| Ioannou, S | 3 |
| Márquez de Prado Urquia, M | 1 |
| Mosquera Lozano, JD | 1 |
| Sánchez Haya, E | 1 |
| Puente Martínez, A | 1 |
| Moore, CB | 5 |
| de Wit, S | 2 |
| Fukasawa, N | 1 |
| Shirakura, K | 1 |
| Lejko-Zupanc, T | 1 |
| Kozelj, M | 1 |
| Lai, PH | 1 |
| Lin, SM | 1 |
| Pan, HB | 1 |
| Yang, CF | 1 |
| Manabe, A | 1 |
| Ebihara, Y | 1 |
| Hosoya, R | 1 |
| Casado, JL | 1 |
| Oliva, J | 1 |
| Pintado, V | 4 |
| Cobo, J | 1 |
| Corral, I | 1 |
| Di Francesco, LF | 1 |
| Compagnucci, P | 1 |
| Batura-Gabryel, H | 1 |
| Wieczorek, U | 1 |
| Mlynarczyk, W | 1 |
| André, N | 1 |
| Millet, V | 1 |
| Bartoli, JM | 1 |
| Lacroze, V | 1 |
| Unal, D | 1 |
| Schwab, U | 1 |
| Chernomas, F | 1 |
| Larcom, L | 1 |
| Weems, J | 1 |
| Carrega, G | 1 |
| Riccio, G | 1 |
| Santoriello, L | 1 |
| Pasqualini, M | 1 |
| Pellicci, R | 1 |
| Wang, JN | 1 |
| Liu, CC | 1 |
| Huang, TZ | 1 |
| Huang, SS | 1 |
| Wu, JM | 1 |
| Safran, DB | 1 |
| Dawson, E | 1 |
| Liu, XP | 1 |
| Chen, RJ | 1 |
| Ener, B | 1 |
| Tarim, O | 1 |
| Kiliç, S | 1 |
| Tanritanir, A | 1 |
| Ildirim, I | 1 |
| Bronstein, JA | 1 |
| Gros, P | 1 |
| Hernandez, E | 1 |
| Larroque, P | 1 |
| Molinié, C | 1 |
| Driessen, M | 1 |
| Ellis, JB | 1 |
| Muwazi, F | 1 |
| De Villiers, FP | 1 |
| Burgaleta, C | 1 |
| Fortun Abete, J | 1 |
| Berenguer Berenguer, J | 1 |
| Castin, A | 1 |
| Moskovitz, B | 1 |
| Srugo, I | 2 |
| Nativ, O | 1 |
| Lozano-Chiu, M | 2 |
| Marco, F | 1 |
| Faucher, JF | 1 |
| Thiébaut, MM | 1 |
| Janbon, F | 1 |
| Cushing, RD | 1 |
| Fulgenzi, WR | 1 |
| Flanagan, PG | 1 |
| Barnes, RA | 1 |
| Just-Nuebling, G | 1 |
| Kurz, M | 1 |
| Mueller, C | 1 |
| Nowak-Goettl, U | 1 |
| Shah, PM | 1 |
| Kornhuber, B | 1 |
| Schuler, US | 1 |
| Haag, C | 1 |
| Schmalreck, AF | 1 |
| Duswald, KH | 2 |
| Muñoz García de Paredes, P | 1 |
| Cobo Reinoso, P | 1 |
| Aguado García, JM | 1 |
| Lumbreras Bermejo, C | 1 |
| Pérez Vela, JL | 1 |
| Caballero Cubedo, R | 1 |
| Sanz Sanz, F | 1 |
| Noriega Rodríguez, AR | 1 |
| Glasmacher, A | 1 |
| Molitor, E | 1 |
| Kuo, MJ | 1 |
| Warfield, AT | 1 |
| Nye, KJ | 1 |
| Crocker, J | 1 |
| Pérez-Gómez, A | 1 |
| Prieto, A | 1 |
| Torresano, M | 1 |
| Díez, E | 1 |
| Mulero, J | 1 |
| Labiano, I | 1 |
| Andreu, JL | 1 |
| Hershman-Sarafov, M | 1 |
| Tubi, O | 1 |
| Bader, D | 1 |
| Laing, RB | 1 |
| Brettle, RP | 1 |
| Leen, CL | 1 |
| Fichtenbaum, CJ | 1 |
| Jenkin, GA | 1 |
| Choo, M | 1 |
| Hosking, P | 1 |
| Johnson, PD | 1 |
| Dib, OP | 1 |
| Lorenz, KJ | 1 |
| Wallner, F | 1 |
| Maier, H | 1 |
| Inoue, Y | 1 |
| Yozu, R | 1 |
| Ueda, T | 1 |
| Kawada, S | 1 |
| Banerjee, P | 2 |
| Liu, QF | 2 |
| Kaw, P | 1 |
| Shayegani, M | 2 |
| Taber, H | 1 |
| Miller, MH | 3 |
| Launay, O | 1 |
| Bouges-Michel, C | 1 |
| Jarrousse, B | 1 |
| Bentata, M | 1 |
| Guillevin, L | 1 |
| Houston, A | 1 |
| Rangel-Frausto, MS | 1 |
| Wiblin, T | 1 |
| Blumberg, HM | 2 |
| Jarvis, W | 1 |
| Martin, MA | 1 |
| Neu, HC | 1 |
| Patterson, JE | 1 |
| Dibb, JC | 1 |
| Roldan, CM | 1 |
| Wenzel, RP | 3 |
| Edmond, MB | 2 |
| Fé d'Ostiani, C | 1 |
| Montagnoli, C | 1 |
| Bacci, A | 2 |
| Beloborodova, NV | 1 |
| Kurchavov, VA | 1 |
| Pozdorovkina, VV | 1 |
| Boĭko, NB | 1 |
| Rogatina, EA | 1 |
| Demina, AM | 1 |
| Schwarze, R | 4 |
| Seebacher, C | 1 |
| Aktug, T | 1 |
| Olguner, M | 1 |
| Akgür, FM | 1 |
| Aldirmaz, C | 1 |
| Hoşgör, M | 1 |
| Fowler, SL | 2 |
| Rhoton, B | 1 |
| Springer, SC | 2 |
| Swails-Wenger, JA | 1 |
| Ainbinder, DJ | 1 |
| Parmley, VC | 1 |
| Mader, TH | 1 |
| Nelson, ML | 1 |
| Wada, M | 1 |
| Baba, H | 1 |
| Imura, S | 1 |
| Doern, GV | 2 |
| Miyazaki, H | 1 |
| Geber, A | 1 |
| Hitchcock, C | 1 |
| Ward, DJ | 1 |
| Marsden, K | 1 |
| Jaraba Caballero, S | 1 |
| Jaraba Caballero, MP | 1 |
| Fernández Gutiérrez, F | 1 |
| Muriel Zafra, I | 1 |
| Huertas Muñoz, MD | 1 |
| Alvarez Marcos, R | 1 |
| Guzmán Cabañas, J | 1 |
| Zapatero Martínez, M | 1 |
| Mahé, C | 1 |
| Karlsson, A | 1 |
| Bolmström, A | 1 |
| Coffman, S | 1 |
| Rennie, R | 1 |
| Sand, C | 1 |
| Heffner, T | 1 |
| Yamane, N | 1 |
| Roel, JE | 1 |
| Gamba, A | 1 |
| Curone, M | 1 |
| Pescio, A | 1 |
| Bruno, C | 1 |
| van Burik, JH | 1 |
| Myerson, D | 1 |
| Hackman, RC | 1 |
| Shulman, HM | 1 |
| Sale, GE | 1 |
| Wenzl, TG | 1 |
| Schefels, J | 1 |
| Hörnchen, H | 1 |
| Skopnik, H | 1 |
| Nozickova, M | 1 |
| Koudelkova, V | 1 |
| Kulikova, Z | 1 |
| Malina, L | 1 |
| Urbanowski, S | 1 |
| Silny, W | 1 |
| Turner, TM | 1 |
| Restrepo, MI | 1 |
| Montalbo, E | 1 |
| Calvo Romero, JM | 1 |
| Alvarez Vega, JL | 1 |
| Salazar Vallinas, JM | 1 |
| Ortega Alberdi, R | 1 |
| Palmer, SM | 1 |
| Howell, DN | 1 |
| Lawrence, CM | 1 |
| Miralles, AP | 1 |
| Davis, RD | 1 |
| Tapson, VF | 1 |
| Rodríguez-Arrondo, F | 1 |
| Aguirrebengoa, K | 2 |
| De Arce, A | 1 |
| Arrizabalaga, J | 1 |
| Iribarren, JA | 1 |
| Von Wichmann, MA | 1 |
| Goenaga, MA | 1 |
| Martínez-Vázquez, C | 1 |
| Fernández-Ulloa, J | 1 |
| Bordón, J | 1 |
| Sopeña, B | 1 |
| de la Fuente, J | 1 |
| Rubianes, M | 1 |
| Barza, M | 1 |
| Fisher, NC | 1 |
| Cooper, MA | 1 |
| Hastings, JG | 1 |
| Mutimer, DJ | 1 |
| Franz, R | 1 |
| Hartmanova, I | 1 |
| Kralinsky, K | 2 |
| Filka, J | 1 |
| Uher, J | 1 |
| Kurak, J | 1 |
| Krizan, S | 1 |
| Flanigan, TP | 1 |
| Klepser, ME | 1 |
| Albukrek, D | 1 |
| Davidson, S | 1 |
| Merlob, P | 1 |
| McCullough, MJ | 1 |
| Araj, GF | 1 |
| Daher, NK | 1 |
| Tabbarah, ZA | 1 |
| Otcenásek, M | 1 |
| Yang, HC | 1 |
| Yazawa, K | 1 |
| Nishimura, K | 1 |
| Miyaji, M | 1 |
| Aoki, FH | 1 |
| Spánik, S | 2 |
| Grausová, S | 2 |
| Krupová, I | 2 |
| Roidová, A | 1 |
| Sálek, T | 1 |
| Sufliarsky, J | 2 |
| Mardiak, J | 2 |
| Alarco, AM | 1 |
| Raymond, M | 1 |
| Herwaldt, LA | 1 |
| Witthuhn, F | 1 |
| Toubas, D | 1 |
| Béguinot, I | 1 |
| Aubert, D | 1 |
| Rouger, C | 1 |
| Remy, G | 1 |
| Pinon, JM | 1 |
| Gee, S | 1 |
| Sullivan, DJ | 3 |
| Coleman, DC | 3 |
| Rössel, P | 1 |
| Nielsen, H | 1 |
| Okogbule-Wonodi, I | 1 |
| Bhat, N | 1 |
| Turner, DL | 1 |
| Johnson, SA | 1 |
| Rule, SA | 1 |
| Clark, MA | 1 |
| Gaunt, T | 1 |
| Czachor, JS | 1 |
| Alva, EM | 1 |
| Khayr, W | 1 |
| Dranitsaris, G | 1 |
| Puodziunas, A | 1 |
| Masiá Canuto, MM | 1 |
| Gutiérrez Rodero, F | 1 |
| Ortiz de la Tabla Ducasse, V | 1 |
| Martín González, C | 1 |
| Escolano Hortelano, CM | 1 |
| Mora Rufete, A | 1 |
| Martín Hidalgo, A | 1 |
| Mateicka, F | 5 |
| Pichnova, E | 1 |
| Grey, E | 2 |
| Sabo, A | 4 |
| Menéndez López, V | 1 |
| Elia López, M | 1 |
| Llorens Martínez, FJ | 1 |
| Galán Llopis, JA | 1 |
| de Nova Sánchez, E | 1 |
| García López, F | 1 |
| Orero, A | 2 |
| Ubeda, P | 2 |
| Pastor, A | 1 |
| Falconi Di Francesco, L | 1 |
| Caselli, F | 1 |
| Gallo, D | 1 |
| Carrillo-Muñoz, A | 1 |
| Perea, S | 1 |
| Francioli, P | 2 |
| Schneider, R | 1 |
| Wu, MM | 1 |
| Chapuis, G | 1 |
| Chiolero, R | 1 |
| Pannatier, A | 1 |
| Schilling, J | 1 |
| Defontaine, A | 1 |
| Declerk, P | 1 |
| Planchenault, C | 1 |
| Hallet, JN | 1 |
| Pavese, P | 1 |
| Brion, JP | 1 |
| Lebeau, B | 1 |
| Grillot, R | 1 |
| Ambroise-Thomas, P | 1 |
| Ayeni, O | 1 |
| Riederer, KM | 1 |
| Wilson, FM | 1 |
| Colović, M | 1 |
| Lazarević, V | 1 |
| Colović, R | 1 |
| Janković, G | 1 |
| Suvajdzić, N | 1 |
| Bogdanović, A | 1 |
| Bila, J | 1 |
| Robinson, LG | 1 |
| Jain, L | 1 |
| Kourtis, AP | 1 |
| van Ogtrop, M | 1 |
| Candelario, M | 1 |
| Bell, A | 1 |
| McMillian, CL | 1 |
| Fringuelli, R | 2 |
| Perito, S | 1 |
| Schiaffella, F | 2 |
| Barluzzi, R | 1 |
| Vecchiarelli, A | 2 |
| Bixel, AS | 1 |
| Tidwell, RR | 1 |
| Boykin, D | 1 |
| Lassnigg, A | 1 |
| Mueller-Uri, P | 1 |
| El-Menyawi, I | 1 |
| Field-Ridley, A | 1 |
| Calendario, M | 1 |
| Piscitelli, SC | 2 |
| Ohnishi, Y | 1 |
| Tawara, A | 1 |
| Sakamoto, T | 1 |
| Arakawa, T | 1 |
| Rowen, JL | 1 |
| Tate, JM | 1 |
| Nordoff, N | 1 |
| Passarell, L | 1 |
| McGinnis, MR | 1 |
| Mrazova, M | 2 |
| Jurga, L | 3 |
| Sevcikova, L | 1 |
| Sorkovska, D | 1 |
| West, D | 1 |
| Novotny, J | 1 |
| Kuipers, ME | 1 |
| de Vries, HG | 1 |
| Eikelboom, MC | 1 |
| Meijer, DK | 1 |
| Swart, PJ | 1 |
| Gubbins, PO | 1 |
| McConnell, SA | 1 |
| Penzak, SR | 1 |
| Ariffin, H | 1 |
| Ariffin, W | 1 |
| Tharam, S | 1 |
| Omar, A | 1 |
| de Bruyne, J | 1 |
| Lin, HP | 1 |
| Hoover, K | 1 |
| Miller, DA | 1 |
| Sucke, AC | 1 |
| Mayers, M | 1 |
| Jandourek, A | 1 |
| Brown, P | 1 |
| Martin, MV | 1 |
| Tietz, HJ | 3 |
| Czaika, V | 2 |
| Sterry, W | 2 |
| Kuhara, T | 1 |
| Seidel, K | 2 |
| Young, GA | 1 |
| Bosly, A | 1 |
| Durrant, S | 1 |
| Gallis, HA | 2 |
| McKinsey, DS | 1 |
| Sharkey, PK | 1 |
| Wise, GJ | 1 |
| Mangi, R | 1 |
| Mosher, A | 1 |
| Thomas, C | 1 |
| Rayatt, S | 1 |
| Wienbren, M | 1 |
| Clarke, J | 1 |
| Mizutani, S | 1 |
| Ino-Ue, T | 1 |
| Kurasawa, M | 1 |
| Uno, Y | 1 |
| Saito, H | 1 |
| Kato, I | 1 |
| Takesako, K | 1 |
| Heslet, L | 1 |
| Christensen, H | 1 |
| Blowey, DL | 1 |
| Garg, UC | 1 |
| Kearns, GL | 1 |
| Warady, BA | 1 |
| Montane, BS | 1 |
| Mazza, I | 1 |
| Abitbol, C | 1 |
| Zilleruelo, G | 1 |
| Strauss, J | 1 |
| Coakley, S | 1 |
| Diaz, R | 1 |
| Rocco, TR | 1 |
| Reinert, SE | 1 |
| Simms, HH | 1 |
| Soni, LM | 1 |
| Burattini, MN | 1 |
| Pignatari, AC | 1 |
| Gompertz, OF | 1 |
| Ramos, AR | 1 |
| Vilgalys, R | 1 |
| Mitchell, TG | 1 |
| Hrastnik, C | 1 |
| Daum, G | 1 |
| Thomas, F | 1 |
| Mebtouche, B | 1 |
| Clavier, H | 1 |
| Kalfon, P | 1 |
| Jarque, I | 1 |
| Saavedra, S | 1 |
| Martin, G | 1 |
| Pérez Bellés, C | 1 |
| Sanz, MA | 1 |
| Arnavielhe, S | 1 |
| Blancard, A | 2 |
| Gonzalez, CE | 1 |
| Piscitelli, S | 1 |
| Bacher, JD | 1 |
| Peter, J | 2 |
| Torres, R | 1 |
| Shetti, D | 1 |
| Katsov, V | 1 |
| Kligys, K | 1 |
| Jabra-Rizk, MA | 1 |
| Falkler, WA | 1 |
| Baqui, AA | 1 |
| Kelley, JI | 1 |
| Meiller, TF | 1 |
| Wirsching, S | 1 |
| Michel, S | 1 |
| Trizna, Z | 1 |
| Chen, SH | 1 |
| Lockhart, S | 1 |
| Lundquist, KF | 1 |
| Smith, EB | 1 |
| Wagner, RF | 1 |
| Böhme, A | 1 |
| Karthaus, M | 1 |
| Hoelzer, D | 1 |
| Weigl, JA | 1 |
| Niki, Y | 1 |
| Anğ, O | 1 |
| Akgün, Y | 1 |
| Erturan, Z | 1 |
| Wanic-Kossowska, M | 1 |
| Kozioł, L | 1 |
| Bajew, L | 1 |
| Roszkowiak, B | 1 |
| Czekalski, S | 1 |
| Taylor, BN | 1 |
| Fichtenbaum, C | 1 |
| Saavedra, M | 1 |
| Slavinsky III, J | 1 |
| Swoboda, R | 1 |
| Wozniak, K | 1 |
| Arribas, A | 1 |
| Flowers, ME | 1 |
| Díaz-Guerra, TM | 2 |
| Monzón, A | 1 |
| Tuccinardi, C | 1 |
| Santilli, S | 1 |
| Monaco, M | 1 |
| Hoste, EA | 1 |
| Vandewoude, KH | 1 |
| Colardyn, FA | 1 |
| Gupta, SK | 1 |
| Dhingra, N | 1 |
| Velpandian, T | 1 |
| Jaiswal, J | 1 |
| Morrissey, J | 1 |
| Huang, JS | 1 |
| Tsai, CJ | 1 |
| Chen, KS | 1 |
| Chen, HY | 1 |
| Shieh, WB | 1 |
| Chapman, RL | 1 |
| Faix, RG | 1 |
| Stocker, M | 1 |
| Caduff, JH | 1 |
| Spalinger, J | 1 |
| Berger, TM | 1 |
| Oggioni, MR | 1 |
| Spinosa, MR | 1 |
| Maggi, T | 1 |
| Magliani, W | 1 |
| Teti, G | 1 |
| Pozzi, G | 1 |
| Roger, PM | 1 |
| Boissy, C | 1 |
| Foucher, R | 1 |
| Mondain, V | 1 |
| Vandenbos, F | 1 |
| le Fichoux, Y | 1 |
| Michiels, JF | 1 |
| Dellamonica, P | 2 |
| Willinger, B | 1 |
| Apfalter, P | 1 |
| Hirschl, AM | 1 |
| Makristathis, A | 1 |
| Rotter, M | 1 |
| Götzinger, P | 1 |
| Wamser, P | 1 |
| Barlan, M | 1 |
| Sautner, T | 1 |
| Jakesz, R | 1 |
| Függer, R | 1 |
| Yoshimura, H | 1 |
| Morii, M | 1 |
| Takada, M | 1 |
| Sawai, T | 1 |
| Mitsutake, K | 1 |
| Shibakawa, M | 1 |
| Kocagöz, S | 1 |
| Unal, S | 1 |
| Entenza, JM | 1 |
| Moreillon, P | 1 |
| Fekete-Forgács, K | 1 |
| Gyüre, L | 1 |
| Lenkey, B | 1 |
| Baldauf, C | 1 |
| Adam, D | 1 |
| Trenschel, R | 1 |
| Peceny, R | 1 |
| Runde, V | 1 |
| Elmaagacli, A | 1 |
| Dermoumi, H | 2 |
| Heintschel von Heinegg, E | 1 |
| Müller, KD | 2 |
| Schaefer, UW | 2 |
| Beelen, DW | 2 |
| Laverdière, M | 1 |
| Bow, EJ | 1 |
| Roberts, RS | 1 |
| Carr, D | 1 |
| Moghaddam, N | 1 |
| Mogyorósy, G | 1 |
| Soós, G | 1 |
| Nagy, A | 1 |
| Huang, YC | 2 |
| Lin, TY | 2 |
| Lien, RI | 1 |
| Kuo, CY | 1 |
| Yang, PH | 1 |
| Hsieh, WS | 1 |
| Klein, A | 1 |
| Haller-Schober, EM | 1 |
| Faulborn, J | 1 |
| Kicklighter, SD | 1 |
| Cox, T | 1 |
| Hulsey, TC | 1 |
| Turner, RB | 1 |
| Neely, MN | 1 |
| Schreiber, JR | 1 |
| Schaufele, RL | 1 |
| Francesconi, A | 1 |
| Vose, M | 1 |
| Beatty, S | 1 |
| Charles, SJ | 1 |
| Paterson, PJ | 1 |
| McWhinney, PH | 1 |
| Kibbler, CC | 1 |
| Prentice, HG | 1 |
| Adler, A | 1 |
| Müller, FM | 2 |
| Minari, A | 1 |
| Wong-Beringera, A | 1 |
| Hindler, J | 1 |
| Brankovic, L | 1 |
| Muehlbauer, L | 1 |
| Steele-Moore, L | 2 |
| Olarinde, O | 1 |
| Watson, MG | 1 |
| Tarrand, J | 1 |
| Prince, R | 1 |
| Rolston, KVR | 1 |
| Geldner, G | 1 |
| Lepper, P | 1 |
| Wiedeck, H | 1 |
| Essig, A | 1 |
| Turney, JH | 1 |
| Badrul, B | 1 |
| Ruslan, G | 1 |
| García, MT | 1 |
| Llorente, MT | 1 |
| Mínguez, F | 1 |
| Prieto, J | 1 |
| Gangadharan, VP | 1 |
| Sasidharan, K | 1 |
| Preetha, S | 1 |
| Chithrathara, K | 1 |
| Muhl, E | 1 |
| Martens, T | 1 |
| Iven, H | 1 |
| Rob, P | 1 |
| Bruch, HP | 1 |
| Verghese, SL | 2 |
| Padmaja, P | 2 |
| Sutha, P | 2 |
| Mathew, T | 2 |
| John, ES | 1 |
| Maraki, S | 1 |
| Hajiioannou, I | 1 |
| Chatzinikolaou, I | 1 |
| Baran, J | 1 |
| Muckatira, B | 1 |
| Dedi, R | 1 |
| Chang, B | 1 |
| Wright, MJ | 1 |
| Brownjohn, AM | 1 |
| Boedeker, KS | 1 |
| Kilzer, WJ | 1 |
| Neuenschwander, MC | 1 |
| Cooney, A | 1 |
| Spiegel, JR | 1 |
| Shibata, S | 1 |
| Kami, M | 2 |
| Kanda, Y | 2 |
| Machida, U | 2 |
| Iwata, H | 1 |
| Kishi, Y | 1 |
| Takeshita, A | 1 |
| Ueyama, J | 1 |
| Morinaga, S | 1 |
| Mutou, Y | 2 |
| Kronvall, G | 1 |
| Karlsson, I | 1 |
| Oakley, KL | 1 |
| Sansonetty, F | 1 |
| Martinez-DE-Oliveira, J | 1 |
| Fonseca, AF | 1 |
| Schmalreck, A | 1 |
| Schultze, W | 1 |
| Wauer, HJ | 1 |
| West, C | 1 |
| Kox, WJ | 1 |
| Segal, RE | 1 |
| Minamoto, GY | 1 |
| Tholakanahalli, VN | 1 |
| Potti, A | 1 |
| Hanley, JF | 1 |
| Merliss, AD | 1 |
| Diener-West, M | 1 |
| Hammond, J | 1 |
| Schreiber, J | 1 |
| Göring, HD | 1 |
| Rosahl, W | 1 |
| Strüben, C | 1 |
| Lakotta, W | 1 |
| Amthor, M | 1 |
| Gunsilius, E | 1 |
| Kähler, CM | 1 |
| Gastl, G | 1 |
| Petzer, AL | 1 |
| Guldaş, NS | 1 |
| Sulcová, M | 1 |
| Walmsley, S | 1 |
| King, S | 1 |
| McGeer, A | 1 |
| Ye, Y | 1 |
| Richardson, S | 1 |
| Bowersox, J | 1 |
| Albert, SG | 1 |
| DeLeon, MJ | 1 |
| Silverberg, AB | 1 |
| Herbrecht, R | 1 |
| Zamfir, A | 1 |
| Letscher-Bru, V | 1 |
| André, MH | 1 |
| Saito, Y | 1 |
| Takahashi, M | 2 |
| Sato, A | 1 |
| Katsuki, T | 1 |
| Ikeda, U | 1 |
| Shimada, K | 2 |
| Bailey, CW | 1 |
| Kovacicova, G | 3 |
| Hanzen, J | 3 |
| Pisarcikova, M | 2 |
| Sejnova, D | 1 |
| Horn, J | 1 |
| Babela, R | 1 |
| Svetlansky, I | 1 |
| Lovaszova, M | 1 |
| Gogova, M | 1 |
| Kao, HT | 1 |
| Kuo, AJ | 1 |
| Hengstler, J | 1 |
| Pournaras, CJ | 1 |
| Leuenberger, P | 1 |
| Wenisch, C | 1 |
| Krause, R | 1 |
| Pernot, C | 1 |
| Aho, S | 1 |
| Caillot, D | 2 |
| Vagner, O | 1 |
| Dalle, F | 1 |
| Durnet-Archeray, MJ | 1 |
| Chavanet, P | 2 |
| Bonnin, A | 1 |
| Strahilevitz, J | 1 |
| Kempley, ST | 1 |
| Mantzoros, CS | 1 |
| Liang, JD | 1 |
| Fang, CT | 1 |
| Patton, LL | 1 |
| Bonito, AJ | 1 |
| Shugars, DA | 1 |
| Kleinpeter, MA | 1 |
| Butt, AA | 1 |
| Streitzig, S | 1 |
| Böhrer, H | 1 |
| Paz, A | 1 |
| Gonen, R | 1 |
| Quintini, G | 1 |
| Barbera, V | 1 |
| Gambino, R | 1 |
| Spadola, V | 1 |
| Minardi, V | 1 |
| Mariani, G | 1 |
| Fluit, AC | 1 |
| Peng, G | 1 |
| Schuman, P | 1 |
| Holloway, W | 1 |
| Neaton, JD | 1 |
| Merrer, J | 1 |
| Nieszkowska, A | 1 |
| Outin, H | 1 |
| Arzumanyan, VG | 1 |
| Semenov, BF | 1 |
| Caksen, H | 1 |
| Kurtoglu, S | 1 |
| Oztürk, A | 1 |
| Cetin, N | 1 |
| Ciftçi, A | 1 |
| Kou, HK | 1 |
| Lin, JW | 1 |
| Chang, KC | 1 |
| Pagano, L | 1 |
| Leone, G | 1 |
| Ally, R | 1 |
| Schürmann, D | 1 |
| Kreisel, W | 1 |
| Carosi, G | 1 |
| Hodges, M | 1 |
| Romero, AJ | 1 |
| Laho, L | 1 |
| Ondrusova, A | 1 |
| Tarekova, Z | 1 |
| Liskova, A | 2 |
| Chovancova, D | 1 |
| Szovenyiova, Z | 1 |
| Brent, NB | 1 |
| Gupta, R | 1 |
| Mittal, A | 1 |
| Bhatnagar, LK | 1 |
| Bansal, NK | 1 |
| Chung, BH | 1 |
| Chang, SY | 1 |
| Kim, SI | 1 |
| Choi, HS | 1 |
| Zhai, W | 1 |
| Giannopoulos, A | 1 |
| Giamarellos-Bourboulis, EJ | 1 |
| Adamakis, I | 1 |
| Georgopoulou, I | 1 |
| Petrikkos, G | 2 |
| Katsilambros, N | 1 |
| Szovényová, Z | 1 |
| Chmelík, B | 1 |
| Rókusz, L | 1 |
| Liptay, L | 1 |
| Kádár, K | 1 |
| Sikić, J | 1 |
| Vukojević, N | 1 |
| Katusić, D | 1 |
| Sarić, B | 1 |
| Jain, P | 1 |
| Khan, ZK | 1 |
| Bhattacharya, E | 1 |
| Ranade, SA | 1 |
| Donowitz, LG | 1 |
| Trachana, M | 1 |
| Roilides, E | 1 |
| Gompakis, N | 1 |
| Kanellopoulou, K | 1 |
| Mpantouraki, M | 1 |
| Kanakoudi-Tsakalidou, F | 1 |
| Skiada, A | 1 |
| Sabatakou, H | 1 |
| Dosios, T | 1 |
| Giamarellou, H | 1 |
| Dhuley, JN | 1 |
| van Rhee, F | 1 |
| Henslee-Downey, JP | 1 |
| Singhal, S | 1 |
| Mehta, J | 1 |
| Mootha, VV | 1 |
| Schluter, ML | 1 |
| Das, A | 1 |
| Pietrucha-Dilanchian, P | 1 |
| Lechin, AE | 1 |
| Kuhn, DM | 1 |
| Chandra, J | 1 |
| Mukherjee, PK | 1 |
| Boyle, BM | 1 |
| Forkin, C | 1 |
| Mulcahy, F | 1 |
| Keane, CT | 1 |
| Hua, YX | 1 |
| Hayasaki, Y | 1 |
| Mata-Essayag, S | 1 |
| Magaldi, S | 1 |
| Hartung de Capriles, C | 1 |
| Deibis, L | 1 |
| Verde, G | 1 |
| Perez, C | 1 |
| Kam, LW | 1 |
| Lin, JD | 1 |
| Morton, A | 1 |
| Eisen, DP | 1 |
| Gee, SF | 1 |
| Polacheck, I | 1 |
| MacMillan, ML | 1 |
| Goodman, JL | 2 |
| DeFor, TE | 1 |
| Weisdorf, DJ | 1 |
| Mardani, M | 1 |
| Hanna, HA | 1 |
| Boktour, M | 1 |
| Abbas, J | 1 |
| Girgawy, E | 1 |
| Hachem, RY | 1 |
| Okuzumi, K | 1 |
| Matsumura, T | 1 |
| Mori Si, S | 1 |
| Hori, A | 1 |
| Kashima, T | 1 |
| Takaue, Y | 1 |
| Hirai, H | 1 |
| Yoneyama, A | 1 |
| Kaltenbach, G | 1 |
| Vogel, T | 1 |
| Noblet-Dick, M | 1 |
| Heitz, D | 1 |
| Berthel, M | 1 |
| Kuntzmann, F | 1 |
| Valentini, P | 1 |
| Delogu, A | 1 |
| De, RG | 1 |
| Boccacci, S | 1 |
| Nacci, A | 1 |
| Sopo, SM | 1 |
| Ranno, O | 1 |
| Alexandridou, A | 1 |
| Reginald, AY | 1 |
| Stavrou, P | 1 |
| Kirkby, GR | 1 |
| Martin-Davila, P | 1 |
| Alvarez, ME | 1 |
| Candelas, A | 1 |
| Moreno, S | 1 |
| Ju, JY | 1 |
| Polhamus, C | 1 |
| Holland, SM | 1 |
| Wang, GC | 1 |
| Chiu, YW | 1 |
| Mazzi, U | 1 |
| Pauwels, EK | 1 |
| Sadkowski, L | 1 |
| Eng, TY | 1 |
| Qvist, H | 1 |
| Skovlund, E | 1 |
| Giercksky, KE | 1 |
| Bukharie, HA | 1 |
| Pelletier, R | 1 |
| Loranger, L | 1 |
| Marcotte, H | 1 |
| Mora, P | 1 |
| Bovey, EH | 1 |
| Johni, ES | 1 |
| Chetwynd, EM | 1 |
| Ives, TJ | 1 |
| Payne, PM | 1 |
| Edens-Bartholomew, N | 1 |
| Tissot, B | 1 |
| Bramary, F | 1 |
| Lundstrom, T | 1 |
| Jones, JM | 1 |
| Sarsam, MA | 1 |
| Clarke, MA | 1 |
| Hedderwick, SA | 1 |
| Branchesi, P | 1 |
| Crescenzi, G | 1 |
| Ancarani, F | 1 |
| Habert, M | 1 |
| Dretler, RH | 1 |
| Conteas, CN | 1 |
| Tuazon, C | 1 |
| Koster, FM | 1 |
| Sattler, F | 1 |
| Squires, K | 1 |
| Islam, MZ | 1 |
| Baran, R | 1 |
| Van Cutsem, J | 2 |
| Viviani, MA | 2 |
| Eloy, O | 1 |
| Ghnassia, JC | 1 |
| Wilson, DC | 1 |
| Tam, JY | 1 |
| Blume, KG | 1 |
| Prober, CG | 1 |
| Tanaka, J | 1 |
| Kasai, M | 2 |
| Masauzi, N | 1 |
| Matsuura, A | 1 |
| Morii, K | 1 |
| Kiyama, Y | 1 |
| Naohara, T | 1 |
| Higa, T | 1 |
| Hashino, S | 1 |
| Siegman-Igra, Y | 1 |
| Rabaw, MY | 1 |
| Tortorano, AM | 1 |
| Malaspina, C | 1 |
| Colledan, M | 1 |
| Paone, G | 1 |
| Rossi, G | 1 |
| Bordone, G | 1 |
| Pagano, A | 1 |
| Byers, M | 1 |
| Feldman, A | 1 |
| Parent, A | 1 |
| Urbak, SF | 1 |
| Degn, T | 1 |
| Poell, RJ | 1 |
| van Furth, R | 2 |
| Bozzette, SA | 1 |
| Gordon, RL | 1 |
| Yen, A | 1 |
| Ito, MK | 1 |
| Fierer, J | 1 |
| Bergman, KA | 1 |
| Horrevorts, AM | 1 |
| Hendershot, EF | 1 |
| Milatovic, D | 1 |
| Tacker, JR | 1 |
| López-Dupla, M | 1 |
| Mora Sanz, P | 1 |
| Pintado García, V | 1 |
| Valencia Ortega, E | 1 |
| Uriol, PL | 1 |
| Khamashta, MA | 2 |
| Aguado, AG | 1 |
| Hernández, JA | 1 |
| Gonzalez-Moreno, M | 1 |
| Llibre, JM | 1 |
| Aloy, A | 1 |
| Casan, CM | 1 |
| Fong, IW | 1 |
| Bannatyne, RM | 1 |
| Cheng, PC | 1 |
| Bodé, S | 1 |
| Pedersen-Bjergaard, L | 1 |
| Hjelt, K | 1 |
| Bren, A | 1 |
| Kandus, A | 1 |
| Lindic, J | 1 |
| Varl, J | 1 |
| Ravisse, P | 1 |
| Sotoyama, K | 1 |
| Cruciani, M | 1 |
| Molesini, M | 1 |
| Vento, S | 1 |
| Bassetti, D | 1 |
| Hidalgo, FI | 1 |
| del Blanco, JC | 1 |
| Villacampa, T | 1 |
| Mallo, JF | 1 |
| Dobloug, JH | 1 |
| Winston, DJ | 1 |
| Greenfield, RA | 1 |
| Fox, B | 1 |
| Kaizer, H | 1 |
| Shadduck, RK | 1 |
| Shea, TC | 1 |
| Stiff, P | 1 |
| Friedman, DJ | 1 |
| Casasnovas, RO | 1 |
| Solary, E | 1 |
| Bonotte, B | 1 |
| Bonin, A | 1 |
| Camerlynck, P | 1 |
| Guy, H | 1 |
| Schuler, U | 1 |
| Ehninger, G | 1 |
| Laatikainen, L | 1 |
| Tuominen, M | 1 |
| von Dickhoff, K | 1 |
| Corbella, X | 2 |
| Castells, M | 1 |
| Berlanga, B | 1 |
| Pontieri, E | 1 |
| Chirletti, P | 1 |
| Lavilla Uriol, P | 1 |
| Gil, A | 3 |
| Valencia, E | 4 |
| López Dupla, M | 2 |
| Khamashta, M | 2 |
| García Puig, J | 2 |
| Ortiz Vázquez, J | 1 |
| Carnevali Ruiz, D | 1 |
| Domínguez, L | 1 |
| Pulido, F | 1 |
| Blázquez, E | 1 |
| Martín, E | 1 |
| Damay, M | 1 |
| Chevalier, MC | 1 |
| Gouraud, F | 1 |
| Jabado, N | 1 |
| Varache, C | 1 |
| Landman-Parker, J | 1 |
| Leverger, G | 1 |
| Garber, GE | 1 |
| Cacciapuoti, A | 1 |
| Parmegiani, R | 1 |
| Antonacci, B | 1 |
| Norris, C | 1 |
| Moss, EL | 1 |
| Menzel, F | 1 |
| Yarosh-Tomaine, T | 1 |
| Hare, RS | 1 |
| Miller, GH | 1 |
| Propst, T | 1 |
| Vogel, W | 1 |
| Propst, A | 1 |
| Dietze, O | 1 |
| Braunsteiner, H | 1 |
| Santeiro, ML | 1 |
| Riggs, D | 1 |
| Weibley, RE | 1 |
| Gordon, DL | 1 |
| Maddern, J | 1 |
| Blade, J | 1 |
| Lopez-Guillermo, A | 1 |
| Rozman, C | 1 |
| Grañena, A | 1 |
| Bruguera, M | 1 |
| Bordas, J | 1 |
| Cervantes, F | 1 |
| Carreras, E | 1 |
| Sierra, J | 1 |
| Montserrat, E | 1 |
| Yamamoto, W | 1 |
| Ino, T | 1 |
| Sakurabayashi, I | 1 |
| Ide, H | 1 |
| Yaginuma, T | 1 |
| Lavilla, P | 2 |
| Ortiz-Vázquez, J | 2 |
| Isobe, Y | 2 |
| Hatano, H | 2 |
| Scholten, SL | 1 |
| Nettleman, MD | 1 |
| Sarrazin, EF | 1 |
| Johnson, TR | 1 |
| Soutar, RL | 1 |
| Case, CP | 1 |
| MacGowan, AP | 1 |
| Brown, NM | 1 |
| Reeves, DS | 1 |
| Whitehead, P | 1 |
| Felmingham, D | 1 |
| Colville, A | 1 |
| Wale, MC | 1 |
| Bignardi, GE | 1 |
| Savage, MA | 1 |
| Coker, R | 1 |
| Davis, SG | 1 |
| Flannery, MT | 1 |
| Simmons, DB | 1 |
| Saba, H | 1 |
| Altus, P | 1 |
| Wallach, PM | 1 |
| Adelman, HM | 1 |
| Reuman, PD | 1 |
| Neiberger, R | 1 |
| Kondor, DA | 1 |
| Fischman, AJ | 1 |
| Alpert, NM | 1 |
| Livni, E | 1 |
| Ray, S | 1 |
| Sinclair, I | 1 |
| Elmaleh, DR | 1 |
| Weiss, S | 1 |
| Correia, JA | 1 |
| Webb, D | 1 |
| Liss, R | 1 |
| Mistlberger, A | 1 |
| Graf, B | 1 |
| van de Rhee, NE | 1 |
| van Kampen, KM | 1 |
| Brockmeyer, NH | 1 |
| Hantschke, D | 1 |
| Olbricht, T | 1 |
| Hengge, UA | 1 |
| Goos, M | 1 |
| Dupouy-Camet, J | 1 |
| Paugam, A | 1 |
| Di Donato, C | 1 |
| Viguié, C | 1 |
| Vicens, I | 1 |
| Volle, PJ | 1 |
| Tourte-Schaefer, C | 1 |
| Bergami, G | 1 |
| Di Mario, M | 1 |
| Barbuti, D | 1 |
| Cozza, R | 1 |
| Ross, SC | 1 |
| Weber, DR | 1 |
| Kantarjian, H | 1 |
| David, C | 1 |
| Barnett, K | 1 |
| Bow, E | 1 |
| Defelice, R | 1 |
| Downs, N | 1 |
| File, T | 1 |
| Karam, G | 1 |
| Roupie, E | 1 |
| Darmon, JY | 1 |
| Brochard, L | 1 |
| Saada, M | 1 |
| Rekik, N | 1 |
| Brun-Buisson, C | 1 |
| Matsumura, Y | 1 |
| Ogawa, M | 1 |
| Tsuji, A | 1 |
| Matsunaga, T | 1 |
| Goto, S | 1 |
| Moulin-Traffort, J | 1 |
| Regli, P | 1 |
| Sarzier, JM | 1 |
| Quilici, M | 1 |
| Lim, SG | 1 |
| Lee, CA | 1 |
| Hales, M | 1 |
| O'Doherty, M | 1 |
| Winter, M | 1 |
| Kernoff, PB | 1 |
| Morrow, JD | 1 |
| Urbain, D | 1 |
| Rahir, F | 1 |
| Weerts, D | 1 |
| Clumeck, N | 1 |
| Persons, DA | 1 |
| Laughlin, M | 1 |
| Tanner, D | 1 |
| Perfect, J | 1 |
| Gockerman, JP | 1 |
| Hathorn, JW | 1 |
| Dupla, ML | 1 |
| García-Puig, J | 1 |
| Wiest, DB | 1 |
| Garner, SS | 1 |
| Simons, DR | 1 |
| Evans, TG | 1 |
| Mayer, J | 1 |
| Cohen, S | 1 |
| Classen, D | 1 |
| Carroll, K | 1 |
| Jakab, K | 2 |
| Kelemen, E | 2 |
| Prinz, G | 1 |
| Török, I | 2 |
| Colmenero, C | 1 |
| Moñux, A | 1 |
| Castro, A | 1 |
| Franklin, IM | 1 |
| Elias, E | 1 |
| Hirsch, C | 1 |
| McIlroy, MA | 1 |
| Sirvent, JM | 1 |
| Váradi, G | 1 |
| Crislip, MA | 1 |
| Mayer, CL | 1 |
| Fioredda, F | 1 |
| Ciravegna, B | 1 |
| Barigione, G | 1 |
| Terragna, A | 2 |
| Røder, BL | 1 |
| Sonnenschein, C | 1 |
| Hartzen, SH | 1 |
| Tolkoff-Rubin, NE | 1 |
| Conti, DJ | 1 |
| Doran, M | 1 |
| DelVecchio, A | 1 |
| Ikemoto, H | 2 |
| Woolley, PD | 1 |
| Roig, P | 1 |
| Martínez, A | 1 |
| Salavert, M | 1 |
| Nieto, A | 1 |
| Navarro, V | 1 |
| Medina, E | 1 |
| Carrasco, R | 1 |
| Muñoz, J | 1 |
| Teira, R | 1 |
| Zubero, Z | 1 |
| Alvarez, M | 1 |
| Cisterna, R | 1 |
| Santamaría, JM | 1 |
| Krisch, H | 1 |
| Sarnow, E | 1 |
| Quabeck, K | 1 |
| Kölbel, M | 1 |
| Kraft, J | 1 |
| Tausch, I | 1 |
| Pertschy, J | 1 |
| Reinke, P | 1 |
| Ziegler-Böhme, H | 1 |
| Heise, W | 1 |
| Arasteh, K | 1 |
| L'age, M | 1 |
| Schweigart, U | 1 |
| Müller, J | 1 |
| Venning, MC | 1 |
| Ford, M | 1 |
| Gould, FK | 2 |
| Mechinaud, F | 1 |
| Rubin, M | 1 |
| Schaison, G | 1 |
| Baruchel, A | 1 |
| Arlet, G | 1 |
| Hector, RF | 1 |
| Yee, E | 1 |
| Meloni, G | 1 |
| Ganzinger, U | 1 |
| Lee, JW | 1 |
| Lecciones, J | 1 |
| Kelly, P | 1 |
| Thomas, V | 1 |
| O'Meeghan, T | 1 |
| Varcoe, R | 1 |
| Thomas, M | 1 |
| Ellis-Pegler, R | 1 |
| Hirschel, B | 1 |
| Klinge, B | 1 |
| Rüchel, R | 1 |
| Bismuth, M | 1 |
| Gourdou, JF | 1 |
| Vas, SI | 1 |
| Bunin, N | 1 |
| Camitta, B | 1 |
| Cohen, J | 1 |
| Maruta, A | 1 |
| Matsuzaki, M | 1 |
| Fukawa, H | 1 |
| Kodama, F | 1 |
| Matsushima, T | 1 |
| Ikeda, H | 1 |
| Tomizawa, S | 1 |
| Nakamura, J | 1 |
| Adachi, M | 1 |
| Kawanishi, M | 1 |
| Tanabe, J | 1 |
| Arai, S | 1 |
| Iguchi, K | 1 |
| Nito, H | 1 |
| Oka, S | 1 |
| Tokitsu, M | 1 |
| Mori, H | 1 |
| Nakata, H | 1 |
| Goto, M | 1 |
| Goto, H | 1 |
| Toyama, K | 1 |
| Lin, KY | 1 |
| Hojo, H | 1 |
| Tsuda, A | 1 |
| Torii, Y | 1 |
| Yoshikawa, O | 1 |
| Matsumura, M | 1 |
| Ebe, T | 1 |
| Inagaki, M | 1 |
| Isonuma, H | 1 |
| Hibiya, I | 1 |
| Hamamoto, T | 1 |
| Taniuchi, A | 1 |
| Akahonai, Y | 1 |
| Mikuni, C | 1 |
| Kawamura, K | 1 |
| Yoshida, T | 1 |
| Keil, TU | 1 |
| Van t Wout, JW | 1 |
| Mattie, H | 1 |
| Levine, J | 1 |
| Bernard, DB | 1 |
| Idelson, BA | 1 |
| Farnham, H | 1 |
| Saunders, C | 1 |
| Nathwani, D | 1 |
| Green, ST | 1 |
| Goldberg, DJ | 1 |
| Kennedy, DH | 1 |
| Thomas, MG | 1 |
| Ellis-Pegler, RB | 1 |
| Lee, PG | 1 |
| Tarry, WF | 2 |
| Bernard, E | 1 |
| Carles, M | 1 |
| Toussaint-Gari, M | 1 |
| Fournier, JP | 1 |
| Shen, SH | 1 |
| Haddad, J | 1 |
| Wright, KA | 1 |
| Hobbs, MM | 1 |
| Durack, DT | 3 |
| Corsini, M | 1 |
| Gastaldi, R | 1 |
| Soliani, M | 1 |
| Dave, J | 1 |
| Hickey, MM | 1 |
| Wilkins, EG | 1 |
| Kirk, AJ | 1 |
| Freeman, R | 1 |
| Corris, PA | 1 |
| Dark, JH | 1 |
| Polak, A | 1 |
| Hughes, CE | 1 |
| Bennett, RL | 1 |
| Tuna, IC | 1 |
| Beggs, WH | 1 |
| Drouhet, E | 1 |
| Isalska, BJ | 1 |
| Stanbridge, TN | 1 |
| Hay, RJ | 1 |
| Clayton, YM | 1 |
| Hendel, L | 1 |
| Svejgaard, E | 1 |
| Walsøe, I | 1 |
| Kieffer, M | 1 |
| Stenderup, A | 1 |
| Burke, J | 1 |
| Cope, NJ | 1 |
| von Fraunhofer, NA | 1 |
| Williams, EW | 1 |
| Richardson, K | 2 |
| Brammer, KW | 2 |
| Marriott, MS | 2 |
| Andrews, RJ | 1 |
| Savani, DV | 2 |
| Smith, KJ | 1 |
| Kennedy, CT | 1 |
| Hopwood, V | 1 |
| Vanden Bossche, H | 1 |
| Cobo, LM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics of Fluconazole Given Intravenously as Prophylaxis or Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit (PACIFIC)[NCT02666716] | 20 participants (Actual) | Observational | 2015-05-31 | Completed | |||
| Phase IV Open Label Non Comparative Trial Of IV Anidulafungin Followed By Oral Azole Therapy For The Treatment Of Candidemia And Invasive Candidiasis[NCT00496197] | Phase 4 | 282 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| A Multicenter, Open Label Pharmacokinetic Study of Fluconazole in Infants[NCT00514358] | 55 participants (Actual) | Observational | 2005-11-30 | Completed | |||
| Pharmacokinetics of a Fluconazole Loading Dose in Infants and Toddlers[NCT00797420] | Phase 1 | 13 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| Studies of Disorders With Increased Susceptibility to Fungal Infections[NCT01222741] | 850 participants (Anticipated) | Observational | 2011-01-07 | Recruiting | |||
| DURATION OF TIME OUTSIDE, BELOW, AND ABOVE THE TARGETED Oxygen SATURATION RANGE In Preterm Infants[NCT00845624] | 102 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis[NCT00666185] | Phase 3 | 523 participants (Actual) | Interventional | 2003-08-31 | Completed | ||
| Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment (The CANTREAT Study): A Prospective, Randomized, Double Blind, Placebo Controlled Pilot Study[NCT00934934] | Phase 2 | 61 participants (Actual) | Interventional | 2010-04-30 | Terminated (stopped due to slow enrollment) | ||
| A Phase III, Double-Blind, Randomized, Multi-Center, Study of the Safety and Efficacy of Anidulafungin vs. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications.[NCT00056368] | Phase 3 | 256 participants (Actual) | Interventional | 2003-03-31 | Completed | ||
| Anidulafungin in Patients With Hematologic Malignancies - An Open-label, Prospective Study to Evaluate the Safety Profile at Prophylactic and Therapeutic Dosages[NCT01053884] | Phase 2 | 10 participants (Actual) | Interventional | 2009-10-31 | Terminated (stopped due to reduced recruitment rate due to non infectious, but competitive trials at our institution) | ||
| Fluconazole Prophylaxis of Thrush in AIDS[NCT00001542] | Phase 4 | 80 participants | Interventional | 1996-07-31 | Completed | ||
| ANTIVORIFUNGOL:Strategy of Antifungal Use in Oncohematological Neutropenic Patients. Use of Voriconazole as Early Treatment.[NCT00386802] | Phase 4 | 115 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
| Invasive Fungal Infections in Patients Following Stem Cell Transplant[NCT04619147] | 300 participants (Anticipated) | Observational | 2021-01-31 | Not yet recruiting | |||
| A Phase III, Randomized, Double-Blind, Comparative Trial of FK463 Versus Fluconazole for Prophylaxis of Fungal Infections in Patients Undergoing a Hematopoetic Stem Cell Transplant[NCT00001937] | Phase 3 | 800 participants | Interventional | 1999-11-30 | Completed | ||
| An Open Multicenter Trial of Fluconazole Oral Suspension in the Treatment of Esophageal Candidiasis in Immunocompromised Patients[NCT00002339] | Phase 3 | 100 participants | Interventional | Completed | |||
| Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections[NCT00033982] | Phase 3 | 50 participants | Interventional | 2002-04-11 | Completed | ||
| Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.[NCT00002132] | 0 participants | Interventional | Completed | ||||
| An Open Intravenous Multiple Dose, Multi-Center Study to Investigate the Pharmacokinetics, Safety and Toleration of Voriconazole in Children Aged 2-12 Years Who Require Treatment for the Prevention of Systemic Fungal Infection[NCT00005912] | Phase 1 | 48 participants | Interventional | 2000-06-30 | Completed | ||
| A Phase II Trial to Evaluate the Safety and Tolerability of Nebulised Amphotericin B Lipid Complex (ABELCET®) in the Prophylaxis of Invasive Pulmonary Aspergillosis During Prolonged Neutropenia in Paediatric Patients With Acute Leukaemia[NCT01615809] | Phase 2 | 32 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia[NCT00001790] | Phase 1 | 120 participants | Interventional | 1998-10-31 | Completed | ||
| A Prospective, Randomized, Comparative Study of the Safety and Efficacy of Clarithromycin Versus Rifabutin Versus the Combination of Clarithromycin Plus Rifabutin for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia or Disseminated MAC Disea[NCT00001030] | Phase 3 | 1,100 participants | Interventional | Completed | |||
| A Randomized, Double-Blind, Three-Arm Study Comparing Combination to Monthly Alternating Nucleoside Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3) With a Prior History of Nucleoside Therapy[NCT00001029] | Phase 2 | 654 participants | Interventional | Completed | |||
| PROCAS: Study Observational Prospective and Multicenter to Determine the Clinic Effectiveness and the Safety of Caspofungin Acetate (CANCIDAS®) in the Treatment of Invader Fungal Infection[NCT00388167] | 320 participants (Anticipated) | Observational | 2004-03-31 | Completed | |||
| Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial[NCT05695521] | Phase 1 | 66 participants (Anticipated) | Interventional | 2023-04-03 | Recruiting | ||
| A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation[NCT01772108] | 42 participants (Actual) | Interventional | 2013-04-30 | Terminated (stopped due to As recruitment rate was lower than anticipated) | |||
| A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women[NCT00000744] | 400 participants | Interventional | Completed | ||||
| A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients[NCT00002304] | 0 participants | Interventional | Completed | ||||
| Evaluation of Antifungal Prophylaxis Against Invasive Fungal Infections During Corticosteroid Containing Therapy for Graft-versus-host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation[NCT01282879] | Phase 4 | 36 participants (Actual) | Interventional | 2009-12-31 | Terminated (stopped due to In interim analysis, this study met the primary hypothesis.) | ||
| A Randomized, Double-blind, Placebo Controlled Trial of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in High-risk Adults in the Critical Care Setting[NCT00520234] | Phase 4 | 222 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Analysis of length of hospital stay based on Kaplan-Meier survival techniques. (NCT00496197)
Timeframe: Baseline up to 6 Week Follow-up (EOS)
| Intervention | days (Mean) |
|---|---|
| Anidulafungin | 18.4 |
Analysis of length of hospital stay based on Kaplan-Meier survival techniques. (NCT00496197)
Timeframe: Baseline up to End of Intravenous treatment (Day 5 up to Day 28)
| Intervention | days (Mean) |
|---|---|
| Anidulafungin | 8.9 |
Overall therapy includes Intravenous and Oral therapy. Participants were to receive at least 5 days and a maximum of 28 days of IV anidulafungin. After that, participants could continue treatment with oral fluconazole or voriconazole for at least 14 days from the day of last positive culture. (NCT00496197)
Timeframe: Baseline up to End of Treatment (Day 5 up to Day 42)
| Intervention | days (Mean) |
|---|---|
| Anidulafungin | 14.1 |
(NCT00496197)
Timeframe: Baseline up to Week 6 Follow-up (EOS) or 30 days after last dose of study drug (whichever was later)
| Intervention | participants (Number) |
|---|---|
| Anidulafungin | 65 |
Participants with a negative culture on Day 1 were not included in the analysis. For participants with a positive culture on Day 1, the first day on which there was a negative culture was determined and then compared to the result of the next culture. If the next culture was also negative, or the next culture was positive but the interval between the 2 cultures was > 3 days, the earlier of the 2 cultures was the day of first negative blood culture. If next culture was positive and taken within 3 days of the previous culture, the process was repeated with the next negative blood culture. (NCT00496197)
Timeframe: Baseline (Day 1) up to Week 6 Follow-up (EOS)
| Intervention | days (Number) |
|---|---|
| Anidulafungin | 3.0000 |
Measured as time to dischargeable (medically dischargeable status) and as time to discharge (actual discharge). Analysis of length of hospital stay based on Kaplan-Meier survival techniques. (NCT00496197)
Timeframe: Baseline up to 6 Week Follow-up (EOS)
| Intervention | days (Mean) | |
|---|---|---|
| Time to dischargeable | Time to discharge | |
| Anidulafungin | 27.3 | 27.1 |
Cause of death (includes all-cause and attributable to Candida infection) reported based on death due to Serious Adverse Events (SAEs). SAEs are any untoward medical occurrence at any dose that results in death, is life threatening, requires in-patient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability or incapacity, results in congenital anomaly or birth defect. Participants may be counted with > 1 cause of death if multiple causes were present. (NCT00496197)
Timeframe: Baseline up to Week 6 Follow-up (EOS) or 30 days after last dose of study drug (whichever was later)
| Intervention | participants (Number) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute myocardial infarction | Acute respiratory failure | Anastomotic complication | Ascites | Atrial flutter | Bile duct cancer | Brain oedema | Cardiac arrest | Cardiac failure congestive | Cardio-respiratory arrest | Chronic hepatic failure | Coagulopathy | Colon cancer | Convulsion | Deep vein thrombosis | Diabetes mellitus | Disease progression | Dyspnoea | Electromechanical dissociation | Endocarditis | Endotracheal intubation | Fungaemia | Gastrointestinal haemorrhage | Gastrointestinal ischaemia | General physical health deterioration | Haemorrhage | Haemorrhage intracranial | Hepatic failure | Hypoglycaemia | Hyponatraemia | Hypotension | Infection | Ischaemic cardiomyopathy | Liver function test abnormal | Lymphoma | Mental status changes | Metastatic gastric cancer | Multi-organ disorder | Multi-organ failure | Multiple myeloma | Multiple sclerosis relapse | Myocardial infarction | Neoplasm malignant | Peritonitis | Peritonitis bacterial | Pneumonia | Pneumothorax | Pulmonary embolism | Pulmonary haemorrhage | Renal failure | Renal failure acute | Renal failure chronic | Respiratory arrest | Respiratory distress | Respiratory failure | Sepsis | Septic shock | Systemic candida | Thrombocytopenia | Wound dehiscence | |
| Anidulafungin | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 5 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 8 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 5 | 1 | 1 | 3 | 2 | 6 | 12 | 7 | 1 | 1 | 1 |
Clinical Success=Cure: resolution of Candida s/s or Improvement: significant but incomplete resolution of s/s; Clinical Failure: at least 3 doses Anidulafungin with no significant improvement in s/s or death due to Candida. (NCT00496197)
Timeframe: End of Intravenous treatment (Day 5 up to Day 28)
| Intervention | participants (Number) | ||
|---|---|---|---|
| Cure | Improvement | Failure | |
| Anidulafungin | 159 | 57 | 16 |
Clinical Success=Cure: resolution of Candida s/s or Improvement: significant but incomplete resolution of s/s; Clinical Failure: at least 3 doses Anidulafungin with no significant improvement in s/s or death due to Candida. (NCT00496197)
Timeframe: End of Treatment (Day 5 up to Day 42)
| Intervention | participants (Number) | ||
|---|---|---|---|
| Cure | Improvement | Failure | |
| Anidulafungin | 160 | 14 | 13 |
Success: Clinical response=Cure (s/s of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (f/u culture negative) or Presumed Eradication (f/u culture n/a and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida spp) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: End of Intravenous treatment (Day 5 up to Day 28)
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 208 | 27 |
Success: Clinical response=Cure (no signs, symptoms [s/s] of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (follow up [f/u] culture negative) or Presumed Eradication (f/u culture not available [n/a] and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida species [spp]) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: End of Treatment (Day 5 up to Day 42)
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 170 | 33 |
Success: Clinical response=Cure (s/s of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (f/u culture negative) or Presumed Eradication (f/u culture n/a and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida spp) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: End of Intravenous treatment (Day 5 up to Day 28)
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 119 | 20 |
Success: Clinical response=Cure (s/s of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (f/u culture negative) or Presumed Eradication (f/u culture n/a and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida spp) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: End of Treatment (Day 5 up to Day 42)
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 99 | 21 |
Success: Clinical response=Cure (s/s of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (f/u culture negative) or Presumed Eradication (f/u culture n/a and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida spp) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: Week 2 Follow-up
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 89 | 27 |
Success: Clinical response=Cure (s/s of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (f/u culture negative) or Presumed Eradication (f/u culture n/a and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida spp) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: Week 6 Follow-up (EOS)
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 75 | 36 |
Microbiological Success=Eradication: negative culture for baseline Candida spp or Presumed Eradication: f/u culture n/a and clinical outcome defined as success (cure or improvement); Microbiological Failure=Persistence: positive culture for at least 1 baseline Candida spp or Presumed Persistence: f/u culture n/a and clinical outcome defined as failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida). (NCT00496197)
Timeframe: End of Intravenous treatment (Day 5 up to Day 28)
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Eradication | Presumed eradication | Persistence | Presumed persistence | |
| Anidulafungin | 163 | 61 | 15 | 3 |
Microbiological Success=Eradication: negative culture for baseline Candida spp or Presumed Eradication: f/u culture n/a and clinical outcome defined as success (cure or improvement); Microbiological Failure=Persistence: positive culture for at least 1 baseline Candida spp or Presumed Persistence: f/u culture n/a and clinical outcome defined as failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida). (NCT00496197)
Timeframe: End of Treatment (Day 5 up to Day 42)
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Eradication | Presumed eradication | Persistence | Presumed persistence | |
| Anidulafungin | 124 | 59 | 6 | 3 |
AEs are any untoward medical occurrence in a clinical investigation subject administered a product or medical device; the event need not necessarily have a causal relationship with the treatment or usage. SAEs are any untoward medical occurrence at any dose that results in death, is life threatening, requires in-patient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability or incapacity, results in congenital anomaly or birth defect. (NCT00496197)
Timeframe: Baseline up to Week 6 Follow-up (EOS) or 30 days after last dose of study drug (whichever was later)
| Intervention | participants (Number) | |
|---|---|---|
| Non-serious Adverse Events | Serious Adverse Events | |
| Anidulafungin | 216 | 134 |
Clinical Success=Cure: resolution of Candida s/s or Improvement: significant but incomplete resolution of s/s; Clinical Failure: at least 3 doses Anidulafungin with no significant improvement in s/s or death due to Candida. (NCT00496197)
Timeframe: Week 2 follow-up
| Intervention | participants (Number) | ||
|---|---|---|---|
| Cure | Improvement | Failure | |
| Anidulafungin | 155 | 9 | 9 |
Clinical Success=Cure: resolution of Candida s/s or Improvement: significant but incomplete resolution of s/s; Clinical Failure: at least 3 doses Anidulafungin with no significant improvement in s/s or death due to Candida. (NCT00496197)
Timeframe: Week 6 follow-up (EOS)
| Intervention | participants (Number) | ||
|---|---|---|---|
| Cure | Improvement | Failure | |
| Anidulafungin | 138 | 8 | 10 |
Success: Clinical response=Cure (s/s of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (f/u culture negative) or Presumed Eradication (f/u culture n/a and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida spp) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: Week 2 Follow-up
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 148 | 46 |
Success: Clinical response=Cure (s/s of Candida) or Improvement (significant, incomplete resolution of s/s) and Microbiological response=Eradication (f/u culture negative) or Presumed Eradication (f/u culture n/a and response of clinical success). Failure: Clinical response=Failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida) and Microbiological response=Persistence (positive culture for ≥1 baseline Candida spp) or Presumed Persistence (f/u culture n/a and clinical outcome= failure). (NCT00496197)
Timeframe: Week 6 Follow-up (EOS)
| Intervention | participants (Number) | |
|---|---|---|
| Success (Cure or Improvement) | Failure | |
| Anidulafungin | 131 | 56 |
Microbiological Success=Eradication: negative culture for baseline Candida spp or Presumed Eradication: f/u culture n/a and clinical outcome defined as success (cure or improvement); Microbiological Failure=Persistence: positive culture for at least 1 baseline Candida spp or Presumed Persistence: f/u culture n/a and clinical outcome defined as failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida). (NCT00496197)
Timeframe: Week 2 Follow-up
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Eradication | Presumed eradication | Persistence | Presumed persistence | |
| Anidulafungin | 30 | 135 | 3 | 5 |
Microbiological Success=Eradication: negative culture for baseline Candida spp or Presumed Eradication: f/u culture n/a and clinical outcome defined as success (cure or improvement); Microbiological Failure=Persistence: positive culture for at least 1 baseline Candida spp or Presumed Persistence: f/u culture n/a and clinical outcome defined as failure (≥3 doses Anidulafungin with no significant improvement in s/s or death due to Candida). (NCT00496197)
Timeframe: Week 6 Follow-up (EOS)
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Eradication | Presumed eradication | Persistence | Presumed persistence | |
| Anidulafungin | 12 | 134 | 2 | 8 |
Sequential organ failure assessment. 0-24 The higher the number the more severe organ failure (NCT00934934)
Timeframe: post randomization
| Intervention | score on a scale (Mean) |
|---|---|
| Placebo | 5.9 |
| Antifungal | 5.9 |
Number of days free of antibiotic use within the first 28 days (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 16 |
| Antifungal | 10 |
(NCT00934934)
Timeframe: 28 days
| Intervention | pg/ml (Mean) |
|---|---|
| VAP withCandida | 116 |
| VAP Without Candida | 129.1 |
(NCT00934934)
Timeframe: 28 days
| Intervention | mg/l (Mean) |
|---|---|
| VAP withCandida | 133 |
| VAP Without Candida | 145.7 |
Measure of the duration of participant stay in the ICU (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 11.5 |
| Antifungal | 13 |
Measure of the duration of the participant's hospital stay (NCT00934934)
Timeframe: 90 days
| Intervention | days (Median) |
|---|---|
| Placebo | 29 |
| Antifungal | 28 |
Number of days free of ICU (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 14 |
| Antifungal | 4 |
(NCT00934934)
Timeframe: 28 days
| Intervention | pg/ml (Mean) |
|---|---|
| VAP withCandida | 97.5 |
| VAP Without Candida | 3 |
Overall recruitment rate per site (NCT00934934)
Timeframe: 32 months
| Intervention | participants per site /month (Number) |
|---|---|
| Overall | 0.6 |
(NCT00934934)
Timeframe: 28 days
| Intervention | ng/ml (Mean) |
|---|---|
| VAP withCandida | 3.0 |
| VAP Without Candida | 22.5 |
Number of days in ICU free of ventilation (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 8 |
| Antifungal | 9 |
The incidence of invasive pulmonary aspergillosis during the Abelcet® prophylactic treatment period was assessed by the relation between the number of patients with invasive pulmonary aspergillosis and the number of paediatric patients on prophylaxis with Acute Leukaemia (AL) undergoing intensive chemotherapy. (NCT01615809)
Timeframe: at the Baseline visit (week 1) and at the end of the profilaxis treatment phase, up to 6 weeks
| Intervention | participants (Number) |
|---|---|
| Amphotericin B (ABELCET®) | 3 |
Percentage of deaths related to Invasive Pulmonary Aspergillosis during the prophylactic treatment period with Abelcet® in paediatric patients with Acute Leukaemia undergoing intensive chemotherapy. (NCT01615809)
Timeframe: at the Baseline visit (week 1) and at the end of the profilaxis treatment phase, up to 6 weeks
| Intervention | percentage of deaths (Number) |
|---|---|
| Amphotericin B (ABELCET®) | 0 |
is assessed by the proportion of patients who discontinue prophylactic treatment with Abelcet® due to an adverse event that is related or not to the study drug or for intolerability to it. The last week of treatment will have a different calendar for each participant, depending on the number of cicles needed by each patient (it has been anticipated up to 5 cicles of 2-6 weeks each). (NCT01615809)
Timeframe: at the Baseline visit (week 1) and during the Last week of treatment, up to 6 weeks
| Intervention | participants (Number) |
|---|---|
| Amphotericin B (ABELCET®) | 0 |
Modified MSG/EORTC criteria for the diagnosis of fungal infections: Proven invasive candidiasis is defined as candidemia, Candida cultured from a sterile site, or histopathological evidence of candida infection. Probable invasive candidiasis is defined as 2 consecutive positive beta glucan levels in the presence of signs and symptoms of infection. (NCT00520234)
Timeframe: Within 7 days after end of therapy
| Intervention | percent of participants (Number) |
|---|---|
| Prophylaxis | 9.8 |
| Placebo | 16.6 |
(NCT00520234)
Timeframe: Up to 14 days after end of therapy
| Intervention | participants (Number) |
|---|---|
| Prophylaxis | 2 |
| Placebo | 2 |
(NCT00520234)
Timeframe: Up to 14 days after end of therapy
| Intervention | participants (Number) |
|---|---|
| Prophylaxis | 1 |
| Placebo | 0 |
227 reviews available for fluconazole and Candida Infection
| Article | Year |
|---|---|
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; H | 2019 |
Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; COVID-19; Fluconazole; Humans | 2022 |
Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis.
Topics: Biofilms; Candida; Candidemia; Candidiasis; Caspofungin; Drug Resistance, Fungal; Fluconazole; Hospi | 2022 |
Systemic antifungal therapy for oesophageal candidiasis - systematic review and meta-analysis of randomized controlled trials.
Topics: Antifungal Agents; Azoles; Candidiasis; Echinocandins; Esophagitis; Fluconazole; Humans; Randomized | 2022 |
Invasive candidiasis in Africa, what is the current picture?
Topics: Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Fluconazole; Humans; Microbial Sensi | 2022 |
Distribution and antifungal susceptibility pattern of
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrat | 2022 |
Candida albicans antibiofilm molecules: analysis based on inhibition and eradication studies.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Microbial Sensitivity Tests | 2023 |
Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Humans | 2023 |
Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.
Topics: Age Factors; Antifungal Agents; Australia; Candida; Candidiasis; Cross Infection; Disease Transmissi | 2019 |
Keratitis Caused by Candida parapsilosis and Subsequent Corynebacterium macginleyi Infection: Case Report and Short Review.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candida parapsilosis; Candidiasis; Ciprofloxacin; Co | 2020 |
Candida Skull Base Osteomyelitis: a Case Report and Literature Review.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Diabetes Complications; Fluconazole; Humans; | 2020 |
Efficacy and safety of posaconazole for the prevention of invasive fungal infections in immunocompromised patients: a systematic review with meta-analysis and trial sequential analysis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Invasive Fungal Infecti | 2020 |
European confederation of medical mycology quality of clinical candidaemia management score: A review of the points based best practice recommendations.
Topics: Antifungal Agents; Blood Culture; Candida; Candidemia; Candidiasis; Central Venous Catheters; Echino | 2021 |
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance | 2020 |
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hum | 2021 |
Otomastoiditis caused by Candida auris: Case report and literature review.
Topics: Antifungal Agents; Candida; Candidiasis; Debridement; Fluconazole; Humans; Male; Mastoiditis; Microb | 2017 |
Renal fungus ball in a patient with retroperitoneal fibrosis: Unique complication in a rare disease.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Disease Management; Fluconazole; Humans; Ki | 2018 |
Antifungal Compounds against
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Wall; Drug Resistance, Fungal; Fluconazole; H | 2017 |
Treatment of Renal Fungal Ball with Fluconazole Instillation Through a Nephrostomy Tube: Case Report and Literature Review.
Topics: Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis; Diabetes Complications; F | 2018 |
Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Topics: Adolescent; Aged; Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents | 2019 |
Candida auris and multidrug resistance: Defining the new normal.
Topics: 14-alpha Demethylase Inhibitors; Aminopyridines; Amphotericin B; Antifungal Agents; Azoles; Candida; | 2019 |
Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Echinocandins; F | 2019 |
Recurrent arthritis caused by Candida parapsilosis: a case report and literature review.
Topics: Antifungal Agents; Arthritis; Candida parapsilosis; Candidiasis; Debridement; Fluconazole; Humans; K | 2019 |
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophtha | 2013 |
Neonatal infectious diseases: evaluation of neonatal sepsis.
Topics: Adaptive Immunity; Anti-Infective Agents; Antibodies, Monoclonal; Antifungal Agents; Bacterial Infec | 2013 |
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria | 2013 |
Candida cerebral abscesses: a case report and review of the literature.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Amphotericin B; Brain Abscess; | 2013 |
Background changing patterns of neonatal fungal sepsis in a developing country.
Topics: Antifungal Agents; Birth Weight; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Female; | 2013 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; | 2013 |
Candida rib osteomyelitis: erythema and nodule in midline scar.
Topics: Candidiasis; Cicatrix; Combined Modality Therapy; Drainage; Fluconazole; Follow-Up Studies; Humans; | 2013 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Hum | 2014 |
Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Discovery; Drug Interactions; Drug Resistance | 2014 |
Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Defibrillators, Implantable; Echinocandins; Echoca | 2014 |
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Europe; Fluc | 2014 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Fluconazole; Humans; Immunoc | 2014 |
Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets.
Topics: Antifungal Agents; Calcineurin; Calcium; Calcium Signaling; Candida albicans; Candidiasis; Cell Memb | 2015 |
Neonatal liver abscesses due to Candida infection in a preterm infant, secondary to malpositioned umbilical lines--a rare entity.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Fluconazol | 2015 |
The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Evolution, Molec | 2016 |
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Disease Management; Fluconazole; Humans; Intensive | 2016 |
[CANDIDIASIS GASTROINTESTINAL TRACT].
Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Drug Resistance, Fungal; Fluconazo | 2016 |
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida | 2016 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Com | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Com | 2008 |
Prevention and treatment of invasive fungal infection in very low birthweight infants.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Device Removal; Fem | 2009 |
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment.
Topics: Amphotericin B; Antifungal Agents; Bacteremia; Candida albicans; Candidiasis; Fluconazole; Humans; I | 2009 |
Antifungals in the ICU.
Topics: Antifungal Agents; Candida; Candidiasis; Critical Illness; Echinocandins; Fluconazole; Humans; Inten | 2008 |
Anidulafungin in the treatment of patients with invasive candidiasis.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidi | 2008 |
[Candidiasis].
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; beta-Glucans; Biomarkers; Candida; Candidiasis; | 2008 |
Fluconazole prophylaxis in the neonatal intensive care unit.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Extremely Low B | 2009 |
Bladder irrigation with amphotericin B and fungal urinary tract infection--systematic review with meta-analysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Randomized Cont | 2009 |
Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature.
Topics: Adult; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Cytarabine; Echinocandins; F | 2009 |
Evolving role of early antifungals in the adult intensive care unit.
Topics: Adult; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Hospital Mortality; Hum | 2009 |
Purulent pericarditis: report of 2 cases and review of the literature.
Topics: Aneurysm, Infected; Aortic Aneurysm, Thoracic; Bacterial Infections; Candida glabrata; Candidiasis; | 2009 |
Candidiasis (oropharyngeal).
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; HIV Infections | 2009 |
[Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Topics: Adult; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Doub | 2009 |
Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles | 2009 |
[Current treatment of candidemia. Role of anidulafungin].
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Suscep | 2008 |
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Il | 2008 |
The use of fluconazole in neonatal intensive care units.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Evidence-Based Medicine; Fluconazole; Humans; Infan | 2009 |
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazol | 2009 |
[Clinical pathogenesis of candidemia caused by non-albicans Candida species].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Risk Factors | 2009 |
Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Hip | 2010 |
Epidemiology and prevention of neonatal candidiasis: fluconazole for all neonates?
Topics: Animals; Candida; Candidiasis; Fluconazole; Humans; Infant, Newborn; Randomized Controlled Trials as | 2010 |
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme S | 2010 |
Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Pr | 2010 |
Candidemia in children.
Topics: Antifungal Agents; Candidiasis; Child; Echinocandins; Fluconazole; Guidelines as Topic; Humans; Risk | 2010 |
Radiotracers for fungal infection imaging.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Chi | 2011 |
[Non-cardiac chest pain].
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Antifungal Agents; Candidiasis; Chest Pain; Diagnosi | 2010 |
Exacerbation of a maternal hiatus hernia in early pregnancy presenting with symptoms of hyperemesis gravidarum: case report and review of the literature.
Topics: Adult; Antifungal Agents; Candidiasis; Cesarean Section; Female; Fluconazole; Hernia, Hiatal; Humans | 2011 |
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.
Topics: Candida; Candidiasis; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Microbial Sensitivity Te | 2010 |
[Oropharyngeal candidiasis in the practical work of the otorhinolaryngologist].
Topics: Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis; Diagnosis, Oral; Drug Res | 2010 |
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Drug Resistance, | 2011 |
In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?
Topics: Anidulafungin; Candida; Candidiasis; Caspofungin; Drug Evaluation, Preclinical; Drug Resistance, Fun | 2011 |
[Candidosis].
Topics: Antifungal Agents; Candidiasis; Catheters; Contraindications; Cross Infection; Disease Susceptibilit | 2011 |
The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidemia; Candidiasis; Dose-R | 2011 |
Pharmacokinetic evaluation of fluconazole in critically ill patients.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Evaluation; Fluconazol | 2011 |
Insights into Candida tropicalis nosocomial infections and virulence factors.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Cross Infection; Drug Resistance, Fungal; Flucon | 2012 |
Strategies for the prevention of neonatal candidiasis.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Infant, Newborn; Infan | 2012 |
Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Can | 2012 |
Onychomycosis: modern diagnostic and treatment approaches.
Topics: Antifungal Agents; Candidiasis; Combined Modality Therapy; Dermatomycoses; DNA, Fungal; Enzyme-Linke | 2013 |
Prevention of fungal infection in transplantation.
Topics: Amphotericin B; Antifungal Agents; Basement Membrane; Candida; Candidiasis; Cytomegalovirus Infectio | 2002 |
Candida lusitaniae infections in the era of fluconazole availability.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cell Culture Techn | 2003 |
[Correlation between in vitro susceptibility to antifungal drugs and the clinical evolution of patients with candidiasis and cryptococcosis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; M | 2002 |
Fluconazole: optimized antifungal therapy based on pharmacokinetics.
Topics: Antifungal Agents; Candida; Candidiasis; Dose-Response Relationship, Drug; Fluconazole; Humans; Micr | 2002 |
[Candidiasis].
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Candidiasis; Diagnosis, Differential; Echinocandins; Fl | 2003 |
Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Corynebacterium Infections; Female; Flu | 2003 |
An unusual cause of vertebral osteomyelitis: Candida species.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Discitis; Female; Fluconazole; Follow | 2003 |
Pancreatic fungal infection.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Mycoses; Pancreatitis, Acute Necrotizi | 2003 |
[Controversy concerning optimal prophylaxis and empirical antifungal therapy in immunocompromised patients].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Administration Schedule; Flucona | 2003 |
[Prophylaxis of candidosis in case of secondary immunodeficiency].
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Immunologic Deficiency Syndromes; Randomized Co | 2003 |
Intraabdominal sepsis: newer interventional and antimicrobial therapies for infected necrotizing pancreatitis.
Topics: Abdominal Cavity; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infect | 2003 |
Isolated native tricuspid valve Candida endocarditis in a non-drug-addicted patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Echocardiography; Endocarditis; Flucona | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Flucona | 2003 |
Strategies for prevention of neonatal invasive candidiasis.
Topics: Antifungal Agents; Candidiasis; Chemoprevention; Cross Infection; Fluconazole; Fungemia; Humans; Inf | 2003 |
Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazol | 2004 |
Antifungals in systemic neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Drug Therapy, Combination; | 2004 |
[Nonclinical studies and clinical studies on fosfluconazole, a triazole antifungal agent (Prodif)].
Topics: Adult; Animals; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cryptococcosis; Fluconazol | 2004 |
Fluconazole for the treatment of candidiasis: 15 years experience.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Candidiasis, Oral; Candidiasis, Vul | 2004 |
[Guidelines for the management of deep mycosis in neutropenic patients].
Topics: Amphotericin B; Aspergillosis; Candidiasis; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipopr | 2004 |
[Strategy for the treatment of fungal infections in critically ill surgical patients].
Topics: beta-Glucans; Candidiasis; Critical Illness; Fluconazole; Humans | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease | 2004 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echin | 2004 |
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Chronic Disease; Fluconazole; Humans; Leukemia, Myel | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococ | 2005 |
Neonatal candidiasis: prophylaxis and treatment.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Drug Combinations; Fluconazole; Hu | 2005 |
Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Very Low Birth Weight; | 2005 |
Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.
Topics: Antifungal Agents; Candidiasis; Critical Illness; Double-Blind Method; Drug Resistance, Fungal; Drug | 2005 |
Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Catheterization, Central Ve | 2005 |
Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Caspofu | 2005 |
Clinical consequences of resistant Candida infections in intensive care.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fl | 2006 |
Current treatment strategies for disseminated candidiasis.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Polyenes; Risk Factors | 2006 |
Fungal infections in solid organ transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic | 2006 |
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Time Factors | 2006 |
Systemic fungal infections in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Risk Factors | 2005 |
Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit.
Topics: Antifungal Agents; Candidiasis; Catheterization, Central Venous; Cross Infection; Emollients; Flucon | 2006 |
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.
Topics: Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 2006 |
Antifungal drug resistance: limited data, dramatic impact?
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; In Vitr | 2006 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Dr | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; | 2006 |
Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.
Topics: Adjuvants, Immunologic; Animals; Antifungal Agents; Candida albicans; Candidiasis; Complement System | 2006 |
Neonatal invasive candidiasis.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; | 2006 |
Fungal peritonitis in children on peritoneal dialysis.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Humans; Infan | 2007 |
Risk of resistance associated with fluconazole prophylaxis: systematic review.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Evidence-Based Medicine; Fluconazole; Human | 2007 |
Combined herpes viral and candidal esophagitis in a CAPD patient: case report and review of literature.
Topics: Acyclovir; Antifungal Agents; Antiviral Agents; Candidiasis; Esophagitis; Fatal Outcome; Female; Flu | 2007 |
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; D | 2007 |
Fungal infections in neonates: update on prevention and treatment.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Echinocandins; F | 2007 |
[Acute cholecystitis and biliary tract infections due to Candida].
Topics: Aged, 80 and over; Antifungal Agents; Biliary Tract Diseases; Bronchitis; Candidiasis; Cholecystecto | 2007 |
Presumed Candida endogenous fungal endophthalmitis: a case report and literature review.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucyto | 2007 |
Neonatal fungal infections: the state of the art.
Topics: Antifungal Agents; Birth Weight; Candidiasis; Clinical Trials as Topic; Fluconazole; Fungemia; Gesta | 2007 |
Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant; Infant, Newborn; Multicenter Studies as | 2008 |
[Prophylaxis against mycoses in neutropenic patients].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Fluconaz | 1994 |
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococc | 1994 |
[Therapy of systemic candidiasis].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Burns; Candidiasis; Flucon | 1994 |
Can we prevent azole resistance in fungi?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resista | 1995 |
Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis.
Topics: Administration, Oral; Anti-Bacterial Agents; Azoles; Candidiasis; Drug Interactions; Female; Flucona | 1995 |
Resistance of Candida species to fluconazole.
Topics: Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests | 1995 |
Use of fluconazole in the treatment of candidal endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Drug Administration Schedule; Drug Ther | 1995 |
Candida epiglottitis in an adult with acquired immunodeficiency syndrome treated with oral fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Epiglottitis; Female; Fluconazole; Humans | 1995 |
Resistant candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Mic | 1994 |
Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity.
Topics: Administration, Oral; Alanine Transaminase; Aspartate Aminotransferases; Candidiasis; Chemical and D | 1994 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fu | 1993 |
Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazo | 1994 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ | 1994 |
Candida tropicalis infections in children with leukemia.
Topics: Abscess; Adolescent; Amphotericin B; Candida; Candidiasis; Cerebrospinal Fluid; Child; Child, Presch | 1993 |
Itraconazole and fluconazole in oropharyngeal candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; | 1993 |
Candida lusitaniae osteomyelitis in a premature infant.
Topics: Candidiasis; Diseases in Twins; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premature | 1993 |
Fluconazole and itraconazole: current status and prospects for antifungal therapy.
Topics: Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Mycoses | 1993 |
Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature.
Topics: Adult; Arthritis, Infectious; Candidiasis; Fluconazole; HIV Infections; Humans; Knee Prosthesis; Mal | 1993 |
Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.
Topics: AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Drug Resistance, Mic | 1993 |
[Rational use of antimycotics against yeast infections].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Chemistry, Pharmaceutical | 1995 |
Epidemiology of candidiasis.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial; Female; Flucon | 1995 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differe | 1996 |
Problems and controversies in the management of hematogenous candidiasis.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Colony- | 1996 |
Is antifungal susceptibility testing useful in guiding fluconazole therapy?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Fluconazole; Fungi; Humans; I | 1996 |
New challenges to the therapy of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Myc | 1996 |
Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Discitis; Female; Fluconazole; Fungemia; Humans; K | 1996 |
Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; H | 1996 |
Resistance to antifungal agents in the critical care setting: problems and perspectives.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Microbial; Fluconazo | 1996 |
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Female; Fluconazole; Humans | 1996 |
Successful therapy of Candida albicans arthritis with a sequential intravenous amphotericin B and oral fluconazole regimen.
Topics: Amphotericin B; Antifungal Agents; Arthritis, Infectious; Candidiasis; Child; Drug Administration Sc | 1996 |
Candida splenic abscess in the absence of obvious immunodeficiency.
Topics: Abscess; Antifungal Agents; Candidiasis; Diabetes Mellitus, Type 1; Drainage; Female; Fluconazole; G | 1997 |
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazo | 1997 |
Azole resistance in Candida.
Topics: Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Ketoconazol | 1997 |
[Plasma and tissue concentrations of fluconazole: discussion of the breakpoint problem].
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Mycoses; | 1996 |
Candidal meningitis in HIV-infected patients: analysis of 14 cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Female | 1997 |
[High-dose therapy with fluconazole > or = 800 mg/day. Review].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dose-Respo | 1997 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; | 1997 |
[Changes in epidemiology of opportunistic infections due to Candida].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Blood; Bone Marrow Transplantation; Candid | 1995 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Antifungal agent resistance of yeasts of clinical significance].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Dru | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
Prophylaxis of fungal infections.
Topics: Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Fluconazole; Immunocompr | 1997 |
Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.
Topics: Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Humans; Microbial Sensitivity Tests; My | 1997 |
High-dose therapy with fluconazole > or = 800 mg day-1.
Topics: Antifungal Agents; Candidiasis; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Human | 1997 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazol | 1998 |
Role of the new azoles in the treatment of fungal osteoarticular infections.
Topics: Adult; Antifungal Agents; Arthritis, Infectious; Candidiasis; Cryptococcosis; Fluconazole; Humans; M | 1998 |
Refractory mucosal candidiasis in patients with human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; F | 1998 |
Refractory mucosal candidiasis in patients with human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; F | 1998 |
Refractory mucosal candidiasis in patients with human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; F | 1998 |
Refractory mucosal candidiasis in patients with human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; F | 1998 |
Candidal epididymo-orchitis: case report and review.
Topics: Aged; Antifungal Agents; Candidiasis; Epididymis; Fluconazole; Humans; Male; Orchitis | 1998 |
[Candida infections in infancy and early childhood].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Dose-Response Relationship, Drug; | 1998 |
Prosthetic knee Candida parapsilosis infection.
Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Knee; Candidiasis; Fluconazole; Humans; Knee Pro | 1998 |
[Use of fluconazole in children less than 1 year old: review].
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant; Infant, Newborn | 1998 |
[Value of high dosage fluconazole in therapy of candida infections in intensive care medicine].
Topics: Antifungal Agents; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Administrati | 1998 |
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options.
Topics: Antifungal Agents; Candida; Candidiasis; Disease Susceptibility; Drug Resistance, Microbial; Drug Th | 1998 |
[Fluconazole administration during pregnancy].
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Female; Fluc | 1998 |
[Status of fluconazole in the therapy of endogenous Candida endophthalmitis].
Topics: Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Humans | 1998 |
[Fungal arthritis--a rare complication of systemic candidiasis or orthopedic intervention. Review of therapeutic experience with fluconazole].
Topics: Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement; Arthroplasty, Replacement, Knee | 1998 |
Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluco | 1999 |
High-dose fluconazole therapy in patients with severe fungal infections.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Administration Schedule; Drug Resistance, Microbial; F | 1999 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis | 1999 |
Administration of fluconazole in children below 1 year of age.
Topics: Antifungal Agents; Candidiasis; Clinical Trials as Topic; Fluconazole; Humans; Infant; Infant, Newbo | 1999 |
Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD).
Topics: Acute Kidney Injury; Antifungal Agents; Candidiasis; Fluconazole; Humans; Renal Replacement Therapy | 1999 |
Current management of funguria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Humans; Male; | 1999 |
Successful treatment of Candida albicans endocarditis in a child with leukemia--a case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Drug Therapy, Combination; Endocar | 1999 |
Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Granulocyte Colony-Stimulati | 1999 |
The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Itraconazole | 1999 |
Role of newer azoles in surgical patients.
Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Desi | 1999 |
Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Fluconaz | 2000 |
Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Cross Infection; Fluconazole; Funge | 2000 |
Candiduria in hospitalized patients: a review.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Humans; Hypericum; Plants, Me | 2000 |
Current management of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Aspergillosis; Can | 2001 |
Antifungal and immunomodulating activities of 1,4-benzothiazine azole derivatives: review.
Topics: Animals; Antifungal Agents; Azoles; Candida; Candidiasis; Econazole; Fluconazole; Humans; Immunity, | 2001 |
Fluconazole dose recommendation in urinary tract infection.
Topics: Antifungal Agents; Candidiasis; Clinical Trials as Topic; Fluconazole; Humans; Mycoses; Urinary Trac | 2001 |
Therapy for fungal infections in leukemia.
Topics: Amphotericin B; Aspergillosis; Azoles; Candidiasis; Fluconazole; Humans; Immunotherapy; Leukemia; My | 2001 |
[Visceral candidiasis].
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Female | 2001 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itr | 2001 |
Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Neoplasms; Candida; Candidiasis; Catheterizatio | 2001 |
Fluconazole in transplant recipients: options and limitations.
Topics: Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Fluconazole; Hematopoietic Stem Cell Tr | 2000 |
Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Fluconazol | 2001 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, | 2001 |
[Prevention of fungal infections in children and adolescents with cancer].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Amphotericin B; Anemia, Aplastic; Antifungal A | 2001 |
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; | 2001 |
Candida lusitaniae catheter-related sepsis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheters, Indwelling; Equipment Contaminat | 2001 |
Management of systemic candidal infections in the intensive care unit.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cross Infection; Drug Resist | 2002 |
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Hematopoietic Stem Cell Transplantation | 2001 |
Management of candiduria.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans | 2001 |
The genetic basis of fluconazole resistance development in Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Drug Resist | 2002 |
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Metho | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th | 1992 |
[Fluconazole--a new antifungal agent].
Topics: Candidiasis; Cryptococcosis; Fluconazole; Humans | 1992 |
Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.
Topics: Amphotericin B; Animals; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans | 1992 |
Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis.
Topics: Candidiasis; Candidiasis, Oral; Esophageal Diseases; Fluconazole; HIV Infections; Humans; Mouth Muco | 1992 |
Fluconazole: a new triazole antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis; Costs and Cost Analysis; Cryptococcosis; Fluconazole; Human | 1991 |
[The significance of fluconazole (diflucan) in the therapy and prevention of candidiasis and cryptococcosis].
Topics: Candidiasis; Cryptococcosis; Fluconazole; Humans | 1990 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; | 1990 |
[New, registered specialty drugs in Austria. Diflucan, Fungata].
Topics: Animals; Candidiasis; Fluconazole; Humans; Mycoses; Opportunistic Infections | 1990 |
127 trials available for fluconazole and Candida Infection
| Article | Year |
|---|---|
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis | 2009 |
Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.
Topics: Age Factors; Animals; Antifungal Agents; Area Under Curve; Candidiasis; Female; Fluconazole; Humans; | 2018 |
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Anidulafungin; An | 2014 |
Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Infant, Newborn | 2014 |
A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Disease | 2015 |
Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; India; Infant, Newborn; Infant, Prematu | 2016 |
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Double-Blind Method; Fe | 2008 |
The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida gla | 2009 |
Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa.
Topics: Adolescent; Adult; Aged; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colitis, Ulcerat | 2009 |
Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
Topics: Antifungal Agents; Candidiasis; Child; Developmental Disabilities; Double-Blind Method; Female; Fluc | 2011 |
Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Administration Schedule; | 2002 |
Fluconazole therapy for Candida albicans urinary tract infections in infants.
Topics: Antifungal Agents; Bezoars; Candidiasis; Fluconazole; Follow-Up Studies; Humans; Infant; Infant, New | 2002 |
Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cohort Studies; | 2002 |
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.
Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Chi-Square Distribution; Critical Illn | 2002 |
Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Ca | 2002 |
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization; Double-Blind Method | 2003 |
Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al.
Topics: Antifungal Agents; Candidiasis; Critical Illness; Fluconazole; Humans; Neutropenia; Placebos; Risk F | 2003 |
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Cohort S | 2003 |
Cyclophosphamide metabolism is affected by azole antifungals.
Topics: Adolescent; Adult; Antifungal Agents; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation | 2004 |
Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients.
Topics: Adrenal Gland Diseases; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; C | 2004 |
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Topics: Administration, Oral; Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Double-Blind Metho | 2004 |
A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Doub | 2004 |
Candiduria in hospital patients: a study prospective.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Cross Infection; Female; Fluconazo | 2004 |
Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Cross Infection; Double-Blind Method; Femal | 2004 |
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Double-Blind Method; Echinocandins; Esophag | 2005 |
Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child, Preschool; Dose-Response Re | 2005 |
Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Catheterization, Central Venous; Double-Blind Meth | 2005 |
Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
Topics: Antifungal Agents; Candidiasis; Critical Illness; Fluconazole; Fungemia; Humans | 2005 |
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg.
Topics: Acute Kidney Injury; Antifungal Agents; Candida glabrata; Candidiasis; Cross-Sectional Studies; Fluc | 2006 |
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Topics: Antifungal Agents; Candida; Candidiasis; Data Interpretation, Statistical; Drug Resistance, Fungal; | 2006 |
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Candidi | 2006 |
Caspofungin in kidney transplant recipients with refractory invasive candidiasis.
Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Esophagus; Fluc | 2007 |
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; | 2007 |
Value of colposcopy in the diagnosis of candidiasis in patients with vulvodynia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Colposcopy; Female; Fluconazole; Humans; Ke | 2007 |
Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anemia, Aplastic; Antibodies, Fungal; Antibody Specificity; | 2006 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.
Topics: Antifungal Agents; Candida; Candidiasis; Cholestasis; Double-Blind Method; Female; Fluconazole; Huma | 2007 |
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; Fluconazol | 2007 |
Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants.
Topics: Antifungal Agents; Candidiasis; Double-Blind Method; Fluconazole; Humans; Infant, Newborn; Infant, P | 2007 |
Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 1995 |
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
Topics: Administration, Oral; Adult; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Cr | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aspergillosis; Aspergillus fumigatus; Candidiasis; Fe | 1995 |
[Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Female; Fluconazole; H | 1993 |
Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Candida; Candidiasis; Child; Child, Preschool; Colony Count | 1994 |
The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures.
Topics: Adult; Bone Marrow Transplantation; Candida; Candidiasis; Clotrimazole; Female; Fluconazole; Hematol | 1994 |
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
Topics: Amphotericin B; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Follow-Up Studies; Fungemia | 1994 |
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Clotrimazole; Drug Resistance, M | 1994 |
Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antigens, Fungal; Candida albicans; Candidiasis; Esoph | 1994 |
Candida in patients of a surgical intensive care unit.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Candidiasis; Female; Fluconazole; Humans; Int | 1994 |
[A clinical study on fluconazole against pulmonary mycosis associated with respiratory diseases].
Topics: Adult; Aged; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Humans; Lung Diseases, | 1994 |
Fluconazole treatment of children with severe fungal infections not treatable with conventional agents.
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Body Weight; Candida; Candidiasis; C | 1994 |
Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group.
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Child; Child, | 1994 |
Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents.
Topics: Age Factors; Body Weight; Candida; Candidiasis; Female; Fluconazole; Humans; Infant; Infant, Low Bir | 1994 |
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Female; Fluconazole; Follow- | 1994 |
The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Candida; Candidiasis; Colony Count, Microbial; Doubl | 1994 |
[A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children].
Topics: Candidiasis; Child; Female; Fluconazole; Fungemia; Humans; Immune Tolerance; Immunologic Deficiency | 1994 |
[Pharmacokinetic and clinical studies on fluconazole in the pediatric field].
Topics: Adolescent; Candidiasis; Fluconazole; Humans; Infant; Male | 1994 |
[Clinical study of fluconazole-injectable and -granules in pediatric patients].
Topics: Administration, Oral; Anemia, Aplastic; Aspergillosis; Candidiasis; Fluconazole; Humans; Injections, | 1994 |
[Experience of fluconazole granules and injection in pediatric patients].
Topics: Administration, Oral; Adolescent; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fluco | 1994 |
[Pharmacokinetic and clinical evaluations of fluconazole in pediatric patients].
Topics: Administration, Oral; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Half-Life; Humans; | 1994 |
Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.
Topics: Adult; Aged; Amphotericin B; Bacterial Infections; Candidiasis; Cause of Death; Colony Count, Microb | 1993 |
Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life.
Topics: Candidiasis; Female; Fluconazole; Half-Life; Humans; Infant, Low Birth Weight; Infant, Newborn; Infa | 1993 |
Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; | 1995 |
Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Costs and Cost Analysis; | 1995 |
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization; Fluconazole; Humans; Time Factors | 1995 |
Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Confidence Intervals; | 1995 |
Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Balanitis | 1996 |
[A multiple center clinical trial on fluconazole for deep-seated fungal infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Fe | 1995 |
Management of candida septicaemia in a regional burn unit.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Burn Units; Burns; Candidiasis; Child; F | 1995 |
Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Case-Control Studies; Female; Fluconazo | 1996 |
Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease.
Topics: Adult; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedul | 1996 |
Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.
Topics: Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Liver Transplantation; Male; Mid | 1996 |
Topical fluconazole therapy of Candida keratitis.
Topics: Abscess; Administration, Topical; Adolescent; Adult; Aged; Candidiasis; Child; Corneal Diseases; Fem | 1996 |
Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Combined Modality Therap | 1996 |
Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Esophagitis; Female; F | 1996 |
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Female; Fluconazole; Humans | 1996 |
Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms.
Topics: Adult; Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Esophageal Diseases; Esophagitis; Esop | 1996 |
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; | 1996 |
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; APACHE; Candidiasis; | 1997 |
Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents | 1997 |
A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Disease | 1997 |
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Confidence Intervals; Female; Fluconazo | 1997 |
[Systemic candidiasis in heroin addicts: therapeutic considerations].
Topics: Antifungal Agents; Candidiasis; Fluconazole; Heroin Dependence; Humans | 1997 |
Oral fluconazole for Candida urinary tract infection.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Hu | 1997 |
Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Candida albicans; Candidiasis; Child; Child, P | 1997 |
The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
Topics: Adolescent; Adult; Antifungal Agents; Autopsy; Bone Marrow Transplantation; Candidiasis; Cohort Stud | 1998 |
A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candida; Candidiasis; Chemical and Drug Induced Live | 1998 |
Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Health C | 1998 |
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Critical Care; Dou | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; | 1999 |
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Catheterization; Cross Infection; Female; F | 2000 |
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Double-Blind Method; Female; Flucon | 2000 |
Treatment of candidal infections with fluconazole in neonates and infants.
Topics: Antifungal Agents; Birth Weight; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Infant; | 2000 |
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.
Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Female; Flu | 2000 |
Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Female; Flucona | 2000 |
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; | 2000 |
Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Female; Flucona | 2000 |
Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant.
Topics: Antifungal Agents; Candida; Candidiasis; Double-Blind Method; Drug Resistance, Microbial; Female; Fl | 2001 |
Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Candid | 2000 |
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.
Topics: Aged; Antifungal Agents; APACHE; Candidiasis; Critical Illness; Double-Blind Method; Female; Flucona | 2001 |
Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Double-Blind | 2001 |
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Consumer Product Safety; Double-Blind Metho | 2001 |
Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Topics: Antifungal Agents; Bacterial Infections; Candida; Candida albicans; Candidiasis; Colony Count, Micro | 2001 |
Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; | 2002 |
Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Double-Blind Method; Fem | 2002 |
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Metho | 1992 |
Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Double-Blind Method; Esophagitis; Esophagosc | 1992 |
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Met | 1992 |
Prophylactic fluconazole and Candida krusei infections.
Topics: Candidiasis; Fluconazole; Humans; Immunosuppression Therapy; Retrospective Studies | 1992 |
Efficacy of fluconazole in the treatment of systemic fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspergillosis; Candidiasis; Female; Fluconazole; Fungemi | 1992 |
New clinical trial for prevention of yeast infections in HIV infected women.
Topics: AIDS-Related Opportunistic Infections; Candidiasis; Female; Fluconazole; Humans | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Double-Blind Method; Fluconazole; Humans; Immunosuppressio | 1992 |
[Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Esophageal Diseases; Female; Fluconazole; Fo | 1992 |
Prophylactic fluconazole and marrow transplantation.
Topics: Bone Marrow Transplantation; Candidiasis; Fluconazole; Humans; Mycoses; Premedication | 1992 |
Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Child, Preschool; Chronic Disease; Female; Fluconazole; Hu | 1991 |
Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
Topics: Adolescent; Adult; Aged; Candidiasis; Candidiasis, Oral; Child; Double-Blind Method; Female; Flucona | 1991 |
Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Alanine Transaminase; Asparta | 1991 |
Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Esophagitis; Female; Fluconazole; Humans; Ma | 1991 |
[Collection of cases in relation to clinical trials of fluconazole in Germany].
Topics: Adult; Candidiasis; Cryptococcosis; Female; Fluconazole; Humans; Male; Meningitis | 1990 |
Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Child; Child, P | 1990 |
Fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antifungal Agents; Candidiasis; Clinical Trials as Topi | 1990 |
[Clinical study of fluconazole on deep-seated fungal infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Cl | 1989 |
Fluconazole in the management of patients with chronic mucocutaneous candidosis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Tria | 1988 |
1611 other studies available for fluconazole and Candida Infection
| Article | Year |
|---|---|
Design and synthesis of 14 alpha-methyl-15-aza-D-homosterols as novel antimycotics.
Topics: Animals; Antifungal Agents; Candidiasis; Chemical Phenomena; Chemistry, Physical; Drug Design; Mice; | 1990 |
Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring.
Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Female; Male; Mice; Microbial Sensitivity Tests; Ra | 1995 |
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi | 1998 |
FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bronchogenic Cyst; Candida albicans; Candidiasis; | 2001 |
Synthesis and biological activity of novel macrocyclic antifungals: acylated conjugates of the ornithine moiety of the lipopeptidolactone FR901469.
Topics: Animals; Antifungal Agents; Candidiasis; Depsipeptides; Hemolysis; Mice; Mice, Inbred ICR; Peptides, | 2001 |
Synthesis and biological activity of novel macrocyclic antifungals. modification of the tyrosine moiety of the lipopeptidolactone FR901469.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Depsipeptides; Erythrocytes; Hemolysis; L | 2001 |
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2.
Topics: Acyltransferases; Animals; Antifungal Agents; Area Under Curve; Benzofurans; Candida albicans; Candi | 2002 |
In vivo characterization of A-192411: a novel fungicidal lipopeptide (II).
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; | 2003 |
Approaches towards the stabilization of hemiaminal function at ornithine unit of mulundocandin.
Topics: Amines; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Stability; Echinocandins; In | 2004 |
Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia.
Topics: Adult; Aged; Antifungal Agents; Area Under Curve; Candida; Candidiasis; Female; Fluconazole; Fungemi | 2007 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementatio | 2007 |
Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.
Topics: Animals; Animals, Newborn; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Microbial | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidias | 2007 |
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colony Count | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis | 2008 |
Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Dose-Respons | 2008 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Ca | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population S | 2008 |
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echino | 2008 |
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hum | 2008 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Funga | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resis | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Cas | 2009 |
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; C | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; In | 2009 |
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Anima | 2009 |
Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.
Topics: Antifungal Agents; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Codon, Nonsense; Dr | 2009 |
An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug | 2010 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Funga | 2010 |
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Disease Models, Animal; DN | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; | 2010 |
Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.
Topics: Animals; Antifungal Agents; Aspartic Acid Endopeptidases; Candida albicans; Candidiasis; Dose-Respon | 2010 |
T-2307 shows efficacy in a murine model of Candida glabrata infection despite in vitro trailing growth phenomena.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Male; Mice; Microbial Sensitivity Tests; | 2010 |
In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis.
Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Catheters; Echin | 2010 |
Novel antifungal agents: triazolopyridines as inhibitors of beta-1,6-glucan synthesis.
Topics: Antifungal Agents; beta-Glucans; Candida; Candidiasis; Drug Stability; Humans; Imidazoles; Microsome | 2010 |
Synthesis and biological activity of desmethoxy analogues of coruscanone A.
Topics: 4-Butyrolactone; Animals; Antifungal Agents; Candida; Candidiasis; Cell Line; Cell Line, Tumor; Cycl | 2011 |
Synthesis and antifungal activity of a new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Cell Line; Humans; Imidazoles; Microbial | 2012 |
Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Can | 2013 |
Synthesis and antimicrobial evaluation of amide derivatives of benzodifuran-2-carboxylic acid.
Topics: Amides; Anti-Infective Agents; Bacterial Infections; Benzofurans; Candida albicans; Candidiasis; Car | 2014 |
2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents.
Topics: Acetamides; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Dose-Response | 2015 |
Novel amalgamation of phthalazine-quinolines as biofilm inhibitors: One-pot synthesis, biological evaluation and in silico ADME prediction with favorable metabolic fate.
Topics: Anti-Infective Agents; Biofilms; Candida albicans; Candidiasis; Computer Simulation; Humans; Phthala | 2016 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol | 2017 |
Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives.
Topics: Antifungal Agents; Candida; Candidiasis; Cryptococcosis; Cryptococcus; HEK293 Cells; Humans; Microbi | 2018 |
New azole antifungals with a fused triazinone scaffold.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Mice; Microbial | 2020 |
Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.
Topics: 14-alpha Demethylase Inhibitors; Animals; Azoles; Candida albicans; Candidiasis; Cytochrome P450 Fam | 2020 |
Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis.
Topics: Animals; Azoles; Biofilms; Candida albicans; Candidiasis; Carbolines; Drug Resistance, Fungal; Drug | 2021 |
Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Binding Sites; Biofilms; Candida; Candi | 2021 |
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungi; HSP90 | 2022 |
Development of Lipo-γ-AA Peptides as Potent Antifungal Agents.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Mic | 2022 |
Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO: a case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antiviral Agents; Candida albicans; Ca | 2021 |
In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis.
Topics: Animals; Antifungal Agents; Caffeic Acids; Candida albicans; Candidiasis; Drug Synergism; Fluconazol | 2021 |
Laboratory-based surveillance of Candida auris in Colombia, 2016-2020.
Topics: Adult; Antifungal Agents; Candida auris; Candidiasis; Child; Colombia; COVID-19; Drug Resistance, Fu | 2022 |
Evaluation of bisphenylthiazoles as a promising class for combating multidrug-resistant fungal infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Resistance, Multiple; Fluconazole; Humans; Micr | 2021 |
Forward and reverse genetic dissection of morphogenesis identifies filament-competent Candida auris strains.
Topics: Animals; Antifungal Agents; Candida auris; Candidiasis; CRISPR-Cas Systems; Disease Models, Animal; | 2021 |
Unmasking of CgYor1-Dependent Azole Resistance Mediated by Target of Rapamycin (TOR) and Calcineurin Signaling in Candida glabrata.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Calcineurin; Candida glabrata; Candidi | 2022 |
Optimisation of fluconazole therapy for the treatment of invasive candidiasis in preterm infants.
Topics: Adult; Antifungal Agents; Body Weight; Candidiasis; Candidiasis, Invasive; Creatinine; Fluconazole; | 2022 |
Recidivant odynophagia secondary to persistent esophageal candidiasis in an immunocompetent patient: the importance of brush cytology.
Topics: Candidiasis; Deglutition Disorders; Esophageal Diseases; Esophagitis; Female; Fluconazole; Humans; M | 2022 |
Chitosan film containing antifungal agent-loaded SLNs for the treatment of candidiasis using a Box-Behnken design.
Topics: Adhesiveness; Administration, Buccal; Animals; Antifungal Agents; Candida albicans; Candidiasis; Chi | 2022 |
Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Female; Fluconazole; Humans; | 2022 |
Competition for Iron during Polymicrobial Infections May Increase Antifungal Drug Susceptibility-How Will It Impact Treatment Options?
Topics: Antifungal Agents; Candida albicans; Candidiasis; Coinfection; Drug Resistance, Fungal; Fluconazole; | 2022 |
A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance.
Topics: Antifungal Agents; Azoles; Biomarkers, Tumor; Candida albicans; Candidiasis; Chromatography, Liquid; | 2022 |
Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofu | 2022 |
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida parapsilosis; Candidiasis; Drug Resistance, Funga | 2022 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Dr | 2022 |
Multilocus sequence typing (MLST) analysis reveals many novel genotypes and a high level of genetic diversity in Candida tropicalis isolates from Italy and Africa.
Topics: Antifungal Agents; Cameroon; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; | 2022 |
Promising Anti-Biofilm Agents and Phagocytes Enhancers for the Treatment of
Topics: Animals; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidiasis; Cattle; Cetrimonium; F | 2022 |
Incidence and factors associated with invasive candidiasis in a neonatal intensive care unit in Mexico.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Invasive; Case-Control Studi | 2022 |
Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia.
Topics: Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Female; Fluconazole; Humans; Male; | 2022 |
Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis.
Topics: Animals; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidiasis; Fluconazole; Mice; Mic | 2022 |
Drug Resistance and Evolvability in an Emerging Human Fungal Pathogen.
Topics: Antifungal Agents; Candida; Candidiasis; DNA Copy Number Variations; Drug Resistance, Fungal; Flucon | 2022 |
Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.
Topics: Antifungal Agents; Azoles; Candida parapsilosis; Candidiasis; Drug Resistance, Fungal; Fluconazole; | 2022 |
Confirmation of fifth
Topics: Antifungal Agents; Candida; Candida auris; Candidiasis; Fluconazole; Humans; Iran; Microbial Sensiti | 2022 |
A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candidemia; Candidiasis; Drug Resistan | 2022 |
Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report.
Topics: Adult; Antifungal Agents; Candidiasis; Esophagitis; Fluconazole; HIV; Humans; Male; Mycoses; Pericar | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Ergosterol; Fluconazole; Methyltr | 2022 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Topics: Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Candidiasis; Enzyme Inhibitors; Fluconazole; | 2023 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Coinfection; COVID-19; Drug Resistance, F | 2023 |
Clinical characteristics of central nervous system candidiasis due to Candida albicans in children: a single-center experience.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System; Central Nervous System Fun | 2022 |
Clinical characteristics of central nervous system candidiasis due to Candida albicans in children: a single-center experience.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System; Central Nervous System Fun | 2022 |
Clinical characteristics of central nervous system candidiasis due to Candida albicans in children: a single-center experience.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System; Central Nervous System Fun | 2022 |
Clinical characteristics of central nervous system candidiasis due to Candida albicans in children: a single-center experience.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System; Central Nervous System Fun | 2022 |
Optimized D-α-tocopherol polyethylene glycol succinate/phospholipid self-assembled mixed micelles: A promising lipid-based nanoplatform for augmenting the antifungal activity of fluconazole.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Mice; Micelles; Phospholipid | 2022 |
Anticandidal Activity of Capsaicin and Its Effect on Ergosterol Biosynthesis and Membrane Integrity of
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Capsaicin; Ergosterol; Fluconazole; Micro | 2023 |
Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates.
Topics: Aminoglycosides; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Mic | 2023 |
Alterations in the Level of Ergosterol in
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Membrane; Drug Resistance, Fungal; Er | 2023 |
Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Cycle Proteins; Drug Resistance, Fungal; Drug | 2023 |
Congenital candidiasis in a full-term infant: A case report.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Fluconazole; Humans; Infant; Infant, Newborn | 2023 |
Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Hu | 2023 |
Small molecule II-6s synergises with fluconazole against Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Fluconazo | 2023 |
First description of Candida haemulonii infecting a snake Boa constrictor: Molecular, pathological and antifungal sensitivity characteristics.
Topics: Animals; Antifungal Agents; Boidae; Candida; Candidiasis; Fluconazole; Humans; Metal Nanoparticles; | 2023 |
A 3-year study of
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Drug Resistance, | 2023 |
Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple; Echinoc | 2023 |
Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fung | 2023 |
Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt.
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candida tropicalis; Candidiasis; Drug Resistan | 2023 |
Synergistic effect of chlorhexidine and azoles on candida biofilm on titanium surface.
Topics: Antifungal Agents; Azoles; Biofilms; Candida; Candida albicans; Candidiasis; Chlorhexidine; Fluconaz | 2023 |
Synergy In Vitro of Nikkomycin Z with Azole Against the Invasive Form of Candida albicans.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug Synergism; F | 2023 |
Developing Novel Coumarin-Containing Azoles Antifungal Agents by the Scaffold Merging Strategy for Treating Azole-Resistant Candidiasis.
Topics: Antifungal Agents; Azoles; Candidiasis; Coumarins; Fluconazole; Humans | 2023 |
Anti-virulence strategy of diaryl chalcogenide compounds against
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Humans; Hyphae; Mi | 2023 |
Alarming Increase of Azole-Resistant Candida Causing Blood Stream Infections in Oncology Patients in Egypt.
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidemia; Candidiasis; Drug Resistance, Fung | 2023 |
The alternating 50 Hz magnetic field depending on the hydrophobicity of the strain affects the viability, filamentation and sensitivity to drugs of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Hydrophobic a | 2023 |
Human Oropharyngeal Candidiasis: From Etiology to Current Treatment.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Fluconazole; Humans | 2023 |
Screening of C. auris among Candida isolates from various tertiary care institutions in Lahore by VITEK 2 and real time PCR based molecular technique.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Hospitals, Teaching; Humans; | 2023 |
Attenuating the emergence of anti-fungal drug resistance by harnessing synthetic lethal interactions in a model organism.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Gain of Func | 2019 |
Postpartum sepsis caused by an intra-abdominal yeast infection.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Postpartum Per | 2020 |
Oesophageal intramural pseudodiverticulosis: a rare endoscopic finding.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Deglutition Disorders; Endoscopy, Dige | 2019 |
Rectal Candidiasis Mimicking Ulcerative Colitis in an Immunocompetent Patient.
Topics: Aged; Candida; Candidiasis; Colitis, Ulcerative; Diagnosis, Differential; Endoscopy, Gastrointestina | 2019 |
Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida paraps | 2020 |
Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates.
Topics: Aspartic Acid Proteases; Candida albicans; Candidiasis; Enzyme Activation; Fluconazole; Gene Express | 2019 |
Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug S | 2020 |
Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Topics: Antifungal Agents; Candida; Candidemia; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluco | 2020 |
Two cases of fungal cyst infection in ADPKD: is this really a rare complication?
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Cysts; Drainage; Fat | 2019 |
Oesophageal tuberculosis with concomitant candidiasis: a rare cause of dysphagia.
Topics: Antifungal Agents; Antitubercular Agents; Candidiasis; Deglutition Disorders; Esophageal Diseases; F | 2019 |
Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility.
Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Italy | 2019 |
Don't mess with the machine - evaluation of fluconazole susceptibility testing for Candida glabrata using the new VITEK2 AST-YS08 card following species modification.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; | 2020 |
A lipase-responsive antifungal nanoplatform for synergistic photodynamic/photothermal/pharmaco-therapy of azole-resistant Candida albicans infections.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Fungal; Ethylene | 2019 |
Inhibition of biofilm- and hyphal- development, two virulent features of Candida albicans by secondary metabolites of an endophytic fungus Alternaria tenuissima having broad spectrum antifungal potential.
Topics: Alternaria; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Endophytes; Fluconazole; Hyp | 2020 |
Antibiotic saving effect of combination therapy through synergistic interactions between well-characterized chito-oligosaccharides and commercial antifungals against medically relevant yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chitosan; Drug Resistance, Fungal; Drug Syn | 2019 |
Necessity to identify candida species accurately with minimum inhibitory concentration determination in each case of bloodstream infections.
Topics: Amphotericin B; Antifungal Agents; Bacteremia; Candida; Candida tropicalis; Candidiasis; Caspofungin | 2020 |
Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance.
Topics: Animals; Antifungal Agents; Candida albicans; Candida parapsilosis; Candida tropicalis; Candidiasis; | 2020 |
A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole.
Topics: Anti-Bacterial Agents; Candidiasis; Fluconazole; Humans; Inflammation; Syphilis | 2020 |
Pediatric oropharyngeal candidiasis: A comprehensive study on risk factors and most prevalent species of Candida.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Infant; Male; Microbi | 2019 |
Overexpression of efflux pump transporter genes and mutations in ERG11 pave the way to fluconazole resistance in Candida tropicalis: A study from a North India region.
Topics: Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Indi | 2020 |
Quantitative analysis of the expression of fluconazole-resistant genes in strains of Candida albicans isolated from elderly people at their admission in an intensive care unit in Manizales, Colombia
Topics: Aged; Candida albicans; Candidiasis; Carrier Proteins; Colombia; Colony Count, Microbial; Cross Infe | 2020 |
In vitro pharmacokinetics/pharmacodynamics modeling and efficacy against systemic candidiasis in Drosophila melanogaster of a bisaryloxypropanamine derivative.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Drosophila melano | 2021 |
Species distribution and antifungal susceptibility patterns of clinical Candida isolates in North Lebanon: A pilot cross-sectional multicentric study.
Topics: Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazo | 2020 |
The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
Topics: Animals; Antifungal Agents; Biofilms; Calcium; Candida albicans; Candidiasis; Drug Resistance, Funga | 2020 |
Screening the antifungal activities of monoterpenes and their isomers against Candida species.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sen | 2020 |
The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo.
Topics: Alcohol Dehydrogenase; Amphotericin B; Animals; Antibodies, Monoclonal; Antifungal Agents; Candida a | 2020 |
[Anti-microbial activity of Rosmarinus officinalis and Zingiber officinale extracts on the species of the genus Candida and on Streptococcus pneumonia].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Ethanol; Fluco | 2021 |
Fungal arthritis with adjacent osteomyelitis caused by Candida pelliculosa: a case report.
Topics: Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Can | 2020 |
Topics: Antifungal Agents; Candida albicans; Candidiasis; Directed Molecular Evolution; Drug Resistance, Fun | 2020 |
Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cell Membrane P | 2020 |
Oxidative stress induced by piperine leads to apoptosis in Candida albicans.
Topics: Alkaloids; Antifungal Agents; Apoptosis; Benzodioxoles; Biofilms; Candida albicans; Candidiasis; Dru | 2021 |
The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug S | 2020 |
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Candidiasis; Continuous Renal Replacement The | 2020 |
Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
Topics: Adult; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidiasis; Candidiasis, Vulvovagina | 2020 |
Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromat | 2021 |
Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidemia; Candidiasis; Cohort | 2021 |
Topics: Antifungal Agents; Azoles; Candida albicans; Candida tropicalis; Candidiasis; Drug Resistance, Funga | 2020 |
Topics: Administration, Intravenous; Aftercare; Aged, 80 and over; Antifungal Agents; Aortic Valve; Candida | 2020 |
High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antitubercular Agents; Candida; Candi | 2020 |
Fungal endocarditis with heart valve replacement and atrial fibrillation posing a treatment challenge: A case report.
Topics: Antifungal Agents; Atrial Fibrillation; Candida parapsilosis; Candidiasis; Caspofungin; Combined Mod | 2020 |
Candidal Prosthetic Hip Infection in a Patient with Previous Candidal Sepsis - A Case Report.
Topics: Arthrocentesis; Arthroplasty, Replacement, Hip; Candida tropicalis; Candidiasis; Debridement; Female | 2020 |
Mrr1 regulation of methylglyoxal catabolism and methylglyoxal-induced fluconazole resistance in Candida lusitaniae.
Topics: Antifungal Agents; Candida; Candidiasis; DNA Restriction Enzymes; Drug Resistance, Fungal; Fluconazo | 2021 |
Verapamil inhibits efflux pumps in
Topics: Animals; Antifungal Agents; Biofilms; Biological Transport; Candida albicans; Candidiasis; Drug Syne | 2021 |
Effectiveness of Fluconazole Prophylaxis in a Targeted High-Risk Group in a Surgical Intensive Care Unit.
Topics: Antifungal Agents; Candidemia; Candidiasis; Critical Care; Fluconazole; Humans; Intensive Care Units | 2021 |
Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis.
Topics: Antifungal Agents; Azoles; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests | 2021 |
Post COVID-19 opportunistic candida retinitis: A case report.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; COVID-19; Eye Infections, Fungal; Fluco | 2021 |
Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Combinations; Drug Resista | 2021 |
Kerion-Like Scalp Mycosis Caused by Candida kefyr.
Topics: Candidiasis; Child, Preschool; Fluconazole; Humans; Kefir; Kluyveromyces; Male; Scalp | 2021 |
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years.
Topics: Amino Acid Substitution; Antifungal Agents; Candida parapsilosis; Candidemia; Candidiasis; Drug Resi | 2021 |
Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Esopha | 2021 |
Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Brazil; Candida; Candidiasis; COVI | 2021 |
Silver nanoparticles offer a synergistic effect with fluconazole against fluconazole-resistant Candida albicans by abrogating drug efflux pumps and increasing endogenous ROS.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Metal Nanopa | 2021 |
Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
Topics: Amino Acid Substitution; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cell W | 2021 |
Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Gene Express | 2021 |
Hyperexpression of CDRs and HWP1 genes negatively impacts on Candida albicans virulence.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Female; Fluconaz | 2021 |
Multiple facial candidal abscesses after self-administered acupuncture in a patient with undiagnosed diabetes mellitus: a case report.
Topics: Abscess; Acupuncture Therapy; Antifungal Agents; Candidiasis; Diabetes Mellitus, Type 2; Drainage; F | 2021 |
8-hydroxyquinoline-5-(N-4-chlorophenyl) sulfonamide and fluconazole combination as a preventive strategy for
Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Equipment Contamination; Fluconazole; Humans; Mic | 2021 |
Highly specific and rapid molecular detection of Candida glabrata in clinical samples.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Fluconazole; Humans; Microbial Sensit | 2021 |
Risk factors for isolation of fluconazole and echinocandin non-susceptible
Topics: Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Resistance, Fungal; Fluconazole; Gre | 2021 |
Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait.
Topics: Amino Acid Substitution; Antifungal Agents; Candida parapsilosis; Candidiasis; Drug Resistance, Fung | 2017 |
Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Human | 2017 |
Regression analysis and categorical agreement of fluconazole disk zone diameters and minimum inhibitory concentration by broth microdilution of clinical isolates of Candida.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candida; Candidiasis; Child; Child, Preschool; Culture M | 2017 |
Transabdominal collection of amniotic fluid "sludge" and identification of Candida albicans intra-amniotic infection.
Topics: Adult; Amniocentesis; Amniotic Fluid; Antifungal Agents; Candida albicans; Candidiasis; Cervix Uteri | 2018 |
Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of
Topics: Ambroxol; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Disease Models, Anima | 2017 |
Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?
Topics: Adult; Aged; Candida; Candidemia; Candidiasis; Female; Fever; Fluconazole; Humans; Liver; Male; Midd | 2017 |
Generational distribution of a Candida glabrata population: Resilient old cells prevail, while younger cells dominate in the vulnerable host.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Cell Adhesion; Cell Division; Cell Wall; | 2017 |
Candidiasis: Prevalence and resistance profiling in a tertiary care hospital of Pakistan.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cross-Sectional | 2017 |
Bullous fixed drug eruption due to fluconazole, imitating herpes simplex.
Topics: Adult; Antifungal Agents; Candidiasis; Diagnostic Errors; Drug Eruptions; Female; Fluconazole; Herpe | 2017 |
Antifungal Activity of Gallic Acid In Vitro and In Vivo.
Topics: Animals; Antifungal Agents; Arthrodermataceae; Candida; Candidiasis; Female; Fluconazole; Gallic Aci | 2017 |
Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Child; Drug Res | 2017 |
Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Dihydropyridine | 2017 |
Potent
Topics: Antifungal Agents; Candida albicans; Candidiasis; Coumarins; Drug Resistance, Fungal; Drug Synergism | 2017 |
Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.
Topics: Aged; Antifungal Agents; Antimicrobial Stewardship; Candida; Candidiasis; Case-Control Studies; Chin | 2017 |
A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Chromosomes, Fungal; Drug Resistance, Fungal; Fluc | 2017 |
Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Clotrimazole | 2017 |
Fruits as the vehicle of drug resistant pathogenic yeasts.
Topics: Antifungal Agents; Azoles; Candida; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Flucon | 2017 |
Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence.
Topics: Animal Structures; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbia | 2017 |
Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.
Topics: Antifungal Agents; Berberine; Biofilms; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Er | 2017 |
In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Topics: Adult; Amphotericin B; Antifungal Agents; Burkina Faso; Candida albicans; Candidiasis; Candidiasis, | 2017 |
Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; C | 2017 |
Antifungal activity of osthol in vitro and enhancement in vivo through Eudragit S100 nanocarriers.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Coumarins; Disease | 2018 |
Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antifungal Agents | 2017 |
(1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis.
Topics: Aged; Antifungal Agents; beta-Glucans; Biomarkers; Candida glabrata; Candidiasis; Drug Monitoring; E | 2017 |
In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cassia; Chloroform; Drug Resistance, Fungal; Ethanol; Fluco | 2018 |
The identification of Meyerozyma guilliermondii from blood cultures and surveillance samples in a university hospital in Northeast Turkey: A ten-year survey.
Topics: Antifungal Agents; Blood Culture; Candida; Candidiasis; Drug Resistance, Fungal; Epidemiological Mon | 2017 |
Fluconazole-induced Sweet's syndrome: A novel association.
Topics: Biopsy, Needle; Candidiasis; Diagnosis, Differential; Drug Eruptions; Female; Fluconazole; Humans; I | 2018 |
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models.
Topics: Antifungal Agents; Biological Availability; Candida; Candidiasis; Clinical Trials as Topic; Drug Adm | 2017 |
Dysphagia: More Than Meets the Eye?
Topics: Aged; Antifungal Agents; Candida; Candidiasis; Deglutition Disorders; Diagnosis, Differential; Endos | 2018 |
Candida oesophagitis incidentally detected by fluorine-18 fluorodeoxyglucose positron emission tomography in a patient with sarcoidosis.
Topics: Candida albicans; Candidiasis; Esophagitis; Female; Fluconazole; Fluorodeoxyglucose F18; Humans; Inc | 2017 |
Investigating the performance of drug delivery system of fluconazole made of nano-micro fibers coated on cotton/polyester fabric.
Topics: Administration, Oral; Candida albicans; Candidiasis; Coated Materials, Biocompatible; Cotton Fiber; | 2017 |
Adjuvant Stromal Amphotericin B Injection for Late-Onset DMEK Infection.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Chemotherapy, Adjuvant; Descemet S | 2017 |
Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Management; Endocarditis; Fem | 2018 |
Mixed yeast infections in Taiwan.
Topics: Antifungal Agents; Candida; Candidiasis; Coinfection; Drug Resistance, Fungal; Epidemiological Monit | 2018 |
Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata.
Topics: Alleles; Antifungal Agents; Candida glabrata; Candidiasis; Computational Biology; Drug Resistance, F | 2018 |
Bilateral Candida endophthalmitis accompanying Candida lusitaniae bloodstream infection: A case report.
Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candida; Candidemia; Candidiasis; C | 2018 |
Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Multiple, Fungal; Flucon | 2018 |
In vivo activity of fluconazole/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, | 2018 |
Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Biological Transport; Candidiasis; Drug Resist | 2018 |
Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cost-Benefit Analysis; Decision Trees; Drug Resistan | 2017 |
Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Dru | 2017 |
A case of Candida septic arthritis with rice body formation in a 2-month-old infant.
Topics: Amphotericin B; Antifungal Agents; Arthritis, Infectious; Candidiasis; Female; Fluconazole; Humans; | 2017 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; F | 2018 |
EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.
Topics: Antifungal Agents; Antimicrobial Stewardship; Candida; Candidemia; Candidiasis; Disease Management; | 2018 |
An in Vitro Study on the Effect of Combined Treatment with Photodynamic and Chemical Therapies on Candida albicans.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cell Membrane; Combined Modality Therapy | 2018 |
Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.
Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; | 2018 |
Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Humans; Light; Microbial Se | 2018 |
Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Caffeic Acids; Candida albicans; Candidiasis; Di | 2018 |
Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Catheter-Relate | 2018 |
[CASE REPORT OF CANDIDA PNEUMONIA].
Topics: Adolescent; Antifungal Agents; Candida albicans; Candidiasis; Delayed Diagnosis; Fluconazole; Humans | 2018 |
Intrathecal spinal abscesses due to
Topics: Abscess; Adult; Antifungal Agents; Candida albicans; Candidiasis; Drainage; Fluconazole; Humans; Imm | 2018 |
Antifungal Treatment and Outcome in Very Low Birth Weight Infants: A Population-based Observational Study of the German Neonatal Network.
Topics: Antifungal Agents; Candida; Candidiasis; Child, Preschool; Cohort Studies; Female; Fluconazole; Foll | 2018 |
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; | 2018 |
Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cluster Analysis; Drug Resistance, Fu | 2019 |
MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; ATP Binding Cassette Transporter, Sub | 2018 |
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates.
Topics: Amino Acid Substitution; Antifungal Agents; Azoles; Candida parapsilosis; Candidiasis; Drug Resistan | 2018 |
Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal | 2018 |
Biodistribution of free and encapsulated
Topics: Administration, Intravenous; Animals; Candida albicans; Candidiasis; Disease Models, Animal; Flucona | 2018 |
Discovery of benzylthio analogs of fluconazole as potent antifungal agents.
Topics: Animals; Antifungal Agents; Benzyl Compounds; Candida; Candida albicans; Candidiasis; Drug Resistanc | 2018 |
In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Candida albicans; Candidiasis; Cyclohexanones; D | 2018 |
Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Caprolactam; Cell Aggregation; Drug Resi | 2018 |
Impact of high MIC of fluconazole on outcomes of Candida glabrata bloodstream infection: a retrospective multicenter cohort study.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Cohort Studies; Female; Fluconazole; Humans; | 2018 |
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
Topics: Adult; Age Factors; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Dose-Respons | 2018 |
Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO.
Topics: Adult; Antifungal Agents; Area Under Curve; Candidiasis; Child; Dose-Response Relationship, Drug; Ex | 2018 |
Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
Topics: Animals; Antifungal Agents; Benzylisoquinolines; Candida albicans; Candidiasis; Disease Models, Anim | 2018 |
Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea.
Topics: Antifungal Agents; Candida parapsilosis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal P | 2018 |
A rare case of acute pancreatitis caused by Candida Albicans.
Topics: Abdominal Pain; Acute Disease; Antifungal Agents; Candida albicans; Candidiasis; Combined Modality T | 2019 |
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitor | 2018 |
Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China.
Topics: Antifungal Agents; Candida; Candidiasis; China; Drug Resistance, Fungal; Fluconazole; Fungemia; Huma | 2018 |
Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the
Topics: Animals; Antifungal Agents; Candida tropicalis; Candidiasis; Disease Models, Animal; Dose-Response R | 2018 |
Polymorphism of Polymeric Amino Acid Regions in Fungal Proteins and Correlation with Altered Echinocandin and Azole Susceptibility.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echi | 2018 |
Evolution of drug resistance in an antifungal-naive chronic
Topics: Alleles; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Cystic Fibrosis; Drug Resistance, | 2018 |
Case Report of a Tubo-ovarian Abscess Caused by Candida kefyr.
Topics: Abdominal Abscess; Abdominal Pain; Adult; Antifungal Agents; Candida; Candidiasis; Cystectomy; Fallo | 2018 |
Clinical Significance of the Floral Shift in Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Caspofungin; Drug | 2018 |
Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Drug Resistance, | 2019 |
[Results of the use of micafungin in newborns].
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Mi | 2019 |
Abrogation of Triazole Resistance upon Deletion of
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida; Candidiasis; CR | 2019 |
Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis.
Topics: Biomarkers; Candida tropicalis; Candidiasis; Computational Biology; Databases, Factual; Drug Resista | 2019 |
Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
Topics: Amino Acid Substitution; Antifungal Agents; Candida parapsilosis; Candidiasis; Cytochrome P-450 Enzy | 2019 |
Unusual case of intra-abdominal candidiasis following laparoscopic hysterectomy.
Topics: Administration, Intravenous; Adult; Antifungal Agents; Candida; Candidiasis; Drainage; Female; Fluco | 2019 |
Rare case of a 3-year-old with
Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis | 2019 |
Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Burkholderia cenocepacia; Candida albicans; Candidiasis; Drug Resistance, Fungal; | 2019 |
Novel mouse monoclonal antibodies specifically recognizing β-(1→3)-D-glucan antigen.
Topics: Animals; Antibodies, Monoclonal; Antifungal Agents; Antigens, Fungal; Aspergillus fumigatus; beta-Gl | 2019 |
Understand the genomic diversity and evolution of fungal pathogen Candida glabrata by genome-wide analysis of genetic variations.
Topics: Candida glabrata; Candidiasis; DNA Copy Number Variations; Drug Resistance, Fungal; Evolution, Molec | 2020 |
A rapidly regressive esophageal squamous papilloma.
Topics: Anti-HIV Agents; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophageal Neoplasms; Fluconaz | 2019 |
Sentinel Case of
Topics: Aged; Antifungal Agents; California; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Echino | 2019 |
Successful treatment of a
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cartilage, Articular; Caspofungin; Dr | 2019 |
Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Topics: Amphotericin B; Animal Structures; Animals; Antifungal Agents; Antipsychotic Agents; Candida albican | 2019 |
Pediatric Giant Cerebral Candida Abscess: A Case Report.
Topics: Brain; Brain Abscess; Candida; Candidiasis; Female; Fluconazole; Humans; Hydrocephalus; Infant; Vent | 2019 |
Fungal Ecology in a Tertiary Neonatal Intensive Care Unit after 16 Years of Routine Fluconazole Prophylaxis: No Emergence of Native Fluconazole-Resistant Strains.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Female; F | 2019 |
Topics: Antifungal Agents; Biofilms; Candida; Candida albicans; Candida parapsilosis; Candidiasis; Colony Co | 2019 |
Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Benzaldehydes; Biological Transport; C | 2019 |
Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
Topics: Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echino | 2019 |
Tinospora cordifolia Aqueous Extract Alleviates Cyclophosphamide- Induced Immune Suppression, Toxicity and Systemic Candidiasis in Immunosuppressed Mice: In vivo Study in Comparison to Antifungal Drug Fluconazole.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cyclophosphamide; Fluconazole; Immunocomp | 2019 |
Case report: a difficult diagnosis to swallow.
Topics: Adult; Candidiasis; Esophageal Achalasia; Esophagoscopy; Female; Fluconazole; Humans; Thiamine; Trea | 2011 |
Transumbilical single port surgery with conventional laparoscopic instruments in horseshoe kidney.
Topics: Adolescent; Antifungal Agents; Candidiasis; Dilatation, Pathologic; Equipment Design; Female; Flucon | 2013 |
In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations.
Topics: Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Cytochrome | 2013 |
Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Creatinine; Critical Illness; Cross Infection; Deoxy | 2013 |
Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Environmental Microbiology; Fluco | 2013 |
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazol | 2013 |
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassett | 2013 |
In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sen | 2013 |
Small chromosomes among Danish Candida glabrata isolates originated through different mechanisms.
Topics: Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; Chromosomes, Fungal; Cross Infectio | 2013 |
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospita | 2013 |
Letter to editor: "Gastric fistula after laparoscopic sleeve gastrectomy: don't forget to treat for Candida".
Topics: Adult; Antifungal Agents; Ascitic Fluid; Candida; Candidiasis; Female; Fluconazole; Gastrectomy; Gas | 2013 |
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis; Coinfec | 2013 |
Endocarditis caused by Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Endocarditis; Fluconazole; H | 2013 |
De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections.
Topics: Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Decision Support Techniques; Echinocandins; F | 2013 |
New clonal strain of Candida auris, Delhi, India.
Topics: Aged; Antifungal Agents; Candida; Candidiasis; Child; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resis | 2013 |
Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Female; F | 2013 |
Tricuspid valve mycetoma in an infant successfully treated by excision and complex tricuspid valve repair followed by fluconazole therapy.
Topics: Antifungal Agents; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Infant; Male; Mycetoma; | 2014 |
A case of rib fungal osteomyelitis.
Topics: Aged; Antifungal Agents; Candidiasis; Dermatomycoses; Fluconazole; Humans; Male; Osteomyelitis; Ribs | 2014 |
Successful conservative treatment of a candida albicans intraperitoneal mesh infection following laparoscopic ventral hernia repair.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Hernia, Ventral; Hernio | 2015 |
Candida arteritis in a pair of renal transplant recipients.
Topics: Aged; Antifungal Agents; Arteritis; Candida albicans; Candidiasis; Fluconazole; Humans; Kidney Failu | 2013 |
In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbi | 2014 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil | 2014 |
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Bacteremia; Candida albicans; Candidiasis; Cath | 2014 |
Is empiric therapy with fluconazole appropriate for esophageal candidiasis?
Topics: Adult; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Esophageal Diseases | 2014 |
Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candida albicans; Candidemia; Candidiasis; Child; Chi | 2014 |
Anidulafungin-induced alopecia.
Topics: Adult; Alopecia; Anidulafungin; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Echinocan | 2014 |
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis.
Topics: Animals; Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Caspofungin; Che | 2014 |
[Antifungal treatment for suspected or proved candidiasis in the critically ill].
Topics: Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis; Critical Illness; Drug Utilization; E | 2014 |
Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.
Topics: Adult; Antifungal Agents; Arthritis; Candida glabrata; Candidiasis; Fluconazole; Humans; Male; Recur | 2014 |
Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; CD4 Lymphocyt | 2014 |
Candidal renal papillary necrosis conquered.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Diabetes Mellitus, Type 2; Fluconazole; Hum | 2013 |
Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals.
Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candid | 2014 |
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis.
Topics: Administration, Intravenous; Aged; Antifungal Agents; Ascites; Bile; Candida; Candidiasis; Fluconazo | 2014 |
In vitro interactions between fluconazole and minocycline against mixed cultures of Candida albicans and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antifungal Agents; Biofilms; Calcium; Candida albicans; Candidiasis; Coinfect | 2015 |
In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; ATP-Binding Cassette Transporters; Candida; Candidi | 2014 |
Glutathione metabolism in Candida albicans resistant strains to fluconazole and micafungin.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazol | 2014 |
A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fu | 2014 |
Is the S405F mutation in Candida albicans ERG11 gene sufficient to confer resistance to fluconazole?
Topics: Amino Acid Substitution; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resista | 2014 |
Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Flucytosine; Humans; | 2014 |
Black hairy tongue (lingua villosa nigra).
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Male; Middle Aged; Tongue, Ha | 2013 |
Potent drugs that attenuate anti-Candida albicans activity of fluconazole and their possible mechanisms of action.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Celecoxib; Cycl | 2014 |
Case report of a ureteral obstruction by Candida albicans fungus balls detected by magnetic resonance imaging in kidney transplant recipient.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Bezoars; Candida albicans; Candidiasis; Flu | 2014 |
Acute Candida thyroiditis complicated by abscess formation in a severely immunocompromised patient.
Topics: Abscess; Adult; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Immunocomprom | 2014 |
Intrastromal antifungal injection with secondary lamellar interface infusion for late-onset infectious keratitis after DSAEK.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Corneal Stroma; Corneal | 2014 |
Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Cell Line; Female; Fluconazole; Fungal Pr | 2014 |
Editorial commentary: Fluconazole therapeutic drug monitoring in children with cancer: not today.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Male; Neoplasms | 2014 |
Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children.
Topics: Adolescent; Antifungal Agents; Candidiasis; Child; Child, Preschool; Critical Illness; Drug Monitori | 2014 |
Hyperphosphatemia in a patient with Candida sepsis.
Topics: Amphotericin B; Antifungal Agents; Blood Chemical Analysis; Candida; Candidiasis; Fluconazole; Human | 2014 |
Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; beta-Lactamases; Candida; Candidiasis; Carrier St | 2014 |
Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by Fluconazole.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Carrier Proteins; Cell Wall; Cytochrome P-450 Enzy | 2014 |
Synthesis and anti-yeast evaluation of novel 2-alkylthio-4-chloro-5-methyl-N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]benzenesulfonamide derivatives.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; | 2014 |
Analysis of the relationship between fluconazole consumption and non-C. albicans Candida infections.
Topics: Adult; Candida; Candidiasis; Cross Infection; Drug Utilization; Fluconazole; Humans; Incidence; Inte | 2014 |
Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Base Sequence; Binding Sites; Candida glabrata | 2014 |
Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis.
Topics: Adhesiveness; Anti-Bacterial Agents; Candida albicans; Candidiasis; Chemistry, Pharmaceutical; Drug | 2016 |
Candida parapsilosis osteomyelitis.
Topics: Amputation, Traumatic; Antifungal Agents; Candida; Candidiasis; Ceftriaxone; Debridement; Drug Thera | 2014 |
Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
Topics: Abdominal Cavity; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Candida; Candidemia; Candi | 2014 |
Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Artemisinins; Artesunate; Biofilms; Candida albicans; Candidiasis | 2015 |
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
Topics: 14-alpha Demethylase Inhibitors; Amino Acid Substitution; Antifungal Agents; Azoles; Candida albican | 2015 |
Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Epithelial Cells; Fluconazole; Humans; Keto | 2016 |
The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia.
Topics: Antifungal Agents; Candida tropicalis; Candidemia; Candidiasis; Cytochrome P-450 Enzyme System; Fluc | 2015 |
In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.
Topics: Animals; Antifungal Agents; Biofilms; Candida glabrata; Candidiasis; Disease Models, Animal; Echinoc | 2015 |
Management of infected non-union of the proximal femur: a combination of therapeutic techniques.
Topics: Adult; Amoxicillin; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Cements; Candidia | 2014 |
Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.
Topics: Antifungal Agents; Base Sequence; Candida; Candidemia; Candidiasis; DNA, Fungal; Drug Resistance, Fu | 2015 |
Three cases of candidiasis misidentified as Candida famata by the Vitek 2 system.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Diagnostic Errors; Female; Fluconazole; Humans | 2015 |
Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Candidiasis; Child; Child, Presc | 2015 |
The evolution of drug resistance in clinical isolates of Candida albicans.
Topics: Adhesiveness; Aneuploidy; Candida albicans; Candidiasis; Drug Resistance, Fungal; Evolution, Molecul | 2015 |
Effects of fluconazole treatment of mice infected with fluconazole-susceptible and -resistant Candida tropicalis on fungal cell surface hydrophobicity, adhesion and biofilm formation.
Topics: Animals; Antifungal Agents; Biofilms; Candida tropicalis; Candidiasis; Cell Membrane; Drug Resistanc | 2015 |
Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model.
Topics: Animals; Antifungal Agents; Benzoquinones; Candida albicans; Candidiasis; Disease Models, Animal; Dr | 2015 |
The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Tea | 2015 |
Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aortic Valve; Candida; Candidiasis; Endocarditis; Fluconazo | 2015 |
Fluconazole treatment of intrauterine Candida albicans infection in fetal sheep.
Topics: Analysis of Variance; Animals; Antifungal Agents; Candidiasis; Female; Fetal Diseases; Fluconazole; | 2015 |
Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cyclosporine; Drug Synergism; Fluconazol | 2015 |
Fungal endocarditis after hybrid periventricular closure of muscular ventricular septal defect by Amplatzer occluder in a child.
Topics: Administration, Oral; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Endocarditis; Fluco | 2015 |
Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Corneal Ulcer; Eye Infect | 2015 |
MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Cluster Analysis; Drug Resistance, Fungal; Flucona | 2015 |
Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross-Sectional Studies; Dose-Resp | 2014 |
Ibuprofen potentiates the in vivo antifungal activity of fluconazole against Candida albicans murine infection.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Candidiasis; | 2015 |
Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Critical Care Outcomes; Critical Illness; Cros | 2015 |
Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery.
Topics: Adult; Ascitic Fluid; Bacteria; Bariatric Surgery; Candida; Candidiasis; Coinfection; Drug Resistanc | 2015 |
Are prophylactic antifungals in highly colonized patients safe and effective?
Topics: Antifungal Agents; Candida; Candidiasis; Critical Illness; Female; Fluconazole; Humans; Male | 2015 |
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Cand | 2015 |
Tubo-Ovarian Abscess Caused by Candida Albicans in an Obese Patient.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Drainage; D | 2015 |
Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Tra | 2015 |
Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Drug Resistance, Fungal; Fluconaz | 2015 |
Candida albicans and Streptococcus pyogenes balanitis: diabetes or STI?
Topics: Amoxicillin; Anti-Bacterial Agents; Antifungal Agents; Balanitis; Candida albicans; Candidiasis; Dia | 2015 |
Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Cross Infection; Disk Diffusion Antimicrobial Tests | 2015 |
Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Prote | 2015 |
Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model.
Topics: Adaptation, Physiological; Animals; Candida albicans; Candidiasis; Copepoda; Disease Models, Animal; | 2015 |
Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Micro | 2015 |
Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Prote | 2015 |
Candida albicans osteomyelitis as a cause of chest pain and visual loss.
Topics: Adult; Amphotericin B; Antifungal Agents; Blindness; Candida albicans; Candidiasis; Chest Pain; Fluc | 2015 |
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albican | 2016 |
Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Chromatography, High Pr | 2015 |
Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole | 2016 |
Effects of Antifungal Soaked Silicone Hydrogel Contact Lenses on Candida albicans in an Agar Eye Model.
Topics: Agar; Antifungal Agents; Candida albicans; Candidiasis; Contact Lenses, Hydrophilic; Drug Delivery S | 2016 |
In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis.
Topics: Adult; Aged; Antifungal Agents; Australia; Candida; Candidemia; Candidiasis; Chromatography, High Pr | 2016 |
Fluconazole use and birth defects in the National Birth Defects Prevention Study.
Topics: Abnormalities, Drug-Induced; Adult; Antifungal Agents; Candidiasis; Case-Control Studies; Female; Fl | 2016 |
Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Cytochrome P-45 | 2016 |
Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans.
Topics: Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Synergism; Eugenol; Fluconazol | 2015 |
The isolation of Candida rugosa and Candida mesorugosa from clinical samples in Ghana.
Topics: Antifungal Agents; Candida; Candidiasis; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Fluco | 2016 |
[Species distribution and antifungal susceptibility of Candida spp. causing superficial mycosis. Coro, Falcon state, Venezuela].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sen | 2015 |
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Chlorocebus aethiops; Drug Resistance, Fu | 2016 |
Fluconazole use during breastfeeding.
Topics: Antifungal Agents; Breast Diseases; Breast Feeding; Candidiasis; Female; Fluconazole; Humans; Infant | 2015 |
Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
Topics: Animals; Antifungal Agents; Apoptosis; Biofilms; Candida albicans; Candidiasis; Catheter-Related Inf | 2016 |
Epidemiology of Candida Infections in HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; | 2015 |
[Xianglian External Lotion Restored the Sensitivity of Drug-resistant Candida albicans Strains to Fluconazole: a Transcriptomics Study].
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drugs, Chinese H | 2015 |
Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
Topics: Animals; Antifungal Agents; Binding Sites; Candida glabrata; Candidiasis; DNA-Binding Proteins; Drug | 2016 |
Endogenous Candida endophthalmitis and osteomyelitis associated with CARD9 deficiency.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; CARD Signaling Adaptor Proteins; Endophthal | 2016 |
Community acquired fungemia caused by Candida pulcherrima: diagnostic contribution of MALDI-TOF mass spectrometry.
Topics: Antifungal Agents; Candida; Candidemia; Candidiasis; Community-Acquired Infections; Fluconazole; Hum | 2016 |
[Clinical analysis of 8 cases of neonatal septicemia caused by Candida haemulonii in neonatal intensive care unit].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; C-Reactive Protein; Candida; Candidiasis; | 2016 |
Bilateral Endogenous Endophthalmitis Caused by Candida albicans After Breast Implant Surgery.
Topics: Adult; Breast Implants; Candida albicans; Candidiasis; Device Removal; Endophthalmitis; Eye Infectio | 2016 |
Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candidiasis; Carcinoma, Hepatocel | 2016 |
Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans.
Topics: Antifungal Agents; Calcium Channel Blockers; Candida albicans; Candidiasis; Drug Resistance, Fungal; | 2016 |
Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
Topics: Animals; Antifungal Agents; Berberine; Biofilms; Candida; Candidiasis; Cell Line; Cell Proliferation | 2016 |
Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates.
Topics: Amino Acid Substitution; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2016 |
Chronic mucocutaneous candidiasis presenting as Candida endophthalmitis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic | 2016 |
Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients.
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cross Infection; | 2017 |
[25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
Topics: Antifungal Agents; Candida albicans; Candidiasis; DNA, Fungal; Drug Resistance, Fungal; Female; Fluc | 2016 |
Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chinese Han women.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fun | 2016 |
Acute Esophageal Necrosis Caused by Candidiasis in a Patient with Systemic Lupus Erythematosus.
Topics: Adult; Anti-Bacterial Agents; Candidiasis; Endoscopy, Digestive System; Esophagus; Female; Fluconazo | 2016 |
Antifungal Susceptibility Testing in HIV/AIDS Patients: a Comparison Between Automated Machine and Manual Method.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Mi | 2016 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungi | 2016 |
Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
Topics: Acute Kidney Injury; Antifungal Agents; Area Under Curve; Candidiasis; Computer Simulation; Critical | 2016 |
Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.
Topics: Antimicrobial Cationic Peptides; Aspergillus fumigatus; Biofilms; Candida albicans; Candidiasis; Cat | 2016 |
The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida albicans; Candidiasis; Cyclosporine; Do | 2016 |
Candida guilliermondii continuous ambulatory peritoneal dialysis peritonitis confirmed by 16s rRNA sequencing.
Topics: Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Fluconazole; Humans; Male; Middle Aged; Perito | 2016 |
Species distribution & antifungal susceptibility pattern of oropharyngeal Candida isolates from human immunodeficiency virus infected individuals.
Topics: Adolescent; Adult; Aged; Antiretroviral Therapy, Highly Active; Candida; Candidiasis; Child; Child, | 2016 |
Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Chorioamnionitis; Cytokines; Female; Fetu | 2016 |
Antifungal susceptibilities of Candida species isolated from urine culture.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Flu | 2016 |
Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.
Topics: Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Biological Transport; Candida glabrat | 2016 |
Role of Non Albicans Candida Spp. and Biofilm in Neonatal ICU.
Topics: Antifungal Agents; Biofilms; Candida; Candida albicans; Candida tropicalis; Candidemia; Candidiasis; | 2016 |
Fungal Esophagitis in a Child with Insulin Dependent Diabetes Mellitus.
Topics: Abdominal Pain; Antifungal Agents; Biopsy; Candida; Candidiasis; Child; Diabetes Mellitus, Type 1; E | 2016 |
Reduced Visual Acuity Following Kidney Stone Extraction.
Topics: Antifungal Agents; Candida; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Human | 2016 |
Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cyc | 2016 |
Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Topics: Antifungal Agents; Caffeic Acids; Candida albicans; Candidiasis; Cells, Cultured; Drug Synergism; Es | 2016 |
Effect of novel triazole-amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies.
Topics: Amino Acids; Antifungal Agents; Candida; Candidiasis; Fluconazole; HEK293 Cells; Humans; Microbial S | 2016 |
Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
Topics: Amino Acid Substitution; Antifungal Agents; ATP-Binding Cassette Transporters; Candida glabrata; Can | 2017 |
Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls.
Topics: Animals; Antifungal Agents; Bird Diseases; Candida glabrata; Candidiasis; Charadriiformes; Cluster A | 2016 |
Use of Intra-Articular Amphotericin B in the Treatment of Candida parasilosis and albicans in Prosthetic Joint Infections (PJI): A Novel Approach to this Difficult Problem.
Topics: Aged; Amphotericin B; Antifungal Agents; Arthroplasty, Replacement, Knee; Candida; Candidiasis; Comm | 2017 |
Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Gas Chromatography-Mass Spect | 2016 |
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Disease Models, Animal; Drug Re | 2016 |
Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report.
Topics: Antifungal Agents; Bone Marrow Transplantation; Candida albicans; Candidiasis; Chronic Disease; Fluc | 2017 |
Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Invasive; Cas | 2016 |
Intra-abdominal
Topics: Abdomen, Acute; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Echinocandi | 2017 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Dr | 2017 |
Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus.
Topics: Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; | 2017 |
Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candida glabrat | 2017 |
Fluconazole-containing agar Sabouraud dextrose plates are not useful when screening for susceptibility in Candida albicans.
Topics: Agar; Antifungal Agents; Candida albicans; Candidiasis; Culture Media; Fluconazole; Glucose; Microbi | 2017 |
Multilocus sequence analyses reveal extensive diversity and multiple origins of fluconazole resistance in Candida tropicalis from tropical China.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; China; Cluster Analysis; Drug Resistance, Fungal | 2017 |
In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined by the time-kill method.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Vi | 2008 |
Why prevent invasive Candida infections?
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Pre | 2008 |
[Candidemia and granulomatous tubulointerstitial nephritis].
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Female; Fluconazole; Human | 2008 |
Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Topics: Antifungal Agents; Australia; Candidiasis; Cross Infection; Drug Resistance, Fungal; Female; Flucona | 2008 |
Significant differences in drug susceptibility among species in the Candida parapsilosis group.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Hum | 2008 |
"String-of-pearls".
Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Fluconazole; Humans; Substance Abuse, Intrav | 2008 |
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.
Topics: Adult; Aged; Antifungal Agents; APACHE; Candida; Candidiasis; Dose-Response Relationship, Drug; Drug | 2008 |
Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
Topics: Antifungal Agents; Candida; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazo | 2008 |
The answer is in: fluconazole prophylaxis is not beneficial for intensive care unit patients without neutropenia.
Topics: Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Fluconazole; Fungemia; Humans; Inten | 2008 |
First case of continuous ambulatory peritoneal dialysis peritonitis due to Candida sake.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Male; Peritoneal Dialysis, Cont | 2009 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis | 2009 |
Prevention of invasive Candida infections in preterm infants: the time is now.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Gestational Age; Humans; Infant, Newborn; Inf | 2008 |
The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Utilization; | 2009 |
Multiple septic complications of disseminated candidiasis following anorectal sepsis in a non-immunocompromised patient.
Topics: Aged, 80 and over; Antifungal Agents; Anus Diseases; Candida albicans; Candidiasis; Epididymitis; Fl | 2008 |
Candida species: species distribution and antifungal susceptibility patterns.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; South Africa | 2008 |
[A case of nail candidiasis with severe deformities treated with oral fluconazole].
Topics: Administration, Oral; Aged; Candidiasis; Female; Fluconazole; Humans; Nails, Malformed; Onychomycosi | 2008 |
ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
Topics: Antibodies, Fungal; Antifungal Agents; ATP-Binding Cassette Transporters; Biological Transport, Acti | 2008 |
Pattern of Candida isolates in hospitalized children.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Child, Hospitalized; Child, Preschool; Cross Infecti | 2008 |
Double-blind active-control trials: beware the comparator you keep.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Double-Blind Method; Echinocandins; Fev | 2008 |
[Case report: Analysis of the critical time delays from the fever increase to the first antimycotic dose during the diagnosis of candidemia].
Topics: Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Fungemia; | 2008 |
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Case-Control Studies; Drug Resistance, Funga | 2008 |
Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candida glabrata; Candidiasis; Fluconazole; Fungemia; Humans; In | 2008 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Flucon | 2008 |
A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Diagnostic Errors; Drug Resistance, Fungal; | 2008 |
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Databases, Factual; Fluconazole; Humans; Microbial | 2008 |
Population pharmacokinetics of fluconazole in young infants.
Topics: Age Factors; Algorithms; Antifungal Agents; Candidiasis; Creatinine; Dose-Response Relationship, Dru | 2008 |
Population pharmacokinetics of fluconazole in young infants.
Topics: Age Factors; Algorithms; Antifungal Agents; Candidiasis; Creatinine; Dose-Response Relationship, Dru | 2008 |
Population pharmacokinetics of fluconazole in young infants.
Topics: Age Factors; Algorithms; Antifungal Agents; Candidiasis; Creatinine; Dose-Response Relationship, Dru | 2008 |
Population pharmacokinetics of fluconazole in young infants.
Topics: Age Factors; Algorithms; Antifungal Agents; Candidiasis; Creatinine; Dose-Response Relationship, Dru | 2008 |
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospital | 2009 |
Treatment-related risk factors for hospital mortality in Candida bloodstream infections.
Topics: Antifungal Agents; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Cohort Studi | 2008 |
Clinical reasoning: rhabdomyolysis after combined treatment with simvastatin and fluconazole.
Topics: Aged; Anticholesteremic Agents; Antifungal Agents; Candidiasis; Diagnosis, Differential; Drug Therap | 2008 |
Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Child, Pre | 2008 |
Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemi | 2009 |
Fluconazole prophylaxis decreases the combined outcome of invasive Candida infections or mortality in preterm infants.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Infant, Extremely Low Birth Weight; In | 2008 |
Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility.
Topics: Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Int | 2009 |
In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sen | 2008 |
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, | 2009 |
Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit.
Topics: Adult; Animals; Antifungal Agents; Candidiasis; Chemoprevention; Dialysis; Fluconazole; Fungemia; He | 2009 |
In vitro photodynamic inactivation of Candida spp. growth and adhesion to buccal epithelial cells.
Topics: Candida; Candidiasis; Cell Adhesion; Cells, Cultured; Cheek; Drug Resistance, Fungal; Epithelial Cel | 2009 |
Persistent Candida parapsilosis funguria associated with an indwelling urinary tract stent for more than 7 years.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Mid | 2008 |
Fluconazole exposure and selection for Candida non-albicans.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans | 2008 |
In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Flavanones; Fluconazole; | 2008 |
Candida epiglottitis: a rare emergent condition--appearance, treatment and pitfalls.
Topics: Aged; Antifungal Agents; Candidiasis; Diagnosis, Differential; Emergencies; Epiglottis; Epiglottitis | 2008 |
[Candidiasis in the experimental model of ulcerative colitis].
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Colitis, Ulcerative; Colon; Disease Models, Animal | 2007 |
Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Topics: Animals; Antifungal Agents; beta-Glucans; Candida albicans; Candidiasis; Caspofungin; Cell Wall; Dis | 2008 |
[Effect of qishen huoxue granule combined with fluconazole on survival rate of mice with systemic C. albaicans infection].
Topics: Animals; Candida albicans; Candidiasis; Disease Models, Animal; Drug Therapy, Combination; Drugs, Ch | 2008 |
Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitalization; Huma | 2008 |
Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
Topics: Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Fluconazole; Humans; Publishing; Ran | 2009 |
Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
Topics: Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Fluconazole; Humans; Publishing; Ran | 2009 |
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms | 2008 |
Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.
Topics: Amino Acid Substitution; Animals; ATP-Binding Cassette Transporters; Candida glabrata; Candidiasis; | 2009 |
[Fournier's gangrene caused by Candida albicans].
Topics: Antifungal Agents; Candida albicans; Candidiasis; Debridement; Diabetes Complications; Diagnosis, Di | 2008 |
Antifungal prophylaxis: identification of preterm neonates at highest risk for invasive fungal infection.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature, Diseases; I | 2009 |
Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Brazil; Candidiasis; Caspofungin; Chi | 2008 |
Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Catheterization, Central Venous; Cath | 2009 |
Candida parapsilosis endocarditis in aged patient.
Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; | 2009 |
Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans.
Topics: Antifungal Agents; Arthroplasty, Replacement, Knee; Biofilms; Candidiasis; Drug Therapy, Combination | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; | 2009 |
Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidia | 2008 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, M | 2009 |
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Topics: Aged; Aged, 80 and over; Animals; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis | 2009 |
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheter-Related Infections; Device Rem | 2009 |
Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Australia; Candida albicans; Candidiasis; Child; Child, Pr | 2009 |
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Flucona | 2009 |
Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
Topics: Antifungal Agents; Asia; Candidiasis; Consensus; Fluconazole; Humans; Intensive Care Units; Pacific | 2009 |
[Species-specific differences in Rhodamine 6G accumulation of Candida isolates detected by flow cytometric analysis].
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Fungal; Flow Cytometry; Fluconazol | 2009 |
Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
Topics: Animals; Antifungal Agents; Antioxidants; Ascorbic Acid; Candida albicans; Candidiasis; Disease Mode | 2009 |
Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug Synergism; E | 2009 |
Data mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility Testing.
Topics: Algorithms; Antifungal Agents; Candida; Candidiasis; Computational Biology; Fluconazole; Humans; Mic | 2009 |
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; | 2009 |
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases | 2009 |
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 2009 |
[Unfortunately it is too often unrecognized. Burning pain in breast feeding].
Topics: Administration, Oral; Adult; Antifungal Agents; Breast Diseases; Breast Feeding; Candida; Candidiasi | 2009 |
Catheter-related fungemia caused by Candida intermedia.
Topics: Adult; Aged, 80 and over; Antifungal Agents; Blood; Candida; Candidiasis; Catheterization, Central V | 2010 |
Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, | 2010 |
[Candida albicans endocarditis after pulmonary artery banding].
Topics: Administration, Oral; Aneurysm, False; Aneurysm, Infected; Antifungal Agents; Candidiasis; Caspofung | 2009 |
Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Topics: Amino Acid Sequence; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bas | 2009 |
Hepatosplenic candidiasis imaged with F-18 FDG PET/CT.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acut | 2009 |
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation.
Topics: Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Cross Infection; Decision Trees; Drug Costs; | 2009 |
Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Microbial Sensitivity | 2011 |
Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
Topics: Administration, Intravaginal; Administration, Oral; Animals; Antifungal Agents; Candida albicans; Ca | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucy | 2009 |
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.
Topics: Area Under Curve; Candidiasis; Computer Simulation; Dose-Response Relationship, Immunologic; Drug Do | 2009 |
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity T | 2009 |
Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Hematopoietic | 2009 |
The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Mic | 2010 |
Azole resistant Candida glabrata vulvovaginitis treated with boric acid.
Topics: Adult; Antifungal Agents; Boric Acids; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Femal | 2009 |
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Chemoprevention; Cross-Over Studies; Drug Util | 2009 |
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candid | 2009 |
Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Corneal Stroma; Corneal Ulcer; Disease Mo | 2010 |
Effects of antifungal agents in sap activity of Candida albicans isolates.
Topics: Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Culture Media; DNA, Funga | 2010 |
Fungal laryngitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Antifungal Agents; Candidiasis; Disease Suscept | 2009 |
Esophageal candidiasis in an immunocompetent girl.
Topics: Adrenal Cortex Hormones; Anti-Ulcer Agents; Antifungal Agents; Asthma; Candidiasis; Drug Therapy, Co | 2009 |
Blood stream infections by Candida glabrata and Candida krusei: a single-center experience.
Topics: Adult; Aged; APACHE; Candida glabrata; Candidiasis; Female; Fluconazole; Fungemia; Humans; Incidence | 2009 |
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
Topics: Antifungal Agents; Candida; Candidiasis; Clinical Protocols; Echinocandins; Fluconazole; Humans; Int | 2009 |
Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006.
Topics: Alleles; Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; F | 2009 |
A rapid and sensitive LC-MS/MS method for determination of fluconazole in human plasma and its application in infants with Candida infections.
Topics: Analytic Sample Preparation Methods; Antifungal Agents; Calibration; Candidiasis; Chromatography, Hi | 2009 |
Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Calcineurin; Candida albicans; Candidiasis; Flucona | 2010 |
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization | 2010 |
In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disulfides; Drug Resistan | 2010 |
In vitro antifungal activity of the berberine and its synergism with fluconazole.
Topics: Antifungal Agents; Berberine; Candida albicans; Candidiasis; Drug Synergism; Fluconazole; Humans; Mi | 2010 |
Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Funga | 2011 |
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive | 2010 |
Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents.
Topics: Acneiform Eruptions; Aged; Boronic Acids; Bortezomib; Candida albicans; Candidiasis; Desonide; Dexam | 2010 |
Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature.
Topics: Antifungal Agents; Candida; Candidiasis; Catheters, Indwelling; Crohn Disease; Fluconazole; Fungemia | 2009 |
In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Disulfides; Drug Synergism; Fluconazole; Humans; Ke | 2010 |
Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cholestasis; Female; Fluconazole; Humans; In | 2010 |
Intraventricular fungus ball: a unique manifestation of refractory intracranial candidiasis in an immunocompetent neonate.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Brain Diseases; Candidiasis; Caspofungin; E | 2009 |
Candida parapsilosis meningitis associated with shunt infection in an adult male.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida; Candidiasis; Drainage; Fluconazole; Flucy | 2010 |
Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Topics: Adult; Aged; Antifungal Agents; Candida glabrata; Candidiasis; Cohort Studies; Critical Care; Critic | 2010 |
Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Aged; Antifungal Agents; Candidiasis; Cardiomyopathy, Hypertrophic; Echinocandins; Endocarditis; Fem | 2010 |
Characterization of plant-derived saponin natural products against Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Erythrocytes; Fluconaz | 2010 |
[Postoperative Candida Iris nodules: report of a case].
Topics: Aged; Candidiasis; Fluconazole; Humans; Iritis; Male; Phacoemulsification | 2009 |
Evaluation by data mining techniques of fluconazole breakpoints established by the Clinical and Laboratory Standards Institute (CLSI) and comparison with those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
Topics: Academies and Institutes; Advisory Committees; Algorithms; Antifungal Agents; Bayes Theorem; Candida | 2010 |
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microb | 2010 |
Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Disk Diffusion Antimicrobial Tests; Fluconazole; Microbial | 2010 |
The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Human | 2010 |
The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; APACHE; Candida; Candidiasi | 2010 |
Esophagitis caused by Candida guilliermondii in diabetes mellitus: first reported case.
Topics: Antifungal Agents; Candida; Candidiasis; Diabetes Complications; DNA, Fungal; DNA, Ribosomal; Esopha | 2010 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidin | 2010 |
Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Critical Care; Cross-Sectional Studies; Drug Resis | 2010 |
Fungal cerebral abscess in a diabetic patient successfully treated with surgery followed by prolonged antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Combined Modality T | 2010 |
In vitro and in vivo antifungal activities of aminopiperidine derivatives, novel ergosterol synthesis inhibitors.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Ergosterol; Female; Fluconazole; Fungi; I | 2010 |
Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans.
Topics: Amiodarone; Animals; Antifungal Agents; Calcium; Candida albicans; Candidiasis; Down-Regulation; Dru | 2010 |
Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fu | 2010 |
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Resistance | 2010 |
Candida albicans peritonitis in a dog.
Topics: Animals; Antifungal Agents; Candidiasis; Dog Diseases; Dogs; Fluconazole; Male; Peritonitis; Surgica | 2010 |
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Topics: Africa; Americas; Antifungal Agents; Asia; Candida glabrata; Candidiasis; Drug Resistance, Fungal; E | 2010 |
Renal allograft loss due to overwhelming invasive Candida infection.
Topics: Adult; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Pyrim | 2010 |
Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Ciprofloxacin; Drug Resistance, Fungal; Fluconazole; | 2010 |
Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Carrier State; Chemoprevention; DNA Fingerprinting | 2010 |
Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Case-Control Studi | 2010 |
Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; | 2010 |
Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, | 2010 |
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Fungem | 2010 |
Antifungal activity of low molecular weight chitosan against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Chitosan; Culture Media; Drug Synergism; Fluconazole; Human | 2010 |
Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Bird Diseases; Brazil; Candida; Candidiasis; Cockatoos; | 2010 |
Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.
Topics: Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Dose-Response Relationship, Drug; Drug R | 2010 |
Risk factors for fluconazole-resistant candidemia.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fun | 2010 |
Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Cohort Studies; Dr | 2010 |
Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Chi-Square Distribution; Cohort Studies; Dev | 2010 |
Microsatellite analysis and susceptibility to FCZ of Candida glabrata invasive isolates in Sfax Hospital, Tunisia.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Cluster Analysis; DNA, Fungal; Female; Fluc | 2011 |
Case report 5: Intensive care unit patient assessed using the Candida Score.
Topics: Accidents, Traffic; Adult; Anidulafungin; Antifungal Agents; Candida albicans; Candidiasis; Echinoca | 2010 |
Case report 6: Candidaemia in a high risk liver transplant recipient.
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Bronchitis; Candida albicans; C | 2010 |
In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Synergism; Eugenol; Fluconazole; Humans; Microbial Sen | 2010 |
Candida esophagitis complicated by esophageal stricture.
Topics: Adult; Antifungal Agents; Candidiasis; Deglutition Disorders; Esophageal Stenosis; Esophagitis; Esop | 2010 |
Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer.
Topics: Administration, Oral; Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Arthroplasty, | 2011 |
The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
Topics: Animals; Antifungal Agents; Biphenyl Compounds; Candida albicans; Candidiasis; Colony Count, Microbi | 2010 |
Cutaneous septic emboli from Candida tropicalis.
Topics: Antifungal Agents; Biopsy; Candida tropicalis; Candidiasis; Child; Embolism; Female; Fluconazole; Fl | 2010 |
The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Resi | 2011 |
Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Diffusion | 2010 |
Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis.
Topics: Aged; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Lumbar Vertebrae; Male; Osteomye | 2011 |
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Chemoprevention | 2010 |
Candida glabrata spinal osteomyelitis.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Humans; Male; Osteomyelitis; Ra | 2011 |
[Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; F | 2010 |
Effect of plant oils on Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Discovery; Drug Resistance, Fungal; Fluconazo | 2010 |
Fluconazole loading dose pharmacokinetics and safety in infants.
Topics: Antifungal Agents; Candidiasis; Chromatography, Liquid; Fluconazole; Humans; Infant; Infant, Newborn | 2011 |
The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis.
Topics: Administration, Topical; Aged; Antifungal Agents; Candida; Candidiasis; Cornea; Corneal Ulcer; Echin | 2011 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; | 2010 |
Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cross Infection; Echinocandins; | 2011 |
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.
Topics: Adult; Antifungal Agents; Candidiasis; Catheter-Related Infections; Catheters, Indwelling; Device Re | 2011 |
In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Disk Diffusion Antimicrobial Tests; Drug Resistance | 2011 |
Clinical microbiology of neonatal candidiasis in Hungary.
Topics: Amphotericin B; Candida; Candida albicans; Candida glabrata; Candidiasis; Cesarean Section; Female; | 2010 |
Effect of Ethiopian multiflora honey on fluconazole-resistant Candida species isolated from the oral cavity of AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Dose-Response Relati | 2010 |
Endogenous candida chorioretinitis in a healthy infant.
Topics: Antifungal Agents; Candida; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fluconazol | 2010 |
Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
Topics: Animals; Candida albicans; Candidiasis; Disease Models, Animal; Disulfides; Female; Fluconazole; Hum | 2011 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of ep
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidin | 2011 |
Intravenous fluconazole for bilateral endogenous Candida endophthalmitis.
Topics: Antifungal Agents; Candidiasis; Diabetic Retinopathy; Drug Administration Schedule; Endophthalmitis; | 2011 |
Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Catheter-Related Infecti | 2011 |
One case of Candidemia developed after surgery for tongue cancer in a young adult.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazo | 2009 |
[Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Female; Fluconazole; Humans; I | 2011 |
Chromogenic medium for direct susceptibility testing of Candida spp. isolated from urine.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbi | 2011 |
Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient.
Topics: Antifungal Agents; Candida; Candidiasis; Discitis; Female; Fluconazole; Humans; Kidney Failure, Chro | 2011 |
Retinal vasculitis as an early indicator of systemic candidal abscesses in a premature infant.
Topics: Abscess; Antifungal Agents; Bacteremia; Candida albicans; Candidiasis; Eye Infections, Fungal; Fluco | 2011 |
Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
Topics: Animals; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Colony Count, Microbial; Disease | 2011 |
[Prosthetic joint infection by Candida spp.].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Arthroplasty, Replacement; Candidiasis; Debridement; Fem | 2011 |
Lingua villosa nigra.
Topics: Anti-Infective Agents; Antifungal Agents; Candidiasis; Clavulanic Acid; Female; Fluconazole; Humans; | 2011 |
Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergil | 2011 |
Number needed to treat in fluconazole prophylaxis in the neonatal intensive care unit.
Topics: Antifungal Agents; Candidiasis; Chemoprevention; Fluconazole; Humans; Infant, Newborn; Intensive Car | 2011 |
Conservative management of Candida infection of prosthetic aortic graft by means of caspofungin and fluconazole alone.
Topics: Antifungal Agents; Aorta, Thoracic; Aortography; Blood Vessel Prosthesis; Blood Vessel Prosthesis Im | 2011 |
Candida urinary tract infections--treatment.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Candidiasis, Invasive; | 2011 |
Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Topics: Acyclic Monoterpenes; Aldehydes; Antifungal Agents; Apoptosis; Candida albicans; Candidiasis; Cell C | 2011 |
Candida glabrata strain relatedness by new microsatellite markers.
Topics: Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; DNA, Fungal; Female; Fluconazole; G | 2012 |
Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Adhesion; Cell Line; Disease Models, | 2011 |
Osteomyelitis as a manifestation of perinatal Human Immunodeficiency Virus disease.
Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; Antifungal Agents; Candida albicans; Can | 2011 |
Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.
Topics: Animals; Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Candidiasis; Catheters; Cell W | 2011 |
Spice oil cinnamaldehyde exhibits potent anticandidal activity against fluconazole resistant clinical isolates.
Topics: Acids; Acrolein; Adenosine Triphosphatases; Animals; Antifungal Agents; Candida albicans; Candidiasi | 2011 |
Use of antifungal agents in pediatric and adult high-risk areas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Asperg | 2012 |
[Antifungal susceptibility test of genotypes of Candida albicans from patients with atrophic or erosive oral lichen planus].
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Genotype; Humans; Lichen Planus, Oral | 2011 |
Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Leuke | 2011 |
Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities.
Topics: Analysis of Variance; Antifungal Agents; Candida glabrata; Candidemia; Candidiasis; Drug Resistance, | 2012 |
In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Diterpenes; Drug Synergism; Fluconazole; Humans; M | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cro | 2011 |
Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, P | 2012 |
Candida lusitaniae discitis after discogram in an immunocompetent patient.
Topics: Antifungal Agents; Candida; Candidiasis; Discitis; Epidural Abscess; Female; Fluconazole; Humans; Im | 2011 |
Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Female; Fl | 2011 |
Invasive fungal bezoar requiring partial cystectomy.
Topics: Aged; Amphotericin B; Antifungal Agents; Bezoars; Candidiasis; Combined Modality Therapy; Cystectomy | 2012 |
A new long-acting liposomal topical antifungal formula: human clinical study.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis; Eye Infectio | 2012 |
Candida albicans prosthetic shoulder joint infection in a patient with rheumatoid arthritis on multidrug therapy.
Topics: Aged; Antifungal Agents; Arthritis, Rheumatoid; Candida albicans; Candidiasis; Diabetes Complication | 2012 |
Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
Topics: Animals; Antifungal Agents; Azoles; Biofilms; Blotting, Northern; Blotting, Southern; Candida albica | 2012 |
An alternative respiratory pathway on Candida krusei: implications on susceptibility profile and oxidative stress.
Topics: Antifungal Agents; Blotting, Western; Candida; Candidiasis; Debaryomyces; Fluconazole; Gene Expressi | 2012 |
Reporting outcomes of randomised controlled trials.
Topics: Antifungal Agents; Candidiasis; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Female; Flucon | 2012 |
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infect | 2012 |
Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Cell Membrane; Cymbopogo | 2012 |
Diagnosis, management and outcome of Candida endocarditis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Anti | 2012 |
Fungal arthritis of the wrist caused by Candida parapsilosis during infliximab therapy for rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antifungal Agents; Antirheumatic Agents; Arthritis, Infectious; Arthritis, R | 2012 |
Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.
Topics: Animals; Antifungal Agents; Antimicrobial Cationic Peptides; Candida albicans; Candidiasis; Candidia | 2012 |
Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.
Topics: Aged; Aged, 80 and over; Candida; Candidiasis; Child; DNA, Ribosomal; Drug Resistance, Fungal; Femal | 2012 |
Candidiasis caused by Candida kefyr in a neonate: case report.
Topics: Amphotericin B; Antifungal Agents; Anus, Imperforate; Candida; Candidiasis; Congenital Abnormalities | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal | 2012 |
Disseminated candidiasis developing during prophylaxis with fluconazole in a small-intestine transplant recipient.
Topics: Adult; Antifungal Agents; Candidiasis; Fluconazole; Humans; Intestinal Diseases; Intestine, Small; M | 2012 |
Multilocus sequence typing of serial Candida albicans isolates from children with cancer, children with cystic fibrosis and healthy controls.
Topics: Adenoids; Adolescent; Antifungal Agents; Candida albicans; Candidiasis; Case-Control Studies; Child; | 2012 |
Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Flucon | 2012 |
Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis; Endocarditis; Fluconazole; Gallb | 2012 |
Diagnosis and treatment of postpartum Candida endophthalmitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fl | 2012 |
Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Candidiasis; Chemoprevention; Extracorporeal Membrane Oxygenation; Female; Flucon | 2012 |
Targeted fluconazole prophylaxis for high-risk very low birth weight infants.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Cohort Studies; Female; Fluconazole; Gestati | 2012 |
Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cohort Studies; Creatinine; Fluconazole; Humans; Hyp | 2012 |
Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Doxorubicin; Drug Resistance, Fungal; Fluconazole; | 2012 |
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
Topics: Adult; Amino Acid Substitution; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Memb | 2012 |
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fung | 2013 |
Candida albicans Msi3p, a homolog of the Saccharomyces cerevisiae Sse1p of the Hsp70 family, is involved in cell growth and fluconazole tolerance.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Doxycycline; Drug | 2012 |
Candida colonization in urine samples of ICU patients: determination of etiology, antifungal susceptibility testing and evaluation of associated risk factors.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazol | 2012 |
Acute candidal pharyngolaryngitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antifungal Agents; Candida; Candidiasis; Fluconazole; | 2012 |
Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans.
Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biofilms; Caco- | 2012 |
Positive interaction of thyme (red) essential oil with human polymorphonuclear granulocytes in eradicating intracellular Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Immunity, Innate; Microbial S | 2012 |
The fungicide fludioxonil antagonizes fluconazole activity in the human fungal pathogen Candida albicans.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Cell Proliferat | 2012 |
The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Prote | 2012 |
Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Biologi | 2012 |
Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; | 2013 |
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug | 2012 |
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; | 2012 |
Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Wall; Female; Fluconazole; Inheritan | 2013 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial | 2012 |
Milbemycins: more than efflux inhibitors for fungal pathogens.
Topics: Animals; Anthelmintics; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albica | 2013 |
68-year-old man with neutropenic fever and upper extremity hematoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherap | 2012 |
Rapidly progressive kidney failure induced by fungal mycelia obstructing indwelling ureteral stents.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Middle Aged; Prosthes | 2012 |
Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Burns; Candida; Candidiasis; Female; Fluconazole; | 2013 |
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Bu | 2012 |
Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species.
Topics: Benzoquinones; Candida; Candidiasis; Drug Synergism; Fluconazole; Humans; Lactams, Macrocyclic; Micr | 2013 |
Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection.
Topics: Abruptio Placentae; Adult; Amnion; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cesarean S | 2013 |
Black oesophagus.
Topics: Acute Disease; Alcoholism; Antifungal Agents; Candidiasis; Endoscopy, Digestive System; Esophageal S | 2013 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; | 2012 |
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Cand
Topics: Antifungal Agents; Candida; Candidiasis; Endpoint Determination; Ergosterol; Fluconazole; Indicator | 2002 |
Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Femal | 2002 |
A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candid | 2002 |
Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Diffusion; Drug Resistance, Fungal; Fluconazole; Hu | 2002 |
Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Laboratories; Microbial Sensitivity Te | 2002 |
Colonization of voice prostheses by albicans and non-albicans Candida species.
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Larynx | 2002 |
Fluconazole susceptibility of Candida species in Singapore by disc diffusion test.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; | 2002 |
South Africa: historic "defiance campaign" imports generic fluconazole.
Topics: Antifungal Agents; Candidiasis; Drug Costs; Drug Industry; Drugs, Generic; Fluconazole; Humans; Inte | 2000 |
Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Fluconazole; Humans | 2002 |
Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Diffusion Chambe | 2002 |
Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (C
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Ho | 2002 |
Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; HIV Infections; Humans; Male; M | 2002 |
Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B.
Topics: Amphotericin B; Arthritis, Infectious; Blast Crisis; Candidiasis; Drug Combinations; Drug Resistance | 2002 |
Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Critical Care; Female; Fever; Fluconazole; Hu | 2002 |
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half | 2002 |
Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Flucytosine; Humans; | 2002 |
Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital.
Topics: Adolescent; Adult; Age Distribution; Aged; Antifungal Agents; Candidiasis; Causality; Comorbidity; C | 2002 |
Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Follow-Up Studies; | 2002 |
Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluconaz | 2002 |
[Candida esophagitis in a non-immunosuppressed patient].
Topics: Adult; Antifungal Agents; Antitubercular Agents; Candidiasis; Esophagitis; Female; Fluconazole; Huma | 2002 |
Pneumonia due to Candida krusei.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Candida; Candidiasis; Fatal | 2002 |
Thrush and breastfeeding.
Topics: Antifungal Agents; Breast Diseases; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Flucon | 2002 |
Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole.
Topics: Antifungal Agents; Candida; Candidiasis; Cloning, Molecular; Cross Infection; Drug Utilization; Fluc | 2002 |
Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Male; Mice; Microbial | 2003 |
[Candida infection in hip alloarthroplasty].
Topics: Antifungal Agents; Arthroplasty, Replacement, Hip; Candidiasis; Femur Head Necrosis; Fluconazole; Fo | 2003 |
Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation.
Topics: Abnormalities, Radiation-Induced; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, | 2003 |
Antifungal prophylaxis for intensive care unit patients: let's fine tune it.
Topics: Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Fluconazole; Humans; Intensive Ca | 2002 |
Successful treatment of Candida albicans osteomyelitis of the spine with fluconazole and surgical debridement: case report.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Debridement; Diabetes Mellitus, Type 1; DNA | 2002 |
Prevalence and antifungal susceptibilities of yeast isolates during one year at a university hospital in Turkey.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Fluconaz | 2002 |
[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case Management; Consensus Development Conferences a | 2003 |
Peritoneal infection with multiple species of Candida: a case report.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; | 2002 |
[Acute obstructive nasal syndrome as expression of infectious mononucleosis. A case report].
Topics: Acute Disease; Adult; Antifungal Agents; Candida albicans; Candidiasis; Diagnosis, Differential; Flu | 2002 |
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal | 2003 |
Candida glabrata spinal osteomyelitis involving two contiguous lumbar vertebrae: a case report and review of the literature.
Topics: Amphotericin B; Candida glabrata; Candidiasis; Fluconazole; Humans; Lumbar Vertebrae; Male; Osteomye | 2003 |
Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance.
Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis; Cohort Studies; Drug Resistance | 2003 |
Caspofungin versus amphotericin B for invasive candidiasis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Caspofungin; Drug Resistance, | 2003 |
An unusual native tricuspid valve endocarditis caused by Candida colliculosa.
Topics: Aged; Amphotericin B; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Male; Tricuspid Valve | 2003 |
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sen | 2003 |
Lack of cross-hepatotoxicity between fluconazole and voriconazole.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Liver; Liver Function Tests; Male; Pyrimidines; | 2003 |
Indocyanine green angiographic features in endogenous Candida chorioretinis.
Topics: Adult; Antifungal Agents; Candidiasis; Chorioretinitis; Female; Fluconazole; Fluorescein Angiography | 2003 |
[Infections by Candida sp. in intensive care. Survey of French practices].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Cross-Sectional Stu | 2003 |
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans | 2003 |
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candid | 2003 |
Shifting patterns in the epidemiology of nosocomial Candida infections.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Cross Infection; Fluconazole; Humans; Incidence; S | 2003 |
Macular hole secondary to fungal endophthalmitis.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Epiretinal Membrane; Eye Infectio | 2003 |
Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Fungemia; Hu | 2003 |
Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctivitis; Cornea; Disease Models, A | 2003 |
Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Age | 2003 |
Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; | 2003 |
Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Humans; Microbial Sensitivity | 2003 |
High-dose fluconazole therapy in Intensive Care Unit.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Intensi | 2003 |
Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combinati | 2003 |
A very low birth weight infant with Candida nephritis with fungus balls. Full recovery after pyelotomy and antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Combined Modality Therapy; Fluconazole; Flucytosine; | 2003 |
Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantatio | 2003 |
Candida of the larynx.
Topics: Antifungal Agents; Candidiasis; Endoscopy; Female; Fluconazole; Humans; Laryngeal Diseases; Middle A | 2003 |
Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Drug Resistance, Fungal; Drug Therapy, Combination; | 2003 |
Combined action of fluconazole and PMNs from uremic patients in clearing intracellular Candida albicans.
Topics: Adult; Aged; Analysis of Variance; Candida albicans; Candidiasis; Case-Control Studies; Chemotaxis, | 2003 |
Dysphagia in patients with systemic lupus erythematosus.
Topics: Candida albicans; Candidiasis; Deglutition Disorders; Esophagitis; Esophagoscopy; Female; Fluconazol | 2003 |
Successful medical treatment of Candida albicans in mechanical prosthetic valve endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Therapy, Combination; E | 2003 |
[Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidia | 2003 |
[A case of generalized candidiasis].
Topics: Aged; Antifungal Agents; Candidiasis; Drainage; Female; Fluconazole; Humans; Hydrothorax; Pericardit | 2003 |
Antifungal susceptibility testing of Candida albicans by flow cytometry.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Flow Cytometry; Fluconazole; Funge | 2003 |
Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candida albicans; Candidiasis; Drug Resistance, | 2003 |
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sen | 2003 |
[Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; | 2003 |
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; C | 2003 |
Systemic candidiasis in a dog.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Catheters, Indwelling; Dog Diseases; Dogs | 2003 |
Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient.
Topics: Abscess; Adult; Amphotericin B; Antifungal Agents; Antimetabolites, Antineoplastic; Candida glabrata | 2003 |
[Treatment of patients with visceral candidiasis].
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis; Drug Administration Schedule; Fem | 2003 |
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; | 2003 |
Attributable mortality of nosocomial candidemia, revisited.
Topics: Age Factors; Antifungal Agents; Candida; Candidiasis; Cohort Studies; Cross Infection; Female; Fluco | 2003 |
Long-term epidemiological survey of Candida species: comparison of isolates found in an intensive care unit and in conventional wards.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; France; Hospital Mort | 2003 |
Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.
Topics: Academic Medical Centers; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tr | 2003 |
Fungal infection of sutureless self-sealing incision for cataract surgery.
Topics: Aged; Aged, 80 and over; Amphotericin B; Aspergillosis; Candidiasis; Corneal Ulcer; Drug Therapy, Co | 2003 |
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period.
Topics: Antifungal Agents; Brain Abscess; Candidiasis; Cross Infection; Drug Resistance, Fungal; Endocarditi | 2003 |
Cervical lymphadenitis caused by Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Child; Fluconazole; Humans; Lymphadenitis; Male; N | 2003 |
Prosthetic joint infections with osteomyelitis due to Candida albicans.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Bone and Bones; Can | 2003 |
Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.
Topics: Antifungal Agents; Candida; Candidiasis; Diffusion; Fluconazole; Humans; Microbial Sensitivity Tests | 2003 |
Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients.
Topics: Antifungal Agents; APACHE; Blood Glucose; Candidiasis; Case-Control Studies; Comorbidity; Female; Fl | 2003 |
Drug resistance genes and trailing growth in Candida albicans isolates.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis; DNA, Complementary; DNA, Fungal; Drug Resi | 2004 |
Recurrent scleral abscess after uncomplicated cataract extraction.
Topics: Abscess; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Therapy, Co | 2004 |
Bilateral renal papillary necrosis due to Candida infection in a diabetic patient presenting as anuria.
Topics: Adult; Antifungal Agents; Anuria; Candidiasis; Diabetes Mellitus, Type 1; Fluconazole; Humans; Kidne | 2003 |
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Drug Resistance, Microbial; Flucon | 2004 |
Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida tropicalis; Candidiasis; Cross Infection; Drug R | 2004 |
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Topics: Amphotericin B; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Microb | 2004 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucy | 2004 |
High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Do | 2004 |
Is there any relationship between fluconazole resistance and some virulence factors in Candida albicans strains?
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Micr | 2003 |
Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Female; Fluc | 2003 |
Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.
Topics: Antifungal Agents; Blotting, Northern; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Drug | 2004 |
Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood; Candida; Candidiasis; Child; C | 2004 |
Caspofungin: new indication. No progress in invasive candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; France; Humans; Peptides; Pyrimidines; | 2004 |
Homozygosity at the MTL locus in clinical strains of Candida albicans: karyotypic rearrangements and tetraploid formation.
Topics: Alleles; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbia | 2004 |
Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DN | 2004 |
[Indications for antifungal treatment in intensive care unit patients].
Topics: Antifungal Agents; APACHE; Candidiasis; Comorbidity; Critical Care; Cross Infection; Fluconazole; Fu | 2004 |
[Peripheral thrombophlebitis in a patient undergoing abdominal surgery].
Topics: Administration, Oral; Aged; Antifungal Agents; Candida albicans; Candidiasis; Catheterization, Centr | 2004 |
Alternatives to amphotericin B for Candida rugosa infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidne | 2004 |
Candida albicans switch phenotypes display differential levels of fitness.
Topics: Antifungal Agents; Blotting, Southern; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluco | 2004 |
[The 'bull's eye' pattern in hepatic tomography].
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Child, Preschool; Drug Therapy, Combination | 2004 |
Prosthetic valve endocarditis due to Candida albicans treated successfully with medical treatment alone.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Candida albicans; Candidiasis; Endocarditis, Bacter | 2004 |
Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model.
Topics: Animals; Animals, Newborn; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Res | 2004 |
Candida parapsilosis keratitis following treatment of epithelial ingrowth after laser in situ keratomileusis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Drug Therapy, Combination; Epithelium, | 2004 |
Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.
Topics: Animals; Antifungal Agents; Blood Proteins; Candida albicans; Candidiasis; Colony Count, Microbial; | 2004 |
In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity | 2004 |
Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chile; | 2004 |
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; | 2004 |
Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Epithelial Cells; Esophagitis; E | 2004 |
In vitro activity of voriconazole against Candida species isolated in Taiwan.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sen | 2004 |
Impact of fluconazole administration on outcomes in critically ill patients.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Case-Control Studies; Critical Illness; Female; Fluc | 2004 |
Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Mic | 2004 |
Sequestration and late activation of lenticular Candida abscess in premature infants.
Topics: Abscess; Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Eye Infections, Fungal | 2004 |
Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; beta-Glucans; Candidiasis | 2004 |
Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Base Sequence; Brazil; Candida albi | 2004 |
Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.
Topics: Animals; Biofilms; Candida albicans; Candidiasis; Catheterization, Central Venous; Drug Resistance, | 2004 |
Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Candidiasis, Oral; Cycl | 2004 |
Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Dru | 2004 |
Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bacteriological Techniques; Candid | 2004 |
Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Caspofungin; | 2004 |
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentra | 2004 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echin | 2004 |
Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Graft vs Hos | 2004 |
In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
Topics: Antifungal Agents; Candida; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Fungal; | 2004 |
Rapid flow-cytometric susceptibility testing of Candida species.
Topics: Antifungal Agents; Candida; Candidiasis; Echinocandins; Flow Cytometry; Fluconazole; Fungal Proteins | 2005 |
Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Candidiasis; Caspofungin; Colony-Forming Units As | 2004 |
Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Eye Infections, Fungal; F | 2004 |
Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients.
Topics: Adult; Age Distribution; Aged; APACHE; Candidiasis; Case-Control Studies; Chi-Square Distribution; C | 2004 |
Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?
Topics: Candidiasis; Case-Control Studies; Critical Care; Cross Infection; Female; Fluconazole; Fungemia; Hu | 2004 |
Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
Topics: Animals; Antifungal Agents; Azepines; Bridged-Ring Compounds; Candida; Candida albicans; Candidiasis | 2005 |
[Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
Topics: Aged; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echi | 2004 |
Vitrectomy with fluconazole infusion: retinal toxicity, pharmacokinetics, and efficacy in the treatment of experimental candidal endophthalmitis.
Topics: Animals; Antifungal Agents; Biological Availability; Candidiasis; Chromatography, High Pressure Liqu | 2004 |
Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support.
Topics: Anti-Bacterial Agents; Antifungal Agents; Calcium; Candidiasis; Cardiomyopathy, Dilated; Cardiotonic | 2004 |
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida glabrata; Candidiasis; Cloning | 2005 |
Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Candida glabrata; | 2005 |
Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Costa Rica; Fluconazole; Flucytosine; Humans; Infant | 2005 |
Caspofungin: a new therapeutic option for fungal endocarditis.
Topics: Adult; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Endocarditis; Fluconazole; Humans | 2005 |
[Tibial osteomyelitis following intraosseous infusion: a case report].
Topics: Antifungal Agents; Candidiasis; Cross Infection; Diagnosis, Differential; Female; Fluconazole; Human | 2004 |
Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
Topics: Animals; Antifungal Agents; Candidiasis; Cyclophosphamide; Dose-Response Relationship, Drug; Echinoc | 2005 |
Simultaneous herpetic and candidal esophagitis in an immunocompetent teenager.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acyclovir; Adolescent; Antifungal Agents; Antiviral Agents; | 2005 |
Molecular epidemiology of Candida species isolated from urine at an intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; DNA Fingerprinting; DNA, Fungal; Drug Resis | 2005 |
Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Humans; Mid | 2005 |
CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Topics: Agar; Antifungal Agents; Blood; Candida; Candidiasis; Chromogenic Compounds; Culture Media; Fluconaz | 2005 |
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, P | 2005 |
Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida tropicalis; Candidiasis; Drug Resistance, Microb | 2005 |
Recurrent Candida tropicalis meningitis.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Craniotomy; Fluconazole; Humans; Male; Meningiti | 2005 |
DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy.
Topics: Aerosols; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Base Se | 2005 |
Bilateral Candida chorioretinitis: involvement of the second eye after 3 years.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Fluc | 2005 |
In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Ho | 2005 |
Candidal arthritis after complete treatment of systemic candidiasis.
Topics: Amphotericin B; Antifungal Agents; Arthritis; Candidiasis; Diabetes, Gestational; Female; Fluconazol | 2005 |
Candida albicans lung abscess sensitive to fluconazole and responding only to amphotericin B in a non-immunocompromised critically ill patient.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Critical Illness; Fluconazole; Hum | 2005 |
Renal ultrasonography and detection of pseudomycelium in urine as means of diagnosis of renal fungus balls in neonates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Humans; Infant, Newbor | 2005 |
CARE-2 fingerprinting of Candida albicans isolates.
Topics: Antifungal Agents; Base Sequence; Blotting, Southern; Candida albicans; Candidiasis; DNA Fingerprint | 2005 |
Potential of plant oils as inhibitors of Candida albicans growth.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Humans; Microbial Sen | 2005 |
Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.
Topics: Antifungal Agents; Candida; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazo | 2005 |
In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Drug Evaluation, | 2005 |
Azole resistance in neonatal intensive care units in Argentina.
Topics: Antifungal Agents; Argentina; Candida; Candidiasis; Drug Resistance, Microbial; Drug Resistance, Mul | 2005 |
A fatal fungus.
Topics: Abscess; Aged; Antifungal Agents; Candidiasis; Coronary Artery Bypass; Drainage; Fatal Outcome; Fluc | 2005 |
Invasive Candida species infections: a 5 year population-based assessment.
Topics: Antifungal Agents; Canada; Candida; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, | 2005 |
Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida tropicalis; Candidiasis; Cyclophosphamide; Disea | 2005 |
[Posterior retinal hole secondary to a candida retinitis].
Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fluconazole; Humans; Laser Coagulatio | 2005 |
An esophageal mass with coexistent Mycobacterium chelonae and Candida albicans infections in an immunocompetent adult.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Fluconazole; Humans; Imipene | 2006 |
Transplantation of yeast-infected cardiac allografts: a report of 2 cases.
Topics: Adult; Amphotericin B; Candida albicans; Candidiasis; Fluconazole; Follow-Up Studies; Graft Survival | 2005 |
[Fungal endocarditis found at onset of lower limb acute aortic occlusion; report of a case].
Topics: Acute Disease; Antifungal Agents; Aortic Diseases; Arterial Occlusive Diseases; Candidiasis; Combine | 2005 |
Candidosis in children with onco-hematological diseases in Chennai, south India.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Cohort Studies; Drug Resistance, Fungal; Female; Flu | 2005 |
Emphysematous pyelonephritis caused by Candida infection.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Diabetes Mellitus, T | 2005 |
Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
Topics: Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cross Infection; Drug Administration Sched | 2005 |
Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.
Topics: Antifungal Agents; Candidiasis; Cohort Studies; Female; Fluconazole; Gestational Age; Humans; Incide | 2005 |
Invasive fungal infections at The Norwegian Radium Hospital 1998-2003.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Cancer Care Facilities; Ca | 2005 |
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; | 2005 |
Candida esophagitis.
Topics: Aged; Antifungal Agents; Candidiasis; Esophagitis; Fluconazole; Humans; Male | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glab | 2005 |
Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus; Biological Evo | 2005 |
Clinical evaluation of ERCP and naobiliary drainage for biliary fungal infection--a report of five cases of severe combined bacterial and fungal infection of biliary tract.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Biliary Tract Diseases; Candid | 2005 |
A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
Topics: Algorithms; Antifungal Agents; Candida glabrata; Candidiasis; Drug Evaluation; Fluconazole; Humans; | 2005 |
Establishing surrogate markers for fluconazole resistance in Candida albicans.
Topics: Antifungal Agents; Biomarkers; Candida albicans; Candidiasis; Drug Resistance, Fungal; Ergosterol; F | 2005 |
Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Topics: Adolescent; Anemia, Aplastic; Antifungal Agents; Candida; Candidiasis; Caspofungin; Chemoprevention; | 2005 |
Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
Topics: Antifungal Agents; Candida; Candidiasis; Catheters, Indwelling; Cross Infection; Drug Resistance, Fu | 2005 |
Experience with caspofungin in the treatment of persistent fungemia in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandin | 2005 |
[Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Ca | 2005 |
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Farnesol; Flucona | 2005 |
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Topics: Anti-Infective Agents; Candida glabrata; Candidiasis; Case-Control Studies; Cross Infection; Female; | 2005 |
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Fluconazol | 2005 |
Successful treatment of Candida glabrata peritonitis with fluconazole plus flucytosine in a premature infant following in vitro fertilization.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Therapy, Combination; Fertilization in Vitro; | 2005 |
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluc | 2005 |
Survival of candida sepsis in extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Endocarditis; Extracorporeal Memb | 2005 |
[A man with Candida pyopneumopericarditis and cardiac tamponade in conjunction with gastric tube infection].
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Cardiac Tamponade; Esophageal Neoplasms; Esophagus | 2005 |
Treatment of invasive fungal infections in immunocompromised patients with fluconazole.
Topics: Adult; Antifungal Agents; Candidiasis; Cryptococcosis; Female; Fluconazole; Humans; Immunocompromise | 1989 |
Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
Topics: Antifungal Agents; Aspergillosis; Candida; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant | 2006 |
Late-onset donor-to-host transmission of Candida glabrata following corneal transplantation.
Topics: Aged; Amphotericin B; Anterior Chamber; Candida glabrata; Candidiasis; Cornea; Corneal Ulcer; Diseas | 2006 |
Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Caspofungin; Cost-Benefit Ana | 2005 |
Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Device Removal; Drug The | 2006 |
Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Female; Fluconazole; Gastrointestina | 2006 |
Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Communicable Diseases, Emerging; Dru | 2005 |
[Respiratory tract mycotic infection in phthisiological practice: species composition and susceptibility of the Candida clinical isolates to antifungal agents].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itrac | 2005 |
Fluconazole for the prevention of fungal infections: get ready, get set, caution.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Fluconazole; Humans; Infant, Newborn; Infant, Prema | 2006 |
[Pulmonary fungal infection in malignant hematological diseases: an analysis of 14 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Fluconazole; Hematol | 2005 |
Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Brazil; Candida; Candidiasis; Child; | 2005 |
Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, | 2006 |
Fluconazole prophylaxis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans | 2006 |
Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Female; Fluconaz | 2006 |
Mediastinitis and retropharyngeal abscess following delayed diagnosis of glass ingestion.
Topics: Anti-Infective Agents; Antifungal Agents; Candidiasis; Ciprofloxacin; Diagnostic Errors; Escherichia | 2006 |
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans | 2006 |
Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
Topics: Antifungal Agents; Blood; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fatal Out | 2006 |
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans | 2006 |
The glyoxylate cycle enzyme activities in the pathogenic isolates of Candida albicans obtained from HIV/AIDS, diabetic and burn patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Burns; Candida albicans; Candidiasis; Citr | 2006 |
Epidemiological trends in nosocomial candidemia in intensive care.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Utilization; Female; Flu | 2006 |
Pore formers promoted release of an antifungal drug from functionalized polyurethanes to inhibit Candida colonization.
Topics: Adsorption; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Catheterization, Central Ven | 2006 |
Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Topics: Antifungal Agents; Berberine; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug Synergism | 2006 |
[Oesophageal candidiasis: clinical and mycological analysis].
Topics: Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Esophagitis; E | 2005 |
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Disease Models, Animal; D | 2006 |
Microscopic polyangitis triggered by fungal infection.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antifungal Agents; Candidiasis; Fluconazole; Glomerulonephri | 2006 |
Recurrent candidaemia in a neonate with Hirschsprung's disease: fluconazole resistance and genetic relatedness of eight Candida tropicalis isolates.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; | 2006 |
Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Fluconazole; Health Care Costs; Humans; Infa | 2006 |
An unusual case of deep candidosis presenting as an infiltrating tumour of the chest wall.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Male; Middle Aged; Thoracic Wall | 2006 |
Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; APACHE; Candida; Candidiasis; | 2006 |
Candida parotitis with abscess formation.
Topics: Abscess; Acute Disease; Aged; Candida albicans; Candidiasis; Combined Modality Therapy; Contrast Med | 2006 |
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
Topics: Antifungal Agents; Birth Weight; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Flu | 2006 |
Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.
Topics: Antifungal Agents; Biological Evolution; Candida; Candida albicans; Candida glabrata; Candidiasis; F | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole | 2006 |
In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Micro | 2006 |
Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole | 2006 |
The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; APACHE; Candida; Candidiasis; Critica | 2006 |
Predisposing conditions for Candida spp. carriage in the oral cavity of denture wearers and individuals with natural teeth.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Carrier State; Dentures; Female; Fluconazole; Human | 2006 |
Control of a Candida glabrata prosthetic endovascular infection with posaconazole.
Topics: Candida glabrata; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Huma | 2006 |
Pyomyositis with hepatic and perinephric abscesses caused by Candida albicans in a diabetic nephropathy patient.
Topics: Abdominal Abscess; Antifungal Agents; Candida albicans; Candidiasis; Diabetic Nephropathies; Diagnos | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; | 2006 |
Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Cytomegalovirus Infections; D | 2006 |
Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Caspofungin; Cyclosporine; E | 2006 |
Effect of fluconazole consumption on long-term trends in candidal ecology.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Utilization; Fluconazole; Fungemia; H | 2006 |
Candidemia in Norway (1991 to 2003): results from a nationwide study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida al | 2006 |
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Cohort Studies; Female; Fluconazole; Fungemia; Humans; | 2006 |
An unusual case of Candida tropicalis and Candida krusei arthritis in a patient with acute myelogenous leukemia before chemotherapy.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Candida; Candidiasis; Fatal Outcome; Fluconazole; Hu | 2007 |
cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Bone Marrow Transplantation; Candida albicans; | 2006 |
Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Drug Administration Sch | 2006 |
In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, | 2006 |
Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; DNA-Binding Proteins; Drug Resistance, Mul | 2006 |
Successful treatment of Candida tropicalis arthritis, osteomyelitis and costochondritis with caspofungin and fluconazole in a recipient of bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Arthritis, Infectious; Bone Marrow Transplantation; Candida tropicali | 2006 |
Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Female; F | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; | 2006 |
[The analysis of the phenotypic characters of candida fungi isolated from the patients].
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Inpatients; Microbial Sensitivity Test | 2005 |
Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Ergosterol; Female; Fluco | 2007 |
Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida tropicalis; Candidiasis; Drug | 2006 |
[Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Funge | 2006 |
Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient.
Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Fluconazole; HIV; HIV | 2006 |
Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth.
Topics: Antifungal Agents; Candida; Candidiasis; Chi-Square Distribution; Female; Fluconazole; Humans; Infan | 2006 |
[Mycotic complications of shunt infection in children with primary hydrocephalus].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cerebrospinal Fluid; Child, Preschool; Female; Fluco | 2002 |
Infectious myositis involving the piriformis in a patient with rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal; Antifungal Agents; Antirheum | 2006 |
Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
Topics: Animals; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Candida albicans; Candidiasis; Corn | 2006 |
Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
Topics: Alkaline Phosphatase; Antibiotic Prophylaxis; Antifungal Agents; Bilirubin; Candidiasis; Case-Contro | 2006 |
Epidemiology of candidemia in a Turkish tertiary care hospital.
Topics: Amphotericin B; Antifungal Agents; Blotting, Southern; Candida; Candidiasis; Cross Infection; DNA Fi | 2006 |
Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
Topics: Algorithms; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida gla | 2006 |
Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method.
Topics: Candida; Candidiasis; Fluconazole; Humans; Image Processing, Computer-Assisted; Microbial Sensitivit | 2006 |
Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Candidiasis; Carbonyl Cyanide m-Chlor | 2006 |
[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].
Topics: Adult; Antifungal Agents; Candidiasis; Cervical Vertebrae; Combined Modality Therapy; Discitis; Epid | 2006 |
Case report: relief of acute obstruction of the Detour subcutaneous pyelovesical bypass.
Topics: Adult; Antifungal Agents; Candidiasis; Fluconazole; Fluid Therapy; Humans; Hydronephrosis; Male; Nep | 2006 |
Is routine fluconazole prophylaxis necessary in preterm infants?
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Intensive C | 2006 |
In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; Chemoprevention; Fluconazole; Fungemia; Humans; Micr | 2006 |
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Flucon | 2006 |
Combined antifungal therapy in a murine infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Colony Count, Microbial; | 2006 |
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Healt | 2006 |
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Global Health; Humans | 2006 |
Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
Topics: Candida; Candidiasis; Fluconazole; Fungemia; Itraconazole; Leukemia; Microbial Sensitivity Tests; Or | 2006 |
[Candida krusei fungemia: do not ignore mycological diagnosis].
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Fungemia; Humans | 2007 |
Fluconazole susceptibility testing of Candida species by flow cytometry.
Topics: Antifungal Agents; Candida; Candidiasis; Flow Cytometry; Fluconazole; Humans; Microbial Sensitivity | 2007 |
[Evaluation and utility of the E-test and Neo-Sensitabs methods in studying fluconazole yeast susceptibility].
Topics: Antifungal Agents; Candida; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Disk Diffusion Ant | 2006 |
Amniocentesis results and novel proteomic analysis in a case of occult candidal chorioamnionitis.
Topics: Adult; Amniocentesis; Antifungal Agents; Candidiasis; Chorioamnionitis; Female; Fluconazole; Humans; | 2006 |
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Cohort Studies; Female; Fever; Fluconazole; | 2006 |
Echinocandins for candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Female; Fluconaz | 2007 |
Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity T | 2007 |
Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Female; Fluconaz | 2007 |
Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines.
Topics: Adult; Aged; Antifungal Agents; Body Weight; Candida; Candida glabrata; Candidiasis; Cohort Studies; | 2007 |
Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Hospitals, University; Hu | 2007 |
Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, U | 2007 |
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Cand | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Cand | 2007 |
Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study.
Topics: Aged; Antifungal Agents; Candidiasis; Costs and Cost Analysis; Female; Fluconazole; Hospital Mortali | 2007 |
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; DNA Fingerprinting; DNA, Fungal; Fluconazole; Hemato | 2007 |
Endogenous ocular candidiasis: changes in epidemiology and factors associated with poor functional outcome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Female; Fluconazole; | 2007 |
Non-healing gastric ulcer associated with Candida infection.
Topics: Adult; Antifungal Agents; Candidiasis; Fluconazole; Humans; Male; Stomach Ulcer; Wound Healing | 2007 |
Could risk assessment for non-albicans Candida improve empiric treatment for invasive candidiasis?
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Risk Assessment | 2007 |
Posaconazole.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Capsules; Drug Approval; Drug D | 2007 |
Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
Topics: Animals; Antifungal Agents; Candidiasis; Conjunctiva; Disease Models, Animal; Echinocandins; Eye Inf | 2007 |
First reported case of a Candida glabrata perihepatic abscess as a complication of percutaneous endoscopic gastrostomy tube placement.
Topics: Abdominal Abscess; Antifungal Agents; Candida glabrata; Candidiasis; Female; Fluconazole; Gastrostom | 2007 |
Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Outbreaks; Drug Resistance, Fungal; | 2007 |
Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Cluster Analysis; DNA Fingerprinting; DNA, Funga | 2007 |
A case of malignant otitis externa caused by Candida glabrata in a patient receiving haemodialysis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Gallium Radiois | 2007 |
[Two cases of spondylodiscitis due to Candida sp].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Discitis; Fluconazole; Humans; Magnetic Reson | 2007 |
Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection.
Topics: Antifungal Agents; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Fluconazole; Fungemia; Hum | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albi | 2007 |
Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Dimethyl Sulfoxide; Drug Resistance, Fung | 2007 |
Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Cluster Analysis; DNA, Fungal; Drug Resistance, | 2007 |
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Dose-Response | 2007 |
In vitro interaction of micafungin and fluconazole against Candida.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Humans; Lipopep | 2007 |
Excision of the tricuspid valve in a baby with Candida endocarditis.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Failure; Humans; Infant; Ni | 2007 |
Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Ur | 2007 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; I | 2007 |
Neuroinfections and antimicrobials: do we need new molecules or new strategies?
Topics: Anti-Infective Agents; Brain Diseases; Candidiasis; Cross Infection; Drug Resistance, Microbial; Flu | 2007 |
Echinocandins--first-choice or first-line therapy for invasive candidiasis?
Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Fluconazole; Fungemia; Humans; Infant, | 2007 |
Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery.
Topics: Adult; Candida albicans; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Heart | 2007 |
One year prospective survey of Candida bloodstream infections in Scotland.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bacterial Infections; Candida; Candidiasis; Catheters, I | 2007 |
Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Candida; Candidiasi | 2007 |
Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida tropicalis; Candidia | 2007 |
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistanc | 2006 |
[In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; | 2007 |
[Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fun | 2007 |
A cluster of Candida krusei infections in a haematological unit.
Topics: Candida; Candidiasis; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Finland; Fluconazole; H | 2007 |
Candida lusitaniae arthritis in an intravenous drug user.
Topics: Adult; Amphotericin B; Arthritis, Infectious; Blood Sedimentation; Candida; Candidiasis; Fluconazole | 2007 |
Candidemia-induced acute interstitial nephritis.
Topics: Acute Disease; Administration, Oral; Adult; Antifungal Agents; Candidiasis; Caspofungin; Diagnosis, | 2007 |
Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole.
Topics: Antifungal Agents; Candidiasis; Child; Electrocardiography; Fluconazole; Heart Conduction System; Hu | 2008 |
Candida osteo-chondromyelitis complicating thoraco-abdominal esophageal surgery.
Topics: Antifungal Agents; Candidiasis; Debridement; Esophagus; Fluconazole; Humans; Male; Middle Aged; Oste | 2007 |
Prophylactic fluconazole in preterm neonates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Fluconazole; Humans; Hygiene; Incidence; Infa | 2007 |
Anidulafungin and fluconazole for candidiasis.
Topics: Anidulafungin; Antifungal Agents; Candidiasis; Confidence Intervals; Echinocandins; Fluconazole; Hum | 2007 |
Anidulafungin and fluconazole for candidiasis.
Topics: Administration, Oral; Analysis of Variance; Anidulafungin; Antifungal Agents; Candidiasis; Catheteri | 2007 |
Prophylactic fluconazole in preterm neonates.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Pre | 2007 |
Ocular lesions in disseminated candidiasis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Chorioretinitis; Diabetes C | 2007 |
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Carrier Proteins; Dose-Response Relations | 2007 |
[Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model].
Topics: Administration, Rectal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candidi | 2007 |
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; H | 2007 |
Risk factors for poor outcome of fungal peritonitis in Chinese patients on continuous ambulatory peritoneal dialysis.
Topics: Antifungal Agents; Candidiasis; China; Female; Fluconazole; Humans; Male; Middle Aged; Peritoneal Di | 2003 |
Direct comparison of the pharmacodynamics of four antifungal drugs in a mouse model of disseminated candidiasis using microbiological assays of serum drug concentrations.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; F | 2007 |
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; | 2008 |
EUCAST technical note on fluconazole.
Topics: Antifungal Agents; Area Under Curve; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fun | 2008 |
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Candida; Candidiasis; Drug Resis | 2007 |
Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cluster Analysis; Cross Infection; DNA Fing | 2008 |
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Topics: Academic Medical Centers; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fun | 2008 |
Evaluation of glucose-methylene-blue-mueller-hinton agar for E-test minimum inhibitory concentration determination in Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbi | 2007 |
Endophthalmitis associated with intravenous drug use.
Topics: Antifungal Agents; Beverages; Candidiasis; Citrus; Cocaine; Cocaine-Related Disorders; Endophthalmit | 2007 |
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Test | 2008 |
Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Cell | 2008 |
Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump.
Topics: Antifungal Agents; Biological Transport; Candida albicans; Candidiasis; Combined Modality Therapy; D | 2008 |
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europ | 2008 |
Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Endocarditis; Female; Fluconazole | 2008 |
Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Topics: Amino Acid Substitution; Antifungal Agents; Candida; Candidiasis; DNA Mutational Analysis; DNA, Fung | 2008 |
[Fungal infections of the lower urinary tracts in urological patients].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cryptococcosis; Female; Fluconazole; | 2007 |
Effect of fluconazole prophylaxis on the incidence of invasive candida infections and bacteraemias in patients with acute leukaemia.
Topics: Adult; Bacteremia; Candidiasis; Fluconazole; Humans; Leukemia; Retrospective Studies | 2008 |
[Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Fluconazole; Hematol | 2008 |
Systemic illnesses unexpectedly presenting as acute appendicitis: case studies.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Appendicitis; Candidiasis; Female; Fluconaz | 2008 |
Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Fungemia; Heart Tr | 2008 |
Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cells, Cultured; Chlorpromazine; Drug Resistance, | 2008 |
Case of esophagitis in a posttransplant female patient.
Topics: Antifungal Agents; Candidiasis; Esophagitis; Female; Fluconazole; Humans; Immunocompromised Host; Ki | 2007 |
Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity | 2008 |
Candidosis of brain.
Topics: Aged; Antifungal Agents; Brain; Candidiasis; Central Nervous System Fungal Infections; Diabetes Comp | 2007 |
[Fungal necrotizing external otitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Male; Necrosis; O | 2008 |
Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; b | 2007 |
Acute calculous cholecystitis caused by Candida lusitaniae: an unusual causative organism in a patient without underlying malignancy.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Ceftriaxone; Cholecystitis; F | 2008 |
An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Chromosomes, Fungal; Drug Resistance, Fungal; Fluc | 2008 |
Antifungal prophylaxis for the prevention of neonatal candidiasis?
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Newbor | 2008 |
Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocan | 2008 |
Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Candida albicans; Candidiasis; Cohort Studies; Drug Resis | 2008 |
First, do no harm.
Topics: Antifungal Agents; Candidiasis; Developmental Disabilities; Female; Fluconazole; Humans; Incidence; | 2008 |
Direct fluconazole susceptibility testing of positive Candida blood cultures by flow cytometry.
Topics: Blood; Candida; Candidiasis; Flow Cytometry; Fluconazole; Humans; Microbial Sensitivity Tests | 2008 |
Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis; Cohort Studies; Denmark; Female; Flucon | 2008 |
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Cohort Stu | 2008 |
Antifungal susceptibility against yeasts isolated from pediatric oncology patients.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Child; | 2008 |
Candida parapsilosis septic arthritis in a renal transplant patient.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Candida; Candidiasis; Female; Fluconazole; Humans; I | 2008 |
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Hu | 2008 |
Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.
Topics: Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Female; Fluconazole; | 2008 |
Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Diffusion; Fluconazole | 2008 |
Neonatal Candida parapsilosis meningitis and empyema related to epidural migration of a central venous catheter.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Empyema; E | 2008 |
A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Codon, Nonsense; Drug Resistance, Fungal; Ergoster | 2008 |
Candiduria as an early marker of disseminated infection in critically ill surgical patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Fluconazole; Humans; Surg | 1995 |
In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Aspergillosis; Aspergillus fumiga | 1995 |
Fluconazole therapy for candiduria.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Dose-Response Relationship, Drug; Fluconazo | 1995 |
Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Candida albicans; Candidiasis; Cytokines; Flucona | 1994 |
A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Mar | 1994 |
Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter.
Topics: Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Humans; Kidney Failure, | 1995 |
Re: Fluconazole treatment in Torulopsis glabrata upper urinary tract infection causing ureteral obstruction.
Topics: Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Ureteral Obstruction; Urinary Tr | 1995 |
[The Candida infected hen's egg. An alternative test system for systemic anticandida activity].
Topics: Amphotericin B; Animal Testing Alternatives; Animals; Antifungal Agents; Candida albicans; Candidias | 1995 |
Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species.
Topics: Antifungal Agents; Bacteremia; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Fluconazole; Huma | 1995 |
Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
Topics: Amphotericin B; Animals; Candidiasis; Colony Count, Microbial; Drug Therapy, Combination; Fluconazol | 1995 |
Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole.
Topics: Amphotericin B; Brain Abscess; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytos | 1995 |
Increasing resistance of Candida albicans to fluconazole.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fl | 1995 |
Acute cholecystitis and wound infection due to Candida albicans.
Topics: Acute Disease; Aged; Candidiasis; Cholecystectomy; Cholecystitis; Female; Fluconazole; Humans; Surgi | 1995 |
Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.
Topics: Anuria; Candidiasis; Ciprofloxacin; Cyclosporine; Fluconazole; Hemofiltration; Humans; Liver Transpl | 1995 |
Fluconazole in candida peritonitis in CAPD: an alternative proposal.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Peritoneal Dialysis, Co | 1995 |
Severe Candida krusei infection in an AIDS patient receiving long-term treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Fluconazole; Humans; Male; Middle Aged | 1995 |
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, M | 1995 |
Urinary tract candidiasis in neonates and infants.
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male | 1995 |
Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Dermatomycose | 1995 |
Deadly fungal infections spreading in cancer patients.
Topics: Antineoplastic Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Mycoses; Neoplasms; Opportun | 1995 |
[Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fl | 1993 |
Successful treatment of candida peritonitis with fluconazole.
Topics: Candidiasis; Fluconazole; Humans; Male; Middle Aged; Peritonitis | 1994 |
Treatment of ocular fungal infections with oral fluconazole.
Topics: Administration, Oral; Adult; Aged; Candidiasis; Coccidioidomycosis; Drug Tolerance; Endophthalmitis; | 1995 |
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: use of high dosages of fluconazole or solely removal of the catheter?
Topics: Candidiasis; Fluconazole; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1995 |
Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Azoles; Candida albicans; Candidiasis | 1995 |
Fluconazole prophylaxis for high-risk liver transplant recipients.
Topics: Adult; Candidiasis; Fluconazole; Hepatic Encephalopathy; Humans; Liver Diseases; Liver Transplantati | 1995 |
Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole.
Topics: Abdominal Injuries; Adult; Aged; Breast Neoplasms; Candidiasis; Child; Child, Preschool; Female; Flu | 1995 |
[Candida albicans spondylodiscitis. Treatment with fluconazole alone].
Topics: Adult; Candidiasis; Discitis; Female; Fluconazole; Humans | 1995 |
[Protective effect of human macrophage colony-stimulating factor (hM-CSF) on fungal infection (1). In vivo effect of hM-CSF on systemic candidiasis and in vitro effect of hM-CSF on macrophages activities].
Topics: Animals; Candidiasis; Cells, Cultured; Disease Models, Animal; Fluconazole; Macrophage Colony-Stimul | 1995 |
When to use fluconazole.
Topics: AIDS-Related Opportunistic Infections; Aspergillosis; Candidiasis; Drug Resistance, Microbial; Fluco | 1995 |
Experience in treating secondary systemic mycotic infection after severe burns associated with electric injury.
Topics: Adult; Amputation, Surgical; Burns, Electric; Candidiasis; Ciprofloxacin; Fluconazole; Humans; Male; | 1995 |
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Mice; | 1995 |
Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole.
Topics: Administration, Oral; Animals; Candida; Candidiasis; Endophthalmitis; Fluconazole; Flucytosine; Rabb | 1995 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans | 1995 |
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
Topics: Amphotericin B; Animals; Candidiasis; Cyclophosphamide; Drug Combinations; Female; Fluconazole; Kidn | 1995 |
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kid | 1995 |
Candida parapsilosis prosthetic joint infection unresponsive to treatment with fluconazole.
Topics: Candidiasis; Female; Fluconazole; Humans; Knee Prosthesis; Middle Aged; Prosthesis-Related Infection | 1995 |
When to use fluconazole.
Topics: Amphotericin B; Candidiasis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Fluc | 1995 |
Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine.
Topics: Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant, Low Birth | 1994 |
Fungemia due to fluconazole-resistant Candida albicans in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candida albicans; Candidiasis; Drug | 1994 |
Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole.
Topics: Candida; Candidiasis; Culture Media; Evaluation Studies as Topic; Fluconazole; Humans; Indicator Dil | 1994 |
Fluconazole and amphotericin B antifungal therapies do not negate the protective effect of endogenous tumor necrosis factor in a murine model of fatal disseminated candidiasis.
Topics: Amphotericin B; Animals; Candidiasis; Colony Count, Microbial; Female; Fluconazole; Immunoglobulin G | 1995 |
Treatment of catheter-associated Candiduria with fluconazole irrigation.
Topics: Adult; Aged; Aged, 80 and over; Candida; Candidiasis; Equipment Contamination; Female; Fluconazole; | 1995 |
[Adherence of isolated Candida albicans strains from HIV+ infected patients to buccal epithelial cells: correlation with serotype, sensitivity to fluconazole and virulence].
Topics: AIDS-Related Opportunistic Infections; Bacterial Adhesion; Candida albicans; Candidiasis; Fluconazol | 1994 |
[Obstructive candidiasis: a process with surgical solution].
Topics: Adolescent; Amphotericin B; Candidiasis; Fluconazole; Humans; Infant; Infant, Newborn; Intestinal Ob | 1994 |
[Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
Topics: Candidiasis; Esophageal Diseases; Female; Fluconazole; Hepatitis C; Hepatitis, Chronic; Humans; Inte | 1994 |
Fluconazole-resistant Candida albicans in an immunocompetent child.
Topics: Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Immunocomp | 1994 |
Renal fungus ball in a premature infant successfully treated with fluconazole.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premat | 1994 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Catheterization; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Catheterization, Central Venous; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 1995 |
Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fl | 1993 |
Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis; Drug Administration Sc | 1994 |
Management of candidemia.
Topics: Adult; Amphotericin B; Candidiasis; Fluconazole; Fungemia; Humans; Neutropenia | 1994 |
The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case.
Topics: Aged; Aortic Valve Insufficiency; Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Hu | 1994 |
Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Synergism; Drug Therapy, Combination; | 1994 |
Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment.
Topics: Abscess; Acute Disease; Adolescent; Adult; Aged; Candidiasis; Female; Fever; Fluconazole; Humans; Le | 1994 |
Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Flucytosine; Humans; Infant, New | 1994 |
[Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Drug Resistance, Micro | 1994 |
Endogenous Candida endophthalmitis: a case report.
Topics: Candidiasis; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Humans; Male; Middle Aged; Vitreo | 1994 |
Notable clinical changes of hepatosplenic abscesses in febrile neutropenic patients receiving empiric antifungal treatment with azoles.
Topics: Abscess; Antifungal Agents; Candidiasis; Fever; Fluconazole; Humans; Leukemia; Liver Abscess; Lympho | 1994 |
Treatment of multiple corneal abscesses with fluconazole.
Topics: Abscess; Aged; Aged, 80 and over; Candidiasis; Corneal Diseases; Female; Fluconazole; Humans | 1994 |
Successful peritransplant therapy in children with active hepatosplenic candidiasis.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Child, Preschool; Female; Fluconazole; Hum | 1994 |
Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis; Dose-Response Re | 1994 |
Fatal Candida famata peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis who was treated with fluconazole.
Topics: Aged; Candidiasis; Drug Resistance, Microbial; Fatal Outcome; Fluconazole; Humans; Male; Peritoneal | 1994 |
Renal abscess and fungemia due to Torulopsis glabrata: successful treatment with drainage and fluconazole.
Topics: Abscess; Adult; Candida; Candidiasis; Combined Modality Therapy; Drainage; Female; Fluconazole; Huma | 1994 |
Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans.
Topics: Aged; Amphotericin B; Candidiasis; Coronary Artery Bypass; Drug Administration Schedule; Fluconazole | 1994 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluc | 1994 |
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis; Candidiasis, O | 1994 |
The natural history of esophageal candidiasis after successful treatment in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis; Esophageal Diseases; Fluc | 1994 |
Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments.
Topics: Animals; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Therapy, Combination; Fluconaz | 1994 |
Fluconazole-resistant candidosis in an HIV cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis; Child, Preschool; Cohor | 1994 |
Mortality of hospitalized patients with Candida endophthalmitis.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Endophthalmitis; Fluconazole; Hospital Mortality; Humans; | 1994 |
Fluconazole in the treatment of candida peritonitis in continuous ambulatory peritoneal dialysis: report of a case.
Topics: Administration, Oral; Aged; Candidiasis; Female; Fluconazole; Humans; Peritoneal Dialysis, Continuou | 1993 |
Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat.
Topics: Acute Disease; Animals; Candidiasis; Chronic Disease; Fluconazole; Leukocyte Count; Macrophage Colon | 1994 |
Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.
Topics: Amphotericin B; Animals; Candidiasis; Deoxycholic Acid; Drug Carriers; Drug Combinations; Female; Fl | 1993 |
Case report: Candida meningitis with an intradural filling defect 1 year after candidemia.
Topics: Amphotericin B; Candida albicans; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Fungemia; | 1994 |
Improved medium for fluconazole susceptibility testing of Candida albicans.
Topics: Candida albicans; Candidiasis; Culture Media; Fluconazole; Glucose; Humans; Microbial Sensitivity Te | 1994 |
Successful treatment of Candida prosthetic valve endocarditis with a combination of fluconazole and amphotericin B.
Topics: Amphotericin B; Candidiasis; Endocarditis, Bacterial; Fluconazole; Follow-Up Studies; Heart Valve Pr | 1994 |
[Esophageal mycosis during primary human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Fluco | 1993 |
Genotypic characterization of sequential Candida albicans isolates from fluconazole-treated neutropenic patients.
Topics: Adult; Base Sequence; Candida albicans; Candidiasis; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field | 1994 |
Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Fungemia; Heart V | 1994 |
[Fluconazole therapy for pediatric patients with severe candidal infections].
Topics: Adolescent; Candidiasis; Child; Esophagitis; Female; Fluconazole; Humans; Lung Diseases, Fungal; Mal | 1994 |
Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis; Drug Resistance, Microb | 1993 |
Development of Hansenula anomala infection in a child receiving fluconazole therapy.
Topics: Accidents, Traffic; Amphotericin B; Blood Transfusion; Candida albicans; Candidiasis; Child, Prescho | 1994 |
Neonatal renal candidiasis.
Topics: Amphotericin B; Candidiasis; Diagnostic Imaging; Drug Therapy, Combination; Fluconazole; Humans; Inf | 1994 |
Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bone Marrow Tra | 1994 |
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Endocarditis; Female; Fluc | 1994 |
Candida tenosynovitis in an AIDS patient: a case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Debridement; Drainage; Female; Fluconazol | 1994 |
[The use of diflucan in myelotoxic agranulocytosis].
Topics: Acute Disease; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; | 1993 |
Fluconazole prophylaxis in patients with leukemia.
Topics: Acute Disease; Candidiasis; Fluconazole; Humans; Leukemia | 1993 |
Fluconazole prophylaxis in patients with leukemia.
Topics: Acute Disease; Candidiasis; Fluconazole; Humans; Leukemia | 1993 |
Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Chronic Disease; Endophthalmitis; Eye Infect | 1993 |
Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
Topics: Amphotericin B; Animals; Candidiasis; Fluconazole; Hematopoiesis; Immunosuppression Therapy; Liposom | 1993 |
A pseudocyst infected by Torulopsis glabrata: a unique problem.
Topics: Aged; Amphotericin B; Candida; Candidiasis; Drainage; Female; Fluconazole; Humans; Pancreatic Pseudo | 1993 |
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Topics: Amphotericin B; Bacterial Infections; Bone Marrow Transplantation; Candida; Candidiasis; Fluconazole | 1993 |
Fluconazole resistance in Candida glabrata.
Topics: Aged; Azoles; Candida; Candidiasis; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance, Microbial; | 1993 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Endocarditis; Female; Fluconazole; Heart; Injections, | 1993 |
Should all catheterized patients with candiduria be treated?
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Humans; Therapeutic Irrigation; Urinary Bladder; U | 1993 |
Severe candidal infections in neutropenic patients.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Itraconazole; Ketoconazole; Neutropenia | 1993 |
Postpartum Candida endophthalmitis treated with fluconazole.
Topics: Administration, Oral; Adult; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazo | 1993 |
Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group.
Topics: Acquired Immunodeficiency Syndrome; Agar; Candida albicans; Candidiasis; Culture Media; Drug Resista | 1993 |
Failure of therapy with fluconazole for candidal endophthalmitis.
Topics: Adult; Amphotericin B; Candidiasis; Cross Infection; Endophthalmitis; Female; Fluconazole; Fungemia; | 1993 |
[Hepatosplenic candidiasis in patients treated for hemato-oncological disorders].
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Drug Therapy, Combinati | 1994 |
Failure of fluconazole treatment in Candida meningitis.
Topics: Candidiasis; Fluconazole; Humans; Infant; Male; Meningitis, Fungal | 1993 |
[The treatment of Candida peritonitis during peritoneal dialysis].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Middle Aged; Pe | 1993 |
Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
Topics: Amphotericin B; Animals; Candidiasis; Disease Models, Animal; Fluconazole; Flucytosine; Fungemia; Ga | 1993 |
Hepatic candidiasis: persistent pyrexia in a patient with acute myeloid leukaemia after recovery from consolidation therapy-induced neutropenia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Cytosine; Eto | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
Candida albicans arthritis in a renal allograft recipient with an interaction between cyclosporin and fluconazole.
Topics: Arthritis, Infectious; Candidiasis; Cyclosporine; Drug Interactions; Female; Fluconazole; Humans; Ki | 1993 |
The use of fluconazole in the management of Candida peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Candidiasis; Female; Fluconazole; Humans; Male; Peritonitis | 1993 |
[External cerebrospinal fluid diversion and Candida parapsilosis meningitis. Treatment with fluconazole].
Topics: Adult; Candidiasis; Cerebrospinal Fluid Shunts; Fluconazole; Humans; Male; Meningitis | 1993 |
Postoperative candida keratitis treated successfully with fluconazole.
Topics: Adult; Candidiasis; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Keratotomy, Radial; | 1993 |
[Gas-forming mycosis of the kidney].
Topics: Adult; Candidiasis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fluconazole; Humans; | 1993 |
Successful treatment of Candida albicans osteomyelitis with fluconazole.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Male; Middle Aged; Osteomyelitis | 1993 |
[Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Drug Resistance, Micro | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: Candidiasis; Drug Costs; Esophagitis; Fluconazole; Humans; Ketoconazole | 1993 |
Treatment of Candida albicans fungaemia with fluconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candidiasis; Drug Administration Schedule; Female; Fluco | 1993 |
Fluconazole-resistant Candida albicans after long-term suppressive therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis; Candidiasis, Oral; Drug | 1993 |
Successful antifungal treatment of disseminated candidiasis associated with ARDS.
Topics: Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Middle Aged; Oppor | 1993 |
Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis.
Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prosthesi | 1993 |
[Candida infections in intensive care patients from the viewpoint of the microbiologist].
Topics: Candidiasis; Fluconazole; Humans; Infection Control; Intensive Care Units; Risk Factors | 1993 |
Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species.
Topics: Adolescent; Adult; Aged; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Fluconazole; Hum | 1993 |
Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient.
Topics: Antitubercular Agents; Aortic Aneurysm, Abdominal; Candidiasis; Drug Therapy, Combination; Fluconazo | 1993 |
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytos | 1995 |
Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
Topics: Candida; Candidiasis; Catheterization, Central Venous; Disease Susceptibility; Drug Resistance, Micr | 1996 |
Neonatal Candida parapsilosis outbreak with a high case fatality rate.
Topics: Antifungal Agents; Candidiasis; Cohort Studies; Cross Infection; Female; Fluconazole; Hospital Morta | 1995 |
[Fluconazole level in aqueous humor after oral drug administration in humans].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Aqueous Hu | 1995 |
Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Drug Interactions; Drug Therapy, Co | 1995 |
Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays.
Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Dose-Response Relationship, Drug; Fluconazole; | 1995 |
Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua.
Topics: Antifungal Agents; Candida; Candidiasis; Chromosomes, Fungal; DNA, Fungal; Drug Resistance, Microbia | 1996 |
Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidia | 1995 |
Treatment of native valve Candida endocarditis with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Follow-Up Studies; Heart Valve Di | 1995 |
Parotitis due to Torulopsis glabrata.
Topics: Aged; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Humans; Parotitis | 1995 |
Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Densitometr | 1995 |
Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Mice; Microbial Sensitivity | 1995 |
Candida endophthalmitis in Job syndrome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Chorioretinitis; Drug Thera | 1996 |
Azole drug resistance in yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Micr | 1995 |
[Clinical course and risk of fungal infections development in children with treated with chemo- and radiotherapy for solid tumors].
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Humans; Infant; Male; | 1995 |
[Candida albicans spondylitis: successful treatment with fluconazole. 2 case reports].
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Lumbar Vertebra | 1996 |
Fluconazole failure in two cases of disseminated candidosis.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Electrophoresis, Gel, Pulsed-Field; Female; | 1995 |
[Candidiasis of the liver following successful chemotherapy of acute myeloid leukemia (Fab type 6) and recovery with oral fluconazole therapy].
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Female; Flucon | 1996 |
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Flucon | 1996 |
Candida esophagitis in a child with achalasia.
Topics: Antifungal Agents; Candidiasis; Child; Esophageal Achalasia; Esophagitis; Esophagus; Fluconazole; Hu | 1996 |
Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case-Control Studies; Catheters, Indwelling; Female; | 1996 |
Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole.
Topics: Administration, Inhalation; Amphotericin B; Biopsy; Candidiasis; Candidiasis, Oral; Diabetes Complic | 1996 |
Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Female; Fluco | 1996 |
[Fluconazole in treatment of urinary candidiasis. Experience with 24 patients].
Topics: Adult; Aged; Aged, 80 and over; Candidiasis; Female; Fluconazole; Humans; Male; Middle Aged; Pyuria; | 1995 |
Fluconazole treatment of candidal infections caused by non-albicans Candida species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candidiasis; Female; Fluconazole; Humans; Male; Middle A | 1996 |
Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Fluconazole; Genetic Variation | 1995 |
[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Ca | 1996 |
[A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cross-Over Studies; E | 1996 |
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Deoxyribonucleases, Type II Site-Specific; | 1996 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Endocarditis; Fluc | 1996 |
Deep Candida infection in children receiving allogeneic bone marrow transplants: incidence, risk factors and diagnosis.
Topics: Adolescent; Antibodies, Fungal; Antigens, Fungal; Bone Marrow Transplantation; Candida albicans; Can | 1996 |
Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Resistance, Micro | 1996 |
Candida albicans infection of bilateral polyurethane-coated silicone gel breast implants.
Topics: Adult; Antifungal Agents; Breast Implants; Candida albicans; Candidiasis; Female; Fluconazole; Human | 1996 |
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Administration Schedule; Endocarditis; | 1996 |
Fatal Candida tropicalis fungaemia in a leukaemic patient receiving fluconazole prophylaxis.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Leukemia, | 1996 |
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.
Topics: Adult; Age Factors; Amphotericin B; Antifungal Agents; Bacterial Infections; Candidiasis; Diabetes M | 1996 |
Pancreatic transplantation after thirty years: still room for improvement.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Pancreas Transplantation; Posto | 1996 |
Fluconazole infused via a nephrostomy tube: a novel and effective route of delivery.
Topics: Aged; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Nephrostomy, Percutaneous; Renal | 1995 |
Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Birth Weight; Candidiasis; Congenital Abnormalities; Female; Fluc | 1996 |
Peripheral thrombophlebitis caused by Candida.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Infant; Infant, Newborn | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp.
Topics: Amphotericin B; Anthracyclines; Antibiotics, Antineoplastic; Antifungal Agents; Candida; Candidiasis | 1996 |
Fluconazole monotherapy for candidal meningitis in a premature infant.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Pre | 1996 |
Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
Transient achalasia-like esophageal motility disorder after candida esophagitis in a boy with chronic granulomatous disease.
Topics: Adolescent; Candidiasis; Cytochrome b Group; Esophageal Achalasia; Esophagitis; Fluconazole; Genetic | 1996 |
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococ | 1996 |
Early onset systemic Candida infection in extremely preterm neonates.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Female; Fluconazole; Gestational Age; Humans | 1996 |
Rapid detection of susceptibility to fluconazole in Candida species by a bioluminescence assay of intracellular ATP.
Topics: Adenosine Triphosphate; Antifungal Agents; Bacteria; Bacteriological Techniques; Candida; Candidiasi | 1996 |
Fluconazole therapy for postoperative Candida infections and in coccidioidomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Coccidioidomycosis; Female; Fluconazole; Hu | 1995 |
ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Re | 1996 |
Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
Topics: Agar; Antifungal Agents; Candida albicans; Candidiasis; Chromogenic Compounds; Evaluation Studies as | 1996 |
Rationalizing prescribing for oral and oesophageal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Costs | 1996 |
Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidia | 1996 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination | 1996 |
Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; | 1996 |
Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis; Combined Modality Therapy; Endoph | 1996 |
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cryptococcus | 1997 |
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug R | 1997 |
Variability of plasma fluconazole levels in patients with hematologic malignancy.
Topics: Alanine Transaminase; Antifungal Agents; Bilirubin; Candidiasis; Drug Interactions; Female; Fluconaz | 1997 |
Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts.
Topics: Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; | 1996 |
[Use of Diflucan in the treatment of chronic and recurrent candidosis with involvement of the esophagus].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Child; Chronic Disease; | 1996 |
Idiopathic midesophageal stricture: a new cause of dysphagia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Candidiasis; Deglutition Disorders; Esophageal St | 1997 |
[Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluco | 1996 |
[Focusing on therapy of systemic mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Dose-Response | 1995 |
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals.
Topics: Antifungal Agents; Candidiasis; Censuses; Cross Infection; Cryptococcosis; Drug Resistance, Microbia | 1996 |
[Candida pyelonephritis].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazol | 1996 |
[Curative treatment with fluconazole in 5 cases of invasive candidiasis].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Male; Middle Aged; R | 1996 |
The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
Topics: Amphotericin B; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antifungal Agents; Aspergillos | 1997 |
Hospital-acquired candidaemia: experience from a developing country.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Cr | 1997 |
Reversible fluconazole resistance in Candida albicans: a potential in vitro model.
Topics: Animals; Antifungal Agents; Blotting, Northern; Candida albicans; Candidiasis; Carrier Proteins; DNA | 1997 |
Fluconazole in the management of neonatal systemic candidiasis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Retrospective Studies; Treatme | 1996 |
Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Candida; Candidiasis; Femal | 1997 |
Nursery outbreak of neonatal fungal arthritis treated with fluconazole.
Topics: Antifungal Agents; Arthritis, Infectious; Candidiasis; Disease Outbreaks; Female; Fluconazole; Human | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophores | 1997 |
Effect of nordihydroguaretic acid and fluconazole on the LTC4/PGE2 ratio in the kidney of mice damaged by Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Dinoprostone; Female; Fluconazole; Histoc | 1997 |
Systemic candidiasis in cardiac surgery patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Critical Care; Cross Inf | 1997 |
Bilateral Candida parapsilosis endophthalmitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Endophthalmitis; Eye Infections, Fung | 1997 |
Chronic Candida albicans otitis media in children with immunodeficiency.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Chronic Disease; Diagnosis, Differential; F | 1997 |
Analysis of multiple failure time data from an AIDS clinical trial.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Clinical Trials, Phase III as | 1997 |
Detection and identification of fungal pathogens in blood by using molecular probes.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; DNA, Fungal; Fl | 1997 |
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; D | 1997 |
Candida norvegensis: a fluconazole-resistant species.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resist | 1997 |
Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fatal Outcome; Fluconazole; Humans; Itra | 1997 |
[Maternofetal disseminated candidiasis and high-grade prematurity].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Infant, Newborn; | 1997 |
[Acute renal insufficiency during Candida albicans candidiasis in a 2-month old infant].
Topics: Acute Kidney Injury; Candidiasis; Fluconazole; Humans; Infant; Infusions, Intravenous; Male; Ultraso | 1997 |
The epidemiology of hematogenous candidiasis caused by different Candida species.
Topics: Adult; Aged; Candida; Candidiasis; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Retrosp | 1997 |
The contribution of fluconazole to the changing epidemiology of invasive candidal infections.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans | 1997 |
[Emergency of fluconazole-resistant infections by Candida krusei and Candida glabrata in neutropenic patients].
Topics: Antifungal Agents; Candidiasis; Drug Resistance; Fluconazole; Humans; Neutropenia; Prospective Studi | 1996 |
[In vitro susceptibility testing of Candida species against fluconazole using the microdilution test with Alamar Blue].
Topics: Antifungal Agents; Candida; Candidiasis; Coloring Agents; Drug Resistance, Microbial; Fluconazole; H | 1996 |
[Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Humans; Infectio | 1996 |
[Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Dr | 1996 |
Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Inte | 1997 |
Efficacy of D0870 treatment of experimental Candida vaginitis.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Mice; Mice | 1997 |
[Systematic therapy of vaginal mycoses. Three quarters of women are affected].
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Mycoses; Vaginal Diseases | 1994 |
Can we agree on the treatment of candidiasis?
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; | 1997 |
Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Drug Re | 1997 |
Candida arthritis after total knee arthroplasty--a case of successful treatment without prosthesis removal.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antifungal Agents; Art | 1997 |
A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost | 1997 |
Disseminated miliary cerebral candidiasis.
Topics: Amphotericin B; Antifungal Agents; Brain; Candidiasis; Child, Preschool; Combined Modality Therapy; | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
[Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].
Topics: Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Resistance, Microbial; Female | 1997 |
Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Base Sequence; Candida albicans; Candidias | 1997 |
Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Tri | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Flucona | 1997 |
[Congenital candidiasis: early diagnosis and treatment with fluconazole].
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn | 1997 |
Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Humans; Karyotyping; Microbia | 1997 |
Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Coloring Agents; Cry | 1997 |
Candida famata fungemia in a surgical patient successfully treated with fluconazole.
Topics: Aged; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans; Postoperative Complicat | 1997 |
Laryngeal candidiasis in children.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans | 1997 |
The effect of empiric and prophylactic treatment with fluconazole on yeast isolates in a surgical trauma intensive care unit.
Topics: Antifungal Agents; Candida; Candidiasis; Cohort Studies; Fluconazole; Humans; Intensive Care Units; | 1997 |
Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Candidiasis; Ciprofloxacin; Drug | 1997 |
Systemic candidiasis with acute Epstein-Barr virus infection.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Fluconazole; Humans; Infectious Mononucleos | 1997 |
Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity.
Topics: Aged; Aged, 80 and over; Candidiasis; Dose-Response Relationship, Drug; Fatal Outcome; Fluconazole; | 1997 |
The treatment of systemic candidiasis in neonates with oral fluconazole.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Follow-Up Studies; Fungemia; Hematologic Tests; Humans; | 1997 |
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Fluconazole; Kidney; Male; Mice; Mi | 1998 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconaz | 1998 |
Unusual outcome of disseminated candidiasis treated with fluconazole: a matter of pharmacokinetics?
Topics: Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans | 1998 |
Synovial fluid levels of fluconazole in a patient with Candida parapsilosis prosthetic joint infection who had an excellent clinical response.
Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Knee; Candida; Candidiasis; Female; Fluconazole; | 1997 |
Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection.
Topics: Adult; Aged; Amphotericin B; Amputation, Surgical; Antifungal Agents; Arthrodesis; Candidiasis; Dipl | 1997 |
Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Colorimetry; Fluconazole; Humans; Immunocom | 1997 |
[Candidemia: a never ceasing challenge].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Retr | 1997 |
[Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Candidiasis; Cathe | 1997 |
Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, | 1997 |
Invasive candidiasis of the tonsil.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Male; Middle Aged; Tonsillitis | 1997 |
[Fungus-ball in a preterm infant successfully treated with fluconazole].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premat | 1998 |
Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Body Weight; Candidiasis; CD4 Lymphocyte C | 1998 |
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; F | 1998 |
[Exophytic papillomatous space-occupying lesions of the larynx as a rare manifestation of candidiasis. Diagnostic and therapeutic consequences].
Topics: Amphotericin B; Antifungal Agents; Biopsy; Candidiasis; Diagnosis, Differential; Fluconazole; Follow | 1998 |
A case report of Candida parapsilosis endocarditis.
Topics: Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Candidiasis; Catheterization, Central Venous | 1998 |
Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Kidney; Mice; Pilot Projects | 1998 |
Candidemia: a nosocomial complication in adults with late-stage AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Cand | 1998 |
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial | 1998 |
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluco | 1998 |
Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; C | 1998 |
[Gas chromatography in express diagnosis of candidiasis and monitoring of antifungal therapy efficacy by D-arabinitol and mannose levels in pediatric patients].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Chromatography, Gas; Female | 1998 |
A new ancient irrigation therapy for childhood renal candidiasis.
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Antifungal Agents; Candidiasis; Female; Flucon | 1998 |
Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial | 1998 |
Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; DNA Fingerprinting; DNA, Fungal; | 1998 |
Infectious crystalline keratopathy caused by Candida guilliermondii.
Topics: Aged; Amphotericin B; Biopsy; Candida; Candidiasis; Cornea; Corneal Diseases; Drug Resistance, Micro | 1998 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participa
Topics: Antifungal Agents; Canada; Candida; Candidiasis; Fluconazole; Fungemia; Humans; International Cooper | 1998 |
Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.
Topics: AIDS-Related Opportunistic Infections; Amino Acid Sequence; Antifungal Agents; Biological Transport; | 1998 |
[Prospective study of Candida-related sepsis in the neonate].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Infa | 1998 |
Analysis of multiple failure time data from an AIDS clinical trial.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis; | 1998 |
Fluconazole and the changing epidemiology of candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans | 1998 |
Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.
Topics: Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis; Culture Media; Fluconazole; Humans; | 1998 |
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colorimetry; Fluconazole; | 1998 |
[Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost | 1998 |
Pharmacokinetics of oral fluconazole in premature infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Adminis | 1998 |
Fluconazole disk diffusion susceptibility testing of Candida species.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Dr | 1998 |
Pradimicin therapy of disseminated Candida tropicalis infection in the mouse.
Topics: Amphotericin B; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antifungal Agents; Candida; Ca | 1998 |
Fluconazole versus Candida albicans: a complex relationship.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Re | 1998 |
Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences.
Topics: Amphotericin B; Animals; Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Candida albica | 1998 |
Candida arthritis in an immunocompetent patient without predisposing factors.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Candida albicans; Candidiasis; Fluconazole; Humans; | 1998 |
Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents.
Topics: Administration, Inhalation; Adult; Aged; Amphotericin B; Anastomosis, Surgical; Antifungal Agents; B | 1998 |
Candidal meningitis in HIV-infected patients: treatment with fluconazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Female; Fluconazole; H | 1998 |
Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Blindness; Candidiasis; Combined Modality Therapy; Endopht | 1998 |
Treatment options for candidal endophthalmitis [editoria; comment].
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Combined Modality Therapy; Endophthalmitis; | 1998 |
Fungal colonisation and fluconazole therapy in acute liver disease.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Liver Fail | 1998 |
Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.
Topics: AIDS-Related Opportunistic Infections; Alleles; Antifungal Agents; Blotting, Northern; Blotting, Sou | 1998 |
Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans; Infant; Infant, Newborn; Male | 1998 |
Antifungal prophylaxis with weekly fluconazole for patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Chemoprevention; Drug Adminis | 1998 |
Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; DNA, Fungal; DNA, Ribosomal; Fluconazole; | 1999 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; | 1998 |
[Candida krusei (Castellani) Berkhout--a potential pathogen with growing importance].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans | 1998 |
Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Colorimetry; Drug Resistance, Microbial; Fluconazo | 1998 |
Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Child; Female; Flu | 1998 |
The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans.
Topics: Antifungal Agents; Brefeldin A; Candida albicans; Candidiasis; Cerulenin; Chromosomes, Fungal; Diami | 1999 |
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Cross Infection; | 1999 |
Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fl | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Can | 1999 |
Fluconazole therapy in Candida albicans spondylodiscitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Discitis; Drug Therapy, Com | 1998 |
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resis | 1999 |
[Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)].
Topics: Acute Kidney Injury; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Monitoring; Fluconazole; H | 1998 |
Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans | 1999 |
The use of fluconazole as a local irrigant for nephrostomy tubes.
Topics: Adult; Antifungal Agents; Candidiasis; Carcinoma, Squamous Cell; Fatal Outcome; Female; Fluconazole; | 1999 |
Candida krusei sinusitis.
Topics: Alcoholism; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fatal Outcome; | 1998 |
[Epidemiology of yeast colonization and oropharyngeal infection other than Candida albicans in patients with HIV infection].
Topics: Adult; Aged; Candida; Candidiasis; Female; Fluconazole; HIV Infections; Humans; Male; Microbial Sens | 1999 |
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; | 1999 |
[Treatment of pelvis fungus ball with ureteral catheterization, fluconazole, and urine alkalinization].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Bicarbonates; Candidiasis; Fluconazole; Humans; Kidney P | 1999 |
[In vitro activity of fluconazole against Candida albicans isolated from blood culture].
Topics: Antifungal Agents; Candida albicans; Candidiasis; Diffusion; Fluconazole; Humans; Indicator Dilution | 1998 |
Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.
Topics: Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Drug Resistance, Microbial; Fluconazole; Human | 1999 |
Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Clinical Laboratory Techniques; Fluconazo | 1999 |
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candidiasis; Candidiasis, | 1999 |
Management of asymptomatic candiduria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazo | 1999 |
Preventing intra-abdominal candidiasis in surgical patients.
Topics: Abdomen; Antifungal Agents; Candidiasis; Fluconazole; Humans; Postoperative Complications | 1999 |
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Clotrimazole; DNA, Fungal; DNA, Mitochondrial; Drug | 1999 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Pres | 1999 |
Clinicians' reaction to positive urine culture for Candida organisms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Attitude of Health Pe | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional S | 1999 |
Hepatosplenic candidiasis after neutropenic phase of acute leukaemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasi | 1999 |
Persistent candidemia in a premature infant treated with fluconazole.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Fungemia; Humans; Infant, Newborn; In | 1999 |
Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial | 1999 |
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
Topics: Amphotericin B; Analysis of Variance; Anidulafungin; Animals; Antifungal Agents; Candida albicans; C | 1999 |
A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cells.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Female; Fluconazole; Injections, | 1999 |
In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
Topics: Antifungal Agents; Benzimidazoles; Candida; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Dr | 1999 |
Cytokines in sepsis due to Candida albicans and in bacterial sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Bacteremia; Candidias | 1999 |
Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Drug Carriers; Fluc | 1999 |
Liposomal amphotericin B for fever and neutropenia.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Drug Carriers; Fluconazole; | 1999 |
Postmortem findings two weeks after oral treatment for metastatic Candida endophthalmitis with fluconazole.
Topics: Administration, Oral; Antifungal Agents; Cadaver; Candidiasis; Endophthalmitis; Fluconazole; Humans; | 1999 |
Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Diagnostic Errors; Drug Resistance, Micro | 1999 |
Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Topics: Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal A | 1999 |
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Synergism; Fluconazole; | 1999 |
Detection of fluconazole-resistant Candida strains by a disc diffusion screening test.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Diffusion; Drug Resistance, Microbial; Fl | 1999 |
Breast pain during lactation that resolved with fluconazole: two case studies.
Topics: Adult; Antifungal Agents; Breast Diseases; Breast Feeding; Candidiasis; Female; Fluconazole; Humans; | 1999 |
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis; | 1999 |
Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Drug Co | 1999 |
Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clotrimazole; Community-Acquired Infections | 1999 |
Case report. Osteomyelitis caused by high resistant Candida guilliermondii.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fingers; Fluconazole; Hand Derm | 1999 |
Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Mac | 2000 |
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bone Marrow Transplantation; Candidiasis; Child; Child, P | 2000 |
Fluconazole use in burns patients.
Topics: Adolescent; Antifungal Agents; Burns; Candidiasis; Female; Fluconazole; Humans | 2000 |
Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.
Topics: Animals; Antibodies, Monoclonal; Antifungal Agents; Antigens, Fungal; Candida albicans; Candidiasis; | 2000 |
[Antimycotic therapy in secondary peritonitis prevents invasive mycosis].
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Mycoses; Peritonitis | 1999 |
Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis.
Topics: Amphotericin B; Antifungal Agents; Ascitic Fluid; Candidiasis; Drug Combinations; Drug Therapy, Comb | 1998 |
Fungal peritonitis in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Fluconazole; Hu | 1998 |
Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.
Topics: Antifungal Agents; Bacterial Infections; Candidiasis; Case-Control Studies; Cohort Studies; Critical | 2000 |
Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis.
Topics: Amphotericin B; Animals; Antibodies, Monoclonal; Antifungal Agents; Candida albicans; Candidiasis; C | 2000 |
Comparative study of agar diffusion test and the NCCLS macrobroth method for in vitro susceptibility testing of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Double-Blind Method; Fluconazole; Humans; Microbial Sensiti | 1999 |
Clonal and spontaneous origins of fluconazole resistance in Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis | 2000 |
Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Cell Membra | 2000 |
[Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Cross | 2000 |
Delay of onset of candidemia and emergence of Candida krusei fungemia in hematologic patients receiving prophylactic fluconazole.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Male; | 2000 |
Case report of three Candida albicans infections detected at delivery.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Delivery, Obstetric; Electr | 2000 |
Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.
Topics: Antifungal Agents; Candidiasis; Double-Blind Method; Fluconazole; Humans; Liver Transplantation; Myc | 2000 |
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Topics: Animals; Candidiasis; Candidiasis, Oral; Child; Colony Count, Microbial; Disease Models, Animal; Dru | 2000 |
Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candida; Candida albicans; Candidiasis; Drug Res | 2000 |
Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candid | 2000 |
Candida parapsilosis chrondritis successfully treated with oral fluconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Cartilage Diseases; Fluconazole; Humans; | 2000 |
Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma.
Topics: Animals; Candida albicans; Candidiasis; Candidiasis, Oral; Disease Models, Animal; Drug Therapy, Com | 2000 |
Candida arthritis in a premature infant treated successfully with oral fluconazole for six months.
Topics: Administration, Oral; Antifungal Agents; Arthritis, Infectious; Candidiasis; Drug Administration Sch | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunoc | 2000 |
Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Ergosterol; Femal | 2000 |
Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Digestive System; Fluconazole; Flu | 2000 |
The final nail.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans | 2000 |
[Factors causing renal failure in patients with disseminated lupus erythematosus: description of three cases].
Topics: Adult; Antifungal Agents; Antiviral Agents; Candidiasis; Female; Fluconazole; Ganciclovir; Herpes Zo | 1999 |
In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Candida albicans; Candidiasis; Dr | 2000 |
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; | 2000 |
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microb | 2000 |
Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.
Topics: Antifungal Agents; APACHE; Bacterial Infections; Candidiasis; Critical Illness; Drug Resistance, Mic | 2000 |
Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Delivery Systems; Endophthalmitis; E | 2000 |
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Comb | 2000 |
Persistently positive cultures and outcome in invasive neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cell Division; Colony Count, Microbial; Female; Fluc | 2000 |
Successful treatment of bilateral renal fungal balls with liposomal amphotericin B and fluconazole in an extremely low birth weight infant.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Infa | 2000 |
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria.
Topics: Administration, Intravaginal; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agen | 2000 |
Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candidiasis; Endocarditis; Fa | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fl | 2000 |
Candida infection of local necrosis in severe acute pancreatitis is associated with increased mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Female; Fluconazole; Hum | 2000 |
Fluconazole-induced convulsions at serum trough concentrations of approximately 80 microg/mL.
Topics: Aged; Antifungal Agents; Candidiasis; Drug Administration Schedule; Female; Fluconazole; Humans; Mal | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; | 2000 |
Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cyclosporine; Disease Models, Animal; Dru | 2000 |
Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Adhesion; Drug Resistance, Microbial | 2000 |
Influence of fluconazole on phagocytosis, oxidative burst and killing activity of human phagocytes. Using a flow cytometric method with whole blood.
Topics: Antifungal Agents; Candidiasis; Flow Cytometry; Fluconazole; Humans; Phagocytes; Phagocytosis; Respi | 2000 |
Candida endocarditis in a premature infant.
Topics: Candida albicans; Candidiasis; Endocarditis; Fatal Outcome; Fluconazole; Humans; Infant, Newborn; In | 2000 |
Fluconazole therapy in neonatal candidemia.
Topics: Antifungal Agents; Candidiasis; Drug Administration Schedule; Female; Fluconazole; Fungemia; Humans; | 2000 |
[Candida endophthalmitis in drug abuse. case report.
Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Fluconazole; Heroin Dependence; Humans; Male | 2000 |
Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Very Low Birt | 2001 |
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Resi | 2001 |
Candida endophthalmitis: an unusual complication of prolonged intravenous access.
Topics: Adolescent; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Equipment Contaminati | 2001 |
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Bone Marrow Transplantation; Candida; Candidiasis; Drug R | 2001 |
Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Acti | 2000 |
Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candida; Candidiasis; D | 2001 |
Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Microbial; Flucona | 2001 |
Candidal abscess in a second primary neoplasm of the neopharynx.
Topics: Antifungal Agents; Candidiasis; Carcinoma, Squamous Cell; Fluconazole; Humans; Male; Middle Aged; Ne | 2000 |
Effect of fluconazole on agar invasion by Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sens | 2001 |
[Invasive Candida infection in surgical patients: a valid clinical entity].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole | 2000 |
SLE, diabetes mellitus and emphysematous infections of the urinary tract.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Diabetes Mellitus, Type 1; Emphysema; Female; Fluc | 2000 |
Candida albicans infection of a prosthetic knee replacement: a case report.
Topics: Antifungal Agents; Candidiasis; Cefuroxime; Cephalosporins; Device Removal; Fluconazole; Humans; Inj | 2000 |
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucy | 2000 |
Chronic systemic (hepatosplenic) candidiasis in a patient with granulocytic sarcoma.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasi | 2000 |
Rapid identification of fluconazole resistance using Chromagar Candida.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Microbial; Fluconazole; Hum | 2000 |
Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Digestive System; Fluconazole; It | 2001 |
Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Util | 2001 |
Candidal endophthalmitis in a renal transplant patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Fe | 2001 |
Laryngeal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Gastroesophageal Reflux; Glottis; Humans | 2001 |
Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Antibiotic Prophylaxis; Antifungal Agents; Antin | 2001 |
Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
Topics: Antifungal Agents; Calibration; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tes | 2001 |
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Culture Media; Echinocandins | 2001 |
Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining with flow cytometry and epifluorescence microscopy.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Flow Cytometry; Fluconazole; Fl | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Flucon | 2000 |
[Candida antigen and antibody kinetics during antifungal therapy in non-neutropenic intensive care patients].
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Fluco | 2000 |
Fluconazole-induced torsade de pointes.
Topics: Aged; Antifungal Agents; Candidiasis; Diverticulitis; Electrocardiography; Female; Fluconazole; Huma | 2001 |
Interstitial lung disease induced by endogenous Candida albicans.
Topics: Antifungal Agents; Antigens, Fungal; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Imm | 2001 |
Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fatal Outcome; Fluconazole; Hum | 2001 |
Disk diffusion method for fluconazole susceptibility testing of Candida albicans strains.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Culture Media; Diffusion; Fluconazole; Humans; Mic | 2001 |
Fungaemia in elderly patients.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fl | 2001 |
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Dru | 2001 |
Concern grows over drug-resistant candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; CD4 Lymphocyte Count; Drug Re | 1998 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifung | 1996 |
Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aged; Antifungal Agents; Candidiasis; Cosyntropi | 2001 |
[Visceral mycotic infections. In clinical practice].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasm | 2001 |
[Fungal infections in intensive care units: a cross-survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucy | 2001 |
Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Echocardiogra | 2001 |
Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
Topics: Adult; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Oral; Carcinoma, Squa | 2001 |
Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Flucytosine; Humans; I | 2001 |
[Endogenous fungal endophthalmitis: results of antifungal treatment with and without vitrectomy].
Topics: Adult; Aged; Aspergillosis; Candidiasis; Combined Modality Therapy; Enophthalmos; Female; Fluconazol | 2001 |
Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood; Candida; Candidiasis; Culture | 2001 |
Standardization of antifungal susceptibility variables for a semiautomated methodology.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dimethyl Sulfoxide | 2001 |
Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies.
Topics: Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis; Drug Prescriptions; Drug Res | 2001 |
Treatment of invasive Candida infection in neonates with congenital cutaneous Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Dermatomycoses; Drug Administration Schedule; Flucon | 2001 |
Candida albicans spinal epidural abscess secondary to prosthetic valve endocarditis.
Topics: Amphotericin B; Candida albicans; Candidiasis; Endocarditis; Epidural Abscess; Female; Fluconazole; | 2001 |
Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Device Removal; Equipm | 2001 |
[Retrospective analysis of fluconazole efficacy in Candida-colonized, non-neutropenic, surgical patients in long-term intensive care].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; APACHE; Candidiasis; Critical Care; F | 2001 |
Candida sepsis following transcervical chorionic villi sampling.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Chorionic Villi Sampling; Diagnosis, Differ | 2001 |
Successful treatment of hepatosplenic candidiasis in an elderly patient with acute myeloid leukemia using liposomal daunorubicin and fluconazole.
Topics: Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents; Candidiasis; Daunorubicin; Di | 2001 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North | 2001 |
Candida albicans prosthetic arthritis treated with fluconazole alone.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Arthritis, Infectious; Candida albicans; Candidiasis; Fe | 2001 |
Drug sensitivity of Candida yeast isolated from patients with allergic diseases.
Topics: Antifungal Agents; Candicidin; Candida; Candidiasis; Clotrimazole; Fluconazole; Humans; Hypersensiti | 2001 |
Use of fluconazole in newborn infants with systemic candidiasis.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Male; Retros | 2001 |
Clinicopathological report of Candida granuloma from an endogenous candidal endophthalmitis.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Female; Fluconazole; Granuloma; Humans; Middle Aged | 2001 |
Fluconazole and Candida krusei fungemia.
Topics: Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Italy; Opportunistic Infections | 2001 |
Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Fungemia; Humans; In | 2001 |
Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment.
Topics: Adult; Antifungal Agents; Breast Diseases; Breast Feeding; Candidiasis; Candidiasis, Oral; Female; F | 2001 |
Oral hypoglycemics and azoles: an important drug interaction.
Topics: Antifungal Agents; Candidiasis; Diabetes Mellitus; Drug Interactions; Female; Fluconazole; Glyburide | 2001 |
Successfully treated renal fungal ball with continuous irrigation of fluconazole.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Kidney Diseases; Male; Middle Aged; Radiography | 2001 |
Resistant mechanisms of Candida albicans to fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistanc | 1999 |
Epididymitis caused by Candida glabrata: a novel infection in diabetic patients?
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Diabetes Mellitus, Type 2; Epididymitis; Fl | 2001 |
Breakthrough candidaemias during empirical therapy with fluconazole in non-cancer and non-HIV adults caused by in vitro-susceptible Candida spp.: report of 33 cases.
Topics: Adult; Analysis of Variance; Antifungal Agents; Candida; Candidiasis; Fluconazole; Fungemia; Humans; | 2001 |
Successful treatment of chronic disseminated candidiasis with fluconazole and a granulocyte-macrophage colony-stimulating factor combination.
Topics: Adult; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Granulocyte-M | 2001 |
Bilateral endogenous Candida endophthalmitis after induced abortion.
Topics: Abortion, Induced; Adult; Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infec | 2001 |
Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and -sensitive strains of Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; DNA, Fungal | 2001 |
Case report. Hepatic abscesses due to Aspergillus terreus in an immunodeficient child.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candida; Candidiasis; Drug Therapy, Co | 2001 |
Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole).
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Itraconazole; M | 2001 |
Hamycin therapy of murine disseminated candidiasis: efficacy and interaction with fluconazole.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Interactions; Fluconazole; Male; Mice; Mice, Inbred BA | 2001 |
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Topics: Adolescent; Adult; Antifungal Agents; Bacteremia; Bone Marrow Transplantation; Candida; Candidiasis; | 2001 |
Intraocular hemorrhages due to warfarin fluconazole drug interaction in a patient with presumed Candida endophthalmitis.
Topics: Adult; Anticoagulants; Antifungal Agents; Candidiasis; Choroid Hemorrhage; Drug Interactions; Endoph | 2002 |
Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.
Topics: Antifungal Agents; Biofilms; Bioprosthesis; Candida; Candida albicans; Candidiasis; Drug Resistance, | 2002 |
Candida dubliniensis candidaemia in an HIV-positive patient in Ireland.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Fatal Outcome; Fluconazole; Fungemia; H | 2002 |
Effects of fluconazole on viable cell count in experimental intraperitoneal Candida abscesses.
Topics: Abdominal Abscess; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Mi | 2000 |
"In vitro" antifungal activity of protease inhibitors.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Candid | 2001 |
Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Incidence; | 2002 |
Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Base Sequence; Candida; Candidiasis; DNA F | 2002 |
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
Topics: Amphotericin B; Antifungal Agents; APACHE; Bone Marrow Transplantation; Candida albicans; Candidiasi | 2002 |
Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Autopsy; Candidiasis; | 2002 |
[Candidemia in elderly people: apropos of 4 cases].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Frail Elderly | 2002 |
Candida albicans endocarditis diagnosed by PCR-based molecular assay in a critically ill pediatric patient.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Child, Preschool; Critical Illness; Down Syndrome; | 2002 |
Candida endophthalmitis after tattooing in an asplenic patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye Infect | 2002 |
Risk factors for breakthrough candidemia.
Topics: Amphotericin B; Anti-Bacterial Agents; Candidiasis; Fluconazole; Fungemia; Humans; Multivariate Anal | 2002 |
Prophylaxis with oral fluconazole and an oral solution of amphotericin B in liver transplant patients.
Topics: Administration, Oral; Amphotericin B; Candidiasis; Female; Fluconazole; Humans; Liver Transplantatio | 2002 |
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Female; Fl | 2002 |
Candida dubliniensis infection, Singapore.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fatal Outcome; Female; Fluconazole; Humans; | 2002 |
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Candidiasis; Diagnosis, Differential; Fluconazole; Hu | 2002 |
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Fluconazole; Head and Neck Neoplasms; Humans; Male; | 2002 |
Antifungal chemoprophylaxis after blood and marrow transplantation.
Topics: Antifungal Agents; Bone Marrow Transplantation; Candida; Candidiasis; Chemoprevention; Fluconazole; | 2002 |
Nosocomial candidemia in a tertiary care hospital in Saudi Arabia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Funge | 2002 |
Voriconazole and fluconazole susceptibility of Candida isolates.
Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazo | 2002 |
[Mycotic endophthalmitis: management and treatment (9 year study)].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Combined Modality | 2002 |
Rapid identification of fluconazole resistance using Chrom agar Candida.
Topics: Agar; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbi | 2001 |
Fluconazole for postpartum candidal mastitis and infant thrush.
Topics: Adult; Antifungal Agents; Candidiasis; Candidiasis, Oral; Female; Fluconazole; Humans; Infant, Newbo | 2002 |
[Candida meningitis after a liver puncture biopsy].
Topics: Adult; Antifungal Agents; Biopsy, Needle; Candida albicans; Candidiasis; Fluconazole; Humans; Liver; | 2002 |
[Antifungal agents can change the balance between resistant and susceptible Candida species].
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hum | 2002 |
[Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Fluconazole; Growth Inhibitor | 2002 |
Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Topics: Aged; Aged, 80 and over; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Endocardi | 2002 |
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Esophageal Disea | 1992 |
Fluconazole antifungal agent.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Child, Preschool; Drug Interactions; Flucona | 1992 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; H | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Fluconazole failure in a child with burns and candidemia.
Topics: Amphotericin B; Burns; Candidiasis; Fluconazole; Humans; Infant; Male | 1992 |
Successful second allogeneic bone marrow transplantation in a relapsed acute myeloid leukemia patient with fungal liver abscess.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candidiasis; Drug Therapy, Combination; Female; | 1992 |
Failure of fluconazole in systemic candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Female; Fluconazole; Fungemia; Humans | 1992 |
Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.
Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Candidiasis; Child; Child, Preschool; Fluconazole; | 1992 |
Fluconazole pharmacokinetics in the cerebrospinal fluid of a child with Candida tropicalis meningitis.
Topics: Candidiasis; Child, Preschool; Female; Fluconazole; Humans; Meningitis, Fungal; Ventriculoperitoneal | 1992 |
Fluconazole in the treatment of candida albicans endophthalmitis.
Topics: Adult; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans | 1992 |
Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice.
Topics: Animals; Candidiasis; Female; Fluconazole; Interleukin-1; Kidney; Leukocyte Count; Liver; Mice; Neut | 1992 |
Biliary concentrations of fluconazole in a patient with candidal cholecystitis: case report.
Topics: Aged; Bile; Candidiasis; Cholecystitis; Cholecystostomy; Fluconazole; Humans; Injections, Intravenou | 1992 |
Acute renal failure in a neonate due to pelviureteric candidal bezoars successfully treated with long-term systemic fluconazole.
Topics: Acute Kidney Injury; Adult; Bezoars; Candidiasis; Female; Fluconazole; Humans; Infant, Newborn; Kidn | 1992 |
Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis.
Topics: Candida; Candida albicans; Candidiasis; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole | 1992 |
Successful use of fluconazole for treatment of urinary tract fungal infections.
Topics: Aged; Aged, 80 and over; Candidiasis; Fluconazole; Humans; Male; Middle Aged; Remission Induction; U | 1992 |
Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
Topics: Biopsy; Candidiasis; Candidiasis, Oral; CD4-CD8 Ratio; Drug Administration Schedule; Esophagitis; Es | 1992 |
Candidal mitral endocarditis and long-term treatment with fluconazole in a patient with human immunodeficiency virus infection.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; HIV Infections; Humans | 1992 |
The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Echinocandins; Female; Fluconazole; Injections, Intra | 1992 |
Candida albicans septicemia in a premature infant successfully treated with oral fluconazole.
Topics: Administration, Oral; Candidiasis; Fluconazole; Humans; Infant, Newborn; Male | 1992 |
Fluconazole in the treatment of fungal infections in kidney-transplanted patients.
Topics: Candidiasis; Fluconazole; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; | 1992 |
Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
Topics: AIDS-Related Opportunistic Infections; Animals; Candida albicans; Candidiasis; Candidiasis, Oral; Cr | 1992 |
[Countermeasure for infections with granulocytopenia].
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Candidiasis; Cephalosporins; Drug Therapy, | 1992 |
Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infection.
Topics: Candidiasis; Female; Fluconazole; Humans; Hydrocephalus; Infant, Newborn; Infant, Premature, Disease | 1992 |
[Candida endophthalmitis. Is fluconazole treatment adequate?].
Topics: Aged; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans | 1992 |
Prophylactic fluconazole and Candida krusei infection.
Topics: Candidiasis; Fluconazole; Humans | 1992 |
Prophylactic fluconazole and Candida krusei infection.
Topics: Candidiasis; Fluconazole; Humans | 1992 |
Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Fluconazole; Follow-Up Studies | 1992 |
Fluconazole treatment in Torulopsis glabrata upper urinary tract infection causing ureteral obstruction.
Topics: Candidiasis; Female; Fluconazole; Humans; Middle Aged; Ureteral Diseases; Ureteral Obstruction | 1992 |
Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis.
Topics: Adult; Antibodies, Fungal; Antigens, Fungal; Candida albicans; Candidiasis; DNA Fingerprinting; DNA, | 1992 |
[Efficacy of fluconazole treatment of candidal endophthalmitis in two heroin addicts].
Topics: Adult; Candidiasis; Endophthalmitis; Female; Fluconazole; Heroin Dependence; Humans; Male | 1992 |
Treatment of candidemia in critically ill surgical patients with intravenous fluconazole.
Topics: Adolescent; Aged; Candidiasis; Cross Infection; Female; Fluconazole; Fungemia; Humans; Injections, I | 1992 |
[Isolated Candida albicans meningitis after treatment of B lymphoma].
Topics: Abdominal Neoplasms; Adolescent; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Can | 1992 |
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Precl | 1992 |
Successful treatment of recurrent hepatic Candida infection with fluconazole after chemotherapy for acute leukemia: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Fluconazole; Fungemia; H | 1992 |
Fluconazole: a position statement by the Society of Infectious Diseases Pharmacists.
Topics: Amphotericin B; Candidiasis; Drug Interactions; Fluconazole; Flucytosine; Humans; Meningitis, Crypto | 1992 |
Fluconazole therapy in a child with Candida tropicalis fungemia.
Topics: Amphotericin B; Candidiasis; Child, Preschool; Fluconazole; Fungemia; Humans; Male; Risk Factors | 1992 |
Treatment of candida epididymo-orchitis with oral fluconazole.
Topics: Administration, Oral; Aged; Candidiasis; Epididymitis; Fluconazole; Humans; Male; Orchitis; Postoper | 1992 |
Chronic systemic candidiasis in acute leukemia.
Topics: Adolescent; Aged; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Child | 1992 |
[A case of Candida albicans endocarditis with impaired lung function].
Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Lung Diseases; Male; Middle | 1992 |
[Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Drug Administration Schedule; Esophageal Dis | 1992 |
Study of suppressive effect of intravenous fluconazole on endogenous Candida endophthalmitis in rabbits.
Topics: Animals; Candida albicans; Candidiasis; Chorioretinitis; Colony Count, Microbial; Endophthalmitis; E | 1992 |
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candidiasis; Drug Therapy, Combination; Fluconaz | 1991 |
Fluconazole or amphotericin for candidosis in neutropenic patients.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Fluconazole; Humans; In Vitro Techniques; Neutropenia | 1991 |
Prophylactic oral fluconazole and candida fungaemia.
Topics: Administration, Oral; Adult; Candida; Candidiasis; Drug Administration Schedule; Fluconazole; Humans | 1991 |
Fluconazole or amphotericin for candidaemia in non-neutropenic patients?
Topics: Adult; Amphotericin B; Candidiasis; Fluconazole; Humans; Male; Neutropenia | 1991 |
Fluconazole and Candida krusei infections.
Topics: Acute Disease; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Fungemia; Humans; Leuke | 1991 |
Fluconazole in the treatment of hepatosplenic candidiasis.
Topics: Candidiasis; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Liver Diseases; | 1992 |
Intraperitoneal and intravenous fluconazole pharmokinetics in a pediatric patient with end stage renal disease.
Topics: Candidiasis; Female; Fluconazole; Humans; Infant; Infusions, Intravenous; Kidney Failure, Chronic; P | 1992 |
Pharmacokinetics of 18F-labeled fluconazole in rabbits with candidal infections studied with positron emission tomography.
Topics: Animals; Candidiasis; Drug Stability; Fluconazole; Fluorine Radioisotopes; Male; Models, Biological; | 1991 |
[Endogenous candida endophthalmitis: a new therapy].
Topics: Adult; Candidiasis; Colitis, Ulcerative; Colonic Polyps; Drug Administration Schedule; Endophthalmit | 1991 |
Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Culture Media; Fluconazole; In Vitro Techniq | 1991 |
Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis.
Topics: Amphotericin B; Animals; Candidiasis; Endocarditis, Bacterial; Female; Fluconazole; Half-Life; Injec | 1991 |
[Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Esophagitis; Female; Fluconazole; Flucytosin | 1991 |
[Resistance to fluconazole in hospitalized patients. Concordance between Candida albicans resistance in vitro and therapeutic failure].
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; | 1991 |
[The echographic diagnosis of Candida albicans cystitis in childhood].
Topics: Candidiasis; Child; Cystitis; Dysgerminoma; Female; Fluconazole; Humans; Opportunistic Infections; S | 1991 |
Hepatosplenic candidiasis: successful treatment with fluconazole.
Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Candidiasis; Child; Child, Preschool; Fluconazole; | 1991 |
Fluconazole therapy of candidal native valve endocarditis.
Topics: Candidiasis; Endocarditis; Fluconazole; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1991 |
[In vivo and in vitro antifungal activity of fluconazole].
Topics: Animals; Aspergillus; Candida albicans; Candidiasis; Cryptococcus; Drug Resistance, Microbial; Fluco | 1991 |
[Laboratory's controls of antifungal treatment by the fluconazole of the candidiasis in immunocompromised patients].
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; | 1991 |
Fluconazole and Candida krusei fungemia.
Topics: Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans | 1991 |
Fluconazole in neonatal disseminated candidiasis.
Topics: Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases | 1991 |
Fluconazole failure in the treatment of invasive mycoses.
Topics: Amphotericin B; Candidiasis; Coccidioidomycosis; Fluconazole; Humans; Male; Middle Aged; Tomography, | 1991 |
Amphotericin-resistant invasive hepatosplenic candidiasis controlled by fluconazole.
Topics: Adult; Amphotericin B; Candida albicans; Candidiasis; Drug Administration Schedule; Drug Resistance; | 1990 |
Successfully treated candida sinusitis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Empyema, Subdural; Ethmoid Sinusitis; Flucon | 1990 |
Fluconazole-induced jaundice.
Topics: Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazole; HIV Seropositivity; Humans; Jau | 1990 |
Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis.
Topics: Adult; Candidiasis; Enterocolitis; Fluconazole; Humans; Leukemia, Monocytic, Acute; Male; Neutropeni | 1991 |
Fluconazole treatment without catheter removal in Candida albicans peritonitis complicating peritoneal dialysis.
Topics: Adult; Candidiasis; Catheterization, Peripheral; Catheters, Indwelling; Fluconazole; Humans; Male; P | 1991 |
[Amphotericin B resistant severe hepato-splenic candidiasis, responding to fluconazole, in a patient following bone marrow transplantation].
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candidiasis; Female; Fluconazole; Humans; Leukem | 1991 |
Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits.
Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Kidney | 1991 |
Fluconazole in the treatment of candidiasis in immunocompromised children.
Topics: Adolescent; Candidiasis; Child; Child, Preschool; Fluconazole; Humans; Immunologic Deficiency Syndro | 1991 |
Failure of fluconazole therapy in Candida krusei fungemia.
Topics: Aged; Candidiasis; Female; Fluconazole; Humans | 1991 |
Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients.
Topics: Adult; Candidiasis; Cryptococcosis; Female; Fluconazole; Humans; Immunosuppression Therapy; Kidney T | 1990 |
[The suppressive effect of intravenous fluconazole against endogenous candida endophthalmitis in rabbits].
Topics: Animals; Candidiasis; Drug Evaluation; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; | 1990 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucy | 1990 |
Orally administered antifungal therapy for experimental keratomycosis.
Topics: Administration, Oral; Animals; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; | 1990 |
Single-dose fluconazole in the treatment of Candida albicans balanoposthitis.
Topics: Administration, Oral; Balanitis; Candidiasis; Drug Tolerance; Fluconazole; Humans; Male; Pilot Proje | 1990 |
[Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases].
Topics: Adult; Candidiasis; Esophagitis; Female; Fluconazole; HIV Infections; Humans; Male; Prospective Stud | 1990 |
[Meningitis caused by Candida albicans in a patient with AIDS. Treatment with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Fluconazole; Humans; Male; Meningitis | 1990 |
[Prophylaxis and therapy of fungal infections with fluconazole in patients after bone marrow transplantation].
Topics: Adult; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Female; Fluconazole; Humans; Male; M | 1990 |
[Systemic candidiasis in patients after kidney and heart transplantation].
Topics: Adult; Candidiasis; Cross Infection; Fluconazole; Heart Transplantation; Humans; Kidney Transplantat | 1990 |
[The therapy of Candida esophagitis in AIDS patients with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Esophagitis; Esophagoscopy; Fluconazole; Humans; Op | 1990 |
[Systemic candidiasis in intensive care patients after antibiotic therapy].
Topics: Anti-Bacterial Agents; Candidiasis; Fluconazole; Humans; Intensive Care Units; Opportunistic Infecti | 1990 |
Successful treatment of fungal peritonitis in CAPD using oral fluconazole.
Topics: Administration, Oral; Candidiasis; Fluconazole; Humans; Mycoses; Peritoneal Dialysis, Continuous Amb | 1990 |
Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
Topics: Acute Disease; Agranulocytosis; Amphotericin B; Animals; Candidiasis; Chronic Disease; Disease Model | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Crypto | 1990 |
Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor.
Topics: Adult; Candidiasis; Colony-Stimulating Factors; Drug Therapy, Combination; Endocarditis; Fluconazole | 1990 |
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
Topics: Agranulocytosis; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans | 1990 |
Fluconazole concentration in joint fluid during successful treatment of Candida albicans septic arthritis.
Topics: Aged; Arthritis, Infectious; Body Fluids; Candidiasis; Fluconazole; Humans; Joints; Male | 1990 |
Single-dose therapy for esophageal candidiasis with fluconazole.
Topics: Administration, Oral; Adult; Candidiasis; Esophageal Diseases; Female; Fluconazole; HIV Infections; | 1990 |
Topical fluconazole for experimental candida keratitis in rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Biological Availability; Candidiasis; Cornea; Fluco | 1990 |
[Candida albicans cubital tenosynovitis. Apropos of a case with lymphocytic synovial fluid and outpatient treatment using a new antifungal agent, fluconazole].
Topics: Ambulatory Care; Candidiasis; Elbow Joint; Fluconazole; Humans; Male; Middle Aged; Tenosynovitis | 1990 |
Treatment of fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Candidiasis; Catheters, Indwelling; Fluconazole; Humans; Peritoneal Dialysis, Continuous Ambulatory; | 1990 |
Oral fluconazole for treatment of disseminated fungal infection.
Topics: Administration, Oral; Candidiasis; Child; Female; Fluconazole; Humans; Triazoles | 1989 |
Treatment of systemic yeast infection with fluconazole.
Topics: Candidiasis; Fluconazole; Humans; Triazoles | 1989 |
[Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolera | 1989 |
[Clinical evaluation of fluconazole in patients with mycotic infection].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidia | 1989 |
[Experience of fluconazole in pediatric patients].
Topics: Administration, Oral; Adolescent; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; | 1989 |
[Clinical efficacy of fluconazole in urinary tract fungal infections].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Drug Evaluatio | 1989 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Funga | 1989 |
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Dr | 1989 |
[Fluconazole treatment of systemic mycoses].
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; | 1989 |
[AIDS fungus infections. Fluconazole--a new preparation in development].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazol | 1989 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconaz | 1989 |
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent.
Topics: Adult; Antifungal Agents; Candidiasis; Dialysis Solutions; Female; Fluconazole; Humans; Male; Middle | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Di | 1989 |
Fluconazole treatment of Candida glabrata peritonitis.
Topics: Adult; Candida; Candidiasis; Female; Fluconazole; Humans; Peritonitis; Triazoles | 1989 |
Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Diabetes Mellitus, Experimental; Fluconazol | 1989 |
[Value of fluconazole in the treatment of systemic yeast infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Candidiasis; Cryptococcosis; Female; Fluconazole; H | 1989 |
Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Colony Count, Microbial; Fluconazole; Male; Microbial | 1989 |
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; | 1989 |
Fluconazole therapy in an underweight infant.
Topics: Body Weight; Candidiasis; Female; Fluconazole; Humans; Infant; Nutrition Disorders | 1989 |
Fluconazole found effective against candidiasis.
Topics: Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Oropharynx; Pharyngeal Diseases | 1989 |
Fluconazole in renal candidosis.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Kidney Diseases; Male; Middle Aged; Triazoles | 1989 |
Fluconazole and candidosis.
Topics: Adult; Antifungal Agents; Candidiasis; Fluconazole; Heart Transplantation; Humans; Immune Tolerance; | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1987 |
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; | 1988 |
Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients.
Topics: Adult; Aged; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Fluconazole; HIV Seropositivi | 1988 |
Fluconazole in the treatment of candidal prosthetic valve endocarditis.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Mitral Valve; | 1988 |
Use of fluconazole in a patient with documented malabsorption of ketoconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fem | 1988 |
Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Fluconazole | 1988 |
Fluconazole resistance in Candida glabrata.
Topics: Antifungal Agents; Bile; Candida; Candidiasis; Candidiasis, Vulvovaginal; Drug Resistance, Microbial | 1988 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; | 1985 |
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Inte | 1985 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immu | 1986 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous | 1986 |
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraco | 1987 |